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ABSTRACT 
Dicationic palladium(II) complexes have been shown to catalyse a number of important 
asymmetric transformations including Michael, Mannich and aldol reactions. This PhD 
thesis describes work undertaken to discover and develop novel applications of 
dicationic palladium(II) complexes in asymmetric catalysis. The introductory chapter 
outlines the advances in catalytic asymmetric α-functionlisation of β-ketoesters. This 
includes both metal-catalysed and organocatalytic processes with reference to C-C, C-X 
(X = F, Cl, Br), C-N, C-O and C-S bond forming reactions.  
 
Chapter 2 discusses the work towards the synthesis of β-amino acids via Michael 
reactions catalysed by Pd(II) complexes. These reactions failed to proceed with good 
enantioselectivities, leading to the investigation of a number of related transformations.  
 
In the following Chapter the reaction of β-ketoesters with oxaziridines to generate α-
hydroxy-β-ketoesters was discovered. Extensive screening of reaction parameters led to 
the identification of dimethyldioxirane (DMD) as a superior oxidant for this reaction, 
providing ee’s of up to 98%. Examining a range of substrates revealed several key 
structural elements required for both reactivity and enantioselectivity.  
 
Determination of the absolute stereochemistry of the products revealed opposite facial 
selectivity to that reported in a number of related reactions. Chapter 4 discusses the 
results of DFT calculations undertaken by a colleague (Prof H. S. Rzepa), to identify the 
origins of stereoselectivity in the Pd(II) mediated α-hydroxylation of β-ketoesters with 
DMD.  
 
Chapter 5 discusses the investigation of carboxylated pyrrolidinones and succinimides 
as substrates in the hydroxylation reaction. Successful α-hydroxylation provided access 
to 3 classes of synthetically useful hydroxylated N-heterocyclic products with high 
optical purity, and brief synthetic studies directed towards the natural product 
Pramanicin were undertaken. The last Chapter contains experimental procedures and 
characterisation data of all the compounds synthesised during the course of this project. 
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Chapter 1: Introduction 
1.1. Catalytic Asymmetric α-Functionalisation of β-Ketoesters  
 
Scheme 1. α-Functionalisation of β-ketoesters. 
The reaction of an α-substituted β-ketoester (1-1) with an electrophile introduces a 
quarternary chiral centre at the α-carbon (1-2, Scheme 1). The reaction proceeds via the 
achiral intermediate enolate 1-3, hence chirality in the starting material (1-1) is not 
transferred to the product (1-2).  
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Scheme 2. Asymmetric synthesis of Daunomycin. 
The introduction of a new stereogenic centre in this reaction makes it amenable to the 
development of asymmetric methodologies. Successes in this area have resulted in the 
availability of a wide range of products of type 1-2 with synthetically useful levels of 
optical purity. The significance of this field of chemistry is demonstrated by a number 
of complex targets that have been synthesised, with chirality introduced via β-ketoester 
1-1 1-2 
1-3 
1-4 1-6 
1-7 
1-5 
1-6 
2 
functionalisation. Examples include Davis and co-workers’ formal synthesis of the 
naturally occurring chemotherapeutic agent Daunomycin (1-7, Scheme 2). α-
Hydroxylation of 1-4 was achieved in >95% ee employing a stoichiometric amount of a 
chiral oxaziridine reagent (1-5).1  
 
Another example is Deng and co-workers’ approach to (+)-Tanikolide (1-11) via an 
asymmetric Michael reaction (Scheme 3). This differs from the above example as 
asymmetry is induced catalytically by the organocatayst 1-9, as opposed to employing a 
chiral reactant or reagent. Conversion of 1-8 to 1-10 was achieved with complete 
stereocontrol and the target molecule was acquired in 7 steps from 1-8 with an overall 
yield of 41%.2 
 
 
Scheme 3. Asymmetric synthesis of Tanikolide. 
This chapter will cover major advances in catalytic methods available for 
functionalising β-ketoesters asymmetrically. Thus non-catalytic methods including the 
use of chiral auxiliaries (eg. 2-phenylcyclohexanol)3,4 and chiral reagents (eg. Davis’ 
reagent, N-fluorosultams)5-7 will not be included. Also, this review will focus on 
methods involving the activation of β-ketoesters as nucleophiles. This excludes the field 
of asymmetric allylic substitution chemistry, which proceeds via electrophile activation. 
This reaction, pioneered by Trost,8 was first applied to β-ketoesters in 1997 (Scheme 4)9 
and has subsequently been investigated by many other groups.10-19 
1-8 
1-9 
1-10 
1-11 
1-10 
3 
 
Scheme 4. Asymmetric allylation of β-ketoesters. 
Outside the field of Pd-allyl chemistry, electrophile activation is rare in asymmetric 
chemistry of β-ketoesters, including just a few applications of proline catalysis,20,21 and 
one example of transition metal catalysis.22 
1.1.1. Lewis Acid-Catalysed Methods 
The use of chiral Lewis acid catalysis in β-ketoester functionalisation has been applied 
to C-C, C-X, C-N, C-S and C-O bond forming reactions. Mechanistically, the majority 
of these systems take advantage of a favourable chelation of the 1,3-dicarbonyl moiety 
of the β-ketoester with the Lewis acid, forming chiral, nucleophilic enolates (1-12, 
Scheme 5). Often the addition of a base is not required, with the deprotonation of 1-1 
occurring under equilibrium conditions.  
 
Scheme 5. Chiral Lewis acid-catalysed β-ketoester functionalisation. 
1.1.1.1. Michael Reactions 
The Michael reaction involves 1,4-conjugate addition of an enolate to an α,β-
unsaturated carbonyl compound (Scheme 6). It is the most widely investigated area of 
asymmetric β-ketoester functionalisation reactions and can lead to a structurally diverse 
range of products (1-14). Depending on the choice of reaction partners, a stereogenic 
centre can be formed at either the α- or β-carbon of the product. Prochiral β-ketoesters 
(1-1, R2 ≠ H) lead to formation of a non-racemisable chiral centre at the α-carbon, 
whereas Michael adducts of unsubstituted β-ketoesters (1-14, R2 = H) rapidly 
[η3-C3H5PdCl]2 
1-12 1-1 1-2 
4 
tautomerise in solution. Employing prochiral enones (1-13, R5 ≠ H) results in products 
with chirality at the β-position. 
 
Scheme 6. Asymmetric Michael reactions. 
The first Lewis acid-catalysed Michael reaction was published by Brunner and co-
workers in 1984 where the reaction of methyl indanone carboxylate (1-15) with methyl 
vinyl ketone (1-16), was reported to proceed in 66% ee (Scheme 7). The reaction is 
catalysed by a complex generated in situ from the chiral diamine 1-17 and Co(acac)2. 
However chiral induction was only observable at low temperature leading to a long 
reaction time, and could not be extended to other substrates.23  
 
Scheme 7. Cobalt catalysed asymmetric Michael reaction. 
The next major advancement in the area of β-ketoester functionalisation was made in 
1994 with the introduction of BINOL-lanthanum catalysts by Shibasaki and co-workers. 
The first reported the isolation of a ketoester enolate, which was then used as a catalyst 
(1-18, Scheme 8). Only one β-ketoester substrate was tested in asymmetric Michael 
reactions, giving 1-19 in 86% yield and 62% ee.24  
 
 
Scheme 8. Synthesis and Michael reactions of catalyst (S)-1-18. 
(S)-1-18 
1-16 1-15 
1-17 
1-14 
1-1 
(1-13) 
1-18 (10 mol%) 
1-19 
5 
A second generation catalyst developed by Shibasaki and co-workers that applies more 
generally to β-ketoesters is lanthanum-sodium-BINOL (LSB, 1-20, Scheme 9). Various 
β-ketoesters reacted with methyl vinyl ketone at -50 °C in the presence of 1-20, and 
gave products 1-21 with yields of 73-98% and ees of 62-91%. In addition, α,β-
unsaturated esters could be used as acceptors if the temperature was raised to room 
temperature, giving enantioselectivities of up to 89%. This catalyst is said to be 
multifunctional as NMR studies suggested the Michael acceptor binds to the lanthanum 
while the donor forms a catalyst-bound sodium enolate (1-22).25,26 
 
 
   
Scheme 9. Michael reactions catalysed by 1-20. 
Later, efforts were made to develop air-stable alternatives to 1-18 and 1-20, leading to 
the synthesis of the linked-BINOL ligand (1-23, Scheme 10). This was mixed in 1:1 
ratio with La(OiPr)3 and the resulting solution concentrated to give catalyst 1-24.27  
 
           
Scheme 10. Synthesis of air stable lanthanum catalyst (R,R)-1-24. 
(R)-1-20 1-22 
(R)-1-20 (5 mol%) 
(R,R)-1-23 
(R,R)-1-24 
1-21 
6 
 
Table 1 compares results obtained with catalysts 1-18, 1-20 and 1-24. In studies using 1-
18 and 1-24, reaction of only one β-ketoester substrate was reported (entries 1 and 2), 
with moderate enantioselectivities observed. Both these catalysts however gave 
excellent results in the reaction of malonates with prochiral enones (entry 3). This 
indicates these catalysts can invoke excellent stereoselectivity at the β-carbon but not at 
the α-carbon. Conversely, catalyst 1-20 gave high enantioselectivity in all cases, 
achieving a high level of stereoselectivity at both the α- and β-position.  
 
Table 1. Comparison of catalysts 1-19, 1-22 and 1-25. 
Entry Donor Acceptor Product 
Catalyst 
1-18 1-20 1-24 
1 
  
 
86% 
yield 
62% ee 
93% 
yield 
83% ee 
- 
2 
  
 
- 
85% 
yield 
93% ee 
97% 
yield 
75% ee 
3 
 
 
BnO
O
OBn
O
O
*
94% 
yield 
92% ee 
97% 
yield 
88% ee 
98% 
yield 
>99% ee
 
Investigating the structure of the linker region of ligand 1-23 allowed further tuning of 
the system. Varying the length of the carbon chain and choice of donor atom led to the 
identification of superior ligands 1-25 and 1-26 (Scheme 11). Catalysts 1-27 were 
isolated in a procedure analogous to that for catalyst 1-24, and showed improved results 
in reactions that employ α-unsubstituted β-ketoesters (1-28).28 Precise structures of 
these catalysts (1-24 and 1-27) are unknown as NMR and MS spectra of these La-
linked-BINOL complexes suggest the presence of a number of species in solution.  
7 
    
 
Scheme 11. Synthesis and Michael reactions of catalysts (S,S)-1-28. 
However these catalysts (1-27) were unsuccessful in combination with α-substituted β-
ketoesters (1-29). High yields and enantioselectivities were only achieved when ligand 
1-26 (R=Et) was employed, and the catalyst generated in-situ, with a ligand:metal ratio 
of 2:1 (Scheme 12). In this system, only moderate diastereoselectivities were reported. 
As was observed with catalysts 1-18 and 1-24, high levels of stereoselectivity were 
associated with the stereogenic centre at the β-carbon for products 1-30.29  
 
Scheme 12. Michael reactions with ligand (S,S)-1-26. 
Another catalyst capable of generating quarternary centres in high ees is that generated 
from Ni(OAc)2 and (R,R)-trans-1,2-diaminocyclohexane, reported by Christoffers and 
co-workers in 2000 (Scheme 13). Although ees of up to 91% were achieved, this was 
attained with only one substrate (1-31) and the 74% ee achieved for the product 1-32 
corresponds to the opposite enantiomer. The reaction was believed to proceed via the 
formation of an enamine between the diamine and ketoester, capable of coordinating to 
the nickel centre as a tridentate ligand (1-33). Coordination of the enone to the metal 
(S,S)-1-25 
 
(S,S)-1-25 (n = 1) 
(S,S)-1-26 (n = 2) 
(S,S)-1-27 (10 mol%) 
 
1-29 
 
(S,S)-1-27 
 
(S,S)-1-26 (10 mol%) 
La(OiPr)3 (5 mol%) 
 
1-28 
 
1-30 
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centre is also proposed for the transition state, which would make this a bifunctional 
catalyst with an unusual mode of action.30 
 
Scheme 13. Nickel catalysed Michael reactions. 
The next major development in this area was made in 2002 with the report of dicationic 
palladium complexes by Sodeoka and co-workers (1-34, Scheme 14). These air- and 
moisture-stable compounds can catalyse Michael additions of a broad range of tert-
butyl β-ketoesters to enones with consistently high yields and selectivities, although 
reactions are often slow.31,32  
 
 
           
Scheme 14. Palladium-catalysed Michael reactions. 
Selected results shown in Table 2 demonstrate a dependence on the presence of a bulky 
ester substituent on the substrate for good selectivity (entries 1 and 2 vs entry 3). 
Another general trend observed was that cyclic substrates reacted faster than acyclic 
substrates (entry 4). Investigations with prochiral enones showed that a moderate level 
of diastereoselectivity can be achieved (entries 5 and 6). 
1-34a (X = TfO, Ar = Tol) 
1-34b (X = PF6, Ar = Ph) 
1-34c (X = TfO, Ar = Ph) 
1-31 
 
1-32 
 1-33 
 
1-34a/c (5-10 mol%) 
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Table 2. Michael reactions catalysed by 1-34a/c. 
Entry Donor Acceptor Catalyst
Time 
(h) 
Temp
(° C) 
Yield 
(%) 
ee (dr) 
(%) 
1a 
  
1-34a 24 -20 83 25 
2a 
  
1-34a 24 -20 90 38 
3 
  
1-34a 24 -20 92 92 
4 
  
1-34c 72 0 88 90 
5 
  
1-34c 24 -20 89 99 (8/1) 
6b 
 
1-34c 30 0 90 99 (3.8/1) 
aCH2Cl2 solvent. bMeOH added upon completion of reaction and product isolated as 
dimethylacetal. 
 
Further investigations showed that these reactions can be carried out in ionic liquids 
with only a small loss of selectivity, facilitating reuse of the catalyst. At the end of the 
reaction, product was extracted with Et2O while the catalyst remained immobilised in 
[hmim][BF4]; no drop in ee was observed over 5 cycles.33  
 
These reactions are assumed to proceed via the chiral Pd-enolate 1-35, the formation of 
which generates one equivalent of acid concomitantly (Scheme 15).  However, this 
species was not observable by NMR, as it exists in a disfavourable equilibrium with 1-
34. 
 
Scheme 15. Formation of chiral palladium enolates from 1-34. 
Catalysts 1-34 were modified by reaction with a base (NaOH) or molecular sieves (4 
Å), to generate dimeric complexes with bridging hydroxyl groups (1-36, Scheme 16). 
 
(R)-1-34 
 
1-35 
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Scheme 16. Synthesis of catalysts 1-36. 
The dimeric catalyst catalyst 1-36a was found to be considerably less active than 1-34a 
in the Michael reaction. After a reaction time of >1 week only 28% conversion was seen 
in the reaction of 1-37 with MVK (Scheme 17).  
 
Catalyst Temp (° C) Time (h) Yield (%) ee (%) 
(R)-1-34a -20 24 92 92 
(R)-1-36a -10 to rt 268 28 66 
 
Scheme 17. Comparison of catalysts 1-34a and 1-36a in the Michael reaction. 
To explain this observation, mechanistic studies were undertaken using the diketone 1-
38 as a model substrate. NMR spectra of 1-36a in the presence of excess 1-38 showed 
complete conversion to the enoate 1-39 (Scheme 18). This differs from the equilibrium 
observed earlier for catalyst 1-34 (Scheme 15) as the hydroxyl ligands on 1-36a act as a 
weak Brønsted base, removing the acid generated upon formation of the enolate (1-39), 
shifting the equilibrium to the right. 
 
 
Scheme 18. Formation of a chiral palladium enolate from 1-36. 
(R)-1-34 
 
1-36a (X = TfO, Ar = Tol) 
1-36b (X = PF6, Ar = Ph) 
1-36c (X = TfO, Ar = Ph) 
1-38 
 
1-36a 
 1-39 
 
1-37 
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The failure of catalyst 1-36a in the Michael reactions is therefore attributed to the 
absence of the acid generated by 1-34 (Scheme 15). This is believed to protonate the 
electrophile, thereby activating it towards nucleophilic attack (1-40, Figure 1). 
 
 
Figure 1. Electrophile protonation in palladium-catalysed Michael reactions.  
The lanthanum and palladium catalysts discussed offer good generality accross a 
number of substrates and can be deployed in air. However, a number of other systems 
have also been developed that are worthy of note. One such system was published in 
2005, which employs the Ca-H8-BINOL catalyst 1-41 (Scheme 19). The trend in 
selectivity is the reverse of that seen in many other systems, with methyl esters giving 
the highest selectivities. Consequently, results with this catalyst only supersede those 
achieved with palladium catalyst 1-34a for small ester substituents. Product 1-43 is 
acquired in 80% ee with catalyst 1-41, compared with only 25% ee observed for the 
reaction catalysed by 1-34a (Table 2, entry 1).34  
              
Scheme 19. Calcium-H8-BINOL-catalysed Michael reactions. 
Catalysts based on Sc(OTf)3 also promote asymmetric Michael reactions. The first 
publications by Nakajima and co-workers utilised the biquinoline N,N’-dioxide ligand 
1-44 (Scheme 20). Only alkyl indanone-2-carboxylates were reported as substrates, and 
1-40 
 
(R)-1-41 (10 mol%) 
 
(R)-1-41 
1-42 1-43 
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high ee was only observed for the tert-butyl ester, however these reactions proceeded at 
room temperature and reaction times were short.35,36    
 
Scheme 20. Sc(OTf)3-1-44-catalysed Michael reactions. 
Higher ees have since been obtained by Kobayashi and co-workers using scandium 
triflate and chiral bipyridine 1-46 (Scheme 21). A range of indanone-based substrates 
(1-45) gave consistently excellent results irrespective of the size of the ester group. 
However other substrates studied gave inferior results; 1-47 was obtained in poor yield 
after a very long reaction time, and only 69% ee was obtained for cyclopentanone 
product 1-48. Due to poor catalyst solubility these reactions were carried out at an 
unusually high temperature (40 °C) and very high dilution (0.02 M). The authors 
proposed that this reaction proceeds via protonation of the electrophile in a mechanism 
analogous to that discussed for the palladium catalysts 1-34.37  
 
Scheme 21. Sc(OTf)3-1-46-catalysed Michael reactions. 
1-44 
1-44 (5 mol%) 
(S,S)-1-46 
(S,S)-1-46 (6 mol%) 
1-45 
1-47 1-48 
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Brønsted acid-activation of the Michael acceptor is also evoked in studies by Mezzetti 
and co-workers. Using the ruthenium PNNP complex 1-49, addition of a halide 
scavenger generates a solution of dicationic complex 1-50 which was shown to catalyse 
Michael reactions of MVK (Scheme 23).38,39 
 
Scheme 22. Michael reactions catalysed by(S,S)-1-49. 
Three β-ketoester substrates were examined, as summarised in Table 3. Good results 
were obtained for a tert-butyl ester (entry 2) but the corresponding ethyl ester gave poor 
enantioselectivity (entry 4) and the acyclic substrate studied reacted slowly to give a 
poor yield (entry 6). In every case, addition of Et2O (entries 2, 4 and 6 vs entries 1, 3 
and 5) gave a significant increase in rate and selectivity.  
 
Table 3. (S,S)-1-49-catalysed Michael reactions. 
Entry Product Solvent Time (h) Yield (%) ee (%) 
1 
 
CH2Cl2 24 94 79 
2 CH2Cl2/Et2O (1:1) 18 >99 93 
3 
 
CH2Cl2 24 95 40 
4 CH2Cl2/Et2O (1:1) 18 >99 63 
5 
 
CH2Cl2 72 26 60 
6 CH2Cl2/Et2O (1:1) 72 41 85 
 
The authors proposed that 1-50 reacts with β-ketoesters to form a complex containing a 
non-enolised 1,3-dicarbonyl ligand (1-51, Scheme 23) which can be deprotonated with a 
mild base to form the enolate 1-52, however this species was inactive in the Michael 
reaction. This mirrors the results with the palladium catalysts 1-34 and 1-36, suggesting 
that Brønsted acid catalysis is crucial for this reaction. The rate acceleration by Et2O is 
(S,S)-1-49 
(S,S)-1-50 
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believed to be due to the solvent acting as a proton shuttle, potentially activating the 
electrophile through hydrogen bonding (1-53), as opposed to formal protonation. 
 
Scheme 23. Mechanism of (S,S)-1-49-catalysed Michael reactions. 
Lindstrom, Wennerberg and co-workers published interesting findings concerning the 
use of water as a solvent in asymmetric Michael reactions. Screening identified a 
combination of Yb(OTf)3 and proline as an appropriate catalytic system for aqueous 
reactions (Scheme 24). However significant enantioselectivity could not be extended to 
substrates other than ethyl acetoacetate and 2-cyclohexenone.40 The highly polar nature 
of this solvent presents a challenge due to the strong competitive binding of solvent over 
ligand and substrate to the metal. Enantioselective reactions are possible in this instance 
due to the absence of a background reaction; the metal and ligand are only catalytically 
active when complexed to each other.  
 
Scheme 24. Yb(OTf)3-proline-catalysed Michael reactions in water. 
Nitroalkanes are versatile building blocks in organic synthesis, undergoing Henry 
reactions,41 Nef reactions,42 nucleophilic displacement43 and reduction to amines, 
among others. As a result there has been significant effort to adopt nitroalkenes as 
electrophiles in asymmetric Michael reactions (Scheme 25). There have been two 
significant developments in this area using Lewis acidic catalysts, namely 1-5444,45 and 
1-55.46  
1-51 
1-50 
1-52 
1-52 
1-53 
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Scheme 25. Michael reactions to nitroalkenes. 
Table 4. Results for Michael reactions to nitroalkanes. 
Entry Product 
1-54a 1-55b 
Yield (%) ee (%) Yield (%) ee (%) 
1 
 
99 97 - - 
2 
 
96 92 99 90 
3 
 
95 58 94 94 
aReactions conducted in toluene at -20 °C with 2 mol% catalyst. bReactions 
conducted in toluene at rt with 2 mol% catalyst. 
 
Table 4 shows selected results for these two catalysts. The ruthenium system (1-54) is 
also capable of catalysing additions to enones (entry 1), but its success with nitroalkenes 
is dependent on the structure of the β-ketoester, with bulkier β-substituents (R1) giving 
higher ees (entry 2 vs entry 3). Conversely the nickel catalyst (1-55) gave good 
1-54 (2 mol%) 
 
1-55 (2 mol%) 
 
1-54  
 
1-55  
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selectivity with several donors (entries 2 and 3), and significantly faster reactions. Both 
systems employed only 2 mol% catalyst, though the nickel catalyst (1-55) can be 
utilised at room temperature, simplifying the reaction protocol. α-Substituted β-
ketoesters are not investigated as substrates with either system.  
 
The nickel catalyst 1-55 reported by Evans and co-workers in 2006, contains trans-
N,N’-diaminocyclohexane ligands. The success of the system in the Michael reactions 
of nitroalkenes is believed to be due to hydrogen bonding between the partly dissociated 
ligand and nitro group (Figure 2).  
 
 
Figure 2. Proposed mechanism of 1-55-catalysed additions to nitroalkenes. 
1.1.1.2. Other C-C Bond Forming Reactions 
Other carbon electrophiles have been applied to the α-functionalisation of β-ketoesters, 
most significantly in the Mannich reaction, where imines were employed. A Cu(II) 
bis(oxazoline) catalyst was reported in 2003 by Jørgensen and co-workers that gave ees 
of up to 93% at room temperature, employing α-imino ester 1-56 as the acceptor 
(Scheme 26).47  
 
 
Scheme 26. Copper-bis(oxazoline)-catalysed Mannich reactions. 
As was often observed, the selectivity was dependent on the presence of a large ester 
substituent, however smaller esters can be accommodated with the use of 
tris(oxazolidinone) ligand 1-58 in combination with Cu(ClO4)2. Under these conditions 
the Mannich product of ethyl 2-methylacetoacetate and 1-56 was obtained in an 
1-56 
 
(R,R)-1-57  
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improved 84% yield and 90% ee (Scheme 27), compared with 90% yield and 42% ee 
obtained with catalyst Cu(OTf)2-1-57. In this system, reducing the catalyst loading to 
0.01 mol% does not alter the enantioselectivity or diastereoselectivity, implying a 
complete absence of uncatalysed reaction, even when exposed to air and moisture. 
However this is not synthetically useful as the reactions are extremely sluggish, taking 
36 h at -28 °C to complete.48 
 
 
 
Scheme 27. Copper-trisox-catalysed Mannich reactions. 
Catalytic asymmetric aldol reactions represent an important field of research. However 
β-ketoesters have rarely been used as nucleophiles, due to their insufficient 
nucleophilicity and the potential for reversible reactions. However the reactions of β-
ketoesters with the highly reactive aldehyde paraformaldehyde in the presence of 
palladium catalyst 1-34c and its Pt analogue 1-59 have been demonstrated (Scheme 
28).49   
 
 
Scheme 28. Palladium and platinum-catalysed additions to paraformaldehyde. 
Catayst loading 
(mol%) 
Yield (%) dr ee (%) 
10 84 13/87 90 
1 75 13/87 89 
0.1 59 13/87 91 
0.01 36 13/87 90 
Cu(ClO4)2-1-58 
 
1-58  
 
1-34c / 1-59 (5 mol%) 
 
1-34c (M = Pd) 
1-59 (M = Pt) 
 
1-56 
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Sodeoka and co-workers investigated three tert-butyl β-ketoesters in this system (Table 
5). Cyclic substrates gave the best results, while the acyclic β-ketoester required an 
impractically long reaction time.  
 
Table 5. Results for palladium and platinum-catalysed aldol reactions. 
Entry Substrate Product Catalyst
Time 
(h) 
Yield 
(%) 
ee 
(%) 
1a 
 
1-34c 30 91 86 
2 
 
1-59 66 92 71 
3 
 
1-59 89 54 80 
aAcCl and pyridine added at end of reaction.   
  
A protocol often used to alter selectivity and overcome reversibility problems in aldol 
reactions is the use of acetals as pro-electrophiles (1-60). Under anhydrous acidic 
conditions, electrophilic oxonium ions (1-61) will be generated in-situ (Scheme 29).50  
 
 
 
Scheme 29. Generation of electrophilic oxonium ions. 
This method has been used to extend the scope of the palladium/platinum-catalysed 
aldol reactions of β-ketoesters to a number of acetals with excellent results (selected 
results in Table 6).51 All cyclic β-ketoesters gave high enantioselectivities using catalyst 
1-34c (entries 1, 2 and 4), however reactions with acyclic substrates proceeded in 
considerably higher yield when catalyst 1-59 was employed (entry 3, compared to 41% 
yield obtained with catalyst 1-34c).  
  
1-61 1-60 
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Table 6. Results for palladium- and platinum-catalysed additions to acetals. 
 
Entry β-Ketoester Acetal Catalyst Yield (%) dr ee (%) 
1 
 
1-34c 70 4.5:1 >99 
2 
 
 
1-34c 50 1.9:1 99 
3 
  
1-59 71 1.3:1 97 
4 
 
1-34c 82 6.3:1 99 
 
One final example of a Lewis acid-catalysed asymmetric C-C bond forming reaction of 
a β-ketoester is an intramolecular cyclisation published by Yang and co-workers 
(Scheme 30). Under radical conditions, 1-62 cyclised to 1-63 with complete 
diastereoselectivity (C-1 and C-2) and high ees.52  
 
 
 
Scheme 30. Mg-catalysed radical cyclisations. 
1.1.1.3. C-Halogen Bond forming reactions 
Procedures for asymmetric fluorination, chlorination and bromination of β-ketoesters 
have all appeared in the last decade, however it is fluorination that has attracted the 
greatest level of interest.53,54 A likely reason for this is the biological activity and 
1-34c / 1-59 (5-10 mol%) 
 
1-62 1-63 
(S,S)-1-57 
(S,S)-1-59 (33-110 mol%) 
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metabolic stability often associated with organofluorine compounds.55,56 Successes in 
this area have been dependent on the development of highly efficient fluorinating agents 
such as 1-64 to 1-66 (Figure 3). 
                         
 
Figure 3. Electrophilic fluorinating agents. 
The first report of a catalytic asymmetric halogenation of a β-ketoester was a 
fluorination reaction, published in 2000 by Togni and co-workers (Scheme 31). Two 
air-stable titanium catalysts (1-67 and 1-68) were isolated, and were able to catalyse 
fluorination reactions of β-ketoesters using Selectfluor (1-64). In all cases highest 
selectivities were achieved with 1-68.57 
 
 
Scheme 31. Ti(TADDOLato)-catalysed fluorination.      
These catalysts were later found to be applicable to other halogenation reactions (Table 
7). Use of N-chloro and N-bromosuccinimides (1-69 and 1-70) under these conditions 
led to chlorinated (entries 2, 5 and 7) and brominated (entries 3 and 8) products 
respectively, though the latter were obtained with very low levels of stereoselectivity. 
High yields were achieved in all cases, and best results were obtained with substrate 1-
71 (entries 6-8).58 
1-64 1-65 1-66 
1-67 1-68 
1-69 (X = Cl) 
1-70 (X = Br) 
1-67 / 1-68 (5 mol%) 
Catalyst 1-67: Catalyst 1-68: 
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Table 7. Ti(TADDOLato)-catalysed halogenations. 
Entry Substrate Catalyst Reagent Yield (%) ee (%)
1 
 
1-68 1-64 -a 62 
2 1-68 1-69 85 59 
3 1-67 1-70 84 8 
4 
 
1-68 1-64 -a 48 
5 1-68 1-69 85 60 
6 
 
1-68 1-64 -a 81 
7 1-68 1-69 94 88 
8 1-67 1-70 90 23 
aYield >80%. 
 
Later the chlorinating agent 4-(dichloroiodo)toluene (1-71) was used in combination 
with catalyst 1-68, to give optically active chlorinated products 1-72 with various ester 
substituents (Scheme 32). However small structural changes to the rest of the substrate 
resulted in a loss of ee, eg. products 1-73 and 1-74. The halogenation reagent 1-71 
generates HCl as a by-product, which is neutralised by pyridine in this system. High 
concentations of 1-71 were found to be detrimental to selectivity due to a competing 
uncatalysed reaction. Hence the optimal protocol required slow addition of the reagent, 
carried out at 50 °C.59 
 
 
Scheme 32. Ti(TADDOLato)-catalysed chlorination reactions with 1-71. 
In 2002 Sodeoka and co-workers demonstrated that the palladium Lewis acids 1-75 and 
1-76 are effective catalysts for α-fluorination of β-ketoesters (Scheme 33). The study 
was restricted to cyclic and acyclic tert-butyl β-ketoesters. The fluorination of these 
1-71 
1-68 (5 mol%) 
1-71 
1-73 
1-72 
1-74 
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substrates proceeded with high yields and enantioselectivities, except the reaction of the 
acyclic substrate tert-butyl 2-methylacetoacetate. The low isolated yield (49%) obtained 
was attributed to the volatility of product.60  
 
Scheme 33. Palladium-catalysed fluorination reactions. 
Catalysts 1-75 and 1-76 are closely related to catalysts 1-36a-c described earlier. These 
catalysts exhibit Brønsted basicity, making them unsuitable for the Lewis acid-Brønsted 
acid-catalysed Michael reactions (Scheme 17). However they can catalyse the 
fluorination reaction, as the activation of the electrophile is not required for the reaction 
to proceed.  
 
The procedure used for the Michael chemistry to immobilise these catalysts in an ionic 
liquid could also be applied to the fluorination reactions with comparable results; no 
drop in ee was observed over 10 cycles using [hmim][BF4].33     
 
The next significant body of work was a collection of publications in 2004-2005 using 
bis(oxazolidinone) ligands 1-57 and 1-77 in combination with salts of the late transition 
metals copper and nickel (Scheme 34). The catalyst 1-57-Cu(OTf)2 was shown by 
Jørgensen and co-workers to catalyse chlorination and bromination by NCS/NBS (1-
69/1-70) with ees of up to 77% and 82% respectively (equation 1).61 Simultaneously, 
Cahard and co-workers showed that 1-77-Cu(OTf)2 in the presence of the achiral 
(R)-1-75 / (R)-1-76 (2.5 mol%) 
1-75a (P-P = (R)-Xylyl-BINAP, X = OTf) 
1-75b (P-P = (R)-Xylyl-BINAP, X = BF4) 
1-76a (P-P = (R)-Xylyl-SEGPHOS, X = OTf) 
1-76b (P-P = (R)-Xylyl-SEGPHOS, X = BF4) 
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additive HFIP could catalyse fluorination with NFSI with ees of up to 85% (equation 
2).62 Finally, a publication by Shibata, Toru and co-workers showed that very high 
enantioselectivities (83-99%) could be achieved for fluorination of β-ketoesters 
containing bulky ester substituents with catalyst 1-57-Ni(ClO4)2. This was extended to 
the chlorination reaction with the reagent CF3SO2Cl, achieving excellent results for 
cyclic β-ketoesters (equation 3).63 
 
          
 
 
 
Scheme 34. Cu/Ni-bis(oxazolidinone)-catalysed fluorination reactions. 
A system that is particularly successful in the fluorination of substrates containing 
smaller ester substituents is shown in Scheme 35, employing an unusual scandium-
binapthyl phosphate complex 1-78. Both cyclic (1-79) and acyclic (1-80) products are 
obtained with good selectivties. This is the first application of the commercially 
available fluorinating agent NFPY-OTf (1-66) to an asymmetric fluorination reaction.64  
(S,S)-1-57 (R = tBu) 
(S,S)-1-77 (R = Ph) 
1-57 (10 mol%) 
Cu(OTf)2 (10 mol%) 
1-71 / 1-72 
 
(R,R)-1-77 (1 mol%) 
Cu(OTf)2 (1 mol%) 
NFSI 
1-77 (10 mol%) 
Ni(ClO4)2 (10 mol%) 
NFSI/CF3SO2Cl 
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Scheme 35. Scandium-binapthyl phosphate-catalysed fluorination reactions. 
Togni, Mezzetti and co-workers have achieved good yields and enantioselectivities for a 
range of ketoesters in fluorinations with NFSI (1-67, Scheme 36), using the ruthenium 
catalyst 1-49 employed previously in asymmetric Michael reactions (Section 1.1.1.1).65 
 
 
Scheme 36. Ru-(PNNP)-catalysed fluorination reactions. 
1.1.1.4. C-N Bond Forming Reactions 
Jørgensen and co-workers set an impressive precedent for amination of ketoesters with 
catalyst 1-77-Cu(OTf)2, achieving excellent results by adopting azodicarboxylate 1-85 
as an electrophile, generating hydrazine products 1-84 (Scheme 37). Enantioselectivities 
for a wide range of β-ketoesters all exceeded 95% using a catalytic loading as low as 0.5 
mol%.66  
1-78 
 
1-78 (10 mol%) 
1-66 
1-49 (10 mol%) 
NFSI 
1-49  
1-79 
 
1-80 
 
1-81  1-82  1-83  
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Scheme 37. Copper triflate-bis(oxazolidinone)-catalysed amination reactions. 
Subsequently, consistiently high enantioselectivities (91-99%) were achieved by Kim 
and co-workers employing palladium catalyst 1-34b for the reaction of cyclic ketoesters 
with 1-85 to 1-88 (Scheme 38). Reactions were extremely sluggish when R4 = OMe or 
the bulkier electrophile 1-88 was employed.67 
O
OR1
O
MeOH, rt, 0.5-170 h
n = 1, 2
R1 = Et, tBu
R3 = H, OMe
R4 = H, OMe
nR4
R3
O
OR1
O
nR4
R3
NCO2R2
HN
CO2R2
P
Ph2
Ph2
P
Pd
OH2
OH2
2+
[PF6]-2
56-98% yield
91-99% ee
 
Scheme 38. Palladium-catalysed amination reactions. 
In studies directed towards the synthesis of α-fluorinated amino acids, Togni and co-
workers employed catalyst 1-77-Cu(OTf)2 in the amination of α-fluorinated ketoesters, 
attaining ees of 87-93% (Scheme 39).68 
  
1-77-Cu(OTf)2 (0.5 mol%) 
1-85 
1-85 (R2 = Bn) 
1-86 (R2 = Et) (DEAD) 
1-87 (R2 = iPr) (DIAD) 
1-88 (R2 = tBu) 
(R,R)-1-77 
1-34b (5 mol%) 
1-85 – 1-88 
1-34b  
1-84 
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Scheme 39. Copper-catalysed amination reactions of α-fluoro-β-ketoesters. 
1.1.1.5. C-S Bond Forming Reactions 
The only Lewis acid catalyst that has been applied to sulfenylation chemistry is the 
Ti(TADDOLato) complex 1-68. Employing the highly electrophilic reagent 
phthalamide N-sulfenyl chloride (1-89), phthalimide protected thiol products were 
obtained in excellent yield but with only moderate ees (Scheme 40). The failure of this 
system to achieve high enantioselectivities was attributed to the high reactivity of the 
electrophile, leading to a significant racemic uncatalysed reaction.69 
  
 
Scheme 40. Ti(TADDOLato)-catalysed sulfenylation reactions. 
Adopting the less reactive electrophile PhSCl gave good results for sulfenylation of β-
ketoesters and α-fluoro-β-ketoesters (Scheme 41). Although reaction times were shorter 
than in the reaction of 1-89, yields were lower. Highest selectivities were achieved with 
substrates containing very bulky ester substituents (e.g. products 1-90 to 1-92).70  
1-77 (5 mol%) 
Cu(OTf)2 (5.5 mol%) 
1-85 / 1-86 
1-68 
(1-89) 
1-68 (2 mol%) 
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Scheme 41. Ti(TADDOLato)-catalysed sulfenylation reactions. 
1.1.1.6. C-O Bond Forming Reactions 
The effectiveness of the Ti(TADDOLato) complex 1-68 and the Ru(PNNP) complex 1-
49 for hydroxylation reactions were also demonstrated by Togni, Mezzetti and co-
workers in 2004 (Scheme 42). The racemic oxaziridine 1-94a was found to be an 
effective oxidant when used in combination with the titanium catalyst, generating α-
hydroxy products 1-93 with ees reaching 94%. However small changes in substrate 
structure resulted in a large drop in ee. The same substrates were examined with the Ru 
catalyst 1-49 in combination with hydrogen peroxide, however yields were low and ees 
of the ketoester adducts did not exceed 36%.71 
 
 
 
 
Scheme 42. Ti(TADDOLato) and Ru(PNNP)-catalysed hydroxylation reactions. 
1-68 (5 mol%) 
1-90 
 
1-91 1-92 
 
1-68 (5 mol%) 
1-49 (5 mol%) 
1-94a (R1 = NO2, R2 = H) 
1-94b (R1 = H, R2 = Me) 
1-94c (R1 = NO2, R2 = Me) 
1-94a 
1-68 
 
1-49 
1-93 
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Comparing the performance of catalysts 1-68 and 1-49, a relationship between the 
enantioselectivity and the substrate’s enol content was noted (Table 8). In the former, 
substrates for which the enol form is present in substantial amounts underwent 
uncatalysed reactions resulting in diminished ee (entries 3 and 4). Generally, ketoesters 
containing a six membered ring (cyclohexanone or tetralone) are the most enolised, 
hence cyclopentanone (entry 1) and acyclic substrates (entry 2) performed best in this 
system. On the other hand, reactions catalysed by the Ru complex 1-49 showed the 
opposite trend, giving the best results with highly enolised substrates (entries 3 and 4). 
The crucial factor is this catalyst’s ability to tolerate the presence of water, allowing the 
use of hydrogen peroxide. Unlike oxidant 1-94a, this oxidant does not react with 
enolised ketoesters in the absence of catalyst. 
 
Table 8. Ti(TADDOLato) and Ru(PNNP)-catalysed hydroxylation reactions. 
Entry Substrate 
Enol 
(%) 
1-68a 1-49b 
Yield 
(%) 
ee 
(%) 
Yield 
(%) 
ee 
(%) 
1 
 
3 89 84 0 - 
2 
 
4 97 94 0 - 
3 
 
18 93 9 42 20 
4 
 
50 >99 4 53 36 
aReactions conducted with oxidant 1-94a in CH2Cl2 at rt. aReactions conducted 
with oxidant H2O2 in CH2Cl2 at rt.  
 
A few years later, Toru, Shibata and co-workers reported the use of the complex 1-95-
Ni(ClO4)2 for the hydroxylation of cyclic ketoesters using racemic, saccharin-derived 
oxaziridine 1-96 as oxidant (Scheme 43). tert-Butyl and 1-adamantyl esters gave ees 
consistiently above 90%. The use of other ester substituents were not reported and the 
only acyclic substrate reported gives only 27% yield after 50 h, suggesting that this 
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catalytic system is only suitable for hydroxylation of cyclic β-ketoesters with bulky 
ester substituents.72  
 
Scheme 43. Ni-(DBFOX)-catalysed hydroxylation reactions. 
1.1.2. Organocatalysis and Phase-transfer Catalysis 
The number of publications relating to asymmetric organocatalytic reactions of β-
ketoesters is vast, as is the scope of the electrophiles. However, the majority of 
organocatalysts employed rely upon a few simple modes of action. Nucleophile 
activation is most commonly evoked, through the formation of a tertiary amine capable 
of hydrogen bonding to the proton of an enolised ketoester (Scheme 44). Often, 
catalysts also interact with the electrophile via a hydrogen bond donor such as an 
alcohol, thiourea, amide or amine moiety. 
 
Scheme 44. Mechanism of action for a typical organocatalyst. 
The field is largely dominated by the use of the readily available cinchona alkaloids 
quinine (1-97a), dihydroquinine (1-97b), quinidine (1-98a), dihydroquinidine (1-98b) 
and their derivatives (Figure 4). Quinine and quinidine are diastereomers but are 
generally found to give virtually identical enantioselectivities for opposite enantiomers. 
This implies that the stereochemistry at the C-8 and C-9 positions is crucial for 
selectivity whereas the stereochemistry at the C-3 and C-4 positions has little 
1-95-Ni(ClO4)2 (10 mol%) 
1-96, 4 Å MS
1-95 
1-96  
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stereoinductive effect. One of the major drawbacks of these catalysts is that reactions 
can be impractically slow (>24 h) for less reactive substrates.   
              
 
Figure 4. Cinchona alkaloids used as organocatalysts. 
Another class of organocatalysts are phase-transfer catalysts, which induce chirality via 
the formation of an ion pair with the ketoesters. The current state-of-the-art is 
dominated by N-alkylated cinchona alkaloid derivatives 1-99 introduced by Pochapsky 
and co-workers73 and successfully applied by the groups of Corey74 and Lygo,75  as well 
as the N-spiro chiral quarternary ammonium salts (1-100) pioneered by Maruoka 
(Figure 5).76-78  
  
N
X-
Ar
Ar  
 
Figure 5. Phase-transfer catalysts. 
1.1.2.1. Michael Reactions 
Scheme 45. The first organocatalytic Michael reaction. 
In 1973, preceding the first Lewis acid-catalysed methods by more than a decade, 
Långström and Bergson first demonstrated the ability of a chiral organic molecule to 
catalyse enantioselective Michael reactions to β-ketoesters (Scheme 45). In the presence 
1-97a (R=CH=CH2) 
1-97b (R=Et) 
1-98a (R=CH=CH2) 
1-98b (R=Et) 
1-99 1-100 
1-101 
1-101 (57% ee, 0.3-6.8 mol%) 
1-102 
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of an optically enriched catalyst 1-101 (57% ee), enones reacted with β-ketoester 1-102, 
to give enantioenriched products; however, ees of products were not determined.79  
 
Shortly after, major advances were made by Wynberg and co-workers, using quinine (1-
97a) as a catalyst and obtaining ees of up to 76% in the reaction of 1-102 with MVK. In 
this work, several major factors required to achieve selectivity with cinchona alkaloids 
were also determined (Scheme 46).80,81  
 
Scheme 46. The first cinchona alkaloid-catalysed Michael reaction. 
More recently, Deng and co-workers showed that the modified quinine catalyst 1-103 is 
highly effective for a range of substrates (Scheme 47). The alcohol in quinine was 
arylated by anthracene in this catalyst and a hydrogen bond donor was introduced at the 
6’-position on the quinoline ring. Excellent yields, enantioselectivities and 
diastereoselectivities were observed with a range of enones and α,β-unsaturated 
aldehydes. Adopting 2-chloroacrylonitrile as the electrophile, non-contiguous 
stereogenic centres can be generated with high diastereoselectivity. However, 
synthetically useful ees are only reported with tert-butyl and CH(CF3)2 esters.2,82,83 
 
Scheme 47. 1-103-catalysed Michael reactions. 
1-97a (10 mol%) 
1-102 
1-103 
1-103 (1-20 mol%) 
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The dihydroquinine based catalyst, 1-104, has been show to catalyse the Michael 
reaction of 1-105 to chalcone with high chiral induction at the β-carbon (Scheme 48). 
This catalyst (1-104) did not have the generality demonstrated by Deng’s catalyst (1-
103); only one β-ketoester was reported. However this substrate was an ethyl ester, 
which was not reported in the work with catalyst 1-103.84 
O
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Scheme 48. 1-104-catalysed Michael reactions. 
Organocatalytic Michael reactions of nitroalkenes have been studied extensively and 
results compete well those achieved with transition metal catalysis.85-87 Catalysts for 
their reaction with β-ketoesters include the 6’-hydroxy cinchona alkaloid 1-103, which 
gave excellent diastereoselectivities, and ees generally >98% (Scheme 49).88 However 
very low temperatures and long reaction times (up to 4 days) were required for optimal 
results.  
 
Scheme 49. 1-103-catalysed Michael addition to nitroalkenes. 
1-104 
1-104 (10 mol%) 
1-105 
1-103 
1-103 (10 mol%) 
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Catalysts 1-105,89 1-10690 and 1-10791 also gave excellent results for additions to 
nitroalkenes (Scheme 50). While the three systems gave roughly comparable results, the 
reactions of 1-105 had the broadest substrate scope. In comparison, reactions catalysed 
by 1-107 were restricted to cyclopentanone and indanone-derived substrates. 
 
 
 
 
 
 
 
 
Scheme 50. Michael reactions to nitroalkenes. 
Further extending the scope of this reaction, Zhong and co-workers demonstrated the 
use of 9-amino-9-deoxyepiquinine (1-108) in domino Michael-Henry reactions, forming 
highly functionalized 5- and 6-membered carbocycles (Scheme 51). Excellent yields, 
ees and diastereoselectivities were observed in all reported reactions.92,93  
1-105 1-106 1-107 
1-105 (10 mol%) 
1-106 (0.5 mol%) 
1-107 (10 mol%) 
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Scheme 51. Domino Michael-Henry reactions catalysed by 1-108. 
Catalyst 1-108 has also been shown to effect double-Michael reactions to afford  
carbocycles with equally impressive enantio- and diastereoselectivities (Scheme 52).94 
 
Scheme 52. Double-Michael reactions catalysed by 1-108. 
Additions to other Michael acceptors such as quinones95 and maleimides96 were 
catalysed by quinine with good results (1-97a, Scheme 53).  
 
Scheme 53. 1-97a-catalysed additions to quinines and maleimides. 
1-108 (15 mol%) 
1-108  
1-108 (15 mol%) 
1-97a (20 mol%) 
1-97a (10-20 mol%) 
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1.1.2.2. Other C-C Bond Forming Reactions 
The Mannich reaction of ketoesters with N-acyl imines can be effected by a range of 
catalysts (1-105 and 1-109 to 1-112), including phase-transfer catalyst 1-112 (Figure 
6).97-101  
  
Figure 6. Catalysts employed in Mannich reactions. 
The results obtained with these catalysts are summarised in Scheme 54. All reactions 
proceeded very sluggishly at low temperatures (reaction times were not reported in 
some cases), giving excellent enantioselectivities with cyclic β-ketoesters. The reactions 
of catalyst 1-109 were extended to include unsubstituted acyclic susbstrates (R1 = H), 
and a wide range of acceptors (equations 1 and 2). Conversely, reactions of catalysts 1-
110 and 1-111 were only examined with one β-ketoester (equations 3 and 4). In the 
systems employing catalysts 1-109 and 1-112 the electrophile is generated in-situ from 
the sulfone by elimination of HSO2Ar, avoiding the need to isolate the unstable imine 
(e.g. equation 5). 
1-105 1-109 1-110 
1-111 
1-112 
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Scheme 54. Organocatalytic Mannich reactions. 
Enantioselective alkylation of β-ketoesters has been studied using cinchona alkaloid 
derived catalysts with some success,102 however they are overshadowed by a class of N-
spiro chiral quarternary ammonium phase-transfer catalysts pioneered by Maruoka and 
co-workers (1-113, Scheme 55). These have been applied to the generation of all carbon 
quarternatry centres and heterofunctionalised quarternary centres. Prochiral α-alkyl,77,78 
α-benzoyloxy,76 α-fluoro103 and α-amino β-ketoesters104 have been employed, leading to 
products with high yields and enantioselectivities. In contrast to many other 
organocatalytic systems, reaction times are generally between 2-24 h, using only 1 
mol% catalyst.  
1-105 (10 mol%) 
1-109 (10 mol%) 
1-110 (10 mol%) 
1-111 (5 mol%) 
1-112 (2.5 mol%) 
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Scheme 55. 1-113-catalysed alkylation reactions. 
The use of aziridine acceptors was described in a report where 1-114 was used as 
catalyst (Scheme 56). Achiral aziridines gave excellent enantioselectivities, and chiral 
electrophiles gave excellent diastereoselectivities. The stereochemical outcome of the 
diastereoselective reactions were catalyst-controlled as opposed to substrate-controlled, 
hence epimers 1-115 and 1-116 were both obtained with high diastereoselectivity.105 
  
1-113 (1 mol%) 
1-113  
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Scheme 56. 1-114-catalysed additions to aziridines. 
A notable class of C-C bond forming reactions was reported by Jørgensen and co-
workers, where N-arylated cinchona alkaloid derivatives 1-117a and 1-117b act as 
phase-transfer catalysts in the additions of β-ketoesters to a number of unusual 
electrophiles (Figure 7, Table 9). Nucleophilic substitution reactions occurred with 
fluorobenzenes (entry 1) and with several β-substituted Michael acceptors (entries 2-4). 
α,β,γ,δ-unsaturated alkenes underwent 1,6-conjugate additions (entry 5), and electron-
deficient allenes lead to unusual Michael reaction products (entry 6). 
 
                   
 
Figure 7. Phase-transfer catalysts. 
  
1-114 (10 mol%)  
1-115 1-116 
1-114  
1-117a 1-117b 
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Table 9. Reactions of phase-transfer catalysts 1-117 and 1-118. 
Entry Catalyst Electrophile Product 
Yield 
(%) 
ee (%)
1106,107 1-117b 
  
68-93 85-94 
2108 1-117a  
 
42-90 60-94 
3109 1-117a 
 
 
77-96 75-97 
4110 1-117a 
 
 
62-99 44-98 
5111 1-117a 
 
 
66-99 79-99 
6112 1-117a 
 
59-97 67-96 
 
1.1.2.3. C–Heteroatom Bond Forming Reactions 
Organocatalytic α-fluorination of β-ketoesters was achieved by employing the chiral 
phase-transfer catalyst 1-118 (Scheme 57). Enantioselectivities do not equal those 
achieved with Lewis acids described earlier and the substrate scope explored is 
comparatively narrow. However, reactions were conducted at room temperature and 
reaction times are extremely short.113  
40 
 
Scheme 57. 1-118-catalysed fluorination reactions. 
Concurrently, organocatalyst 1-119 was employed successfully in chlorination and 
bromination reactions with ees of up to 96% and 84% respectively. The trichloro and 
tribromo quinolinones (1-120 and 1-121) served as mild reagents and were selected to 
eliminate the background reactions such as those observed with NCS and NBS (Scheme 
58).114 
               
Scheme 58. 1-119-catalysed halogenations reactions. 
Several organocatalysts have applications in additions of β-ketoesters to azo compounds 
(Figure 8). Jørgensen and co-workers demonstrated the use of the alkaloid β-
isocupreidine 1-122, giving good results for a number of cyclic and ayclic substrates, 
although reactions were extremely slow (Table 10, entry 1).115 The chiral guanidine 1-
123 enabled significantly faster reactions and excellent results (entry 2).116 The thiourea 
1-124 was also successful in this reaction, providing ees of up to 99%, but its use was 
only demonstrated with cyclic ketoesters (entry 3).117 Finally, Maruoka and co-workers 
(1-65), 
1-118 
1-118 (10 mol%) 
1-119 (10 mol%) 
1-120 / 1-121 
1-119  1-120  1-121 
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applied chiral phosphonium salt 1-125 as a phase-transfer catalyst with excellent results 
and broad substrate scope (entry 4).118 
 
Figure 8. Organocatalytic amination catalysts. 
Table 10. Results of organocatalytic amination reactions. 
 
Entry Catalyst R 
Temp  
(°C) 
Time  
(h) 
Yield 
(%) 
ee 
(%) 
1 1-122 Et, tBu, Ph -52 to rt 16-143 86-99 83-90 
2 1-123 Et, tBu -60 0.5-24 54-99 62-98 
3 1-124 tBu -70 to -30 3-240 85-95 93-99 
4 1-125 tBu -20 to -40 2-96 84-99 73-95 
 
Hydroxylation reactions have also been achieved organocatalytically, in a patent by 
Dupont as a route to 1-126, an intermediate in the synthesis of the insecticide 
Indoxacarb (1-127, Scheme 59).119 Cinchonine (1-128), in combination with tert-butyl 
hydroperoxide reportedly gave the optically enriched product 1-126 with up to 50% ee. 
This novel method was deemed more suitable for scaleup than others examined, 
including the use of chiral oxaziridines developed by Davis and co-workers, or 
Sharpless’ AD-mix.120  
1-124 
1-122  
1-123 
1-125 
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Scheme 59. 1-128-catalysed hydroxylation and Indoxacarb synthesis. 
Following this report, Jørgensen and co-workers have shown that using dihydroquinine 
1-97b as a catalyst, various β-ketoesters reacted with the oxidant cumyl hydroperoxide 
with up to 80% ee. However the scope of this reaction was limited to a small range of 
cyclic substrates (Scheme 60).  
 
Scheme 60. Dihydroquinine-catalysed hydroxylation reactions. 
Recently, a more successful approach was reported using a combination of the chiral 
phosphoric acid 1-129 and a nitroso compound (1-130), where very high 
enantioselectivity can be achieved (up to 98% ee). Results were consistently good for 
cyclic substrates, but as observed with most metal-catalysed systems, high yields and 
ees were not achievable for acyclic substrates (Scheme 61).121  
 
Scheme 61. 1-129-catalysed hydroxylation reactions.  
1-126 
1-126 
1-127 1-128 
1-128 
1-129 
1-129 (1 mol%) 
1-130 
1-97b (20 mol%) 
1-130 
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1.2. Aims 
The aim of this project was to discover novel applications of dicationic palladium(II) 
complexes such as 1-34c as Lewis acids in asymmetric catalysis (Figure 9). This class 
of dicationic palladium(II) complexes are air- and moisture-stable, hence easy to store 
and handle with a long shelf life. They have been applied with great success to a 
number of catalytic asymmetric processes, including the Michael, aldol, fluorination 
and amination reactions described above. Also procedures for their immobilisation in 
ionic liquids have also been developed, facilitating catalyst recycling.  
 
 
 
Figure 9. Dicationic palladium(II) salt 1-34c. 
In addition to the reactions discussed above, catalyst 1-34c has previously been shown 
by our group to be highly effective for aza-Michael reactions of α,β-unsaturated 
oxazolidinones, carbamates and imides (Scheme 62). The high enantioselectivities can 
be attributed to the presence of a 1,3-dicarbonyl moiety in the substrate, which is able to 
chelate to the palladium to generate a chiral, activated complex.122,123  
 
Scheme 62. 1-34-catalysed aza-Michael reactions. 
The reaction proceeded well with electron-poor anilines, however electron-rich 
nucleophiles such as para-anisidine (R2=OMe) gave poor results. The diminshed ee was 
1-34c (2-10 mol%) 
1-34c 
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explained by the existence of an uncatalysed reaction. However the rate of these 
reactions is also lower, due to catalyst inhibition via irreversible binding of the aniline 
to the metal centre (Scheme 63). This effect can be overcome by adding the aniline 
slowly throughout the course of the reaction, thus maintaining a low aniline 
concentration.123  
 
Scheme 63. Catalyst deactivation by electron-rich anilines. 
Due to the excellent results achieved in the aza-Michael reaction, as well as the findings 
published by Sodeoka and Kim,31,33,60,67,124,125 we felt that further investigation of these 
catalysts was justified. The work focusses on the generation of useful and synthetically 
challenging functionalities, with the goal of achieving high yields and 
enantioselectivities in novel catalytic processes.  
1-34c  
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Chapter 2: Reactivity of Dicationic Pd(II) Triflates  
2.1. Studies Towards γ-Amino Acids 
The project initiated with an investigation into methods of synthesising masked γ-amino 
acids, which are targets of broad biological interest. For example, γ-aminobutyric acid 
(GABA, 2-1, Figure 10) is a naturally-occurring inhibitor of the central nervous system, 
and much work on γ-amino acids has been focused towards the generation of optically 
active analogs.126 Also, γ-amino acids readily cyclise to form lactams (2-2) which often 
show biological activity127-129 and are fundamental building blocks in organic chemistry. 
 
Figure 10. γ-Amino acids and lactams. 
2.1.1. Catalyst Preparation 
As described in Chapter 1, a number of chiral, dicationic Pd(II) complexes (1-34, 1-36, 
1-75 and 1-76) have been employed as catalysts in asymmetric transformations. Among 
these, catalyst 1-34c has been applied most widely, used in Michael additions, aldol 
reactions and aza-Michael reactions, hence it was selected for our initial studies. The 
analogous dimeric catalyst 1-36c was also investigated for comparison. 
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Figure 11. Dicationic palladium(II) complexes. 
2-1 
2-2 
1-34a (X = TfO, Ar = Tol) 
1-34b (X = PF6, Ar = Ph) 
1-34c (X = TfO, Ar = Ph) 
1-76a (X = OTf, Ar = Xylyl) 
1-76b (X = BF4, Ar = Xylyl) 
 
1-36a (X = TfO, Ar = Tol) 
1-36c (X = TfO, Ar = Ph) 
1-75a (X = OTf, Ar = Xylyl) 
1-75b (X = BF4, Ar = Xylyl) 
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Catalyst 1-34c was generated in two steps from palladium nitrate, which was first 
converted into palladium triflate by suspension in triflic acid, according to a literature 
procedure (Scheme 64).130 After stirring for 2 h, the resultant slurry was separated by 
centrifugation and the residue dried under vacuum at 120 °C for 18 h, giving a purple 
powder. The procedure was carried out under rigorously anhydrous conditions and the 
product stored over phosphorous pentoxide desiccant, as palladium triflate is highly 
moisture sensitive, decomposing in seconds upon exposure to air. 
 
 
Scheme 64. Synthesis of palladium triflate. 
According to a procedure developed by our group,131 catalyst 1-34c was generated by 
addition of (R)-BINAP to a solution of palladium triflate in dry MeCN (Scheme 65). 
After stirring for 20 min, the product (R)-1-34c was crystallised from the resulting 
solution by addition of Et2O in 95% yield. 1H NMR revealed the formation of a mixed 
solvate complex,132 however, 31P NMR of the product contains a broadened peak at 
+33.0 ppm, implying ligand exchange is fast in solution on the NMR timescale. 
 
Scheme 65. Synthesis of 1-34c. 
Following a literature procedure,124 1-34c dimerised upon treatment with 0.07 M 
sodium hydroxide to form 1-36c, which was isolated as an orange solid in 87% yield 
after recrystallisation from CH2Cl2/Et2O (Scheme 66). This species can be identified by 
a peak in the 1H NMR at -2.85 ppm, typical of a bridging OH resonance, and a single 
peak in the 31P NMR at +29.1 ppm. 
  
(R)-1-34c 
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Scheme 66. Synthesis of 1-36c. 
2.1.2. Synthesis of γ-Amino Acids 
Our strategy towards γ-amino acids was divided into two distinct approaches. The first 
involved the reaction of a nitroalkane with a Michael acceptor (Scheme 67). These 
products (2-3) could feasibly be elaborated into substituted, optically active γ-amino 
acids by reduction of the nitro group and conversion of the carbonyl moiety to a 
carboxylic acid. 
 
Scheme 67. Synthetic strategy for γ-amino acids. 
There have been various successful asymmetric examples of γ-amino acid synthesis via 
this method, the most significant of which are outlined below. In a system demonstrated 
by Palomo, α-hydroxy enones 2-4 were employed as acceptors in the presence of a 
chiral Lewis acid 2-5.133 The magnesium-catalysed reactions are highly 
enantioselective, though impractically slow. The products were oxidatively cleaved with 
NaIO4 to give γ-nitro carboxylic acids (2-6, Scheme 68).  
 
 
Scheme 68. Mg-catalysed additions of nitromethane. 
(R)-1-34c 
(R)-1-36c 
2-3 
2-5 (10 mol%) 
2-5 2-6 
2-4 
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In 2002, Kanemasa reported the use of nickel catalysts 1-95 in the enantioselective 
addition of nitromethane to acyl pyrazoles 2-7. This gave excellent results in the 
presence of 4Å molecular sieves (Scheme 69).134 Reduction of the nitro products lead 
directly to the γ-lactams 2-8. 
Scheme 69. Ni-1-77-catalysed additions of nitromethane. 
Several organocatalysts have also been successfully employed, including thiourea 1-
105, as demonstrated by Takemoto and co-workers in 2006. Good enantioselectivities 
were achieved in additions of nitromethane to acceptors 2-9 but reactions were 
impractically slow (Scheme 70).135 The system was aided by the presence of a 2-
methoxy substituent on the imide, which was proposed to form a hydrogen bond to the 
imide NH, stabilizing the required conformation of the substrate. 
  
Scheme 70. 1-105-catalysed additions of nitromethane. 
In 2008 Vakkulya and Soós employed cinchona alkaloid thiourea organocatalyst 1-104 
in the reaction of nitromethane with N-acylpyrroles 2-10. Good ees were observed, and 
reaction times were <24 h for some substrates, although many were again very slow 
(Scheme 71).136 The products were saponified to esters by heating in methanol. 
1-105 
1-105 (10 mol%) 
1-77 
1-77 (10 mol%) 
Ni(ClO4)2 / Ni(OAc)2 (10 mol%) 
2-9 
2-7 
2-8 
49 
Scheme 71. 1-104-catalysed additions of nitromethane. 
The proline derivative 2-11 has been applied to the asymmetric conjugate additions of 
nitroalkenes to α,β-unsaturated aldehydes, which gave γ-nitroaldehydes with 
consistiently high enantioselectivities (Scheme 72).137 These can be elaborated into γ-
amino acids, including the pharmaceutical agent (R)-Baclofen (2-12), used for the 
treatment of spinal cord injury-induced spasm. The catalytic reactions proceeded 
significantly faster than those catalysed by 1-105 and 1-104 discussed above, although a 
high catalyst loading (20 mol%) was employed. 
 
 
Scheme 72. 2-11-catalysed additions of nitroalkanes. 
In addition, numerous reports describe asymmetric additions of nitroalkanes to α,β-
unsaturated ketones. However, these products are not easily converted to γ-amino 
acids.138-145 
 
Our second approach to γ-amino acids was to react nitroalkenes with Michael donors, 
generating γ-nitro esters. This method has the potential to generate stereogenic centres 
at the α-, β- and γ-positions and products of such reactions have been elaborated into 
highly functionalised pyrrolidines 2-13 (Scheme 73).146  
1-104 
1-104 (10 mol%) 
2-11 
2-11 (20 mol%) 
2-12 
2-10 
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Scheme 73. Michael additions to nitroalkenes. 
This reaction has been successfully catalysed asymmetrically by nickel,44 ruthenium,45 
cinchona alkaloid derivatives88-94 and a chiral guanidine,147 as discussed in Chapter 1. 
2.1.3. Nitroalkane – Michael Acceptor Approach  
2.1.3.1. Synthesis of precursors 
A range of substituted nitromethanes and methyl N-benzylidenealaninate were 
synthesised and studied as nucleophiles (Figure 12). Nitromethane was commercially 
available and 2-14 to 2-17 were synthesised according to literature procedures.  
 
Figure 12. Nucleophiles examined. 
The synthesis of phenylnitromethane (2-14) was problematic. Benzyl alcohol was 
reacted with sodium nitrite in a mixture of acids, according to a literature procedure 
(Scheme 74).148 1H NMR analysis of the crude mixture showed no starting material 
remaining, indicated by the absence of a peak corresponding to the benzylic methylene 
at 4.58 ppm.149 The desired product (2-14) can be clearly identified by the presence of a 
singlet in the 1H NMR at 5.43 ppm,150 however this was not observed in the crude 
mixture. The reaction instead produced solely benzyl nitrite (2-18), identified by a peak 
at 5.71 ppm in the 1H NMR.151 
 
Scheme 74. Formation of benzyl nitrite. 
2-13 
2-14 2-15a 
2-16 2-17 2-15b 
2-18 
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The second method proved to be more successful, where the reaction of sodium nitrite 
with benzyl bromide in DMF and urea at low temperature produced a mixture of 
products, which were distilled (85-110 °C, 0.3 Torr) to remove the benzyl nitrite ester 
and benzoic acid side-products.150 The desired product 2-14 was isolated as a colourless 
oil in 28% yield, comparable to the literature value of 31% yield.   
 
Scheme 75. Synthesis of 2-14. 
Ethyl 2-nitropropanoate (2-15b) was synthesised from ethyl chloroformate via the 
imidazole derivative in 57% overall yield, according to literature procedures (Scheme 
76). In the first step, two equivalents of imidazole were added to ethyl chloroformate, 
generating imidazolium chloride as a side product, which can be removed by filtration, 
simplifying the workup procedure.152 The resultant oil was then treated with nitroethane 
in the presence of KOtBu to furnish 2-15b in 57% yield (reported yield was 90%).153 
The product was characterised by a distinctive doublet at 1.82 ppm in the 1H NMR 
corresponding to the α-proton. A sample of ethyl 2-nitroacetate (2-15a) had been 
synthesised by an analogous procedure from nitromethane by another member of the 
group. 
 
Scheme 76. Synthesis of 2-15b. 
2-Nitro-1-phenylethanone (2-16) was synthesised from 1-benzoylimidazole and 
nitromethane according to a modified literature procedure.154 The mixture was refluxed 
for 18 h, and upon cooling, the potassium salt of the product was collected by filtration, 
taking care to keep the residue wet, as nitro salts are potentially explosive. The salt was 
dissolved in water, acidified and extracted, and then the crude was recrystallised to give 
the product as white crystals in 29% yield (Scheme 77). The reported conditions for this 
reaction differ in that the isolated sodium salt of nitromethane is reacted directly with 1-
benzoylimidazole, giving an improved yield of 58%. The product can be identified by 
the methylene peak in the 1H NMR spectrum at 5.93 ppm, and a C=O stretch in the IR 
at 1699 cm-1, typical of an aryl ketone. 
2-18 2-14  
28% 
2-15b 2-19 
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Scheme 77. Synthesis of 2-nitro-1-phenylethanone. 
Methyl N-benzylidenealaninate (2-17) has been used extensively as a nucleophile in the 
synthesis of amino acid derivatives,155,156 and was synthesised from rac-methylalanine 
hydrochloride and benzaldehyde (Scheme 78). The reactants were stirred in aqueous 
sodium carbonate for 2 h, then extracted using CH2Cl2. This procedure has been used in 
the condensation of methylalanine hydrochloride with several substituted benzaldehydes 
giving yields of 72-85%,157 however in this work, the reaction with unsubstituted 
benzaldehyde resulted in a lower yield of 59%. The product can be identified by a 
characteristic singlet in the 1H NMR at 8.32 ppm, corresponding to the CHN moiety.  
 
 
Scheme 78. Synthesis of 2-17. 
Two electrophiles, 2-20 and 2-21 were investigated in this work. A sample of 2-20 had 
been prepared by another group member in a previous project.123  
 
 
Figure 13. Electrophiles examined. 
2-21 was synthesied in three steps from 2-oxazolidinone. According to the literature 
procedure,158 2-oxazolidinone was deprotonated with nBuLi, and acylated with 2-
chloroacetyl chloride, giving 2-22 in quantitative yield, closely matching the literature 
yield of 96%. This was then heated in triethylphosphite to generate the phosphonate 
ester 2-23 in 93% yield, which was condensed with acetaldehyde in a HWE reaction to 
give butenoyl-N-oxazolidin-2-one (2-21) in 63% yield as a low melting solid. Analysis 
of the 1H NMR of the crude reaction mixture revealed exclusive formation of the E-
alkene in the HWE reaction, determined by comparison to literature values.159 As is 
2-17 
2-16 
2-20 2-21 
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expected, the alkene protons for the E-isomer couple to each other more strongly (J = 
15.2 Hz) than those for the Z-isomer (J = 11.5 Hz).  
 
Scheme 79. Synthesis of 2-21. 
2.1.3.2. Michael Additions 
Our first attempt at asymmetric Michael reactions was based on the previous success of 
1-34c as a catalyst in the aza-Michael reactions developed by our group.122,123,160,161 In 
this reaction the chiral induction depends on the formation of a chelate between Michael 
acceptors of type 2-24 and the catalyst (Scheme 80). 
 
Scheme 80. Reactivity of chelating Michael acceptors. 
We proposed that the same chelate would react with nitroalkenes, leading to chiral 
masked γ-amino acid products (2-25, Scheme 81).  
 
 
Scheme 81. Nitroalkane anions as nucleophiles. 
2-22 
2-21 
2-25 
1-34c 
2-24 
2-23 
1-34c 
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The Michael acceptor N-((E)-but-2-enoyl)-benzamide (2-20) was adopted in our initial 
studies. As the first step of the reaction requires deprotonation of the nitro compound, 
these reactions would be expected to be promoted by the presence of a base. For this 
reason, catalyst 1-36c was employed (Scheme 82), which is believed to exist in 
equilibrium with its monomeric form 2-26. The hydroxyl ligand can act as a mild 
Brønsted base to deprotonate the nitroalkene, generating the Lewis acid 1-34c as the 
conjugate acid. Thus 1-36c can be considered a bifuctional catalyst, acting as both a 
Brønsted base and a Lewis acid. 
 
Scheme 82 
This bifunctionality of catalyst 1-36c has been demonstrated by Sodeoka in the aza-
Michael reaction.162 Catalyst inhibition by high concentrations of electron rich anilines 
was overcome by adding the nucleophile as its triflate salt and catalyst 1-36c. Using this 
system, deprotonation of the amine salt by the catalyst generated the free base gradually 
as the reaction progressed.  This technique allows the scope of the reaction to be 
extended to include highly electron-rich nucleophiles such as benzyl amine (Scheme 
83). 
Scheme 83. Employing amine salts in aza-Michael reactions. 
In our initial work, the acceptor 2-20 was subjected to a series of reactions with 
different nucleophiles (Table 11) with THF as solvent to maintain homogeneity. 
Reactions were carried out in Radley tubes, which were charged with catalyst, then 
purged with nitrogen prior to addition of dry THF. Reactants were then added to the 
1-34c 
2-26 
(R)-1-36c (2.5 mol%) 
1-36c 
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solution in a single portion. No reaction was detected by TLC in any case at room 
temperature after 4 h, so they were heated to reflux for a further 18 h. When an 1H NMR 
spectrum of a concentrated aliquot of each reaction mixture was recorded, only starting 
materials were observed. 
 
Table 11. Reactions of 2-20 with nitrogen containing nucleophiles.a 
 
Entry Nucleophile pKab Yield 
1 
 2-17 
~19.2c,163 No Reaction 
2                                    17.2
164 No Reaction 
3               2-14 12.2
165 No Reaction 
4 
         2-15a
9.1166 No Reaction 
5 
                2-16   
7.7167 No Reaction 
aReaction Conditions: 2-20 (1 mmol), nucleophile (1 eq), rac-1-36c (2.5 mol%), 
THF (1 mL), 24 h, rt - reflux. bValues in DMSO. cValue for ethyl N-(4-
chlorobenzylidene)alaninate. 
 
The nucleophiles 2-17 (entry 1) and nitromethane (entry 2) were selected as they have 
both been used in amino acid synthesis.133-137,155,156 The pKa values for these species are 
high (Table 11), so the deprotonation of these species may not occur under the reaction 
conditions. With this in mind, more C-H acidic nucleophiles 2-14, 2-15a and 2-16 were 
also examined (entries 3 to 5).  
 
Previously, salts of anisidine (pKa 4.56 in DMSO/H2O, 4/1)168 and benzylamine (pKa 
9.81 in DMSO)169 had been employed successfully in this system (Scheme 83).162 
Through comparison of these values with those for the carbon nucleophiles (Table 11), 
the more acidic nitroalkanes (entries 4 and 5) would be expected to deprotonate under 
these conditions. In fact, the 31P NMR of a 1:1 mixture of (R)-1-36c with the 
nucleophile 1-phenyl-2-nitroethanone (2-16) showed an interesting interaction (Figure 
14, Spectrum B).  
rac-1-36c (2.5 mol%) 
2-20 
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Figure 14. A: 31P NMR spectrum of (R)-1-36c in THF. B: 31P NMR spectrum of (R)-1-36c and 2-
16 (1:1) in THF. DMSO-d6 as external reference. 
The peak at 29.1 ppm is due to the dimeric catalyst (1-36c) and the small peak at 33.7 
ppm indicates the presence of the monomeric catalyst (1-34c). The doublets at 34.3 ppm 
and 31.9 ppm form an AB spin system (J = 23.4 Hz) showing the formation of a 
complex between the catalyst and substrate (2-27). The presence of 1-34c suggests that 
the nucleophile existed in its deprotonated form, as no other proton source was present 
in the system (scheme 26). If this is a true equilibrium, then it would appear the reaction 
between 2-28 and 2-20 simply does not proceed in the presence of 1-34c.  
 
Scheme 84. Interaction of 2-16 with 1-36c. 
Seeking the existence of an acid-catalysed route, catalyst 1-34c was employed under the 
same reaction conditions. In this system, the nucleophile would either react as a neutral 
species in its enol form (2-29), or be acidic enough to be slightly deprotonated under the 
reaction conditions, however, no reaction was observed in this case.  
A 
B 
2-27 
δP 34.3, 31.9 
J 23.4 Hz 
 
1-36c  
δP 29.1 
2-16 
1-34c 
δP 33.7 
2-28 
2-27 1-36c 
1-34c 
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Scheme 85. 1-34c-catalysed reaction of 2-16. 
The possibility that the basic catalyst could deprotonate the N-H of the acceptor was 
also considered (Scheme 86). The pKa of a typical imine (Ac2NH, pKa 17.9 in 
DMSO)170 is substantially higher than that of 2-20, suggesting that this deprotonation is 
unfeasible, nevertheless chelation of the catalyst could stabilize the anion, shifting this 
equilibrium to the right.  
 
 
Scheme 86. Deprotonation of 2-12. 
To eliminate the possibility of this undesired interaction, the alkenoyl N-oxazolidinone 
2-21 was adopted as an acceptor, but again no reaction was observed by 1H NMR after 
18 h (Scheme 87).   
 
Scheme 87. Attempted addition to 2-21. 
Further to this, a number of other electrophiles were screened in reactions with 2-16. It 
was hoped that either the proposed palladium bound nucleophile (2-27) or the unbound 
enolate (2-28) would react, however no product was seen with β-nitrostyrene, 
acrylonitrile or methyl vinyl ketone in the presence of rac-1-36c (Table 12, entries 1-3). 
The reactions were also repeated unsuccessfully with catalyst rac-1-34c (entries 4 to 7).  
  
1-36c 
2-16 
rac-1-36c (2.5 mol%) 
2-21 
2-20 
(R)-1-34c (5 mol%) 
2-29 
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Table 12. Reactions of various electrophiles with 2-16.a 
 
Entry Electrophile Catalyst Yield 
1  rac-1-36c No Reaction
2 
 
rac-1-36c No Reaction
3  rac-1-36c No Reaction
4  rac-1-34c No Reaction
5 
 
rac-1-34c No Reaction
6  rac-1-34c No Reaction
7 2-21 rac-1-34c No Reaction
 Reaction conditions: 2-16 (0.2 mmol), electrophile (1.2 eq), 
1-34c (5 mol%)/1-36c (2.5 mol%), THF, rt, 24 h. 
 
A correlation between nitroalkyl anions’ pKa and nucleophilicity has been shown to 
exist; more C-H acidic nitroalkanes generally lead to less nucleophilic anions upon 
deprotonation.150 Hence, 2-16 is likely to be the least reactive of the nucleophiles 
studied (2-13 to 2-17, Table 11). Based in this assumption, the reactions in Table 12 
were repeated using the less acidic ethyl nitroacetate (2-15a, Table 13). The 31P NMR of 
this substrate with 1-36c (2:1 mixture) showed only the peak corresponding to 1-36c, 
with no apparent formation of a substrate-bound complex.  
  
2-16 
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Table 13. Reactions of various electrophiles with 2-16.a 
 
Entry Electrophile Catalyst Yield 
1  rac-1-36c No Reaction
2 rac-1-36c 43% 
3  rac-1-36c No Reaction
5 2-21 rac-1-36c No Reaction
6  rac-1-34c No Reaction
7 rac-1-34c No Reaction
8  rac-1-34c No Reaction
9 2-21 rac-1-34c No Reaction
 Reaction conditions: 2-15a (0.2 mmol), electrophile (1.2 eq), 
1-34c (5 mol%)/1-36c (2.5 mol%), THF, rt, 24 h. 
 
Again, no reaction was observed with 2-21, β-nitrostyrene or acrylonitrile in the 
presence of either catalyst 1-34c or 1-36c (entries 1 and 3 to 8). However, a slow 
reaction was observed with methyl vinyl ketone to generate 2-31. The product was 
identified in the crude reaction mixture by the characteristic double doublet at 5.24 ppm 
in the 1H NMR, corresponding to the methine proton at the stereogenic carbon. It was 
subsequently isolated by flash chromatography. 
 
Acrylonitrile and β-nitrostyrene are both considered to be more electrophilic towards 
1,4-additions than methyl vinyl ketone, so their inability to react in this system suggests 
that the methyl vinyl ketone is activated. The most likely explanation is that a small 
amount of monomeric catalyst (1-34c) is generated, which acts as a Lewis acid in this 
system (2-30, Scheme 88). 
2-15a 
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Scheme 88. Possible mechanism of reaction of methyl vinyl ketone with 2-15a. 
It was not known whether such a complex with methyl vinyl ketone would be capable 
of reacting asymmetrically, as the molecule only binds through a single point on the 
metal, and is likely to have substantial conformational freedom. To introduce a non-
racemisable stereocentre into the molecule, the reaction was repeated with the similar 
cyclic enones 2-cyclopentenone and 2-cyclohexenone, however no reaction was seen in 
either case (Scheme 89).  
 
Scheme 89. Attempted reactions with prochiral enones. 
Again using methyl vinyl ketone as the electrophile, the reaction was repeated with the 
racemic nucleophile ethyl 2-nitropropanoate (2-15b, Scheme 90). This reaction was 
considerably slower, and the product 2-31b was isolated in 21% yield after 72 h. The 
reaction can be monitored by the disappearance of the quartet at 5.22 ppm due to 2-15b 
in the 1H NMR spectrum, and the appearance of a multiplet at 2.59-2.38 ppm due to 
methylene peaks in the product.    
 
Scheme 90. Reaction of methyl vinyl ketone with 2-15b. 
rac-1-36c 
(R)-1-36c (2.5 mol%) 
2-31a 
2-30 
2-15b 
(R)-1-36c (2.5 mol%) 
2-15a 
2-15a 
2-31b 
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The enantiomers of the product could not be separated by chiral HPLC. According to a 
literature procedure,171 2-31b was derivatised to the ethylene glycol ketal (2-32) by 
heating a mixture of 2-31b, ethylene glycol and catalytic para-toluenesulfonic acid in 
toluene. Quantitative yield of 2-32 was obtained, which was sufficiently pure for 
characterisation without the need for chromatography. The 1H NMR of the product 
differs from 2-32, as it contains a multiplet at 3.90-4.00 ppm corresponding to the 
ethylene protons on the dioxolane ring.  
 
Scheme 91. Derivatisation of 2-32. 
Enantiomers of 2-32 were successfully separated by chiral HPLC, but no ee was 
observed (Table 14, entry 1).  The reaction was repeated in various solvents with little 
improvement in the reaction rate in any case, although a small ee of 13% was observed 
when the reaction was run in CH2Cl2 (entries 2 and 3).  In an attempt to improve this, 
the reaction it was repeated in CH2Cl2 with 10 mol% of catalyst at a higher 
concentration (4 M in 2-15b) for 70 h. This was the final investigation using 
nitroalkanes, as the reaction was still incomplete, giving a yield of 65% and an ee of 
only 4% (entry 4).  
 
Table 14. Effect of various solvents on the addition of ethyl nitroacetate to methyl vinyl ketone.a 
EtO
O
NO2
O
EtO
O
NO2
O
*rt, 72 h
 
Entry Solvent Yield (%)a ee (%)b
1 THF 22 3 
2 CH2Cl2 23 13 
3 Toluene 9 7 
4b CH2Cl2 65 4 
aReaction conditions: 2-15b (0.5 mmol), methyl vinyl 
ketone (2 eq), (R)-1-36c (2.5 mol%), rt, 24 h, THF 
(0.5 mL). aIsolated yield. bDetermined by chiral 
HPLC. Absolute stereochemistry assigned by 
comparison of [α]D to reported values.b10 mol% 
catalyst, 4 M in 2-15b. 
2-31b 2-32 
(R)-1-36c (2.5 mol%) 
2-15b 2-31b 
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2.1.4. Nitroalkene – Michael Donor Approach 
2.1.4.1. Synthesis of Precursors 
A range of nucleophiles were investigated in this part of the study, including the 
commercially available substrates 2-34 to 2-39 (Figure 15).  
 
  
Figure 15. Michael donors investigated. 
Methyl cyclopentanone-2-carboxylate (2-33) was synthesised by esterification of adipic 
acid with methanol in quantitative yield,172 followed by Dieckmann cyclisation to give 
the desired product in 88% yield after flash chromatography (Scheme 92).173  
 
Scheme 92. Synthesis of methyl cyclopentanone-2-carboxylate. 
The nitroalkene 2-41a was synthesized via a Henry reaction from benzaldehyde 
according to a procedure described in a patent.174 β-Nitrostyrene (2-41a) is a highly 
crystalline yellow solid, and precipitates from the solution upon acidification, 
simplifying the workup (Scheme 93). This product contains a distinctive singlet in the 
1H NMR at 8.03 ppm, corresponding to the benzylic proton. The same procedure was 
adopted for the synthesis of 1-nitropropene (2-41b) from acetaldehyde; however, the 
this product was a volatile liquid, requiring aqueous workup and distillation. The 1H 
NMR spectrum of 2-41b contains a multiplet at 7.19-7.10 ppm. 
  
2-33 
2-33 2-34 2-35 
2-39 2-38 2-37 
2-36 
2-40 
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Scheme 93. Synthesis of nitroalkenes. 
2.1.4.2. Michael Additions 
Our decision to investigate the reactions of β-ketoesters was based on previous 
successes of additions to enones by palladium catalysts (Scheme 94).31,32,60,175 The 
formation of reactive, chiral enolates from β-ketoesters with catalysts of type 1-34 has 
been demonstrated, however their reactivity with nitrogen containing electrophiles has 
not. 
Scheme 94. Reactions of palladium enolates. 
The first system studied was the reaction of 2-33 with β-nitrostyrene (2-41a) in the 
presence of 1-34c (Scheme 95). These substrates were chosen in our initial 
investigations, as this reaction had been demonstrated by a number of other groups.88-91 
The reaction was expected to proceed smoothly, as nitroalkenes are more activated 
towards 1,4-additions than the enones, which had been successfully employed by 
Sodeoka (Scheme 94). However, no reaction occurred in THF in the presence of rac-1-
34c at room temperature after 6 h, or upon heating to reflux for a further 18 h. 
 
Scheme 95. Michael addition to β-nitrostyrene. 
NMR analysis of a 1:1 mixture of 2-33 and 1-34c showed no change in the 31P NMR 
spectrum, but the 1H NMR showed significant broadening of the peak corresponding to 
2-41a (R = Ph) 77% yield 
2-41b (R = Me) 49% yield 
1-34c (5 mol%) 
2-41a  2-33 
1-34c 
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the α-proton of the β-ketoester (Figure 16). This is attributed to the fast, reversible 
formation of a catalyst-nucleophile complex such as 2-42a or 2-42b.  
 
 
 
 
Figure 16.  A: 1H NMR spectrum of 2-33 in CDCl3. B: 1H NMR spectrum of 2-33 (1 eq) and 1-
34c (1 eq) in CDCl3.  
It was postulated that protonation of the MVK is required in the reaction of enones 
catalysed by 1-34c (Scheme 94).32 A likely explanation for our result is that protonation 
of the nitroalkene did not take place under the reaction conditions, hence the 
electrophile was not sufficiently activated. 
 
The possibility that the enolate 2-42b was not forming under the reaction conditions 
was also considered. To investigate this further, the reaction was repeated using the 
dimeric catalyst rac-1-36c. Again, no reaction was observed (Scheme 96).  
2-42a 2-42b 
A 
B 
O
O
O
H
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Scheme 96. Reaction of 2-33 with 2-41a.  
31P NMR of a 2:1 mixture of 2-33 with catalyst 1-36c confirmed the formation of the 
nucleophile-catalyst complex 2-21 (Figure 17). The peak at 29.1 ppm corresponds to 
catalyst 1-36c, and the two doublets at 33.8 and 29.4 ppm are an AB spin system, due to 
the formation of complex 2-42b. Although this does not prove that such a species exists 
in the presence of catalyst 1-34c, it demonstrates that unactivated 2-41a does not react 
directly with the chelate complex 2-42.  
 
Figure 17. 31P NMR spectrum of a 2:1 mixture of 2-33 and 1-36c. 
The reaction was repeated with the less hindered electrophile 2-41b in the presence of 
catalysts rac-1-34c and rac-1-36c; no reaction was seen in either case after 24 h 
(Scheme 97).  
 
Scheme 97. Reaction of 2-33 with 2-41b. 
The possibility that the formation of the reactive intermediate 2-43 is reversible in the 
presence of 1-36c was also considered (Scheme 98). 
  
1-34c (5 mol%) / 1-36c (2.5 mol%) 
1-36c (2.5 mol%) 
2-41a  2-33 
2-33 2-41b 
1-36c 
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Scheme 98. Reversible Michael addition. 
A range of proton sources with very different pKa values were added to the system in an 
effort to accelerate the protonation of such a species (2-43). Using 1 equivalent of the 
proton source, some conversion was observed at reflux in several cases (Table 15). 
Water was found to be the most effective (entry 1) with conversion decreasing with 
increasing acidity of the proton source. Also, partial decarboxylation (~ 5%) of the 
starting material to form cyclopentenone was observed for entries 1-3 and complete 
decarboxylation of the starting material was observed with CSA (entry 4). Rates of 
conversion were calculated by integrating peaks in the 1H NMR corresponding to 2-33 
(triplet, 3.12 ppm), cyclopentanone (triplet, 2.19 ppm) and 2-44 (multiplet, 4.24-4.08 
ppm).  
 
Table 15. The effect of proton sources on the 1-36c-catalysed addition to β-nitrostyrene.a 
 
 
Entry Proton Source pKa176 
Conversion (to 
product, %) 
1 Water 32.0 52% b
2 Phenol 18.0 38% c
3 2-Methoxy-phenol 17.8 33% c
4 CSA ~1.6 0% c, d
aReaction conditions: 2-33 (1 eq), 2-41a (1 eq), rac-1-36c (2.5 mol%), proton 
source (1 eq), THF, reflux, 18 h. bIsolated yield after column 
chromatography. cConversion determined by 1H NMR by integration of 
peaks for 2-33, cyclopentanone and 2-44. dComplete hydrolysis of ketoester 
was observed. 
 
As a control, the reaction with water (entry 1) was repeated in the absence of palladium 
and a similar reaction rate was observed (100% conversion, 168 h). Also, the reaction 
reached completion within 24 h upon addition of 20 mol% of KF, in the absence of 
catalyst and proton source. These results led us to conclude that in the presence of water 
or fluoride, an enolate (2-45) or hydrogen bond activated enol (2-46/2-47) intermediate 
2-43  
2-33 2-41a 2-44 
 rac-1-36c (2.5 mol%) 
2-33 2-44  
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is likely to be responsible for the reactivity (Figure 18). Obviously this would not result 
in chiral induction, hence no further work was carried out using these additives. 
 
 
Figure 18. Possible intermediates in water/fluoride-catalysed reactions. 
Returning to the assumption that the nitro group could not be activated by protonation 
under the reaction conditions, our attention turned to other methods of activating the 
electrophile. Ureas are known for their ability to form hydrogen bonds with nitro groups 
(2-48),177 so N,N’-dimethylthiourea (2-49) and N,N’-diphenylurea (2-50) were 
investigated as additives in the reaction (Figure 19). 
 
Figure 19. Nitro group activation by ureas/thioureas. 
The additive 2-49 promoted the addition of 2-33 to β-nitrostyrene in the presence of 
rac-1-36c (Table 16, entry 2), however a slow background reaction was also observed 
in the absence of the palladium catalyst (entry 3). Conversely the presence of the 
monomeric catalyst rac-1-34c in this reaction had a detrimental effect on the rate (entry 
1). Additive 2-50 also promoted the reaction in the presence of rac-1-36c (entry 5) but 
the reaction was significantly slower. No reaction was observed in the absence of 
catalyst, or in the presence of catalyst rac-1-34c (entries 4 and 6). 
 
  
2-49 2-50 
2-45 2-46 2-47 
2-48 
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Table 16. The effect of various additives on the addition to β-nitrostyrene.a 
 
Entry Catalyst Additive Time (h) Conversion (%)
1 rac-1-34c 2-49 30 10 
2 rac-1-36c 2-49 2 100c 
3 None 2-49 30 89 
4 rac-1-34c 2-50 30 < 5 
5 rac-1-36c 2-50 30 39 
6 None 2-50 30 < 5 
aReaction conditions: 2-33 (1 eq), 2-41a (1.2 eq), 1-34c (5 mol%)/1-36c (2.5 mol%), 
additive (1 eq), THF, 30 h. bCalculated from 1H NMR.  
 
It appeared that the thiourea 2-49 activates the nitro group significantly in the reaction 
catalysed by 1-36c. Consequently, it was adopted as an additive in further experiments. 
To assess whether any chiral induction was occurring in this system the reaction was 
repeated with the chiral catalyst (R)-1-36c with various amounts of thiourea 2-49 (Table 
17, entries 1-4). The additive clearly accelerated the reaction, but no significant 
enantioselectivity was observed. Products were isolated as a ~3:1 mixture of 
diastereomers. The dr was determined by integration of the CH2NO2 resonances in the 
1H NMR at 5.03 (major diastereomer) and 4.85 (minor diasteromer), while the ee was 
Determined by chiral HPLC.  
 
Table 17. The reaction of 2-33 with 2-41a.a 
Entry Additive (eq) 
Time 
(h) 
Yield 
(%) dr
b ee
c (Diastereomer) 
(Major, %) (Minor, %) 
1 2-49 (0.05) 36 90 3.4:1 1% 3% 
2 2-49 (0.2) 24 91 2.7:1 0% 0% 
3 2-49 (1) 2 93 3.6:1 2% 5% 
4 2-49 (5) 1.5 94 3.8:1 1% 2% 
 5d 2-49 (1) 2 94 3.4:1 0% 5% 
6 2-50 (1) 4 92 2.9:1 0% 5% 
aReaction conditions: 2-33 (1 eq), 2-41a  (1.2 eq), additive, 1-36c (2.5 mol%), THF, rt. 
bDetermined by 1H NMR. cDetermined by chiral HPLC. Absolute stereochemistry assigned 
by comparison of [α]D to reported values. dReaction mixture stirred for 5 mins before 
addition of 2-33. 
 
In an attempt to clarify the effect of the thiourea in this system, an NMR experiment 
was undertaken, where catalyst 1-36c and an excess of thiourea 2-49 were dissolved in 
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CDCl3. The 31P NMR spectrum showed the complete disappearance of the peak at 
+29.1 ppm (spectrum A, Figure 20) corresponding to 1-36c, and the appearance of an 
AB spin system at +29.9 ppm and +23.1 ppm with a coupling constant of 30 Hz 
(spectrum B, Figure 20). The nature of this species is unknown, but presumably 
involves at least one thiourea bound to the palladium. If this binding is strong, the 
desired palladium bound enolate cannot form, thus inhibiting the catalytic reaction. 
Possible structures for this species include complexes 2-51a and 2-51b. 
 
 
Figure 20. A: 31P NMR spectrum of 1-36c. B: 31P NMR spectrum of 1-36c and 2-49 (8 eq). 
At this juncture, we concluded that using thiourea to activate the system was unlikely to 
lead to any enantioselectivity. Instead, a variety of other nucleophiles including β-
ketoesters, a malonate and a β-diketone were examined (Table 18). 
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Table 18. Nucleophiles screened with 2-41b.a 
 
Entry Nucleophile Catalyst Yieldb 
1 1-34c No Reaction 
2 1-36c No Reaction 
3 1-34c No Reaction 
4 1-36c No Reaction 
5 
 
1-34c No Reaction 
6 1-36c 92% 
7 
 
1-34c No Reaction 
8 1-36c No Reaction 
aReaction conditions: Nucleophile (1 eq), 2-41a (1.2 eq), 1-34c (5 mol%)/1-
36c (2.5 mol%), THF, rt, 4 h. bIsolated yield. 
 
Gratifyingly, ethyl acetoacetate reacted with β-nitrostyrene in the presence of 1-36c in 
92% yield and the reaction was complete within 4 hours (entry 6). However no 
significant ee was observed by employing catalyst (R)-1-36c (Scheme 99). The reaction 
was repeated with the bulkier substrate tert-butyl acetoacetate but the reaction was 
substantially slower and again racemic products were obtained.  
 
R Time (h) Yield (%) dr eea (%) 
Et 4 92 1.2:1 0 (6) 
tBu 16 25 1.2:1 1 (5) 
aValue for minor diastereomer in parenthesis. 
 
Scheme 99. Reactions of acetoacetates. 
As the stereocenter generated at the α-carbon can racemise in these substrates, the only 
non-racemisable stereocenter is that at the β-carbon. The results suggest that selectivity 
is not induced at this position.  
 
It was concluded that β-nitrostyrene was not a suitable substrate for this system. Unlike 
methyl vinyl ketone, it cannot be activated under the reaction conditions without 
(R)-1-36c (2.5 mol%) 2-52a (R = Et) 
2-52b (R = tBu) 
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promoting a dominant uncatalysed reaction. With this in mind, the potent Michael 
acceptor acrylonitrile was tested in the reaction with 2-33 under the same conditions. 
However, no reaction was seen in the presence of 1-34c (Scheme 100).  
 
Scheme 100. Michael addition to acrylonitrile. 
2.1.5. Other Michael Additions  
Up to this point, attempts to construct molecules with a nitrogen functionality that could 
easily be modified to give chiral γ-amino acids had been unsuccessful. At this juncture 
we decided that the scope of the study should be broadened to include other Michael 
reactions that can generate interesting, chiral, synthetic building blocks.  
 
A report by Evans and co-workers demonstrated the highly enantioselective addition of 
β-ketoesters to N-acylthiazolidinethiones catalysed by chiral Ni(II) complexes 2-53 
(Scheme 101).22 In the proposed mechanism, the catalyst bound Michael acceptor reacts 
directly with the enolised β-ketoester.   
 
Scheme 101. 2-53-catalysed Michael additions. 
This report prompted us to study the reactions β-ketoesters with N-((E)-but-2-enoyl)-
benzamide (2-20) in the presence of 1-34c (Table 19). It was hoped that the enol forms 
of the β-ketoesters would be sufficiently reactive without needing to be formally 
deprotonated. However, no reaction was seen in any case after 4 h at rt. 
(R)-1-34c (5 mol%) 
2-53 
2-53 (10 mol%) 
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Table 19. Screening results of varous nucleophiles with N-((E)-but-2-enoyl)-benzamide.a 
 
Entry Nucleophile Additive Yield 
1 
     
None No Reactiona 
2 DBU No Reaction 
3 piperidine No Reaction 
4 
      
None No Reactiona 
5 DBU No Reaction 
6 piperidine No Reaction 
7 
     
None No Reactiona 
8 DBU No Reaction 
9 piperidine No Reaction 
10 
MeO
O
OMe
O None No Reactiona 
11 DBU No Reaction 
12 
     
None No Reactiona 
13 DBU No Reaction 
14 piperidine No Reaction 
aReaction conditions: Nucleophile (1 eq), 2-20 (1.2 eq), 1-34c (5 mol%), 
additive (5 mol%), THF, rt, 18 h. aReaction time: 4 h. 
 
A catalytic amount of DBU was added to each reaction mixture to deprotonate the 
nucleophile. It was hoped that the enolate would react enantioselectively with the 
palladium bound Michael acceptor (Scheme 102). Once again, no reaction was seen in 
any case (entries 2, 5, 8, 11 and 13). However before the addition of the base, the peaks 
corresponding to the alkene protons appeared broadened in the 1H NMR, which was 
attributed to the reversible binding of 2-20 to the catalyst, but after addition of DBU 
these peaks appeared sharp, implying the catalyst was no longer binding to the Michael 
acceptor.  
 
Scheme 102. Nucleophile deprotonation by DBU. 
1-34c (5 mol%) 
2-20 
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Finally, the reaction was repeated with the keto-containing substrates, adding the 
secondary amine piperidine. It was hoped that an enamine intermediate would be more 
reactive than the equivalent enol (Scheme 103). Again, no reaction was seen in any case 
(entries 3, 6, 9 and 14).  
 
Scheme 103. Nucleophile activation by piperidine.  
2.2. Wider Investigation of Palladium(II)-Catalysed Reactions 
The first part of our studies did not reveal any suitable substrates for asymmetric 
catalysis effected by catalysts 1-34c and 1-36c, but it did provide us with an improved 
understanding of the behaviour of these systems.  
2.2.1. Synthesis of Precursors 
The cyclic β-ketoester 1-102 was adopted as a model compound for several reactions. It 
possesses a strong UV chromophore, which simplifies reaction monitoring by TLC. It 
was prepared by a modified literature procedure, whereby 1-indanone was added to a 
solution of sodium hydride and dimethyl carbonate in toluene at 60 °C. The crude oil 
was distilled (140 °C, 0.1 Torr) to give the β-ketoester in 66% yield, which solidified 
upon standing (Scheme 104).178 The reported yield of 91% was not matched due to poor 
recovery during distillation. 
 
Scheme 104. Synthesis of methyl indanone-2-carboxylate. 
Following a literature procedure, cis-stilbene oxide (2-54) was synthesised in 99% yield 
from cis-stilbene and mCPBA in CH2Cl2 (Scheme 105).179 Cyclohexene oxide (2-55) 
was purchased from a commercial supplier.  
  
1-102 
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Scheme 105. Synthesis of cis-stilbene oxide. 
2.2.2. Additions to Enol Ethers 
The reaction of methyl indanone-2-carboxylate (1-102) with 2,3-dihydrofuran in the 
presence of 1-34c generated cyclic ether 2-56 in 33% yield (Scheme 106). The product 
was isolated as a 1:1 mixture of diastereomers, determined by integration of peaks in the 
1H NMR spectrum corresponding to H-1. The novel structure was confirmed by the 
presence of a multiplet at 4.77-4.71 ppm corresponding to H-2, and various multiplets at 
2.3-1.4 ppm corresponding to H-3 and H-4.  
 
Scheme 106. Reactions of enol ethers. 
Mechanistically the reaction proceeds via protonation of the enol ether to generate the 
active electrophile (2-57), which reacts with the activated β-ketoester (Scheme 107, 
equation 1). The reaction was not investigated further as shortly after this discovery, 
similar work was published (equation 2) where it was demonstrated that in the presence 
of 1-34c, electrophilic oxonium ions (2-58) could be generated from acetals such as 2-
59, as discussed in chapter 1.50  
 
Scheme 107. Generation of oxonium ions. 
2.2.3. Additions to Aromatic Compounds 
Another range of electrophiles assessed were the aromatic heterocycles such as pyrrole, 
furan, indole and benzofuran. C-3 protonation of these species could potentially allow 
rac-1-34c 1-102 
2-54 
2-56 
2-57 
2-59 2-58 
2-55 
2-56 
1-102 
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additions by the same mechanism as was found to proceed in the reaction with 2,3-
dihydrofuran, generating 2-substituted heterocycles, however no reaction was observed 
in THF with any of these heterocycles (Scheme 108). 
 
Scheme 108. Reactions of aromatic heterocycles. 
2.2.4. Additions to Epoxides  
The success of the additions to cyclic enol ethers led us to attempt the reaction of 
cyclopentanone-2-carboxylate 2-33 with cyclohexane oxide as the electrophile in the 
presence of 1-34c (Scheme 109). Again, the electrophile was chosen as it can be 
activated by protonation. Under these conditions, none of the desired product 2-60 was 
formed, although a slow decomposition of the cyclohexane oxide was observed.  
 
Scheme 109. Reaction of cyclohexene oxide. 
This decomposition suggested the epoxide was being activated, either by Brønsted acid 
as intended, or by binding of the catalyst. The notion of a catalyst bound epoxide led to 
the investigation of other nucleophiles in this reaction. Gratifyingly, the addition of 
aniline to cyclohexene oxide in the presence of (R)-1-34c, proceeded in 55% yield with 
complete consumption of the cyclohexene oxide (Scheme 110). The product was 
isolated as a single diastereomer, identified as the trans-product by comparison of the 
1H NMR with literature data. The trans-isomer is characterised by a peak at 3.17 ppm 
(ddd),180 which is shifted to 3.44-3.37 ppm (m) for the cis-isomer.181 
 
 
Scheme 110. Reaction of aniline with cyclohexene oxide. 
1-34c (5 mol%) 
(R)-1-34c 
1-102 
2-33 
2-61 
rac-1-34c 
2-60 
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The enantiomers were separated by chiral HPLC, although no significant 
enantioselectivity was observed, even by varying temperature or solvent (Table 20, 
entries 1-4). On the othe hand, no reaction was observed with the nucleophiles benzyl 
alcohol or diphenyl amine (entries 5 and 6). 
 
Table 20.  Additions to cyclohexene oxide.a 
Entry Nucleophile Solvent Temp  (°C) 
Time  
(h) 
Yield  
(%)b 
ee 
(%)c 
1 aniline THF rt 4  55 4 
2 aniline THF -30 30  -d 7 
3 aniline CH2Cl2 -30 30  -d 4 
4 4-chloroaniline CH2Cl2 rt 18  18 4 
6 benzyl alcohol CH2Cl2 rt 18  0 - 
7 diphenyl amine CH2Cl2 rt 18  0 - 
aReaction conditions: Nucleophile (1 eq), cyclohexene oxide (1.2 eq), 1-34c (5 mol%). 
bIsolated yield. cDetermined by chiral HPLC. Absolute stereochemistry assigned by 
comparison of [α]D to reported values. dProduct not separated from crude mixture. 
 
Ring opening of a meso-epoxide is a desymmetrisation reaction, where the absolute 
stereochemistry of the product is dependent on the regioselectivity of the attack 
(Scheme 111).  
 
 
Scheme 111. Desymmetrisation of cyclohexene oxide. 
There are numerous examples of this approach to synthesise optically active β-amino 
alcohols, catalysed by chiral Lewis acids. Highly selective catalysts developed for this 
reaction include 2-62,182 2-63183 and 2-64184 (Figure 21).  
  
(S,S)-2-61 (R,R)-2-61 
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Figure 21. Catalysts for asymmetric epoxide ring opening. 
Table 21 shows results obtained for aniline additions to cyclohexene oxide and cis-
stilbene oxide using these catalysts. In every case, the amino alcohol product 2-61 is 
formed with lower enantioselectivity than the corresponding product (2-65a) derived 
from cis-stilbene. 
 
Table 21. Epoxide ring opening results.a 
 
 
Entry Catalyst 
Product 2-61 Product 2-65a 
Yield (%) ee (%) Yield (%) ee (%) 
1 2-62 96 54 95 93 
2a 2-63 92 39 90 78 
3b 2-64 95 67 99 99 
aAddition of  triphenylphosphine improved selectivities. bAddition of 2-
methoxybenzylidene benzylamine improved selectivities. 
 
In light of this trend, further studies were undertaken with cis-stilbene oxide. 4-
Chloroaniline was selected as it does not cause gradual degradation of the catalyst 
during the reaction. The reaction of cis-stilbene oxide with 4-chloroaniline in the 
presence of (R)-1-34c occurred slowly, but in good yield and furnished the expected 
product with an ee of 21% (Scheme 112). Again, only one diastereomer was formed, 
2-62 2-63 
2-64 
2-65a 2-61 
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and comparison with literature data showed this to be the expected syn-product 2-65b, 
identified by the CH doublets at 4.87 and 4.52 (J = 5.6 Hz) in the 1H NMR.183 
Conversely the NMR of the anti-epimer would contain peaks at 4.70 and 5.18 ppm (J = 
4.5 Hz).185 The absolute configuration was determined as (1S,2S) by comparison with 
literature HPLC data.186 
 
Scheme 112. 1-34c-catalysed ring opening of cis-stilbene oxide. 
A variety of solvents were screened in this reaction, analysing the crude mixtures by 
HPLC after 18 h (Table 22). The best result was achieved with MeCN, however this 
reaction was later extremely slow, achieving only 13% conversion in 4 h (determined 
from 1H NMR), compared to 28% obtained using CH2Cl2. The chlorinated solvents 
(entries 1, 6, and 7) all gave similar selectivities, and all other solvents were 
significantly inferior. Notably methanol and DMF (entries 4 and 9) gave the opposite 
enantioselectivity, implying the solvent plays an important role in the stereodefining 
step. 
 
Table 22. Effect of solvents on the addition of 4-cholroaniline to cis-stilbene oxide.a 
Entry Solvent ee (%)b 
1 CH2Cl2 21 
2 THF 1 
3 Dioxane 2 
4 Methanol -6 
5 Toluene 7 
6 DCE 21 
7 Chloroform 17 
8 MeCN 29 
9 DMF -16 
10 DMSO -c 
11 Acetone 5 
aReaction conditions: 4-chloroaniline (1 eq), cis-
stilbene oxide (1.2 eq.), 1-34c (5 mol%), 18 h, rt, 
products not separated from crude mixture. 
bDetermined by chiral HPLC cNo product 
observed. 
 
(1S,2S)-2-65b 
(R)-1-34c (5 mol%) 
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Our group has recently shown that palladium triflate can act as a precursor for catalysts 
of general structure [PdL2(H2O)2]2+[TfO]-2, where L2 is a bidentate ligand (Scheme 
113).187 Active catalysts can be generated by mixing ligand with palladium triflate in 
toluene, enabling rapid parallel screening of ligands.187  
 
Scheme 113. In situ generation of palladium complexes. 
Table 23. Various ligands in the reaction of 4-cholroaniline with cis-stilbene oxide.a 
Entry 
Ligand Catalyst 31P 
(δ, ppm) 
Conversionb 
(%) 
eec
(%) Structure Name 
1 
 
(S,S)-Me Du Phos 81.9 0% - 
2 
 
(R)-Phanephos 47.3 16% -11% 
3 
 
(R)-SpirOP 112.7 11% -7% 
4 
 
(R,R)-DIOP 21.2 17% -1% 
5 
 
(R)-Tol-BINAP 32.5 31% -1% 
6 
 
(R)-P-Phos 29.8 32% 30% 
aReaction conditions: 4-chloroaniline, cis-stilbene oxide (1.2 eq.), [Pd(ligand)(H2O)2]2+[TfO]-2 (5 
mol%), CH2Cl2, rt, 18 h, products not separated from crude mixture. bDetermined by 1H NMR. 
cDetermined by chiral HPLC. Absolute stereochemistry assigned by comparison of [α]D to reported 
values.  
 
We attempted to employ this method of catalyst generation to the reaction of aniline 
with cis-stilbene oxide. However, with CH2Cl2 as the solvent, catalyst 1-34c generated 
in situ failed to give the same result obtained with isolated catalyst. This is likely to be 
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caused by the poor solubility of palladium triflate in CH2Cl2. Due to difficulties 
obtaining repeatable results, a small amount of each catalyst was generated in MeCN 
and isolated either by crystallisation, or by concentration followed by trituration. In each 
case the 31P NMR showed the formation of a single compound. The catalysts were used 
immediately in the reaction of cis-stilbene oxide in CH2Cl2 (Table 23). A small screen 
was performed; the highest ees observed were 30% (entries 6 and 7) and in every case 
the reaction was slow.  
 
In an attempt to accelerate the reaction, it was repeated using (R)-1-34c at a range of 
concentrations. As expected, an increase in concentration gave a greater conversion, 
however it was acompanied by a decrease in the ee (Table 24). 
 
Table 24. Effect of concentration on the reaction of 4-cholroaniline with cis-stilbene oxide.a 
Entry Concentration Conversion (%)b ee (%)c 
1 4 M 64% 16% 
2 2 M 57% 15% 
3 1 M 54% 20% 
4 0.5 M 21% 21% 
aReaction conditions: 4-chloroaniline, cis-stilbene oxide (1.2 eq), (R)-
1-34c (5 mol%), CH2Cl2, rt, 18 h, products not separated from crude 
mixture. bDetermined by 1H NMR. cDetermined by chiral HPLC. 
Absolute stereochemistry assigned by comparison of [α]D to reported 
values.  
 
During the addition of 4-chloroaniline to cis-stilbene oxide, 31P NMR spectra of 
reaction mixtures showed the appearance of an AB spin pattern at 29.3 and 28.2 ppm (J 
= 24.4 Hz), with complete disappearance of the peak at ~33 ppm corresponding to 1-
34c. This was believed to be due to formation of a complex between 1-34c and the 
product 2-65b (Figure 22). This was confirmed by mixing 2-65b (10 equivalents) with 
1-34c in CH2Cl2 and observing an identical 31P NMR spectrum. Such product binding 
deactivates the catalyst, and may be a significant factor in lowering the rate of reaction.  
 
 
Figure 22. Proposed catalyst-product complex. 
2-66 
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Mechanistically, the reaction of aniline can proceed via either an SN1 or SN2 pathway. 
In all reactions with epoxides, only the syn-diastereomer relating to inversion of 
configuration was isolated, strongly suggesting the SN2 pathway is in effect. However 
the possibility of a highly diastereoselective reaction between the carbocation 
intermediate (2-67) and aniline cannot be discounted (Scheme 114). 
 
Scheme 114. Possible pathways in the cis-stilbene oxide ring opening reaction. 
In the reactions described so far, the 4-chloroaniline and cis-stilbene oxide were added 
simultaneously to a solution of the catalyst, and no side products were observed. 
However when the aniline was omitted, the epoxide was rapidly converted to 2,2-
diphenylacetaldehyde (2-68) via phenyl migration within 1 h.  This product was 
observable by NMR in the crude mixture, but required conversion to the DNP derivative 
2-69 prior to isolation (Scheme 115). This Lewis acid catalysed rearrangement has been 
observed before for this substrate.188 
 
Scheme 115. Rearrangement of cis-stilbene oxide by 1-34c. 
The rate of this reaction is significant; rearrangement to 2-68 in the absence of aniline is 
substantially faster (<1 h) than the reaction with 4-chloroaniline (>72 h). As 2-68 is not 
formed when the aniline is present, the aniline must inhibit the rearrangement pathway.  
2.3. Conclusion 
In this chapter, the reactions of nitroalkanes with Michael acceptors in the presence of 
palladium(II) catalysts 1-34c and 1-36c were investigated. These catalysts were 
ineffective, with the exception of the 1-36c-catalysed addition of ethyl nitroacetates 2-
1-34c 
2-67 
2-65b 
2-69 
2-68 
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15 to methyl vinyl ketone, which proceeded slowly under various conditions, with ees 
of 3-13%.  
 
Reactions of nitroalkenes with β-ketoesters catalysed by 1-34c and 1-36c were also 
investigated. 1-36c-catalysed reactions of α-subsitituted β-ketoesters only proceeded in 
the presence of an additive, and dimethyl thiourea was found to be highly activating, but 
led to racemic products. α-Unsubsitituted β-ketoesters reacted with nitroalkenes 
catalysed by 1-36c in the absence of any additive, but no significant chiral induction 
was observed. In an extension to this work, the reaction of β-ketoesters and other 
potential nucleophiles were screened, unsuccessfully, for reaction with the chelating 
Michael acceptor 2-20. 
  
As attempts to identify a novel, asymmetric Michael reaction promoted by palladium(II) 
had been unsuccessful, a number of related reactions were investigated. β-Ketoester 1-
102 was found to react with DHP in the presence of 1-34c, however this reaction was 
not investigated further as similar reactions were published by another group shortly 
after. The reaction of β-ketoester 1-102 with cyclohexene oxide was also examined, 
unsuccessfully, but led to the investigation of 1-34c promoted epoxide ring opening 
with anilines. Screening of various chiral ligands in the reaction of 4-chloroaniline with 
cis-stilbene oxide gave the 2-aminoalcohol with up to 30% ee.   
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Chapter 3: α-Hydroxylation of β-Ketoesters  
In addition to the C-C bond forming reactions of β-ketoesters discussed in Chapter 2, 
we were also interested in α-heterofunctionalisation reactions. Previously, palladium(II) 
salts had been applied to the reaction of β-ketoesters with fluorinating agents60,175 and 
azo compounds,67 leading to C-F and C-N bond forming reactions respectively. 
However, no reports relate to C-O bond forming reactions, which prompted us to 
investigate the α-hydroxylation reaction (Scheme 116). 
 
 
Scheme 116. α-hydroxyation of β-ketoesters. 
3.1. Synthesis of Precursors 
3.1.1. Synthesis of β-Ketoesters 
 
 
 
Figure 23. β-Ketoesters investigated. 
The range of β-ketoesters examined in this study is summarised in Figure 23. The 
synthesis of methyl indanone-2-carboxylate (1-102) was described in Chapter 2, while 
the acyclic ketoesters 3-13 and 3-19 were commercially available. Alkyl 
    1-102 (R=Me) 3-2 (R=Et) 
    3-3 (R=iPr)  3-4 (R=Bn) 
    3-5 (R=tBu)  3-6 (R=1-Ad) 
1-105 (R=Et) 
3-7 (R=Bn) 
1-37 (R=tBu) 
3-8 (R=Me) 
3-9 (R=Et) 
3-10 (R=Bn) 
3-11 
3-12 (R=Me)  
3-13 (R=Et) 
3-14 (R=Bn) 
3-15 (R=tBu) 
3-16 (R=Et) 
3-17 (R=tBu) 3-18  
3-19 
3-20 
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cyclopentanone-2-carboxylates 1-105 and 1-37 were synthesised by other group 
members via literature procedures.189,190 
 
Following a literature method for the synthesis of indanone derivatives 3-3 and 3-5, 
methyl indanone-2-carboxylate (1-102) was transesterified with various alcohols in the 
presence of dibutyl tin oxide.36 The procedure gave the isopropyl ester 3-3 in 69% yield, 
in agreement with the literature value (Table 25, entry 2). The procedure was modified 
for the synthesis of the tert-butyl ester 3-5 by fitting a short air condenser and refluxing 
the reaction mixture vigorously to allow the methanol generated to evaporate, driving 
the reaction to completion (entry 4). As a result, 3-5 was obtained in an improved 81% 
yield, compared to the literature value of 52%. This procedure was also extended to the 
synthesis of ethyl and benzyl esters (3-2 and 3-4) in good yields (entries 1 and 3), and 
the 1-adamantyl ester 3-6 in moderate yield (entry 5).  
 
Reactions were easily monitored by 1H NMR and were judged to be complete upon 
disappearance of the peak corresponding to the methyl ester in 1-102 at 3.82 ppm. 
Products 3-2 to 3-6 were found to decarboxylate slowly upon standing at room 
temperature to give indanone, but could be stored for several months in the freezer.  
 
Table 25. Transesterification of methyl indanone-2-carboxylate. 
 
Entry Substrate R Solvent Time (h) Yield (%) 
1 3-2 Et EtOH 4 79 
2 3-3 iPr iPrOH 18 69 
3 3-4 Bn toluene 4 88 
4 3-5 tBu toluene 3 81 
5 3-6 1-Ad toluene 96 51 
 
According to a literature procedure,191 methyl cyclopentanone-2-carboxylate (2-33) can 
be transesterified to give the benzyl ester (3-7) catalysed by DMAP in cyclohexane 
under Dean-Stark conditions in 89% yield. However the reaction did not reach 
completion after 24 h, as indicated by TLC analysis. This procedure relies on the 
immiscibility of cyclohexane and methanol to drive the reaction to completion; however 
1-102 
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no methanol was seen collecting in the Dean-Stark trap. Subsequently, the reaction was 
repeated in toluene, employing a short air condenser and refluxing vigorously (Scheme 
117). Under these conditions the reaction reached completion in 8 h, although the 
product can only be obtained with a yield of 55%, due to side product formation. 
 
 
 
Scheme 117. Synthesis of benzyl cyclopentanone-2-carboxylate. 
The β-ketoesters 3-8 and 3-9 were synthesised from tetralone via literature procedures 
analogous to that used for the preparation of methyl indanone-2-carboxylate (Scheme 
118).192 The relevant dialkyl carbonate and sodium hydride were stirred in toluene at 60 
°C, while a toluene solution of tetralone was added dropwise. This order of addition was 
required as the reaction is highly exothermic, but does not proceed below 50 °C. Unlike 
the indanone analogues, these products are oils that exist mainly in the enol form, as is 
typical of β-ketoesters containing a 6-membered ring. 
 
Scheme 118. Synthesis of alkyl tetralone-2-carboxylates. 
Benzyl tetralone-2-carboxylate (3-10) was synthesised by transesterification from the 
ethyl ester (3-9, Scheme 119) by a modified literature procedure,193 under the conditions 
previously applied to the transesterification of methyl indanone-2-carboxylate (1-102). 
The starting material and product proved to be inseparable by chromatography; however 
conversion could be monitored by 1H NMR by observing the multiplet at 4.33-4.24 ppm 
and singlet at 5.34 ppm, corresponding to the ester CH2 in the starting material and 
product respectively. The dibutyltin oxide-catalysed reaction was notably slower than 
that for the synthesis of the indanone analogue 3-4, but reached completion after 
refluxing for 18 h. This modification to the procedure resulted in an isolated yield of 
74%, an improvement on the reported yield of 58%.193 
3-37 
3-8, R = Me, 74% 
3-9, R = Et, 56%   
2-33 
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Scheme 119. Synthesis of benzyl tetralone-2-carboxylate. 
Benzyl cyclohexanone-2-carboxylate (3-11) was synthesised in two steps from pimelic 
acid (Scheme 120). Esterification was achieved by following a literature procedure for 
the esterification of 4-ketopimelic acid,194 by reacting the isolated cesium dicarboxylate 
salt with benzyl bromide. Although the reaction proceeded in quantitative yield, 
removal of DMF required aqueous workup followed by flash chromatography. 
Dieckmann condensation of the diester was complete in 18 h, and 3-11 was isolated in 
in 71% yield. Again, this product exists as an oil, mainly in the enol form. 
 
Scheme 120. Synthesis of benzyl cyclohexanone-2-carboxylate. 
Methyl 3-phenyl-2-acetylpropionate (3-12) was synthesised via a transesterification 
reaction from ethyl 3-phenyl-2-acetylpropionate and methanol (Scheme 121), catalysed 
by dibutyltin oxide. The starting material and product could not be separated by 
chromatography, so the removal of the solvent in vacuo followed by addition of 
methanol at 24 h intervals was required to achieve complete conversion. The reaction 
was monitored by 1H NMR, observing the disappearance of the multiplet at 4.12-4.07 
ppm corresponding to the ethyl ester. This product, and all other acyclic β-ketoesters 
synthesised were colourless oils. 
 
Scheme 121. Synthesis of methyl 3-phenyl-2-acetylpropionate. 
Several unsubstituted β-ketoesters were alkylated, including the commercially available 
precursors 2-39, 3-21 and 3-22. tert-Butyl benzoylacetate (3-23) was synthesised 
according to a literature procedure from tert-butyl acetoacetate (Scheme 122).195 This 
unusual reaction proceeds via formation of an imine, which is able to eliminate MeCN 
to generate the β-ketoester product (3-23). The crude product was recovered in 19% 
3-10   
3-11   
3-12  
87 
yield and used directly in the next step without purification, however the literature yield 
for this reaction is not reported.  
 
Scheme 122. Synthesis of tert-butyl benzoylacetate. 
Benzyl bromide and iodomethane reacted cleanly with these β-ketoesters (3-20 to 3-23) 
in the presence of potassium carbonate (Table 26). All reactions were easily monitored 
by 1H NMR, following the disappearance of the α-methylene peak (3.4-4.0 ppm). 
Methylated products were characterised by a quartet signal at 3.6-4.4 ppm, and 
benzylation products by the presence of a triplet or double doublet resonance at 3.7-4.6 
ppm. This procedure was used to generate a range of substrates in 72-86% yield. No 
overalkylated products were observed, even when 2 equivalents of alkylating agent was 
used. 
 
Table 26. Mono-alkylation of unsubstituted β-ketoesters.   
 
Entry R1 R2 R3X Product Yield (%) 
1 Me Bn BnBr 3-14 86 
2 Me tBu BnBr 3-15 72 
3 Ph Et MeI 3-16 85 
4 Ph tBu MeI 3-17 75 
5 Me Bn MeI 3-18 76 
6 Ph Et BnBr 3-20 83 
2-39  3-21  3-22 
3-23  2-39  
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This method could not be extended to reactions with allyl bromide however, as an 
inseperable mixture of starting material, mono and disubstituted products was obtained, 
as determined by integration of the alkene and ester peaks in the 1H NMR spectrum 
(Scheme 123). 
Scheme 123. Alkylation with allyl bromide. 
3.1.2. Synthesis of Oxidants 
Various oxidizing agents were synthesised, including oxaziridines 1-94b and 1-94c, 
obtained in two steps according to literature procedures.196,197 A mixture of para-
toluenesulfonamide and the corresponding benzaldehyde was reacted under Dean-Stark 
conditions catalysed by amberlyst-15, to provide N-benzylidene toluenesulfonamides 3-
24 (Scheme 124). At the end of the reaction, the catalyst was removed by filtration of 
the hot solutions, which afforded crystalline product upon cooling. These products were 
used directly in the oxidation by mCPBA under phase-transfer conditions, giving 
moderate overall yields of 1-94, which is consistent with literature values. 1H NMR 
spectroscopy allowed these reactions to be followed by monitoring the resonance signal 
of the benzylic CH peak. In the benzaldehydes, a peak was observed at ~10.0 ppm, 
shifting to ~9 ppm for the sulfone imines (3-24) and ~5.5 ppm for the oxaziridines (1-
94). 
 
Scheme 124. Synthesis of oxaziridines. 
Cyclic oxaziridine 1-96 was synthesised according to a literature procedure (Scheme 
125).198 Methylation of saccharin gave the intermediate sulfone imine (3-25), and this 
3-24  1-94b (R = H), 62%, 2 steps  
1-94c (R = NO2), 51%, 2 steps  
 
3-24a (R = H), 
3-24b (R = NO2) 
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crude product was oxidized via the same procedure used for oxaziridines 3-19a and 3-
19b. The overall yield was significantly lower than the literature value (54%, 2 steps) 
due to a poor recovery in the methylation step. This may have been caused by 
contamination of the reaction mixture by water, as a large amount of starting material 
was recovered upon acidification of the aqueous washings. 
 
Scheme 125. Synthesis of oxaziridines. 
Dimethyldioxirane (DMD) was generated according to a literature procedure (Scheme 
126).199 A buffered aqueous solution of acetone was reacted with oxone 
(2KHSO5·KHSO4·K2SO4), and distillation provided a dilute solution of DMD in 
acetone. The yield with respect to the active component of oxone (potassium 
peroxymonosulfate, KHSO5), is extremely low (~1%) as the majority of the reagent 
spontaneously decomposes to molecular oxygen. However the starting materials are 
inexpensive and the procedure is simple, making it practical at laboratory scale. The 
concentration of the resulting solution of DMD in acetone was determined by titration 
with phenyl methyl sulfide, which reacts with DMD rapidly to form phenyl methyl 
sulfoxide. 1 mL of the DMD solution was added to c.a. 0.2 mmol of the sulfide and the 
resulting solution was concentrated and analysed by 1H NMR spectroscopy. Conversion 
of sulfide to sulfoxide was determined by comparing integration of the sulfide signal at 
~2.5 ppm and sulfoxide signal at ~2.9 ppm. Depending on the reaction conditions, 
typical concentrations range between 0.05-0.09 M. The DMD solution is volatile and 
gradually decomposes at room temperature, but can be stored in a sealed vessel in the 
freezer for several days. 
 
 
Scheme 126. Synthesis of DMD. 
  
3-25  1-96  
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3.1.3. Synthesis of Catalysts 
During the course of this work the complex [Pd(R-Phanephos)(H2O)2]2+[TfO]-2 (3-26) 
was investigated as a catalyst. This was synthesised by the same procedure employed 
for the BINAP analogue 1-34c (Scheme 127). Whilst the BINAP catalyst was readily 
crystallised from MeCN/Et2O, the phanephos catalyst is less crystalline than 1-34c, 
requiring a different workup procedure. Concentration of the reaction mixture gave an 
orange oil, which was triturated with cyclohexane to give a solid. Recrystallisation from 
THF/cyclohexanone gave an orange powder which gradually darkened in colour to red 
upon standing. Although the 1H NMR is difficult to interpret due to the presence of 
several broad peaks, the 31P NMR of this complex contains a single peak at 47.8 ppm. 
Further characterisation was provided by a satisfactory elemental analysis.   
 
Scheme 127. Synthesis of catalyst 3-26. 
3.1.4. Synthesis of Racemic α-Hydroxy-β-ketoesters 
The development and validation of HPLC methods required the synthesis of a racemic 
sample of every α-hydroxy-β-ketoester investigated. In most cases, this was acquired by 
employing the catalysts rac-1-34c or rac-1-36c under the conditions of the asymmetric 
hydroxylation procedures. Several procedures employing aerobic oxygen, as discussed 
in Section 3.2.1, were also employed. Three indanones were oxidised in the presence of 
cobalt(II) chloride200 with consistiently good yields (Table 27, entries 1-3), however 
tetralones 3-9 and 3-10 gave poor results under these conditions (entries 4 and 5). In 
comparison, 3-8 was oxidised in 76% yield when the catalyst cerium(III) chloride201 
was employed (entry 6). 
  
(R)-3-26 
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Table 27. Aerobic oxidation of cyclic substrates. 
 
Entry Substrate Catalyst Time (h) Yield (%) 
1 3-2 (R = Et, n = 1) CoCl2a 20 67 
2 3-3 (R = iPr, n = 1) CoCl2a 20 66 
3 3-4 (R = Bn, n = 1) CoCl2a 20 67 
4 3-9 (R = Et, n = 2) CoCl2a 24 No reaction 
5 3-10 (R = Bn, n = 2) CoCl2a 18 26 
6 3-8 (R = Me, n = 2) CeCl3b 0.5 76 
aReaction conditions: Substrate (1 eq), 1 atm O2, CoCl2 (5 mol%), MeCN/IPA (2/1), 
60 °C. bReaction conditions: 1 atm O2, CeCl3.7H2O (5 mol%), IPA, rt. 
 
Acyclic substrates gave α-hydroxy products via aerobic oxidation with mixed results. 
Cobalt chloride-catalysed the oxidation of several ketoesters in varying yields (Table 
28, entries 1, 3 and 4), however the reaction failed for α-benzyl substrates (entries 2 and 
6). Hydroxylation of α-benzyl substrate 3-20 was also attempted with cerium chloride201 
unsuccessfully. However, these substrates were successfully oxidised in the presence of 
cesium carbonate202 (entries 2 and 6-9). 
 
Table 28. Aerobic oxidation of acyclic substrates. 
 
Entry Substrate R1 R2 R3 
Yield, % (time, h) 
CoCl2a CeCl3b Cs2CO3c 
1 3-19 Me Ph Et 61 (20)   
2 3-13 Me Bn Et 0d (24)  55 (48) 
3 3-18 Me Me Bn 23 (24)   
4 3-16 Ph Me Et 40 (24)   
5 3-17 Ph Me tBu   0d (18) 
6 3-20 Ph Bn Et 0d (18) 0d (4) 32 (72) 
7 3-12 Me Bn Me   76 (24) 
8 3-15 Me Bn tBu   56 (24) 
9 3-14 Me Bn Bn   32 (24) 
aReaction conditions: 1 atm O2, CoCl2 (5 mol%), MeCN/IPA (2/1), 60 °C. bReaction 
conditions: 1 atm O2, CeCl3.7H2O (5 mol%), IPA, rt. cReaction conditions: 1 atm air, 
Cs2CO3 (10 mol %), DMF, rt. dStarting material recovered. 
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3.2. α-Hydroxylation Reactions 
3.2.1. Reagents 
The α-hydroxylation of β-ketoesters has been carried out using a wide range of 
oxidants. Peracids have been employed as oxidants for racemic reactions with some 
success. Although high yielding examples do exist,203 the reaction is generally low 
yielding due to competing Baeyer-Villiger oxidations (Scheme 128, equation 1).204 This 
problem is usually overcome by forming the relevant silyl enol ether which is able to 
undergo oxidation cleanly, forming hydroxylation products after hydrolytic 
rearrangement of the epoxide (equation 2).205 This two step procedure is known as the 
Rubottom oxidation.206   
 
Scheme 128. Reactions of peracids with β-ketoesters. 
Another reagent used for the α-hydroxylation of β-ketoesters is DMD (Table 29). The 
reaction proceeds slowly uncatalysed (entry 1),207 but can be accelerated by addition of 
either fluoride (entry 2) or Ni(acac)2 (entry 3).208 
 
Table 29. Relative rates of α-hydroxylation by DMD.  
 
Entry Additive  
DMD 
(eq) 
Time 
(h) 
Yield 
(%) 
1 None 3 72 100 
2 KF (1 eq) 1 1 85 
3 Ni(acac)2 (10 mol%) 1 3.5 >95 
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As discussed in section 3.1.4, molecular oxygen can also be used to α-hydroxylate β-
ketoesters in the presence of a metal catalyst (Table 30). Cesium carbonate gave good 
results for the small range of acyclic substrates reported (entry 1),202 conversely 
manganese acetate209 and cerium chloride201 were mostly successful for cyclic 
substrates (entries 2 and 4). Cobalt chloride is more generally applicable, giving good 
yields for both cyclic and acyclic substrates (entry 3).200  
 
Table 30. Aerobic oxidation of β-ketoesters. 
   
 
Entry Catalyst 
Product 3-27 Product 3-28 
Time (h) Yield (%) Time (h) Yield (%) 
1 Cs2CO3a 65 75 - - 
2 Mn(OAc)2b - - 14 89 
3 CoCl2c 24 65 2 83 
4 CeCl3d 16 30 16 99 
aReaction conditions: 1 atm air, Cs2CO3 (10 mol %), DMF, rt. bReaction conditions: 1 atm O2, 
Mn(OAc)2.4H2O (5 mol%), CH2Cl2, rt. cReaction conditions: 1 atm O2, CoCl2 (5 mol%), MeCN/IPA, 60 °C. 
dReaction conditions: 1 atm O2, CeCl3.7H2O (5 mol%), IPA, rt. 
 
The first asymmetric α-hydroxylation was reported by Davis, employing a 
stoichiometric amount of chiral oxaziridines 3-29 (Scheme 129).5 Low temperatures 
were required for these reactions due to the high reactivity of the lithium enolates. Even 
so, side reactions were often observed. As discussed in chapter 1, several racemic 
oxaziridines (1-94a and 1-96), hydrogen peroxide, tert-butyl hydroperoxide, cumyl 
hydroperoxide and 4-chloronitrosobezene (1-130) have since been employed in catalytic 
asymmetric versions of this reaction.71,72,121,210,211 These methods have generally 
superseded the use of chiral oxaziridines in the hydroxylation of β-ketoesters. However, 
chiral oxaziridines have been generally applied to the asymmetric α-hydroxylation of 
ketones,212 whereas catalytic methods have not been demonstrated. 
 
3-27 3-28 
94 
 
Scheme 129. α-Hydroxyation with chiral oxaziridines. 
In light of this, a number of oxidants were screened for reactivity with 1-102 in the 
presence of catatlyst 1-34c (Table 31). Best results were seen with racemic oxaziridines 
1-94b and 1-94c, giving clean reactions that were complete within 18 h, with some level 
of enantioselectivity (entries 1 and 2). Conversely, the chiral camphorsulfonyl 
oxaziridines (+)-3-23a and (-)-3-23a did not afford any reaction under these conditions 
(entries 3 and 4). These reagents are considerably more sterically hindered than 
oxaziridines 1-94b and 1-94c and this may explain their lack of reactivity. Other 
commercially available oxidants studied gave disappointing results. No reaction was 
observed with hydrogen peroxide (entry 5) and the organic peroxide tBuOOH led to 
very slow reaction with 13% enantioselectivity for the opposite enantiomer (entry 6). 
Reasonable yield was observed with mCPBA, but again the enantioselectivity was low 
(entry 7). By employing oxone, complete conversion was observed, however side 
product formation led to a low isolated yield (entry 8).  
  
3-29a (X = H) 
3-29b (X = Cl) 
3-29c (X = OMe) 
2) 3-23 
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Table 31.  Hydroxylation of 1-102 by various oxidants.a 
 
Entry Oxidant 
Conversionb 
(%) 
Yield 
(%) 
eec 
(%) 
1 100 99 30 (S)-(+) 
2 100 95 26 (S) 
3 
 
0 - - 
4 
 
0 - - 
5 H2O2 (30%, aq.) 0 - - 
6 tBuOOH (80%, aq.) 27 24 13 (R)-(-) 
7 mCPBA (70%) 71 64 16 (S) 
8 Oxone 100 24 13 (S) 
aReaction conditions: 1-102 (23.4 mg, 0.123 mmol), (R)-1-34c (10 mol%), oxidant (1.2 
eq), CH2Cl2 (0.5 mL), rt, 18 h. bCalculated by 1H NMR. cDetermined by chiral HPLC. 
Absolute stereochemistry assigned by comparison of [α]D to reported values. 
3.2.2. α-Hydroxylation With Oxaziridine 
3.2.2.1. Palladium-BINAP-Catalysed Reactions 
Of the various oxidants screened, best results were achieved with oxaziridine 1-94b, so 
a series of experiments were undertaken to optimise this reaction to improve the 
enantioselectivity. Reaction mixtures were analysed by 1H NMR, revealing a large 
number of components present during the course of the reaction. As well as starting 
material (keto and enol form) and product, the oxaziridine generates the by-product 3-
24a, which partially hydrolyses under the reaction conditions, generating benzaldehyde 
and para-toluenesulfonamide (Scheme 130). All of these components could be 
1-34c (10 mol%) 
(+)-3-29a  
(-)-3-29a  
1-94b 
1-94c 
3-30 
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identified in the crude NMR by the resonance signals highlighted in Scheme 130, 
allowing the progress of the reaction to be determined without the need for purification. 
In addition, HPLC conditions were developed that allowed the enantioselectivity to be 
determined from the crude mixture after removing the catalyst by filtration through a 
plug of silica, avoiding the need for column chromatography in the majority of the 
reactions (those where only conversions are reported). 
 
Scheme 130. Observed by-products. 
To investigate the effect of reaction medium on the outcome, a range of solvents were 
screened, keeping all other reaction parameters unchanged (Table 32). Despite the 
diverse range of solvents investigated, the original choice, CH2Cl2, was found to give 
the highest enantioselectivity. Overall, the solvent seemed to have little bearing on the 
result, with all reactions reaching completion within 18 h with no side product 
formation evident by 1H NMR, and most afforded ees of 20-30% (entries 1-7). The poor 
result with MeCN may be attributed to a strong competitive binding of the solvent to the 
metal centre (entry 8), while the inhomogeneous solution observed for the reaction in 
toluene may account for this poor result (entry 9).  
  
3-24a 
1-102 
3-30 
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Table 32. Solvent screening.a 
 
Entry Solvent 
Conversionb 
(%) 
eec
(%) 
1 MeOH 100 28 (S)-(+)
2 Chloroform 100 28 
3 iPrOH 100 26 
4 DMF 100 26 
5 THF 100 26 
6 Et2O 100 20 
7 EtOAc 100 20 
8 MeCN 100 13 
9 toluene 100 12 
aReaction conditions: 1-102 (0.123 mmol), (R)-1-34c (10 mol%), 
1-94b (1.2 eq), solvent (0.5 mL), 18 h. bCalculated by 1H NMR, 
cDetermined by chiral HPLC. Absolute stereochemistry assigned 
by comparison of [α]D to reported values.  
 
The choice of counterion was also briefly studied using commercially available 
palladium salts, generating the catalyst in-situ (Table 33). The use of palladium 
dichloride led to an inactive catalyst, giving low conversion and racemic products (entry 
1). This is unsurprising, as the strongly coordinating chloride ion would be more 
difficult to displace from the metal centre than triflate. Interestingly, the acetate and 
nitrate counterions gave good catalytic activity and ees similar to that of triflate (entries 
2 and 3). 
 
Table 33. Counterion screen.a 
 
Entry Precursor Conversion (%)b ee (%)c 
1 PdCl2 8 2 
2 Pd(OAc)2 100 25 (S)-(+) 
3 Pd(NO3)2 100 31 (S)-(+) 
aReaction conditions: PdX2 (10 mol%), (R)-BINAP (11 mol%), 
CH2Cl2, 30 mins, then 1-102 (1 eq), 1-94b (1.2 eq), rt, 18 h. 
bCalculated by 1H NMR. cDetermined by chiral HPLC. Absolute 
stereochemistry assigned by comparison of [α]D to reported values.  
 
1-34c (10 mol%) 
1-94b (1.2 eq) 
1-102 
1-94b (1.2 eq) 
1-102 
3-30 
3-30 
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Continuing to employ CH2Cl2 as solvent and triflate as counterion, the reaction was 
repeated with the dimeric catalyst 1-36c, and the rate of reaction compared to that with 
catalyst 1-34c, which initially had been allowed to react for 18 h without monitoring 
(Table 34). Both reactions were found to reach completion after 2 h, giving identical 
enantioselectivity (entries 1 and 2). In the absence of catalyst, the reaction proceeded 
with only 12% conversion after 5 h, under otherwise identical conditions (entry 3).  
 
Table 34. Comparison of catalysts 1-34c and 1-36c.a 
 
Entry Catalyst 
Time 
(h) 
Conversionb 
(%) 
eec  
(%) 
1 (R)-1-34c (10 mol%) 2 100 30 (S)-(+)
2 (R)-1-36c (5 mol%) 2 100 30 
3 None 5 12 - 
aReaction conditions: 1-102 (0.123 mmol), (R)-1-34c (10 mol%)/(R)-1-36c (5 
mol%), 1-94b (1.2 eq), CH2Cl2 (0.5 mL), 18 h. bCalculated by 1H NMR, 
cDetermined by chiral HPLC. Absolute stereochemistry assigned by 
comparison of [α]D to reported values.  
 
With this reaction failing to give product in high enantioselectivity under a variety of 
conditions, we turned our attention to the structure of the substrate. Previously, Sodeoka 
had shown that substrates containing tert-butyl esters lead to the highest 
enantioselectivities in 1-34c-mediated Michael additions, and that the substituent on the 
ester has a powerful effect on the selectivity.31,213 Hence, the substrate tert-butyl 
indanone-2-carboxylate (3-5) was investigated (Table 35). The anticipated trend in 
enantioselectivity was not observed, as nearly racemic products were obtained using 
both (R)-1-34c and (R)-1-36c. As with the methyl ester (1-102), this cannot be 
explained by a competing uncatalysed pathway, as the reaction proceeded with only 
16% conversion after 4 h in the absence of catalyst (entry 3). The catalysed reactions 
were repeated at -30 °C; again no significant ee was seen (entries 4 and 5). 
 
  
1-94b (1.2 eq) 
1-102 3-30 
99 
Table 35. Reactions of 3-5.a 
 
Entry Catalyst 
Time  
(h) 
Temp 
(°C) 
Conversionb 
(%) 
eec  
(%) 
1 (R)-1-34c (10 mol%) 2 rt 100 5 
2 (R)-1-36c (5 mol%) 2 rt 100 13 (S)-(+) 
3 None 4 rt 16 - 
4 (R)-1-34c (10 mol%) 24 -30 100 10 
5 (R)-1-36c (5 mol%) 18 -30 100 7 
aReaction conditions: 3-5 (0.123 mmol), (R)-1-34c (10 mol%)/(R)-1-36c (5 mol%), 1-94b (1.2 
eq), CH2Cl2 (0.5 mL). bCalculated by 1H NMR, cDetermined by chiral HPLC. Absolute 
stereochemistry assigned by comparison of [α]D to reported values.  
 
It was concluded that the tert-butyl substrate (3-5) was simply a poor match with these 
catalysts, thus, a number of other substrates were tested (Table 36). Both tert-butyl and 
benzyl cyclopentanone carboxylates gave low ees, but showed some improvement 
compared to the tert-butyl ester 3-5 (entries 1 and 2).  
 
Table 36. Hydroxylation of various substrates.a 
Entry Substrate Product 
Time 
(h) 
Yieldb 
(%) 
eec 
(%) 
1 
 
O
OtBu
O
OH 3-32 
4 90 23 (S)-(-) 
2 
 3-33 
2 77 24 (S)-(+) 
aReaction conditions: Substrate (1 eq.), 1-34c (10 mol%), 1-94b (1.2 eq.), CH2Cl2 (0.5 mL), rt. 
bIsolated yield. cDetermined by chiral HPLC. Absolute stereochemistry assigned by 
comparison of [α]D to reported values.  
 
Although enantioselectivities were low for a range of cyclic substrates the catalytic 
system was also tested for its ability to hydroxylate acyclic substrates. Acyclic 
substrates are generally less reactive, and so far there are, no general, enantioselective 
systems for their α-hydroxylation.  
 
1-94b (1.2 eq) 
3-5 3-31 
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Four structurally diverse acyclic substrates (3-13 and 3-16 to 3-19) were examined 
under the conditions of the α-hydroxylation reaction; however TLC did not reveal 
product formation in any case (Scheme 131).  
 
Scheme 131. Attempted reactions of acyclic substrates catalysed by 1-34c. 
There are several factors leading to the reduced reactivity of acyclic β-ketoesters. 
Compared to cyclic substrates, these species have additional conformational freedom as 
they are able to rotate about the α,β-C-C bond (3-34, Figure 24), thus formation of the 
palladium-enolate is entropically disfavoured. Conversely, cyclic substrates (3-35) are 
conformationally restricted, with the α-substituent (R2) held antiperiplanar to the 
carbonyl, favouring the formation of the chelate ring.  
 
Figure 24. α,β-C-C Bond rotation in acyclic substrates. 
A second factor disfavouring the formation of enolates from acyclic substrates is the 
steric clash between the α- and β-substituents. In the conformation required for 
chelation of the enolate, these substituents are eclipsed (Figure 25).  
R1
O
R2
OR3
O
[Pd]
 
Figure 25. Eclipsing of substituents in acyclic, chelating enolates. 
These factors led us to hypothesise that the enolate intermediates were not forming 
under the reaction conditions. With this in mind, we investigated the reactivity of 
acyclic substrates 3-12 to 3-18 with the dimeric catalyst 1-36c (Table 37). As discussed 
in chapters 1 and 2, this catalyst has Brønsted basic character which aids the formation 
3-34 3-35 
1-94b (1.2 eq) 
1-34c (10 mol%) 
3-13 3-16 3-18 3-19 
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of enolate complexes, potentially helping to overcome the disfavourable entropic and 
steric effects. 
 
Indeed, in the presence of catalyst 1-36c the reactions of a range of acyclic substrates 
proceeded to give enantioenriched α-hydroxy products. Yields were good for most 
substrates, however those containing phenyl substituents at R1 or R2 (entries 2, 4 and 8) 
required longer reaction times to reach completion. Encouragingly, enantioselectivity of 
48% was observed for the reaction of substrate 3-12 (entry 5). An overall trend was 
noted across the alkyl 2-acetyl-3-phenylpropionate substrates 3-13 to 3-15, where a 
larger ester substituent results in a slower reaction and lower enantioselectivity (entries 
1 and 5-7).  
 
Table 37. Reactions of acyclic substrates catalysed by 1-36c.a 
 
Entry Substrate R1 R2 R3 Product 
Time 
(h) 
Yieldb 
(%) 
eec 
(%) 
1 3-13 Me Bn Et 3-36 6 58 43 (S)-(+) 
2 3-16 Ph Me Et 3-37 48 38 29 (S)-(-) 
3 3-18 Me Me Bn 3-38 4 71 6 
4 3-19 Me Ph Et 3-39 52 29 1 
5 3-12 Me Bn Me 3-40 18 74 48 (+) 
6 3-14 Me Bn Bn 3-41 18 68 16 (+) 
7 3-15 Me Bn tBu 3-42 18 45 8 (S)-(+) 
8 3-17 Ph Me tBu 3-43 68 60 16 (S)-(-) 
aReaction conditions: β-ketoester (1 eq.), 1-36c (10 mol%), 43a (1.2 eq.), CH2Cl2, rt. bIsolated 
yield, cDetermined by chiral HPLC. Absolute stereochemistry assigned by comparison of [α]D to 
reported values.  
 
  
1-94b (1.2 eq) 
1-36c (10 mol%) 
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To compare the enolate formation with cyclic and acyclic substrates, 31P NMR spectra 
of β-ketoester-catalyst mixtures were studied. As expected, a 10:1 mixture of the cyclic 
substrate 1-102 and catalyst 1-36c showed complete conversion to an enolate complex, 
indicated by the observation of an AB spin system in the 31P NMR (Figure 26A). 
Conversely, the same mixture with acylclic substrate 3-13 showed only partial 
conversion of 1-36c to the enolate 3-44 (Figure 26B). This confirms that enolate 
formation is disfavoured with acyclic substrates in this system, leading to the lack of 
reactivity using catalyst 1-34c.          
 
Figure 26. A: 31P NMR spectrum of 1-102 and (R)-1-36c (10:1) in CDCl3. B: 31P NMR spectrum 
of 3-13 and (R)-1-36c (10:1) in CDCl3.  
To further characterise the enolate complex 3-44, a mixture of substrate 3-13 and 
catalyst (R)-1-36c (200:1) was analysed by electrospray mass spectrometry (Figure 27). 
A peak for the cation 3-45 was observed (B) which matched the calculated isotope 
distribution pattern for C57H47O3P2Pd+ (A). 
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Figure 27. A: Calculated isotope distribution pattern for 3-45 (C57H47O3P2Pd+).  B: Observed M+ 
ions of 3-45 by ESI. 
3.2.2.2. Ligand Screen 
As a range of substrates failed to provide ees above 48%, an attempt was made to 
identify a more effective chiral ligand. Although palladium triflate has been shown to 
act as a precursor for catalysts of general structure [Pd(L2)(sol)2]2+[TfO]-2 (where L2 = 
diphosphine ligand), our earlier work with epoxides showed that the catalysts generated 
in situ in CH2Cl2 appeared to have lower activity. To overcome this problem, the 
procedure was modified by mixing the ligand and palladium triflate before adding the 
CH2Cl2, and allowing a longer reaction time of 30 mins for catalyst generation. When 
the hydroxylation of 1-102 was repeated using catalyst 1-34c generated in situ, the 
reaction proceeded in identical ee to the reaction with isolated catalyst. This procedure 
was thus adopted for the generation of a range of catalysts from 21 chiral ligands and 
the ee was determined in each case (Table 38).  
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Table 38. Ligand screening.a 
 
Entry 
Ligand Conversionb 
(%) 
eec 
(%) Name Structure 
1 (R)-BINAP 
 
100 30 (S)-(+) 
2 (S,S)-Me-Du-Phos 
 
100 5 (R)-(-) 
3 (R)-Phanephos 
 
100 53 (R)-(-) 
4 (R)-SpirOP 
 
100 4 (S)-(+) 
5 (R,R)-DIOP 
 
100 1 (R)-(-) 
6 (R)-P-Phos 
 
100 29 (S)-(+) 
7 (R)-MeO-Cl-PHEP 
 
100 28 (S)-(+) 
1-94b (1.2 eq) 
1-102 3-30 
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8 Josiphos J005 
 
100 8 (R)-(-) 
9 Walphos W002 
 
100 11 (R)-(-) 
10 Taniaphos T001 
 
100 45 (S)-(+) 
11 (R)-Xylyl-Phanephos 
 
100 13 (R)-(-) 
12 (R)-MeO-ParaPHOS 
 
100 38 (R)-(-) 
13 (R)-Me-BoPhoz 
 
100 30 (R)-(-) 
14 (R,R)-Me-FerroTANE 
 
100 24 (S)-(+) 
15 (R,R)-Et-FerroTANE Fe P
P
Et
EtEt
Et
 
100 27 (S)-(+) 
16 
Mandyphos M001 
 
100 22 (R)-(-) 
17d 100 50 (R)-(-) 
18 
Mandyphos M002 
 
100 6 (S)-(+) 
19d 100 29 (R)-(-) 
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20 Taniaphos T002 
 
100 4 (S)-(+) 
21 Stanphos 
 
100 25 (R)-(-) 
22 Ph2-iPr-PHOX 
 
100 8 (S)-(+) 
23 Ph2-tBu-PHOX 
 
100 3 (S)-(+) 
24 None - 100 - 
aReaction conditions: Pd(OTf)2.2H2O (10 mol%), ligand (11 mol%), CH2Cl2 (0.5 mL), 30 min, then 1-102 
(0.123 mmol), 1-94b (1.2 eq), rt, 18 h. bDetermined by 1H NMR. cDetermined by chiral HPLC, negative 
values imply opposite selectivity. Absolute stereochemsitry determined by comparison of [α]D to reported 
values. d5.5 mol% ligand. 
 
 The highest ee achieved was 53% with the (R)-Phanephos ligand (entry 3). 
Interestingly, this ligand possesses an unusually large bite angle when complexed to 
palladium (103.7°, compared to 92.7° for BINAP complexed to palladium 
dichloride).214 Unfortunately the structurally related ligands (R)-Xylyl-Phanephos and 
(R)-(MeO)-ParaPHOS gave inferior selectivities (entries 11 and 12). 
 
Good selectivites were also achieved with the closely related Taniaphos and Mandyphos 
ligand classes (entries 10 and 17). Ligands with alkyl groups on the phosphines (entries 
18-20) clearly compared disfavourably to the same ligands with aryl groups (entries 10, 
16 and 17). This suggests that a relatively electron-poor system is favoured, as further 
supported by lower ees seen with other electron-rich ligands (entries 2, 4 and 5). These 
ligands cannot be treated as simple diphosphines, as they contain tertiary amine residues 
also capable of binding to the metal. Hence, Mandyphos ligands essentially possess four 
binding sites. Interestingly these ligands gave significantly improved ees when the 
metal:ligand ratio is 2:1, where presumably one ligand coordinates two molecules of 
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palladium (entries 17 and 19). Another interesting observation is that the ligands with 
axial chirality, i.e. (R)-BINAP, (R)-P-Phos and (R)-MeO-Cl-PHEP all gave very simiar 
ees in the range 28-30%. Hence, this class of ligands was not investigated further 
(entries 1, 6 and 7). 
3.2.2.3. Palladium-Phanephos-Catalysed Reactions 
The ligand (R)-Phanephos was selected for further investigation as it led to the highest 
enantioselectivity (53%) and was available in multigram quantities. A batch of the 
palladium-Phanephos catalyst 3-26 was synthesised and successfully isolated as an air-
stable crystalline solid (section 3.1.3). The choice of solvent was re-optimised for this 
ligand (Table 39), although again only small changes in enantioselectivity were 
observed, and CH2Cl2 was again found to be optimal, giving 56% ee with isolated 
catalyst 3-26 (entry 1). This is a small improvement on the 53% obtained with catalyst 
generated in situ. 
 
Table 39. Solvent screen.a 
 
 
Entry Solvent Conversionb (%) eec (%) 
1 CH2Cl2 100 56 (R)-(-) 
2 MeOH 100 46 
3 DMF 100 40 
4 THF 100 52 
5 EtOAc 100 50 
6 toluene 100 43 
7 MeCN 100 53 
aReaction conditions: 1-102 (0.123 mmol), 3-26 (10 mol%), 1-94b 
(1.2 eq), solvent (0.5 mL), 18 h. bCalculated from NMR, 
cDetermined by chiral HPLC. Absolute stereochemistry assigned by 
comparison of [α]D to reported values.  
 
The choice of Pd precursor was also re-examined in combination with Phanephos 
(Table 40). Unlike the BINAP results (Table 33) the chloride compound was found to 
3-26 
1-102 3-30 
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be catalytically active, though 1H NMR of this crude reaction mixture revealed the 
formation of side products, and the hydroxylated product was racemic (entry 1). 
Employing palladium acetate and nitrate also resulted in diminished ees (entries 2 and 
3), hence triflate remained the counterion of choice.  
 
Table 40. Counterion screen.a 
 
Entry Precursor Conversionb (%) eec (%) 
1 PdCl2 100 1 
2 Pd(OAc)2 100 18 (R)-(-) 
3 Pd(NO3)2 68 36 (R)-(-) 
aReaction conditions: PdX2 (10 mol%), ligand (11 mol%), 
CH2Cl2 (0.5 mL) 30 mins, then 1-102 (0.123 mmol), 1-94b (1.2 
eq), rt, 18 h. bDetermined by  1H NMR. cDetermined by chiral 
HPLC. Absolute stereochemistry assigned by comparison of [α]D 
to reported values.  
 
The reaction was repeated at reduced temperatures (Table 41), and some improvement 
in enantioselectivity was observed. The relationship was not linear, reaching a 
maximum of 69% ee at -20 °C (entry 3).  
 
Table 41. Temperature screen.a  
 
Entry Temp (°C) Time (h) Conversionb eec 
1 0 6 100 52 (R)-(-) 
2 -10 7 100 61 
3 -20 18 100 69 
4d -30 24 100 59 
aReaction conditions: 1-102 (0.123 mmol), 3-26 (10 mol%), 1-94b (1.2 eq), 
CH2Cl2 (0.5 mL). bCalculated from NMR, cDetermined by chiral HPLC. Absolute 
stereochemistry assigned by comparison of [α]D to reported values.dReaction 
mixture not homogeneous. 
 
The oxidising agent 1-94b is chiral, and exists as a racemic mixture (Figure 28). This 
presents an extra level of complexity, as the two enantiomers can, in theory, react with 
1-94b (1.2 eq) 
1-94b (1.2 eq) 
3-26 (10 mol%) 
1-102 
1-102 
3-30 
3-30 
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the catalyst-substrate complex with different rates and enantioselectivities. The reaction 
was repeated using 2.2 equivalents of the oxidising agent, however, an identical 56% ee 
was observed. 
 
 
Figure 28. Enantiomers of 1-94b.  
Table 42. Hydroxylation of various substrates with 3-26.a 
Entry Substrate Product 
Time 
(h) 
Temp 
(°C) 
Yieldb 
(%) 
eec 
(%) 
1 
 3-46
4 rt 62 50 (-) 
2 20 -20 79 52 
3 
 3-47
4 rt 63 49 (-) 
4 20 -20 73 54 
5 
 3-48
2 rt 14 25 (R)-(-) 
6 20 -20 66 38 
7 
 3-49
4 rt 67 49 (R)-(-) 
8 20 -20 69 63 
9 
 3-50
4 rt 78 22 (R)-(+) 
aReaction conditions: β-ketoester (1 eq.), 3-26 (10 mol%), 1-94b (1.2 eq.), CH2Cl2. bIsolated yield. cDetermined 
by chiral HPLC. Absolute stereochemistry assigned by comparison of [α]D to reported values.  
 
The phanephos catalyst 3-26 was examined in the hydroxylation of a range of alkyl 
indanone-2-carboxylates, conducted at room temperature and -20 °C (Table 42, entries 
1-8). The ethyl, iso-propyl and benzyl ester products were all generated with roughly 
50% ee at room temperature (entries 1, 3 and 7), with only the result for the benzyl ester 
improving noticeably at lower temperature (entry 7 vs entry 8). The tert-butyl ester 
performed the worst, achieving only 25-38% ee (entries 5 and 6). A general trend can be 
(2S,3S)-1-94b (2R,3R)-1-94b 
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observed from these results and that of the methyl ester 1-102, suggesting that greater 
steric bulk at the ester substituent is detrimental to the enantioselectivity. 
 
Mirroring the results obtained with the Pd-BINAP catalyst (1-34c) the reaction failed to 
proceed with acyclic substrates (Scheme 132). No product was observed with substrates 
3-29 to 3-32 in the presence of catalyst 3-26.  
 
 
Scheme 132. Attempted hydroxylation of acyclic substrates.  
Our earlier studies had led to the conclusion that enolate formation was crucial to the 
success of these reactions, and that it could be encouraged by employing the Brønsted 
basic catalyst 1-36c. Hence, synthesis of the analogous Pd-Phanephos dimer 3-51 was 
envisaged (Scheme 133).  
 
Scheme 133. Synthesis of the Pd-Phanephos dimer. 
Based on the procedure for the synthesis of catalyst 1-36c, the phanephos catalyst 3-26 
was stirred in CH2Cl2 with a dilute sodium hydroxide solution. The product, obtained as 
a black oil that could not be recrystallised, contained a single peak in the 31P NMR at 
+23.2 ppm, however the 1H NMR appeared to show a complex mixture. Using an 
alternative literature procedure, the phanephos catalyst 3-26 was stirred in wet (reagent 
grade) acetone with 4 Å molecular sieves then filtered through celite and concentrated. 
This gave identical results by NMR, but the product was a dark red solid, which again, 
could not be recrystallised. When this crude material was employed as catalyst in the 
oxidation of 1-102, different batches of the catalyst were found to give widely varying 
ees from 17-50%.  
3-13 3-16 3-18 3-19 
 
1-94b (1.2 eq) 
3-26 (10 mol%) 
3-51 
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In an attempt to develop a more reliable procedure, in situ generation of the dimeric 
catalyst was investigated. Powdered 4 Å molecular sieves were added to a solution of 
catalyst 3-26 in CH2Cl2 and the suspension stirred for 30 min, followed by the addition 
of substrate (1-102) and oxidant (1-94b). This resulted in complete conversion to the α-
hydroxy product within 2 h, with a reproducible ee of 52% (Scheme 134).  
 
Scheme 134. Addition of molecular sieves.  
This procedure was subsequently used to oxidise a range of acyclic substrates (Table 
43). The reaction rates were similar to those observed with the dimeric Pd-BINAP 
catalyst 1-36c. Again, substrates 3-16 and 3-19 were the slowest to react (entries 2 and 
4). The isolated yields were moderate in most cases, with only substrate 3-18 reacting in 
high yield (entry 3). Enantiomeric excesses were low in all products, even employing 
substrate 3-12 (entry 5), which gave the best result of 48% ee with BINAP catalyst 1-
36c.  
 
Table 43. Oxidation of acyclic substrates with 3-26 in the presence of 4Å MS.a 
 
Entry Substrate R1 R2 R3 
Time 
(h) 
Yieldb 
(%) 
eec 
(%) 
1 3-13 Me Bn Et 18 45 14 (R)-(-) 
2 3-16 Ph Me Et 48 56 14 (R)-(+) 
3 3-18 Me Me Bn 18 98 5 
4 3-19 Me Ph Et 48 19 27 (-) 
5 3-12 Me Bn Me 18 48 9 (-) 
aReaction conditions: i) 3-26 (10 mol%), powdered 4Å MS, CH2Cl2, 30 mins. ii) β-
ketoester (1 eq.), 1-94b (1.2 eq.). bIsolated yield. cDetermined by chiral HPLC. 
Absolute stereochemistry assigned by comparison of [α]D to reported values.  
 
Interestingly 31P NMR spectroscopy revealed that the reaction of 3-26 with 4Å 
molecular sieves in CH2Cl2 does not generate the expected species with a singlet at 
+23.2 ppm, in contrast to the same reaction in wet acetone. After stirring 3-26 with 
molecular sieves for 30 min, no change was observed in the 31P NMR spectra. A second 
1-94b (1.2 eq) 
3-26 (10 mol%) 
3-26 
2) 1-102, 1-94b, 2 h 
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experiment was undertaken, stirring catalyst 3-26 for 30 min with molecular sieves, then 
adding the acyclic substrate 3-13 (10 equivalents). This 31P NMR spectrum showed 
solely an AB spin pattern at +46.8 and +39.8 ppm (J = 19.0 Hz), suggesting complete 
conversion of the catalyst to the substrate bound complex 3-52 (Figure 29).  
 
 
Figure 29. Phanephos-Pd-substrate complex. 
 
Figure 30. A: Calculated isotope distribution pattern for 3-53 (C53H49O3P2Pd+).  B: M+ ions of 3-
53 by ESI. 
3-52 
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This species was further characterised by mass spectrometry (ESI), where a peak 
corresponding to the cation 3-53 was observed which matched the calculated isotope 
distribution pattern (Figure 30). 
 
Although the phanephos ligand had provided a promising 56% ee in initial studies, this 
result appeared to be highly substrate specific, as ees of >30% were only observed with 
a handful of alkyl indanone-2-carboxylate substrates. In the final investigation with this 
catalyst, different oxidants were reacted with the methyl indanone substrate (Table 44). 
The saccharin-derived oxaziridine 1-96 provided product cleanly with an ee of 31% 
(entry 1). This compares disfavourably with the oxidant 1-94b, which gave the same 
product in 56% ee under the same conditions. As observed in the initial oxidant screen 
with catalyst 1-34c, the commercially available camphorsulfonyl oxaziridines (+)- and 
(-)-3-29a were unreactive, affording only starting material (entries 2 and 3). Although 
no product was isolated in the reaction of nitrosobenzene (3-54), partial conversion to 
an unknown intermediate was observed. This species proved to be unstable on silica, 
decomposing to give starting material (1-102) and nitrosobenzene (3-54), (confirmed by 
2D TLC). The oxidation reaction with DMD was attempted at a reduced temperature of 
-20 °C, as this reagent is volatile and highly reactive. Under these conditions the 
reaction was complete within 90 min and no side product formation was observed, 
leading to an excellent isolated yield of 91% (entry 5). As the ee of the product was 
negligible, the reaction was repeated at a reduced temperature of -78 °C, then quenched 
with saturated sodium thiosulfate solution after 5 h. 1H NMR showed 51% conversion, 
however the product was obtained with a low ee of 10% (entry 6).  
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Table 44. Oxidant Screen with catalyst 3-26.a 
OMe
OO
OMe
OO
OHoxidant, CH2Cl2
 
Entry Oxidant 
Temp 
(°C) 
Time 
(h) 
Yieldb 
(%) 
eec  
(%) 
1 
3-21 
rt 4 77 31 (R)-(-) 
2 
(+)-3-29a  
rt 18 0 - 
3 (-)-3-29a  rt 18 0 - 
4 
3-54 
rt 2 0 - 
5 DMDd -20 °C 1.5 91 6 
6 DMDd -78 °C 5 51e 10 
aReaction conditions: 1-102 (0.123 mmol), 3-26 (10 mol%), oxidant (1.2 eq.), CH2Cl2 
(0.5 mL). bIsolated yield. cDetermined by chiral HPLC. Absolute stereochemistry 
assigned by comparison of [α]D to reported values.d0.07 M solution in acetone, no CH2Cl2 
added. eProduct not isolated, value is conversion determined from 1H NMR. 
3.2.3. α-Hydroxylation With Dimethyldioxirane (DMD) 
Despite observing poor enantioselectivities with DMD in the presence of the phanephos 
catalyst 3-26, the high yield of the reaction prompted further investigation of this 
oxidant. In contrast to the reactions with oxaziridines, the absence of side products, and 
the volatility of the by-product, acetone, made aqueous workup and column 
chromatography unnecessary. Upon completion of the reaction, the reaction mixture 
was concentrated and filtered through a plug of silica to remove the catalyst, providing 
pure material. To monitor rates of conversion, reaction mixtures were quenched with 
sodium thiosulfate and extracted using Et2O, which was removed in vacuo before 1H 
NMR analysis. 
  
3-26 (10 mol%) 
 
1-102 
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3.2.3.1. Reactions of DMD With Cyclic Substrates 
Several substrates were hydroxylated with DMD in the presence of the Pd-Phanephos 
catalyst 3-26 (Table 45). However ees were low in all cases and comparison of HPLCs 
and optical rotations with literature data72 indicated that the absolute stereochemistry 
was S for 3-5 (entry 2) and R for 3-6 (entry 3). This implies opposing facial selectivity 
in the two reactions, meaning the stereoinductive effect is highly substrate specific. 
 
Table 45. Reactions of alkyl indole-2-carboxylates with DMD.a 
 
Entry Substrate Product Yieldb (%) eec (%) 
1 3-3 (R=iPr) 3-46 85 3 
2 3-5 (R=tBu) 3-48 90 26 (S)-(+) 
3 3-6 (R=1-Ad) 3-55 94 16 (R)-(-) 
aReaction conditions: ketoester (0.123 mmol.), 3-26 (10 mol%), DMD (0.07 M in 
acetone, 1.2 eq.), -20 °C, 0.5 h. bIsolated yield. cDetermined by chiral HPLC. 
Absolute stereochemistry assigned by comparison of [α]D to reported values.  
 
The reaction of substrate 1-102 was repeated with catalyst 1-34c, which proceeded 
smoothly at -20 °C with a promising 34% ee (Table 46, entry 1). Reducing the 
temperature to -78 °C provided a noticeable improvement to 47% ee (entry 2). 
However, at this temperature the reaction was incomplete after 5 h, making the 
procedure impractical, as such a low temperature is difficult to maintain over long 
reaction times. Repeating these reactions with catalyst 1-36c, it was hoped that similar 
rate acceleration to that seen with oxaziridine 1-94b would be observed. However this 
catalyst (1-36c) afforded lower reaction rates at both -20 °C and -78 °C (entries 3 and 
4). The mechanistic implications of this observation will be discussed in detail in 
chapter 4. 
  
3-26 (10 mol%) 
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Table 46. Initial investigations with DMD catalysed by Pd-BINAP catalysts.a 
 
Entry Catalyst 
Temp  
(°C) 
Time 
(h) 
Conversionb
(%) 
eec  
(%) 
1 1-34c -20 0.5 99d 34 (S)-(+) 
2 1-34c -78 5 67 47 
3 1-36c -20 2 41 35 
4 1-36c -78 5 0 - 
aReaction conditions: 1-102 (0.123 mmol), 1-34c (10 mol%)/1-36c (5 mol%), 
DMD (0.07 M in acetone, 1.2 eq.). bCalculated from NMR. cDetermined by 
chiral HPLC. Absolute stereochemistry assigned by comparison of [α]D to 
reported values.dIsolated yield. 
 
To examine any background process, the reactions were repeated in the absence of 
catalyst, revealing that minimal reaction took place at low temperatures (Table 47, 
entries 1 and 2). However, rapid oxidation took place at room temperature (entry 3), 
suggesting careful temperature control may be crucial to obtain high enantioselectivity.  
 
Table 47. Uncatalysed reactions with DMD.a 
Entry 
Temp  
(°C) 
Time  
(h) 
Conversionb 
(%) 
1 -78 5 0 
2 -20 1 6 
3 rt 0.17 100 
aReaction conditions: 1-102 (0.123 mmol), DMD 
(0.07 M in acetone, 1.2 eq.). bCalculated from NMR.  
 
Initial experiments were carried out by adding the cold DMD solution to the solid 
catalyst and substrate in a Radley tube immersed in a cold bath. This method could 
potentially lead to an exotherm upon mixing, so the order of addition was modified to 
avoid this, by dissolving the substrate and catalyst in a small amount of CH2Cl2 before 
cooling to the desired temperature and adding cold DMD solution dropwise. Under 
these conditions, a slightly improved ee of 39% was seen employing catalyst 1-34c at -
20 °C (c.f. 34% ee, Table 46, entry 1). Reducing the temperature to -30 °C gave no 
further improvement in selectivity, with 96% yield and 39% ee. 
 
117 
Following a literature procedure,215 10 mL of DMD solution in acetone (0.082 M) was 
diluted with ice water and extracted using CH2Cl2 (1 mL), washing with a phosphate 
buffer. The resulting solution of DMD in CH2Cl2 had an increased concentration of 
0.189 M. This solution was subsequently employed in the hydroxylation reaction of 1-
102, giving 94% yield and 40% ee. The result shows that removing acetone from the 
reaction mixture has a negligible effect on the reaction outcome. 
 
Table 48 shows the results obtained for the hydroxylation of a range of indanone-2-
carboxylates, using the optimised protocol at -20 °C. All reactions proceeded cleanly, 
with no side products observed, hence no chromatography was required. Under these 
conditions, a clear trend in ee can be observed for the alkyl esters, with increased alkyl 
substitution leading to higher enantioselectivity (entries 1, 2 and 4). The ee reached a 
maximum with the tert-butyl ester (3-5, entry 4) but drops sharply for the adamantyl 
ester (3-6, entry 5). A poor result was also seen for the benzyl ester (3-4, entry 3).  
 
Table 48. Reaction of DMD with various indanone-2-carboxylates.a 
 
Entry Substrate Time (h) Yieldb (%) eec (%) 
1 3-2 (R=Et) 4d 78 54 (+) 
2 3-3 (R=iPr) 4d 79 60 (+) 
3 3-4 (R=Bn) 4d 67 25 (S)-(+) 
4 3-5 (R=tBu) 0.5 88 86 (S)-(+) 
5 3-6 (R=Ad) 0.5 99 29 (S)-(+) 
aReaction conditions: Substrate (0.123 mmol), 1-34c (10 mol%), DMD (0.07 
M in acetone, 1.2 eq.), CH2Cl2, -20 °C. bIsolated yield. cDetermined by chiral 
HPLC. Absolute stereochemistry assigned by comparison of [α]D to reported 
values.dReaction time not optimised. 
 
The same reactions were repeated with a reduced catalytic loading of 5 mol% (Table 
49), and all reactions proceeded quickly (>0.5 h) and cleanly. Enantioselectivities were 
substantially lower in several cases (entries 1, 3 and 4), however, the ee of the tert-butyl 
product 3-31 was not significantly affected (entry 5). 
  
1-34c (10 mol%) 
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Table 49. Reaction of DMD with various indanone-2-carboxylates with reduced catalyst 
loading.a 
Entry Substrate 
Yieldb 
(%) 
eec 
(%) 
1 1-102 (R=Me) 95 26 (S)-(+) 
2 3-2 (R=Et) 88 48 (+) 
3 3-3 (R=iPr) 86 48 (+) 
4 3-4 (R=Bn) 91 15 (S)-(+) 
5 3-5 (R=tBu) 95 85 (S)-(+) 
6 3-6 (R=Ad) 90 33 (S)-(+) 
aReaction conditions: Substrate (0.123 mmol), 1-34c (5 
mol%), DMD (0.07 M in acetone, 1.2 eq.), CH2Cl2, -20 °C, 
0.5 h. bIsolated yield. cDetermined by chiral HPLC. Absolute 
stereochemistry assigned by comparison of [α]D to reported 
values. 
 
At 5 mol% catalyst loading, various other substrates were examined to assess the scope 
of the highly enantioselective reaction (Table 50). All reactions were complete in 30 
minutes with no side product formation. Results for cyclopentanones 1-105, 3-7 and 1-
37 (entries 1-3) all exceeded the enantioselectivities observed for the equivalent 
indanones 3-2, 3-4 and 3-5 (Table 49, entries 2, 4 and 5) with the same trend in ee with 
ester substituent (tBu > Et > Bn). Substrates containing 6-membered rings did not 
generally give high enantioselectivities, however the tetralone substrates 3-8 to 3-10 
again show the same trend in ee with ester substituent (tBu > Et > Bn). The 
cyclopentanone substrate 3-11 (entry 7) gave an ee of 66%, equalling that for the benzyl 
ester 3-7 (entry 2). Analysis of these results led to the conclusion that the optimal 
substrate was a β-ketoester containing a 5-membered ring and a tert-butyl ester.  
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Table 50. α-Hydroxylation of a structurally diverse range of cyclic substrates.a 
Entry Substrate  Product 
Time  
(h) 
Yieldb  
(%) 
eec  
(%) 
1 
1-105
3-56 0.5 89 87 (S)-(-) 
2 
3-7
3-33 0.5 78 66 (S)-(-) 
3 
1-37
3-32 0.5 88 98 (S)-(-) 
4 
3-8
3-57 0.5 74 10 (S)-(-) 
5 
3-9
3-58 0.5 80 20 (-) 
6 
3-10
3-59 0.5 84 1 
7 
3-11
3-60 0.5 80 66 (-) 
aReaction conditions: Substrate (0.123 mmol), 1-34c (5 mol%), DMD (0.07 M in acetone, 1.2 eq.), 
CH2Cl2 (0.5 mL), -20 °C, 0.5 h. bIsolated yield. cDetermined by chiral HPLC. Absolute 
stereochemistry assigned by comparison of [α]D to reported values. 
3.2.3.2. Reactions of DMD With Acyclic Substrates 
Due to the highly reactive nature of the oxidant, the reaction proceeded with short 
reaction times at low temperature, hence, we expected the scope could be extended to 
the less reactive acyclic substrates. 3-13 was chosen for initial investigations as it is 
commercially available and the phenyl group provides sufficient UV chromophore to 
facilitate HPLC analysis. In the presence of catalyst 1-34c (10 mol%) at -20 °C, no 
conversion was observable by 1H NMR after 1 h (Table 51, entry 1). Raising the 
temperature to 0 °C the reaction still proceeded slowly, failing to reach completion after 
20 h, although the reaction proceeded with a reasonable 61% ee (entry 2). 
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As was observed with cyclic substrates, using catalyst 1-36c led to lower reaction rates, 
with no product formation detectable by 1H NMR after 20 h at 0 °C (entry 4). 
Previously, Adam and Smerz have shown that protic solvents can accelerate the 
epoxidisation reactions of DMD,216 prompting us to add ethanol (0.5 mL) to this 
reaction mixture, however no reaction was observed after a further 4 h (entry 5).  
 
Table 51. Investigating acyclic substrates with DMD.a 
 
Entry Catalyst 
Temp  
(°C) 
Time  
(h) 
Yieldb  
(%) 
eec  
(%) 
1 1-34c -20 1 0 - 
2 1-34c 0 20 49 61 (S)-(+) 
3 1-36c -20 1 0 - 
4 1-36c 0 20 0 - 
5d 1-36c 0 4 0 - 
aReaction conditions: Substrate (0.123 mmol), 1-34c (10 mol%)/1-36c (5 
mol%), DMD (0.07 M in acetone, 1.2 eq.), CH2Cl2 (0.5 mL). bIsolated yield. 
cDetermined by chiral HPLC. Absolute stereochemistry assigned by 
comparison of [α]D to reported values. dEtOH (0.5 mL) added. 
 
The reaction with catalyst 1-34c at 0 °C was extended to several other substrates, with 
generally poor results (Table 52). Although the reaction of 3-18 reached completion 
within 20 h, the isolated yield was moderate and the ee of the product was only 37%.    
 
Table 52. α-Hydroxylation of acyclic substrates with DMD.a 
 
Entry Substrate  R1 R2 R3 Yieldb (%) eec (%) 
1 3-16 Ph Me Et 0 - 
2 3-18 Me Me Bn 54 37 (-) 
3 3-19 Me Ph Et 0 - 
aReaction conditions: Substrate (0.123 mmol), 1-34c (10 mol%), DMD (0.07 M 
in acetone, 1.2 eq.), CH2Cl2 (0.5 mL). bIsolated yield. cDetermined by chiral 
HPLC. Absolute stereochemistry assigned by comparison of [α]D to reported 
values.  
 
3-13 
1-34c (10 mol%) 
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To investigate the effect of the ester substituent on the enantioselectivity, analogues of 
the best performing acyclic substrate 3-13 were examined (Table 53, entries 1, 3, 5 and 
7). The highest enantioselectivity was observed with the tert-butyl ester (entry 5) and 
the lowest with the benzyl ester (entry 3), closely matching the trends observed with 
cyclic substrates. 
 
As reactions were very slow, resulting in low rates of conversion, the experiments with 
the substrates 3-33, 3-29 and 3-35 were repeated with increased catalyst loading (20 
mol%) and a larger excess of DMD (entries 2, 4 and 7). Although these reactions were 
still incomplete, requiring separation of the remaining starting material by column 
chromatography, isolated yields of the products were substantially higher and ees were 
marginally improved. 
 
Table 53. α-Hydroxylation of alkyl 3-phenyl-2-acetylpropionates.a 
 
Entry Substrate  
Cat. Loading 
(mol%) 
DMD 
(eq) 
Time 
(h) 
Yieldb 
(%) 
eec  
(%) 
1 3-12  
(R = Me) 
10 1.2 18 15 54 (+) 
2 20 2.0 48 65 62 
3 3-13  
(R = Et) 
10 1.2 20 49 61 (S)-(+) 
4 20 2.0 48 65 62 
5 3-14  
(R = Bn) 
10 1.2 48 52 32 (+) 
6 3-15  
(R = tBu) 
10 1.2 48 8 86 (S)-(+) 
7 20 2.0 48 55 88 
aReaction conditions: Substrate (0.123 mmol), 1-34c, DMD (0.07 M in acetone), CH2Cl2 (0.5 mL), 
0 °C. bIsolated yield. cDetermined by chiral HPLC. Absolute stereochemistry assigned by 
comparison of [α]D to reported values.  
3.3. Conclusion 
Palladium-catalysed enantioselective α-hydroxylation of β-ketoesters has been 
investigated with several reagents, catalysts and substrates. Employing catalyst 1-34c, 
oxaziridines were identified as suitable oxidising agents, however ees observed were 
≤30% with all the β-ketoesters examined in this work. The enantioselectivity of the 
reaction of methyl indanone-2-carboxylate (1-102) was improved from 30% to 56% by 
1-34c 
DMD (0.07 M in acetone) 
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adopting the Pd-phanephos catalyst 3-26, identified by ligand screening. However this 
catalyst led to poor enantioselectivities with other substrates. 
 
Acyclic substrates failed to react with either the Pd-BINAP catalyst 1-34c or Pd-
phanephos catalysts 3-26. Generation of the intermediate substrate-catalyst complex 
was identified as a crucial step in these reactions. Adopting the modified Pd-BINAP 
catalyst 1-36c, formation of the enolate species can be encouraged, and reactions 
proceeded with up to 48% ee, though remained slow for some substrates. The 
equivalent phanephos-dimer catalyst (3-51) could not be isolated, however adding 
molecular sieves to the reaction was shown to facilitate enolate formation, allowing the 
reactions to proceed. While this modification allowed the scope of the reaction to be 
extended, enantioselectivities were low.  
 
Adopting the oxidant DMD afforded significantly higher enantioselectivities, up to 98% 
with cyclic ketoesters. Screening of substrates identified a number of structural 
attributes required to achieve high ees. In every compound series investigated, the tert-
butyl ester was optimal, and in general, substrates containing 5-membered rings were 
superior to those with 6-membered rings. Some acyclic substrates were found to react 
sluggishly, with ees of up to 88%. In contrast to the reactions of oxaziridine 1-94b, no 
reaction was observed when adopting the dimeric catalyst 1-36c. 
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Chapter 4: Mechanism of the Hydroxylation 
Reaction 
α-Hydroxylation of β-ketoesters is generally assumed to proceed via epoxidation of the 
enol or enolate 4-1, followed by ring opening of the oxy-epoxide 4-2. The alkoxide 
generated would typically remain complexed to the metal (4-3), requiring protonation to 
liberate the α-hydroxy product (Scheme 135, equation 1). This mechanism has been 
proposed for the reaction of both oxaziridines71 and DMD.208 The epoxide 4-4 has been 
isolated from the Mn(OAc)2-catalysed reaction of ethyl benzoylacetate with molecular 
oxygen, suggesting epoxide intermediates are also present in the hydroxylation 
reactions of ketoesters under these conditions (Scheme 135, section 2).209   
 
Scheme 135. Mechanism of hydroxylation reactions. 
The epoxide forming step is of particular interest to us, as it is the stereo-defining step. 
Attack on the enolate 4-1 can occur on the top face (Si-face) or on the bottom face (Re-
face), leading to S- and R-products respectively.  
 
DFT calculations by Houk and co-workers at the B3LYP/6-31G* level show that 
epoxidation of alkenes by DMD can proceed either via a synchronous or asynchronous 
transition state, depending on the alkene substitution.217,218 In a synchronous transition 
state, bond forming occurs at the same rate to both carbons of the epoxide, whereas in 
4-1 4-2 
4-3 
4-4 
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an asynchronous transition state, one forms faster (Scheme 136). While the calculations 
suggested ethylene reacts via a synchronous transition state, unequal C-O bond lengths 
were observed with unsymmetrical alkenes. The longer bond is always to the carbon 
bearing substituents capable of stabilising radical or cationic character on the carbon. 
 
 
Scheme 136. Transition states in alkene epoxidation by DMD. 
In addition, Houk and co-workers showed that the orientation of the DMD is consistient 
in all calculated transition states, favouring a ‘spiro’ transition state over a ‘planar’ 
transition state (by 7.4 kcal mol-1 for ethene, Figure 31).  
 
 
Figure 31. Spiro and planar transition state geometries for DMD epoxidations. 
More recent calculations at the same level of theory by Breslow, Friesner and co-
workers has shown that spiro transition states are dominant in the reactions of a number 
of more complex, chiral dioxiraines.219 Evidence for the accuracy of these transition 
state geometries is supported by the observation that calculated enantioselectivities 
closely match those experimentally observed in most of the asymmetric reactions 
studied (Table 54). 
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Table 54. Comparison of experimental ees with those calculated at B3LYP/6-31G*(solution). 
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Entry Catalyst Calculated ee (%) Experimental ee (%) 
1220 4-5 60 76 
2221 4-6 79 86 
3222 4-7 96 94 
4223 4-8 99.5 97 
 
This Chapter describes our work towards understanding the mechanism of the 
palladium(II)-catalysed hydroxylation reactions. Particular focus is on the origins of 
stereoselectivity in the highly enantioselective reactions of ketoesters with DMD 
catalysed by 1-34c.  
4.1. Reaction Rate Study 
During our studies of the palladium-catalysed α-hydroxylation, it emerged that the rate 
of reaction had a complex dependence on the choice of oxidant and catalyst. The 
difference in rate is more pronounced with acyclic substrates, so the β-ketoester 3-13 
was adopted for further study. To clearly illustrate the relative reaction rates, 
hydroxylation reactions were carried out in parallel, using oxidants 1-94b and DMD 
(1.2 equivalents), and catalysts 1-34c and 1-36c (both 10 mol% in palladium, Figure 
32). All reactions were carried out at 0.04 M concentration of ketoester at room 
temperature. Aliquots of the reactions with oxaziridine 1-94b were quenched by 
filtering an aliquot through silica to remove the catalyst (no observable uncatalysed 
reaction occurs), whereas aliquots of the reactions with DMD were simply concentrated 
in vacuo to remove the oxidant. Conversion was determined by integration of the peaks 
in the 1H NMR at 3.80 ppm (CH, starting material) and 3.44 ppm (CH2Ph, product).  
 
  
4-5 4-6 4-7 4-8 
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In the reactions of oxaziridine 1-94b, the reaction was faster with catalyst 1-36c, 
reaching completion in <24 h (Figure 32). Conversely, the reactions of DMD proceeded 
faster with catalyst 1-34c. It should be noted that the reaction of DMD with catalyst 1-
34c had a high initial rate, but failed to reach completion due to 
decomposition/evaporation of the DMD over the course of the reaction.  
 
 
 
Figure 32. Relative rates with different catalysts and oxidants. 
As discussed previously, enolate formation is disfavoured with catalyst 1-34c, due to the 
concomitant formation of an equivalent of triflic acid. Conversely, enolate formation is 
favoured with Brønsted basic catalyst 1-36c (Scheme 137). The relative rates shown in 
Figure 32 suggests that for reactions involving the oxaziridine 1-94b, the reaction rate is 
dependent on the formation of the intermediate enolate complex 4-73, as the rate is 
higher using the dimeric catalyst 1-36c. However when reaction employs DMD, the 
opposite was observed, suggesting that the enolate formation may not be rate 
determining in this system. 
 
3-13 
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Scheme 137. Enolate formation with catalysts 1-34c and 1-36c. 
A full catalytic cycle can be constructed for the 1-34c promoted reaction, beginning 
with reversible formation of the enolate (Scheme 138, step A). The enolate 4-9 then 
reacts to form the chiral epoxide 4-10 (step B), which rearranges to the Pd-alkoxide 4-
11 (step C). The final step is presumably protonolysis, using the triflic acid generated in 
step A to reform the catalyst (step D). 
 
 
 
Scheme 138. Mechanism of 1-34c-catalysed reactions. 
Triflic acid can potentially accelerate step B by protonating or H-bonding to the DMD, 
which would be expected to affect the enantioselectivity. However, the reaction of 
methyl indanone-2-carboxylate (1-34) was found to proceed with virtually the same 
4-9 
1-34c 
4-10 
4-11 
1-34c 
1-36c 
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enantioselectivity with catalyst 1-34c (34% ee) as with 1-36c (35% ee). Although this 
observation is far from conclusive, it suggests that triflic acid may not be involved in the 
stereo-defining step.  Another possibility is that triflic acid may accelerate the reaction 
by increasing the rate of protonolysis in step D. 
 
In the reaction mediated by catalyst 1-36c, no triflic acid is present; hence liberation of 
product from the alkoxide 4-11 is likely to involve protonolysis by water, regenerating 
the Pd-OH species 4-12 (Scheme 139, step D). It is possible that this process is 
sufficiently slow to become the rate determining step. However, this analysis fails to 
explain the high rate of the 1-36c mediated reaction of oxaziridine 1-94b. In this case it 
is possible that product release is somehow accelerated by the presence of the 
oxaziridine or imine byproduct, allowing the reaction to progress in the absence of 
triflic acid.  
 
 
Scheme 139. Mechanism of 1-36c-catalysed reactions.  
 
4-11 
4-10 
4-9 
4-12 
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4.1.1. Determination of Absolute Stereochemistry 
Comparison of optical rotation and chiral HPLC data for hydroxylation products with 
reported values allowed the determination of the absolute stereochemistry of twelve β-
ketoesters (Figure 33). In all cases, catalysts (R)-1-34c and (R)-1-36c led to formation of 
the (S)-enantiomer using both oxidants 1-94b and DMD.  
 
Figure 33. Absolute stereochemistry of hydroxylation products. 
However, the majority of the reported absolute configurations of the compounds in 
Figure 33 were not determined experimentally, but assigned by analogy with the 
absolute configuration of 3-57. The configurations of tetralone derived β-ketoesters 3-
57 and 4-13 were determined experimentally by Davis and co-workers using circular 
dichroism.5  
 
Circular dichroism involves passing circularly polarised light through a solution of a 
chiral compound and recording the absorbance as a function of wavelength. The 
difference in absorption with left and right circularly polarised light (ΔA) is then 
calculated, and is usually reported as the molar circular dichroism Δε according to the 
relationship 
ΔA =  Δε𝑐𝑙 
  
where C is the concentration in moles per litre (mol L-1) and l is the path length in 
centimeters (cm).224  
 
In Davis’ report, details of the method used to determine the absolute configurations 
from this data were not given. To confirm these original assignments, the CD spectra 
were recalculated using time-dependent DFT theory. These calculations were performed 
3-57 
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by a colleague* at the B3LYP/aug-cc-pVTZ level with continuum solvation field 
correction for methanol. For hydroxy product 3-57, the reported experimental values 
were λmax (nm) (Δε): (R)-3-57: 312 (+0.41), 354 (-0.32); (S)-3-57: 311 (-0.49), 355 
(+0.26), and for 4-13: λmax (nm) (Δε): (R)-4-13: 345 (+0.32), 383 (-0.18); (S)-4-13: 343 
(-0.32), 380 (+0.17).5 The calculated spectra for the S-isomers (Figures 34 and 35), 
agreed with the observed sign of Δε, confirming the absolute stereochemistry of the 
above α-hydroxy β-ketoesters.  
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Figure 34. Calculated ECD Spectrum for (S)-3-57. 
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Figure 35. Calculated ECD Spectrum for (S)-4-13. 
 
*Prof Henry Rzepa, Imperial College London 
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4.1.2. Rationalisation of the Stereochemistry 
 
Figure 36. Products of Pd-(R)-BINAP-catalysed reactions.  
The (S)-α-hydroxy products 4-19 obtained in the reactions catalysed by complexes 
derived from (R)-BINAP must arise from selective attack on the Si-face (Figure 36). 
This stereochemical outcome of the reaction was unexpected, as results with very 
similar catalysts, including Michael reactions,31,32 aldol reactions,51,225 fluorination 
reactions60,175 and amination reactions67 reported the opposite selectivity. In these 
reactions, selectivity is observed for preferential attack on the Re-face, leading to 
products 4-100 to 4-104. 
  
P PPd
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Figure 37. Steric model for Re-selectivity in Pd-(R)-BINAP catalysis. 
Previously, a simple steric model was proposed by Sodeoka and co-workers to explain 
the selectivity of the Michael reactions (4-20, Figure 37).32 The steric interactions 
described in this model fit the ‘quadrant rule’, often applied to predict or explain the 
stereochemical outcome of reactions mediated by metal-BINAP complexes.226 This rule 
defines the steric environment provided by the four phenyl groups on (R)-BINAP, two 
of which are located axially, and two equatorially. Viewing the complex from the metal 
side (4-21), the equatorial phenyl groups can be seen to spatially occupy, therefore 
block, quadrants 2 and 4. Thus, in the model proposed by Sodeoka and co-workers, the 
4-14 
4-15 
4-16 
4-17 4-18 4-19 (this work) 
4-20 4-21 
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repulsion between the ligand and ester forces the tert-butyl group to adopt the least 
hindered conformation at the Si-face of the enolate. This blocks the approach of the 
Michael acceptor, leading to favoured reaction at the Re-face. This explanation is 
supported by the experimental observation that substrates containing bulky tert-butyl 
esters lead to higher enantioselectivities.  
4.1.2.1. DFT Calculations 
As the stereoselectivity in the α-hydroxylation reaction clearly does not fit the model 
proposed for similar α-functionalisation reactions, a thorough investigation into the 
factors leading to the observed stereoselectivity was required. DFT calculations were 
carried out by a colleague,* attempting to construct quantitative transition state models. 
Si-Face attack of DMD on both enantiomers of various enolate complexes was 
modelled. For clarity, in the following discussion, instead of Si-face attack on (S)-Pd-
enolates, Re-face attack on (R)-Pd-enolates is shown (Figure 38). 
 
Figure 38. Enantiomeric transition states (energetically identical). 
Initially, the methyl ester 2-33 was investigated as the substrate, as it requires a reduced 
computer time required to calculate the transition states (Si-4-24 and Re-4-24). In order 
to determine the origins of stereoselectivity, the tert-butyl ester 1-37 was then 
investigated as this is the most enantioselective reaction experimentally (98% ee); 
factors leading to stereoselectivity were expected to be most prominent with this 
substrate.  
 
Calculations were performed at the B3LYP level of theory, which was found to 
successfully predict the outcomes of asymmetric-dioxirane mediated epoxidations, as 
described in section 4. However, the present system contains an added level of 
complexity due to the presence of an ion pair complex ([Pd]+[TfO]-). For this, the basis 
set cc-pVDZ was employed, with a pseudopotential basis set for Pd, and enhanced with 
a continuum solvation model (acetone). Once transition state geometries had been 
 
*Prof Henry Rzepa, Imperial College London 
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calculated, entropic and thermal corrections were applied, giving free energies of 
activation.  
 
 
Figure 39. Reactions studied with DFT calculations. 
A significant observation in the calculated transition states Si and Re-4-25 was the 
absence of any significant distortion of the ester from the plane of the chelate ring in 
either transition state. Even in the case of the tert-butyl ester, an s-cis conformation was 
maintained throughout the transformation in transition states for both Si- and Re-face 
attack. This is a significant deviation from the model proposed by Sodeoka, where the 
origin of stereoselectivity is dependent on the out-of-plane conformation of the ester.  
 
Results showed the reaction proceeding via a highly asynchronous transition state, with 
the DMD approaching from directly above the α-carbon (Figure 40). In addition, the 
approach was strongly directed by two hydrogen bonds between the oxidant and ortho-
aryl C-H groups on the BINAP ligand. The formation of these bonds required some 
distortion of the aryl groups’ conformations, and they were present in the transition 
states for both Si- and Re-face attack. Similar interactions can be seen between the 
ligand and the counterion, which was found to bind in a pocket on the opposite face of 
the enolate to the DMD (Figure 40).  
  
(R)-4-22 (R = Me) 
(R)-4-23 (R = tBu) 
(R)-1-34c 
2-33 (R = Me) 
1-37 (R = tBu) 
(Si)-4-24 (R = Me) 
(Si)-4-25 (R = tBu) 
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Figure 40. Side view of transition states for tert-butyl ester. 
Although the same interactions were observed in both diastereomeric transition states, 
some differences in the geometries are apparent. In the favoured transition state (Si)-4-
25, both hydrogen bonds to DMD were found to be ~2.5 Å in length. Conversely, one 
such hydrogen bond in (Re)-4-25 is significantly longer (2.99 Å).  
 
 
Figure 41. View along newly forming C-O bond. Counterion omitted for clarity. 
Closer inspection of the ester group revealed a significant difference in its interactions 
with the ligand in the two transition states. In Si-4-25, two methyl groups on the tert-
butyl ester were located in close proximity to the equatorial phenyl substituent (~2.9 Å) 
and at this distance, favourable C-H/π interactions are possible (Figure 42). These 
(Si)-4-25  (Re)-4-25  
(Si)-4-25  (Re)-4-25  
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interactions are considered the weakest form of hydrogen bonding, though are largely 
dispersive, and act to stabilise this transition state.227  
 
In TS(Si) this was not observed; instead the equatorial phenyl group adjacent to the ester 
was oriented to allow a hydrogen bond to DMD, and a methyl substituent on the oxidant 
was positioned close to the phenyl group and ester, disrupting the interaction. This 
difference in the two transition states may be significant, as the existence of a C-H/π 
interaction is dependent on the presence of a highly substituted ester substituent, 
matching the experimental requirement for high enantioselectivity. 
         
 
Figure 42. C-H/π interaction in TS(Si). 
The free energy barrier (ΔG ‡) for the reactions showed that for the methyl ester 
transition states 4-24, Si-face attack (ΔG ‡ = 10.9 kcal mol-1) was favoured over Re-face 
attack (ΔG ‡ = 12.3 kcal mol-1) by 1.4 kcal mol-1. However, the calculated free energy 
barriers with the tert-butyl ester transition states 4-25 predicted the opposite outcome, 
slightly favouring Re-attack (ΔG ‡ = 12.8 kcal mol-1) over Si-attack (ΔG‡ = 13.3 kcal 
mol-1) by 0.5 kcal mol-1. While the magnitude of these energies is reasonable, the ΔΔG‡ 
for the tert-butyl ester did not agree with experimental observations, as the reaction of 
tert-butyl cyclopentanone-2-carboxylate (1-37) proceeds with preferential attack on the 
Si-face, in 98% ee.  
 
  
(Si)-4-25  (Re)-4-25  
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For this reaction, the enantioselectivity can be correlated to the difference in free energy 
barriers ΔΔG‡ for the two diastereomeric transition states. The ee is given by  
 
ee =  𝑘ௌ௜ −  𝑘ோ௘𝑘ௌ௜ +  𝑘ோ௘ 
 
where k is the reaction rate constant for Si or Re-face attack. Assuming the starting 
materials for the diasteromeric reactions are identical, i.e. they are elementary reactions, 
transition state theory gives219 
 
∆∆G‡ = RT ln 𝑘S୧𝑘Rୣ 
 
where R is the gas constant and T is temperature in Kelvin. Hence, at -20 °C, an ee of 
98% requires a difference in the free energies of activation of 3.22 kcal mol-1.   
 
The B3LYP-DFT procedure does not include a term to calculate long range dispersive 
effects, such as those proposed between the ligand and tert-butyl group (Figure 42), and 
this limitation was considered a likely cause of the discrepancy between the calculated 
ΔΔG‡ and experimental observations. A DFT method containing a semi-empirical 
dispersion correction term, B97D,228 was thereby employed, and the transition states 
fully re-optimised at this level of theory. However, this led to transition states with 
implausible geometries, and ΔG‡ values of ~1.7 kcal mol-1. Instead, single point energy 
evaluations at the B97D level were performed on the transition state geometries 
acquired with the B3LYP-DFT procedure. With the methyl ester, this lowered the 
energy of Si-4-24 by a further 0.9 kcal mol-1, relative to Re-4-24. More significantly, 
with the tert-butyl ester enolate Si-4-25, this lowered the free energy barrier by 1.2 kcal 
mol-1 relative to Re-4-25, making the Si-face attack favoured by 0.7 kcal mol-1. 
Although the ΔΔG‡ value obtained for the tert-butyl ester by this method was too small 
to agree with experimental observations, the correct enantiomer was at least predicted. 
 
Finally, the calculations were repeated with the dispersion corrected ωB97XD 
method,229 which unlike B97D, resulted in plausible geometries. Again, ΔG‡ values 
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suggested lower activation energy for Si-face attack (4-24: ΔΔG‡ = 4.3 kcal mol-1, 4-25: 
ΔΔG‡ = 0.8 kcal mol-1) but these values failed to match experimental observations. 
4.2. Conclusion 
Analysis of the reaction rates provided insight into the reaction mechanism, revealing an 
important effect of triflic acid in the α-hydroxylation reactions with DMD. Despite 
significant rate acceleration in the presence of triflic acid, its precise role has not been 
fully elucidated.   
 
The absolute stereochemistry of the optically active products was determined by 
comparison with literature data for twelve compounds. The (S)-configuration of the 
products implied unexpected Si-face selectivity, contrary to that predicted by the 
molecular-mechanical model proposed for similar reported reactions.  
 
A quantitative transition state model was constructed using the B3LYP-DFT method, 
leading to the identification of a number of unexpected features in the transition state. 
The s-cis conformation of the tert-butyl ester was maintained, and favourable 
interactions were observed between the tert-butyl group and ligand in the Si-face attack. 
Also, hydrogen bonds were observed from the ligand to both the electrophile and triflate 
counterion. Single point energy evaluations using the dispersion-corrected DFT method 
B97D led to a reversal of the calculated ΔΔG‡ for the reaction of tert-butyl 
cyclopentaonone-2-carboxylate (1-37), demonstrating the importance of long-range 
dispersive interactions in this system. It is likely that errors resulting from the 
calculation of dispersive interactions are at least partly responsible for the discrepancy 
between the calculated and experimental observations. This leads us to conclude that the 
origin of stereoselectivity is not attributable to a small number of interactions that 
clearly differ between diasteromeric transition states. Instead the difference in free 
energies arises from the sum of the effects of a large number of weak interations. 
4.3. Future Work 
The mechanistic study of the hydroxylation requires further investigation, as the DFT 
calculations revealed a surprising level of complexity in the transition states, yet failed 
to provide energies that accurately reflect experimental observations. Studies were 
limited by the computer time required to perform calculations, and a full investigation 
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of the involvement of the triflate counterion and triflic acid has not yet been possible. 
Only one position of the triflate ion was investigated, resulting in a significantly reduced 
energy barrier, however it is possible that other binding modes exist with lower or 
similar energies. Removing the counterion entirely has a major effect on the outcome, 
with a ΔΔG‡ value of 3.6 kcal mol-1 in favour of Si-face attack (tert-butyl ester), which 
corresponds closely to the experimentally determined value of 3.22 kcal mol-1.  The 
positioning of the triflic acid also deserves attention, as this may help to determine its 
role in the reaction, hence the origin of the rate acceleration observed in the presence of 
catalyst 1-34c versus 1-36c. 
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Chapter 5: Further Scope and Synthetic Studies 
Extensive work with β-ketoesters had led to the development of a highly 
enantioselective α-hydroxylation reaction, and structural features of the substrate 
required for high enantioselectivity had been identified. In the next stage of the project 
we aimed to extend the scope of the reaction to generate synthetically useful, optically 
active hydroxylated products. 
5.1. Hydroxylated N-Heterocycles 
A survey of the literature revealed a number of hydroxylated N-heterocyclic natural 
products, e.g. 5-1 to 5-6, and several of these were found to have significant biological 
activity (Figure 43).230-235 (-)-Pramanicin has attracted particular interest due to its 
synthetically challenging, densely functionalised N-heterocyclic structure and its 
notable antifungal activity, culminating in two successful total syntheses.236,237 In 
addition, anisomycin (5-5) possesses strong and selective activity against pathogenic 
protozoa and several strains of fungi, and has been used in the treatment of amoebic 
dysentery.234 
Figure 43. Hydroxylated N-heterocyclic natural products. 
5-1 
5-2 
5-3 
5-4 
5-5 5-6 
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5.1.1. Extending the Scope of the α-Hydroxylation Reaction 
We chose to investigate whether the catalytic system we had developed for α-
hydroxylation could be extended to the synthesis of hydroxylated N-heterocycles. Using 
our knowledge of the structural features required for high enantioselectivity, we 
envisaged that compounds of type 5-7 and 5-8 would be suitable target substrates to 
demonstrated the utility of the catalytic methodology (Figure 44). Both containing a 
tert-butyl β-ketoester in a 5-membered ring, these are structurally similar to tert-butyl 
cyclopentanone-2-carboxylate (1-37), which was hydroxylated in 98% ee. 
 
 
Figure 44. Proposed structures of N-heterocyclic substrates. 
Although the synthesis of compounds of structure 5-7 (R = Boc104 and R = Bn238) has 
been reported, we were concerned about the stability of the corresponding α-hydroxy 
products. Such products (5-9) contain hemiaminal functionality (N-C-OH), which can 
potentially undergo elimination either by route A or route B (Scheme 140) to form 5-10 
or 5-11 respectively. Both of these reactions would destroy the newly formed chiral 
centre, leading to achiral or racemic products. 
 
 
Scheme 140. Potential side reactions of hemiaminals. 
In fact, the closely related hemiaminal 5-12 has been reported to exist as an equilibrium 
mixture with its open-chain isomer 5-13 (Scheme 141).239 Attempts to separate 5-10 and 
5-11 failed, and VT NMR studies confirmed the operation of an equilibrium process 
between the two species.  
 
 
Scheme 141. Reversible formation of hemiaminal 5-12. 
5-7 5-8 
5-9 5-10 5-11 
5-12 5-13 
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In light of this, N-heterocycles 5-7 were not synthesised, and the isomeric N-
heterocycles 5-8 were investigated instead. A number of such compounds have been 
reported, including the N-ethoxycarbonyl species 5-14,240 the racemic 2-substituted 
pyrrolidinone 5-15238 and the N-Boc species 5-16,241,242 as a potassium salt.  
 
 
Figure 45. Reported 4-tert-butoxycarbonyl 3-pyrrolidinones. 
In addition, the corresponding α-hydroxy product 5-17 had been reported, and was used 
as an intermediate in the (racemic) synthesis of an influenza virus neuraminidase 
inhibitor (5-18, Scheme 142).243   
 
Scheme 142. Synthesis of neuraminidase inhibitor 5-18.  
To extend the scope of the reaction further, 3-alkoxycarbonyl 2-pyrrolidinones were 
examined as substrates. Many of these species had been previously reported, including 
5-19a-d,244-247 simplifying the investigation of such molecules (Figure 46). However 
these species are not β-ketoesters, but β-amidoesters, and as a result, their inclusion in 
the α-hydroxylation reaction represents a significant broadening of the substrate scope. 
To the best of our knowledge, the corresponding α-hydroxy products (5-20) had not 
been reported, making this a novel class of compounds.  However, hydroxylated 
oxindoles 5-21 are benzo-fuzed analogues of 5-20, which have been reported by several 
groups.248-251  
  
5-14 5-15 5-16 
5-17 5-18 
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Figure 46. Reported 3-alkoxycarbonyl 2-pyrrolidinones. 
5.1.2. Synthetic Studies Towards N-Heterocycles 
Several of the hydroxylated N-heterocycles that inspired this work contain common 
structural features, prompting us to undertake synthetic studies towards the fully 
substituted heterocyclic cores of 5-1 to 5-4. Our first goal was to synthesise the 
heterocyclic ring of pramanicin (5-22). We proposed that this fully substituted 
pyrrolidine could be accessed by reduction of the ketone 5-23, which in turn could be 
synthesised by the reaction of 5-24 with formaldehyde (Scheme 143). This reveals a 
potential α-hydroxylation product of 5-25. 
  
Scheme 143. Retrosynthesis of 5-22 by the tetramic acid route. 
The work began with the synthesis of a tetramic acid precursor (5-25), for which 
suitable literature procedures exist.252 However these species were predicted to have 
very different reactivity to the β-ketoesters previously investigated, as the pKa of the α-
proton is significantly lower. Also, there are two possible binding modes through which 
the reaction can proceed (5-26 and 5-27) which are likely to lead to opposite 
enantiomers (Figure 47).  
5-19a (R = H) 
5-19b (R = Bn) 
5-19c (R = Boc) 
5-19d (R = Ts) 
5-21 5-20 
5-22 5-23 5-24 
5-25 
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Figure 47. Possible Pd-enolate complexes. 
Both the reduction and aldol steps generate new chiral centres (Scheme 143), and the 
diastereoselectivity of these reactions requires consideration. In the aldol step, the 
electrophile must approach the Si-face of the enolate 5-28 (Figure 48). This is likely to 
be heavily influenced by the choice of ester and alcohol protecting group, with a bulkier 
ester and smaller, or directing protecting group favouring Si-attack.  
 
In the reduction step, Re-face attack by the reagent is required. Steric factors are likely 
to be highly influential, with the Si-face shielded by the ester substituent, and the Re-
face shielded by the tertiary alcohol and hydroxymethylene group. It was hoped that by 
employing a bulky ester substituent, Re-face attack would be dominant, particularly if a 
reagent such as borane were employed, as interaction between the boron and the alcohol 
substituents may encourage attack from the desired face (5-29).  
 
 
Figure 48. Stereoselectivity in the aldol and reduction steps. 
If these factors failed to deliver the desired diastereomer, it is possible that the 
stereochemistry could be corrected by a Mitsunobu inversion. An example of this 
procedure is Sha and co-workers’ synthesis of Lentiginosine (5-30, Scheme 144).253 
However this is an option of last resort as it adds extra steps with poor atom economy to 
the synthesis. 
 
Scheme 144. Inversion of stereochemistry via Mitsunobu reaction. 
5-28 5-29 
5-30 
5-26 5-27 
144 
The second route was a more general approach to the cores of several naturally 
occurring N-heterocycles. We proposed that heterocycles 5-32 to 5-34 could be derived 
from the common intermediate 5-31 (Scheme 145).  
 
Scheme 145. Synthesis of various natural product analogues. 
The Fusarin C core (5-32) could be synthesised from 5-31 by selective addition of a 
carbon nucleophile at C-5 followed by formation of an epoxide, possibly via an alkyl 
sulfonyl intermediate (Scheme 146).  
 
Scheme 146. Synthesis of the core of Fusarin C. 
Synthesis of the (+)-pramanicin core 5-33 (note that this is the unnatural enantiomer), 
also requires addition of a carbon nucleophile at C-5, however the hemiaminal then 
requires reduction by a mild reducing agent such as sodium cyanoborohydride254 
(Scheme 147). The route to azaspirene 1 appears to be the simplest, requiring only the 
addition of a benzyl nucleophile at C-5. 
5-32 5-33 5-34 
5-31 
5-1 5-3 5-4 
5-32 
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Scheme 147. Synthesis of the core of Pramanicin. 
To assess the feasibility of these routes, reported reactions of carbon nucleophiles with 
succinimides were researched. Several closely related systems have been shown to react 
with the required regioselectivity. It should be noted that the hemiaminals generated in 
this reaction are believed to readily tautomerise in solution hence the 
diastereoselectivity of this reaction is inconsequential.  
 
Rovis and co-workers utilised samarium diiodide in a  modified Barbier reaction for the 
benzylation of tricycle 5-35, though the low isolated yield suggests the significant 
formation of side products (Scheme 148).255 This transformation is particularly 
applicable to the synthesis of Azaspirene 1. 
 
 
Scheme 148. Samarium diiodide mediated benzylation reaction. 
Also, Czarnocki and co-workers showed that phenyllithium was able to add selectively 
to succinimide 5-36 (Scheme 149).256 Regioselective attack on succinimides has also 
been effected by Grignard reagents257 and DIBAL,258 proceeding with attack at the less 
hindered carbonyl.  
 
Scheme 149. Regioselective arylation of succinimdes. 
Thus, an approach to intermediate 5-31 via hydroxylation of the enolate of succinimide 
5-37 was envisaged (Scheme 150). This step would be expected to generate the wrong 
diastereomer, as the ester group blocks attack from one face of the enolate (5-39). 
5-33 
5-35 
5-36 
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Several strategies were considered to circumvent this problem, including adopting a 
bulky protecting group on the existing alcohol, or a FGI to reduce the steric bulk of the 
ester. Multi-step procedures via 5-40 or 5-41 were also considered, which would be 
expected to lead to the desired diastereomer through selective hydride attack and 
protonation respectively.   
 
The precursor 5-37 would in turn be accessed via asymmetric α-hydroxylation of an 3-
alkoxycarbonyl succinimide (5-38). These are a known class of compounds, and various 
literature methods are available for their construction. 
 
 Scheme 150. Retrosynthetic strategy to 5-31. 
5.2. Synthesis of Precursors 
The N-protected amino acids 5-42 were acquired via literature procedures from glycine 
ethyl ester hydrochloride.259-261 Three 3-pyrrolidinones (5-43a-c) were then generated 
via a reported method for the synthesis of the potassium salt of 5-43c, which were 
protonated to release the product (Scheme 151).241 A procedure to recrystallise the N-
Boc product 5-43c from hexane was developed, avoiding the need for chromatography. 
These products gradually decomposed over several days at room temperature, so were 
used immediately in the hydroxylation reactions, or stored briefly in the freezer. 1H 
NMR of these species (5-38) was complex as they are rotomeric at room temperature, 
while also existing as keto-enol mixtures.  
5-31 5-37 
5-39 
5-31 
5-31 
5-40 
5-41 
5-38 
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Scheme 151. Synthesis of 3-pyrrolidinones. 
Two 2-pyrrolidinones were synthesised as substrates for study in the α-hydroxylation 
reaction. According to literature procedures,245 the N-benzyl species 5-45 was obtained 
in two steps from 2-pyrrolidinone via N-benzylation in 79% yield, followed by reaction 
with NaHMDS and (Boc)2O in 80% yield (Scheme 152). However, the limiting reagent 
in the second step is (Boc)2O, which was employed sub-stoichiometrically (0.5 
equivalents). Addition of 1 equivalent of (Boc)2O resulted in formation of a mixture, 
from which none of the desired product could be isolated. 
 
Scheme 152. Synthesis of 2-pyrrolidinones. 
The N-Boc analogue 5-47 was also synthesised in two steps from 2-pyrrolidinone. The 
reaction with chlorotrimethylsilane, following to a literature procedure, gave 5-46 in 
71% yield after distillation (Scheme 153).244 According to a reported procedure for the 
synthesis of tert-butyl 2-pyrrolidinone-3-carboxylate (5-48),244 5-46 was reacted with 
NaHMDS and (Boc)2O. However the expected N-H product (5-48) was not observed in 
the 1H NMR spectrum of the crude reaction mixture; only the N-Boc product 5-47 was 
isolated in 34% yield. This may have been due to the presence of unreacted (Boc)2O in 
the reaction mixture upon quenching, i.e. an incomplete reaction, which would also 
explain the low yield. The TMS group is rapidly hydrolysed by water, allowing the 
anhydride to react with the N-H product 5-48. As with the N-Bn product 5-45, a large 
excess of the enolate was required. When the reaction was repeated with 1 equivalent of 
the enolate, neither 5-47 nor 5-48 were formed, and a number of unidentified species 
were observed in the crude mixture.  
5-42a (P=Moc) 85% 
5-42b (P=Cbz) 14% 
5-42c (P=Boc) 100% 
5-43a (P=Moc) 51% 
5-43b (P=Cbz) 33% 
5-43c (P=Boc) 85% 
5-45 5-44 
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Scheme 153. Synthesis of 5-47. 
The syntheses of two tetramic acids (5-49 and 5-50) were also attempted (Figure 49). 
Substrate 5-49 was selected as the PMB group can be easily cleaved from lactams using 
cerium ammonium nitrate,262 and the tert-butyl ester ensures that the highest 
enantioselectivity can be attained in the asymmetric α-hydroxylation. Conversely, 5-50 
is a known compound, facilitating its quick and reliable preparation.   
 
 
 
Figure 49. Tetramic acids. 
The route to 5-49 required mono-tert-butyl malonate (5-51) as a precursor, which was 
synthesised  from Meldrum’s acid according to a literature procedure (Scheme 154).263 
The amino acid ester 5-52 was obtained by alkylation of para-methoxybenzyl amine, 
and was condensed with 5-51 to give the amide 5-53, however the yield of the 
condensation step was low due to difficulty in separating the urea byproduct. This 
amide (5-53) is rotameric at room temperature; hence the 1H NMR spectrum contained 
twice the expected number of peaks. This is likely to be due to slow rotation about the 
amide C-N bond, leading to cis- and trans-conformers.  
 
Cyclisation of 5-53 employing sodium ethoxide generated in situ proceeded cleanly to 
give the product 5-54, which precipitated from the reaction and was collected by 
filtration. This material was water-soluble, facilitating NMR analysis in D2O, and no 
further purification was required. 
5-46 5-47 
5-48 
5-49 5-50 
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Scheme 154. Synthesis of 5-49. 
The final step in the synthesis of 5-49 was the protonation of 5-54, however this proved 
to be problematic. Repeated attempts to acidify an aqueous solution of 5-54, carefully 
reducing the pH to 5, resulted in isolation of a mixture containing none of the desired 
product. The majority of this crude mixture appeared to comprise of the decarboxylated 
species 5-56 (Scheme 155).  
 
Mechanistically, cleavage of a tert-butyl ester usually takes place only under acidic 
conditions. Its occurrence under neutral conditions with this substrate may be 
accelerated by intramolecular proton transfer, leading to the highly stabilised anion 5-
55. 
 
 
 
Scheme 155. Decarboxylation of tetramic acid 5-49. 
5-51 
5-52 
5-51 + 5-52 
5-53 
5-54 
5-49 
5-55 5-56 
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Predicting that decarboxylation cannot proceed with a non acid-labile ester, the 
synthesis was repeated with a known ethyl ester.264 The same route employed for the 
attempted synthesis of 5-49, starting from benzyl amine, ethyl bromoacetate and mono-
ethyl malonate, provided the tetramic acid 5-50 in 21% overall yield (Scheme 156). The 
sodium salt of the product 5-59 was dissolved in water and acidified with 1 M HCl, 
collecting the precipitated product by filtration. 5-50 proved to be stable to isolation, but 
required storage at low temperature as it gradually decomposed at room temperature. 1H 
NMR showed that it exists entirely in the enol form. 
 
Scheme 156. Synthesis of tetramic acid 5-50. 
The next part of the work involved the preparation of five 3-alkoxycarbonyl 
succinimides (5-60a-e, Figure 50). As 5-60a is a known compound,265 it was selected 
initially to assess the suitability of this class of substrates in the hydroxylation reaction, 
whereas succinimides 5-60b-e contain a tert-butyl ester which was expected to provide 
optimal enantioselectivities. 
 
Figure 50. 3-Alkoxycarbonyl succinimides. 
Succinimide 5-60a was synthesised according to literature procedures,265,266 starting 
from bromoacetyl bromide and benzylamine (Scheme 157). The synthesis of amide 5-
61a proceeded in good yield (literature yield was not reported), and the procedure was 
successfully extended to the synthesis of other bromoacetamides 5-61b and 5-61c, 
though the latter was attained in poor yield. The reaction of 5-61a with diethyl malonate 
gave only 19% yield of 5-60a, acompanied by numerous side products. The reported 
5-50 5-59 
5-60a (P=Bn, R=Et) 
5-60b (P=Bn, R=tBu) 
5-60c (P=PMB, R=tBu) 
5-60d (P=tBu, R=tBu) 
5-60e (P=Boc, R=tBu) 
5-57 5-58 
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yield for this reaction is 40%,265 and the discrepancy may be due to difficulties in 
product isolation/purification. The product is a white crystalline solid, identified by the 
observation of an ABX spin system in the 1H NMR spectrum, corresponding to the 
protons on the succinimide ring. 
 
Scheme 157. Synthesis of 5-60a. 
Methyl tert-butyl malonate (5-63) was synthesised from methyl choroformate and 
mono-tert-butyl malonate (Scheme 158). This reaction is believed to proceed via a 
ketene intermediate, and has the advantage of being clean and fast; pure product can be 
obtained after filtering off the triethylamine hydrochloride by-product.267 Reaction of 
this malonate with amides 5-61a and 5-61b by an analogous procedure to that employed 
for 5-60a gave the succinimides 5-60b and 5-60c as white crystalline solids, in 34% and 
29% yields respectively. Again, several side products were observed in these reactions, 
requiring purification by flash chromatography. The desired products were identified by 
the disappearance of the methyl ester peak in the 1H NMR, and observation of an ABX 
system due to the peaks on the succinimide ring. However the reaction with 5-61c 
failed, producing only the uncyclised intermediate 5-64 as a yellow oil, clearly 
identified by a peak in the 1H NMR at 3.76 ppm corresponding to the methyl ester, and 
a parent ion peak in the mass spectrum at 287.  
 
 
Scheme 158. Synthesis of tert-butoxycarbonyl succinimides. 
5-61a (R=Bn) 60% yield 
5-61b (R=PMB) 95% yield 
5-61c (R=tBu) 24% yield 
5-61a 
5-60a  
5-63  
5-61a-c 
5-64 (74%) 
5-63  
5-60b (34%, R = Bn) 
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The cyclisation of 5-64 was subsequently attempted at higher temperature, heating it 
with sodium hydride in toluene. After 20 h at 60 °C only 20% conversion of the starting 
material to product was observed, determined by 1H NMR. After a further 7 h at reflux 
(111 °C), no starting material remained, but several spots were visible by TLC, and the 
desired succinimide 5-60d was isolated in 50% yield, identified by the disappearance of 
the peak for the methyl ester in the 1H NMR spectrum. The same reaction proceeded 
much more cleanly at room temperature in 17 h when the milder base, KOtBu, was 
employed in THF, giving an improved 77% yield (Scheme 159). 
 
Scheme 159. Synthesis of 5-60d. 
So far, applying the literature conditions to the synthesis of 5-60a-d had resulted in poor 
yields (0-34%) in every case. In addition, side products that were difficult to remove by 
chromatography made the reactions time consuming. As the succinimide 5-60c was 
required at multigram scale, attempts were made to improve the procedure. By 
analysing the 1H NMR spectrum of the crude reaction mixture in the synthesis of 5-60c 
two side products (5-65 and 5-66) were identified (Figure 51). To understand how these 
species were formed and how they could be eliminated, the reaction mechanism was 
considered. 
 
Figure 51. Side products in 5-60c synthesis. 
The literature protocol required the addition of a dialkyl malonate to two equivalents of 
sodium hydride in DMF. This mixture was then added to a solution of the relevant 
bromoacetamide. Under these conditions, the sodium malonate 5-67 is presumably first 
alkylated, generating intermediate 5-65 (Scheme 160). Deprotonation of 5-65 by the 
second equivalent of sodium hydride then removes the methine proton, as this is the 
most acidic, leading to 5-68. This deprotonation is unproductive, and the reaction 
instead proceeds via the deprotonated amide 5-69 presumably present in a disfavourable 
equilibrium with 5-68.  
 
5-65 5-66 
5-60d 5-64 
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Evidently one of the side products, 5-65, is an intermediate; however it persisted in the 
reaction mixture, even after extended reaction times. The mechanism suggests this 
could be avoided by employing a small excess of base to ensure the reaction reached 
completion. 
 
Scheme 160. Mechanism of 5-60c synthesis. 
The spiro-fused bicyclic side product 5-66 was generated by the reaction of the desired 
product (5-60c) with a further equivalent of bromoacetamide (5-61b, Scheme 161). 
Crucially this requires product (5-60c) to be formed and deprotonated before the 
bromoacetamide is completely consumed. We proposed that this could be avoided by 
performing the reaction stepwise, converting all the bromoacetamide to 5-65, before 
allowing the ring closing step to take place. This was achieved by adding one equivalent 
of base at the start of the reaction, and adding another portion later, as well as 
employing a small excess (1.2 eq) of malonate. This ensured the bromoacetamide was 
completely consumed, and the excess malonate can be easily separated from the product 
by flash chromatography.  
 
Scheme 161. Mechanism of formation of 5-66. 
Instead of sodium hydride, we chose to employ KOtBu, as using this base had resulted 
in significant rate acceleration in the cyclisation of 5-64 earlier. Also, the commercially 
available di-tert-butyl malonate was employed, avoiding the need to synthesise the 
unsymmetrical methyl tert-butyl malonate. The reaction was carried out in THF, adding 
5-60c  
5-66 
5-67 5-65 
5-68 
5-69 
5-61b 
5-61b 
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1.2 equivalents of the malonate to 1.2 equivalents of KOtBu (Scheme 162). This 
mixture was cooled to 0 °C and the bromoacetamide 5-61b added dropwise as a 
solution in THF. TLC showed complete consumption of the bromoacetamide after a few 
minutes, so a further equivalent of KOtBu was added, allowing the mixture to warm to 
room temperature and stir for 16 h. TLC revealed clean conversion to a single product, 
accompanied by the excess malonate. Chromatography gave the product (5-60c) in a 
greatly improved 67% yield. 
 
Scheme 162. Modified synthesis of 5-60c. 
Our studies towards the N-Boc substrate 5-60e began with the synthesis of N-Boc 
succinimide (5-70) according to a literature procedure (Scheme 163).268 However 
attempts to alkylate 5-70 failed, as the lithium and sodium salts of the anion 5-71 proved 
to be unstable at -78 °C. 
 
Scheme 163. First route to 5-60e. 
Through a correspondence with Prof Keiji Maruoka (Kyoto university), we were 
provided with details of an unpublished route to succinimide 5-60e via N-TMS 
succinimide (5-72, Scheme 164), which was synthesised from succinimide and 
chlorotrimethylsilane in 81% yield. It was stable to deprotonation by NaHMDS, and a 
slow reaction with di-tert-butyl dicarbonate occurred at room temperature. Upon 
quenching, the TMS group hydrolysed, and the N-H reacted rapidly with a second 
equivalent of di-tert-butyl dicarbonate, giving 5-60e in 14% yield, which compares 
favourably with the 7% yield observed by Maruoka and co-workers. The product is a 
2) 5-61b, 0 °C, 10 
5-60c 
(67%) 
5-70 5-71 
5-60e 
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white crystalline solid with the expected ABX spin system visible in the 1H NMR 
spectrum. 
 
 
Scheme 164. Synthesis of 5-60e. 
5.3. α-Hydroxylation of N-Heterocycles 
5.3.1. 3-Pyrrolidinones 
Our study into the α-hydroxylation of N-heterocycles began with 3-pyrrolidinones 5-
43a-c as they are electronically and sterically similar to the carbocyclic β-ketoesters 
studied earlier. Thus, it was gratifying to find that these substrates also reacted with high 
enantioselectivity under previously established conditions (Table 55).  
 
Table 55. α-Hydroxylation of 3-pyrrolidinones.a 
 
 
Entry Substrate Product 
m/z, 
M.NH4+ 
Yieldb  
(%) 
eec 
(%) 
1 5-43a (R = Moc) 5-73a 277 38 95 (+) 
2 5-43b (R = Cbz) 5-73b 353 97 90 (+) 
3 5-43c (R = Boc) 5-73c 319 93 93 (+) 
aReaction conditions: Substrate (0.123 mmol), 1-34c (5 mol%), DMD (0.07 M in 
acetone, 1.2 eq.), CH2Cl2 (0.5 mL), -20 °C, 0.5 h. bIsolated yield. cDetermined by chiral 
HPLC. Absolute stereochemistry assigned by comparison of [α]D to reported values.  
 
It is interesting to note that the choice of protecting group on nitrogen has minimal 
effect on the enantioselectivity of the product. The N-Moc product 5-73a partially 
decomposed within hours at room temperature and required purification by flash 
chromatography, resulting in a low isolated yield (entry 1). In comparison, the Cbz and 
Boc protected products are more stable, and were isolated in high yields without the 
need for chromatography (entries 2 and 3), however, these compounds were also 
5-60e 5-72 
(R)-1-34c (5 mol%) 
5-43a-c 5-73a (R=Moc) 5-73b (R=Cbz) 
5-73c (R=Boc) 
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unstable to storage at room temperature, and must be kept in the freezer. As with the 
substrates 5-43a-c, the α-hydroxy products 5-73a-c were rotomeric, resulting in 
complex NMR spectra. However partial assignment of the 1H signals was possible and 
the presence of M.NH4+ peaks in the mass spectra (ammonia CI) allowed further 
confirmation of these structures. 
5.3.2. 2-Pyrrolidinones 
The 2-pyrrolidinones (5-45 and 5-47) were expected to exhibit different reactivity to 
substrates studied previously, due to the lower acidity of the α-proton. When 5-47 was 
subjected to the previous conditions of the hydroxylation, no reaction was observed 
after 100 min, so the mixture was allowed to warm to 0 °C. After a further 18 h, some 
product formation was evident by TLC and 5-74a was isolated by flash chromatography 
in 27% yield and 78% ee (Table 56, entry 1). To increase the product yield, the reaction 
was repeated with a higher catalyst loading (20 mol%) and larger excess of DMD (2 
equivalents). Under these conditions the reaction was complete after 48 h, providing 
pure 5-74a without the need for chromatography, with essentially the same ee (entry 2).  
 
Table 56. Hydroxylation reactions of 2-pyrrolidinones.a  
 
 
Entry Substrate 
Cat. loading 
(mol%) 
DMD 
(eq) 
Time 
(h) 
Yieldb  
(%) 
eec 
(%) 
1  5-45 (R=Bn) 10 1.2 18 27 78 (+) 
2  5-45 (R=Bn) 20 2.0 48 91 77 (+) 
3  5-47 (R=Boc) 5 1.2 18 99 97 (+) 
aReaction conditions: Substrate (0.123 mmol), 1-34c (5 mol%), DMD (0.07 M in acetone, 1.2 
eq.), CH2Cl2 (0.5 mL), 0 °C, 0.5 h. bIsolated yield. cDetermined by chiral HPLC. Absolute 
stereochemistry assigned by comparison of [α]D to reported values.  
 
Again, no reaction was observed with the Boc-substrate 5-47 at -20 °C after 100 min. 
However when the temperature was raised to 0 °C, the reaction reached completion in 
18 h (entry 3), proceeding noticeably faster than the reaction of 5-45 without the need 
for a high catalyst loading. Product 5-74b was obtained cleanly in an excellent 99% 
yield and 97% ee, providing access to a novel and potentially valuable synthetic 
building block with near perfect enantioselectivity. The difference in reactivity may be 
(R)-1-34c  
5-45 (R=Bn) 
5-47 (R=Boc) 
5-74a (R=Bn) 
5-74b (R=Boc) 
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due to the electron withdrawing nature of the Boc group, increasing the acidity of the α-
proton, thereby aiding its deprotonation.  
5.3.3. Tetramic Acids 
The attempted hydroxylation of tetramic acid 5-50 failed, resulting in degradation of the 
starting material to a capricious reaction mixture within 18 h (Scheme 165). The desired 
product could not be identified in the 1H NMR spectrum of the crude mixture, and 
attempts to separate this mixture by flash chromatography were unsuccessful, due to the 
large number of components present. This result implied that pramanicin could not be 
accessed via the intermediate 5-75.  
 
 
Scheme 165. Attempted hydroxylation of 5-50. 
5.3.4. Succinimides 
The succinimide 5-60a was subjected to the optimised conditions of the α-hydroxyaltion 
reaction, however no product formation was observed by TLC after 30 min. Upon 
raising the temperature to 0 °C, the reaction proceeded cleanly, reaching completion 
within 4 h (Scheme 166). Moderate chiral induction was expected, as the substrate 
contains an ethyl ester which is not optimal for high enantioselectivity. Even so, the 
24% ee obtained is substantially lower than that observed with similar carbocyclic ethyl 
esters 3-46 (54% ee) and 3-56 (87% ee). 
 
Scheme 166. Hydroxylation of 5-60a. 
(R)-1-34c (5 mol%) 
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Employing the tert-butyl esters 5-60b-e gave α-hydroxy products 5-76b-e with 
significantly higher enantioselectivities (Table 57). The best result was obtained with 
the N-benzyl substrate 5-60b (entry 1), and little difference was seen with the PMB 
protected susbtrate 5-60c (entry 2). It was hoped that employing a bulky tert-butyl 
substituent on the nitrogen would increase the enantioselectivity, but the ee was lower 
than the previous two substrates (entry 3). Finally the N-Boc substrate was found to 
proceed with only 49% ee (entry 4), which was disappointing, as close structural 
analogue 5-47 had reacted with almost complete stereoselectivity (Table 57). 
 
Table 57. Hydroxylation of succinimides.a  
 
 
Entry Substrate Time (h) Yield (%) ee (%) 
1  5-60b (R = Bn) 20e 99 83 (+) 
2  5-60c (R = PMB) 14e 92 80 (+) 
3  5-60d (R = tBu) 16e 94 68 (+) 
4  5-60e (R = Boc) 4 92 49f 
aReaction Conditions: Substrate (0.123 mmol), 1-34c (5 mol%), DMD (0.07 M in 
acetone, 1.2 eq.), CH2Cl2 (0.5 mL), 0 °C. bIsolated yield. cDetermined by chiral HPLC. 
Absolute stereochemistry assigned by comparison of [α]D to reported 
values.eUnoptimised. fNo optical rotation observed (too small to measure). 
 
For the proposed synthesis of hydroxylated N-heterocycles, a very high level of optical 
purity (>90% ee) of the α-hydroxylated products was required. The N-PMB succinimide 
5-76c was selected for further study, as it was obtained with reasonably high ee, and 
PMB protecting groups are generally more easily cleaved from succinimides than 
benzyl protecting groups.269  
 
Preparing the catalysts in situ, several chiral ligands were screened in the hydroxylation 
reaction (Table 58). The reactions were carried out in parallel and (R)-BINAP was 
examined as a control, resulting in a marginally reduced ee compared to the reaction 
with isolated catalyst, despite the higher catalyst loading (entry 1). In this study, only 
axially chiral ligands with structures similar to BINAP were investigated, and no 
significant difference in yield or ee was observed in any case (entries 2-6). It is 
interesting to note that the substitution on the aryl groups on the P-donor has no effect 
5-76b (R=Bn) 
5-76c (R=PMB) 
5-76d (R=tBu) 
5-76e (R=Boc) 5-60b-e 
1-34c (5 mol%) 
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on the enantioselectivity in this reaction (entry 1 versus entry 2, and entry 3 versus entry 
4). In light of these results, we continued to employ catalyst 1-34c in further studies. 
 
Table 58. Ligand screen with substrate 5-60c.a 
 
 
Entry 
Ligand Yieldb
(%) 
eec 
(%) Structure Name 
1 
 
(R)-BINAP 87 75 
2 
 
(R)-Tol-BINAP 81 75 
3 
 
(R)-P-Phos 89 74 
4 (R)-Xylyl-P-Phos 86 74 
5 
 
(R)-MeO-PHEP 90 72 
6 
 
(R)-SynPhos 89 71 
aReaction Conditions: Pd(OTf)2.2H2O (10 mol%), ligand (11 mol%), CH2Cl2 (0.5 mL), 
30 min, then 5-60c (0.123 mmol), DMD (0.07 M in acetone, 1.2 eq.), 0 °C, 4 h. 
bIsolated yield. cDetermined by chiral HPLC. Absolute stereochemistry assigned by 
comparison of [α]D to reported values. 
5-60c 5-76c 
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As the α-hydroxy product 5-76c was highly crystalline, the possiibility of achieving 
optical enrichment by recrystallisation was investigated. Optical enrichment occurs 
when the ee of the precipitate differs from that of the mother liquor. If racemic material 
crystallises more readily than non-racemic material, then concentration of the mother 
liquor provides optically enriched material.270 Conversely if enantiopure material 
crystallises, the mother liquor will be of reduced optical purity.119 This phenomenon 
depends on the nature of the packing structures of racemic and non-racemic crystals.271  
 
Repeating the enantioselective synthesis of 5-76c on a larger scale (646 mg) gave the 
product in 97% yield, but with a diminished ee of 72%, potentially due to inferior 
temperature control. 53.0 mg of this material was recrystallised by dissolving in 
minimum ethyl acetate (3 mL) and adding hexane (4 mL) whilst stirring (Method A, 
Table 59). Pleasingly the precipitate was found to be optically pure, demonstrating that 
optical enrichment is possible for this substrate, although only 32% of the product was 
recovered. The procedure was modified, adding 102 mg of 5-76c to hot hexane (2 mL), 
then dissolving it by addition of minimum hot ethyl acetate (2.3 mL). Upon cooling of 
the solution in the freezer, the product crystallised to give a greatly improved recovery 
and a high level of optical purity (Method B).  
 
Table 59. Recrystallisation of 5-76c. 
 
Entry Method 
Scale 
(mg) 
Filtrate Precipitate 
Yield 
(mg) 
Yield 
(%) 
ee 
(%) 
Yield 
(mg) 
Yield 
(%) 
ee 
(%) 
1 A 53 35.6 67 70 17.0 32 >99 
2 B 104 32.8 32 15 66.4 64 97 
 
Further improvement in stereoselectivity was achieved when the reaction was repeated 
on a large scale (846 mg) at -10 °C with an increased catalytic loading. Under these 
conditions the reaction reached completion in 1 h, giving the hydroxyl product 5-76c in 
92% yield and 87% ee (Scheme 167). Recrystallisation of the product from hot 
hexane/ethyl acetate (Method B) gave two crops of crystals with a combined 74% yield 
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(for the recrystallisation) and >99% ee, thus the overall yield for the optically pure 
compound was 68%. 
 
 
Scheme 167. Hydroxylation of 5-60c. 
Although confident of the absolute configurations of our carbocyclic and acyclic β-
ketoester products, no configurations had been reported for hydroxylated N-heterocyclic 
products (5-73a-c, 5-74a,b, 5-76a-e), i.e. they were tentatively assigned as S by 
analogy. To provide further evidence that this was the correct assignment, a single 
crystal of an optically pure sample of (S)-5-76c was obtained by crystallisation from 
methanol. This was analysed by X-ray crystallography by Dr Andrew White (Figure 
52), and the (S)-configuration of the sample was determined by use of the Flack 
parameter [x+ = 0.00(12), x– = 1.04(12)].272 By analogy, it is reasonable to assume that 
all α-hydroxy N-heterocycles generated in this work in the 1-34c mediated reaction with 
DMD, are optically enriched in the (S)-enantiomer. 
 
       
Figure 52. Crystal structure of 5-76c.  
5.4. Synthetic Studies Towards Natural Products 
5.4.1. Synthesis of the Common Intermediate 5-77 
With enantiopure (S)-5-76c in hand, the next step in the synthetic plan required the 
installation of a hydroxyl group at C-4 of the succinimide ring with the (S)-
configuration (Scheme 168). 
1-34c (10 mol%) 
5-76c 
5-76c 
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Scheme 168. Synthesis of 5-77. 
The introduction of a hydroxyl group adjacent to a carbonyl is most commonly achieved 
via the reaction of an oxaziridine with a lithium or sodium enolate.273 The hydroxylation 
of 5-76c would require either protection of the OH group, or formation of a dianion (5-
78), via removal of both the hydroxyl proton and the proton on C-4 (Scheme 169). To 
assess the feasibility of the formation of a dianion, a solution of 5-76c in THF was 
cooled to -78 °C and 2.2 equivalents of NaHMDS were added dropwise. After 10 min, 
an aliquot was removed and quenched with D2O, and the organic extracts analysed by 
1H NMR spectroscopy.  
 
Scheme 169. Deuteration of 5-76c as evidence of dianion formation. 
Complete disappearance of the singlet at 4.05 ppm corresponding to the OH peak was 
noted, and only small peaks remained corresponding to the H-4 of 5-76c (3.10 and 2.85 
ppm). These were replaced by a singlet at 3.07 ppm, i.e. deuteration had occurred at C-
4. Interstingly, only one diastereomer was observed, suggesting that the protonation at 
C-4 was stereoselective.  
 
Figure 53. A: 1H NMR spectrum of 5-76c.B: 1H NMR spectrum of 5-76c-d2. 
5-76c 
5-77 
5-76c 
5-76c-d2 5-78 
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With the evidence that a dianion could be formed by this method, the reaction of 5-76c 
with oxaziridines 1-94b and (-)-3-29a were attempted (Scheme 170). In both cases, the 
oxaziridine was added dropwise to the dianion 5-78 as a solution in THF, whereupon 
the reaction mixture turned a dark grey-blue colour. After 30 min, the mixtures were 
quenched with saturated NH4Cl and extracted using Et2O. 1H NMR of the crude mixture 
showed the presence of both starting material and reagent. Unknown compounds were 
present, but were unstable to isolation. Product formation was not apparent, and there 
was no change when the reaction time was extended for a further 3 h. The reaction with 
oxaziridine 1-94b was also repeated using LiHMDS as the base, and the same results 
were observed. 
 
 
 
Scheme 170. Oxidation of 5-76c with oxaziridines. 
Subsequently,  a Rubottom oxidation was considered, wherein the silyl enol ether 5-79 
could be generated via the dianion 5-78 and treated with mCPBA (Scheme 171). The 
bulky silyl group TBDMS was selected to prevent hydrolysis during aqueous workup. 
The dianion 5-78 was treated with TBDMSCl and stirred for 20 h at room temperature. 
After quenching with ammonium chloride solution, only starting material was 
recovered. 
  
1-94b (-)-3-29a 
5-76c 
5-77 
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Scheme 171. Oxidation of 5-76c via Rubottom oxidation. 
Another route for the preparation of 5-77 was via the ester 5-80 (Scheme 172). It was 
proposed that hydroxylation of 5-80 followed by selective saponification of the benzyl 
ester would lead to the desired intermediate after decarboxylation. This approach has 
the advantage that the stereochemistry is set in the final protonation step, and the 
expected approach of the proton from the least hindered top face would result in 
formation of the desired diastereomer. However the attempted reaction of 5-76c with 
benzyl chloroformate via the dianion 5-78 failed, and only starting material was 
observed in the reaction mixture after 2 h at room temperature (1H NMR). 
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Scheme 172. Oxidation of 5-76c via the benzyl ester. 
Next, we attempted to protect the alcohol in 5-76c as a TMS ether, heating in THF with 
TMSCl (1.1 eq) and NEt3 (1.1 eq). The reaction reached 30% conversion after 5 h, but 
5-79 
5-79 
5-77 
5-76c 
5-80 
5-77 
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failed to proceed further after 20 h. Repeating the reaction with 3 equivalents of reagent 
and base gave the silylated product in 3 h (Scheme 173). After aqueous workup, the 
product 5-81 was judged to be pure enough without the need for chromatography. The 
desired product was easily identified by the presence of a peak in the 1H NMR at 0.20 
ppm, corresponding to the TMS group. 
 
  Scheme 173. TMS protection of 5-76c. 
The deuteration experiment was repeated with the TMS protected derivative 5-81. THF 
solutions of 5-81 were treated with 1.1 equivalents of base, and aliquots quenched with 
D2O, extracted using CH2Cl2 and analysed by 1H NMR (Table 60). At -78 °C neither 
LiHMDS nor NaHMDS appeared to deprotonate 5-81, as no deuterium was observed in 
the product. Remarkably, the outcome was the same when the reactions were conducted 
at room temperature. Suspecting that the steric bulk of the TMS and tert-butyl ester 
groups was blocking access to the acidic protons, the less hindered base n-BuLi was 
then examined. This failed to deprotonate 5-81 at -78 °C, so DMPU was added as a co-
solvent (THF/DMPU, 2/1) as its ability to coordinate lithium has been shown to 
dissociate aggregates of n-BuLi, increasing its reactivity.274 The temperature was then 
raised to -10 °C, however no evidence of deprotonation was observed. Finally the 
temperature was raised to room temperature, whereupon a complete decomposition of 
the starting material to a complex mixture occurred after 5 minutes, as revealed by 1H 
NMR spectroscopy. These results suggest that the α-protons of 5-81 are too sterically 
hindered for this deprotonation to occur at low temperature, and that the resultant anion 
is unstable at room temperature. 
  
5-76c 5-81 
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Table 60. Deprotonation of 5-70.a  
 
Entry Base Temp (°C) Result 
1 NaHMDS -78 No change 
2 NaHMDS rt No change 
3 LiHMDS -78 No change 
4 LiHMDS rt No change 
5 n-BuLi -78 No change 
6 n-BuLi -10 No change 
7 n-BuLi rt Decomposition 
aReaction conditions: 5-72 (1 eq), base (1.1 eq), THF, 1 h. 
5.5. Conclusion 
The scope of the α-hydroxylation reaction has been successfully broadened to include 
N-heteocyclic substrates, and served to confirm the relationship between substrate 
structure and enantioselectivity. The absolute stereochemistry of (S)-5-76c was 
confirmed by X-ray crystallography. 
 
A number of novel, optically active hydroxylated N-heterocycles were synthesised in 
high yields and ees, including the potentially useful synthetic building block 5-76c, 
which could be recrystallised to give optically pure material in good yield. Attempts to 
hydroxylate this species were unsuccessful. Due to time constraints, further synthetic 
studies were not possible.  
5.6. Future Work 
The first objective for synthetic studies towards hydroxylated N-heterocycles is to 
develop a route to the intermediate 5-77 (Scheme 174). While initial attempts to 
hydroxylate 5-76c failed, a number of other options are available, such as the reagents 
MoOPH (Vedejs reagent)275 and oxygen/P(OEt)3.276  
 
 
 
5-81 5-81-d 
5-76c 
5-77 
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Scheme 174. Oxidation of 5-76c. 
However, direct hydroxylation of 5-76c is likely to generate the undesired diastereomer, 
due to the large steric bulk imposed by the tert-butyl ester. This problem could be 
avoided if a FGI were first performed on the ester, such as reduction to an alcohol (e.g. 
DIBAL, 2 eq.), followed by protection of the subsequent 1,2-diol 5-82 (Scheme 175). 
The choice of protecting groups is likely to have a significant impact on the 
diastereoselectivity of the attack on enolate 5-84 in the subsequent hydroxylation 
reaction. Successful synthesis of alcohol 5-77 or 5-85 would allow continued study of 
the planned syntheses of Fusarin C, Pramanicin and Azaspirene 1 (Scheme 145). 
 
Scheme 175. Alternative route to N-heterocycle core structures. 
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Chapter 6: Experimental 
General Experimental. Solvents were dried by passing through columns of molecular 
sieves in a solvent purification system. Unless otherwise stated, all precursors and 
reagents were procured commercially and used as received. Palladium salts were 
provided by Johnson Matthey plc through a precious metals loan agreement. All 
manipulations involving air-sensitive reagents were performed using standard Schlenk 
techniques and oven-dried glassware. Column chromatography and TLC were 
performed on silica gel (Kieselgel 60).  
 
1H, 13C and 31P NMR spectra were obtained on a Bruker Avace at 400 MHz, 161.9 MHz 
and 100.6 MHz respectively. Chemical shifts are reported in δ (ppm), referenced to 
TMS, and J values are given in Hz. Multiplicity is abbreviated to s (singlet), d (doublet), 
t (triplet), q (quartet) and m (multiplet). Infrared spectra were recorded using a Perkin 
Elmer FT-IR spectrometer equipped with an ATR accessory. Optical rotations were 
measured on a Perkin Elmer 343 Polarimeter using a 10 cm solution cell. [α]D values 
are given in 10-1 deg cm2 g-1 and concentrations in g per 100 mL. Melting points 
(uncorrected) were determined on an Electrothermal Gallenhamp apparatus. Single 
crystal X-ray diffraction was performed using an Oxford Diffraction Xcalibur PX Ultra, 
1.54248 Å diffractometer. 
 
HPLC analyses were performed on Gilson and Hewlett Paccard HPLC systems 
equipped with variable wavelength UV detectors and autoinjectors with a 20 μL loop, 
using Daicel Chiralpak AD, AD-H or AS or Chiralcel OD-H or OJ-H columns (250 x 
4.6 mm). GC analyses were obtained on a Hewlett Paccard 5890 instrument using a 
chiraldex G-TA column. Mass spectra (MS) were recorded on either a Micromass 
Autospec Premier or a VG Platform II spectrometer using FAB+, EI, ESI or CI 
techniques. Elemental analyses were carried out by the Science Technical Support Unit 
at London Metropolitan University.  
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6.1. Catalysts 
Palladium triflate dihydrate.130 According to a modified literature procedure, a 
Schlenk tube was charged with palladium nitrate hydrate (220 mg, 0.955 mmol, 
anhydrous basis), which was stirred vigorously under vacuum for 10 min. An outlet 
from the Schlenk tube was then connected to a Dreschel bubbler containing a solution 
of aq. K2CO3 (as a scrubber of gaseous by-products). The vessel was then flushed by a 
nitrogen stream, while triflic acid (1.6 mL) was added dropwise. When fuming had 
ceased (2 h), the slurry was transferred to boiling tubes and separated by centrifuge. The 
triflic acid was decanted off and the residue dried in a heated dessicator at 120 °C for 18 
h, giving palladium triflate dihydrate (396 mg, 94%) as a lilac powder.   
 
[Pd(R-BINAP)(H2O)2]2+[TfO]-2 (1-34c).132 A dry 
Schlenk tube was purged and charged under 
nitrogen atmosphere (inverted funnel) with 
palladium triflate (1.46 g, 3.32 mmol) and dry 
CH3CN (30 mL) forming an orange solution. (R)-
BINAP (2.07 g, 3.32 mmol) was added in one portion. After stirring for 20 min the 
solution was filtered through a short plug of celite, to remove traces of palladium black 
and unreacted (R)-BINAP. The yellow solution was then diluted with Et2O (180 mL). 
The precipitated product was collected by filtration, giving the complex (3.428 g, 97%) 
as a yellow crystalline solid. νmax/cm-1 1438, 1281, 1241, 1222, 1093, 1025, 744, 693; δH 
(CDCl3) 7.86-7.84 (6H, m), 7.70-7.63 (12H, m), 7.56-7.50 (4H, m), 7.22 (2H, t, J 6.6), 
7.06-7.02 (3H, m), 6.90 (3H, br s), 6.73 (2H, d, J 8.6), 4.00-3.75 (4H, m, br), 1.91 (3H, 
s); δP (CDCl3) +33.0 (s); δC (CDCl3) 139.6, 135.0, 134.9, 134.8, 134.5, 133.0, 132.9, 
132.0, 130.4, 130.3, 129.4, 129.3, 129.1, 128.7, 128.5, 127.7, 127.6, 127.0, 124.5, 
123.9, 123.0, 122.4, 122.0, 121.0, 118.9, 118.8, 118.3, 2.3; m/z (FAB) 877 (3%, 
C45H32F3O3P2PdS+), 728 (21), 437 (80), 154 (100). 
 
[{Pd(R-BINAP)(μ-OH)}2]2+[TfO]-2 (1-36c).124 1-34c (1.14 g, 1.07 mmol) was 
dissolved in CH2Cl2 (14 mL) and 
NaOH (0.07 M, 14 mL) was 
added. After stirring for 30 min 
the biphasic mixture was 
P
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separated, and the organic layer washed with H2O (3 x 20 mL), dried (MgSO4) and 
concentrated in vacuo. The crude product was recrystallised from CH2Cl2/Et2O, giving 
the complex (944 mg, 98%) as an orange crystalline solid. νmax/cm-1 3056, 2370, 2342, 
1436, 1265, 1154, 1097, 1030, 747, 696; δH (CDCl3) 7.73-7.70 (6H, m), 7.66-7.64 (6H, 
m), 7.55-7.47 (16H, m), 7.44-7.40 (6H, m), 7.23-7.21 (10H, t, J 7.0), 7.11-7.03 (16H, 
m), 6.59 (4H, d, J 8.6), -2.85 (2H, s, OH); δP (CDCl3) +29.1 (4P, s); δC (CDCl3) 138.6, 
138.6, 138.5, 134.7, 134.4, 132.9, 131.7, 131.6, 130.1, 128.9, 128.9, 128.8, 128.5, 
128.2, 127.0, 126.9, 124.8, 124.1, 123.4, 123.0, 122.8, 120.4, 119.9, 119.8. m/z (ESI) 
1585 (45%), 1536 (65), 1467 (42), 1403 (20).  
 
[Pd(R-Phanephos)(H2O)2]2+[TfO]-2 (3-26). A dry 
Schlenk tube was purged with N2 and charged with 
palladium triflate (996 mg, 2.26 mmol), (R)-Phanephos 
(1.43 g, 2.49 mmol) and dry CH3CN (20 mL). The 
solution was stirred for 2 h, then concentrated in vacuo 
and triturated with cyclohexane (50 mL). The precipitated solid was collected and 
recrystallised from THF/cyclohexane, giving the complex II (1.54 g, 67%) as an orange 
crystalline solid. NMR of the isolated complex showed a mixed solvate complex. 
νmax/cm-1 1438, 1280, 1225, 1161, 1026, 721, 693; δH (CDCl3) 8.33 (4H, s, br), 7.87-
7.46 (16H, m), 7.34 (2H, d, J 18.8), 6.77 (2H, d, J 7.8), 6.63 (2H, s), 4.99 (2H, s), 2.81-
2.65 (6H, m), 2.32-2.16 (2H, m), 2.00 (3H, s, CH3). δP (CDCl3) +47.8 (s); δC (CDCl3) 
139.8, 139.7, 139.4, 138.0, 137.1, 136.9, 136.6, 136.5, 136.3, 135.9, 135.5, 134.1, 
133.8, 132.8, 131.7, 131.2, 129.2, 35.7 (CH2), 34.8 (CH2), 34.7 (CH2), 32.0 (CH2); 
HRMS: m/z (FAB) 682 (82%), 154 (100); Anal. Calcd for C42H38F6O8P2PdS2: C, 49.59, 
H, 3.77%. Found: C, 49.67, H, 3.66%.  
6.2. Compounds Used in Chapter 2 
Nitrophenylmethane (2-14). According to the literature procedure,150 a 
solution of sodium nitrite (2.90 g, 42.5 mmol) and urea (3.30 g, 55 mmol) 
in DMF (50 mL) was cooled to -20 °C and benzyl bromide (3.00 mL, 25 mmol) was 
added dropwise. After 5 h at this temperature the mixture was poured into ice/H2O (100 
mL), extracted using Et2O (3 x 50 mL), washed with H2O (2 x 50 mL), dried (MgSO4) 
and concentrated in vacuo. The residue was distilled (65-87 °C, 0.3 Torr, lit.150 68-72 
°C, 0.4 Torr) giving nitromethyl benzene (959 mg, 28%) as a colourless oil. νmax/cm-1 
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1556, 1375, 1313; δH (CDCl3) 7.49-7.46 (5H, m, Ar), 5.46 (2H, s, CH2); δC (CDCl3) 
130.0 (Ar), 129.7 (Ar), 129.1 (Ar), 80.0 (CH2); m/z (EI) 137 (M+, <1%), 103 (13), 91 
(100), 65 (18). 
 
N-(Ethoxycarbonyl) imidazole (2-19).  According to the literature 
procedure,152 ethyl chloroformate (2 mL, 20.9 mmol) was dissolved 
in dry THF (10 mL) and cooled to 0 °C. A solution of imidazole 
(2.85 g, 41.8 mmol) in THF (10 mL) was added dropwise over 10 min. The mixture was 
stirred at rt for 18 h. The suspension was then filtered to remove the imidazole 
hydrochloride and the filtrate concentrated in vacuo to give the imidazole (7.30 g,  
100%) as an orange oil. νmax/cm-1 1766 (C=O), 1472, 1385, 1262, 1242; δH (CDCl3) 
8.13 (1H, s, NCHN), 7.42 (1H, s, CH), 7.06 (1H, s, CH), 4.47 (2H, q, J 7.2, CH2), 1.43 
(3H, t, J 7.2, CH3); δC (CDCl3) 148.6 (C=O), 137.0 (Ar), 130.5 (Ar), 117.1 (Ar), 64.4 
(CH2), 14.6 (CH3); m/z (EI) 140 (M+, 48%), 95 (15), 81 (25), 68 (100). 
 
2-Nitro-propionic acid ethyl ester (2-15b).277 A flask was charged 
with KOtBu (2.40 g, 21.4 mmol) and DMSO (80 mL), then nitroethane 
(1.54 mL, 21.4 mmol) was added dropwise. After 20 min the solution 
was cooled to 0 °C and a solution of N-(ethoxycarbonyl) imidazole (3.00 g, 21.4 mmol) 
in dry DMSO (40 mL) was added, maintaining the temperature below 10 °C during the 
addition. After stirring for 72 h at room temperature the reaction mixture was poured 
into a slurry of acetic acid (1.4 mL, 23.5 mmol) and ice (150 g), then extracted using 
CH2Cl2. The combined organic extracts were washed with brine (100 mL), then H2O (2 
x 100 mL), then dried (MgSO4) and concentrated in vacuo. The residue was purified by 
column chromatography (hexane/ethyl acetate, 15/1) to give the ester (1.78 g, 57%) as a 
colourless oil. νmax/cm-1 2988, 1749 (C=O), 1564, 1206; δH (CDCl3) 5.22 (1H, q, J 7.2, 
CHNO2), 4.32 (2H, q, J 7.0, CH3CH2O), 1.82 (3H, d, J 7.2, CH3CHNO2), 1.34 (3H, t, J 
7.0, CH3CH2O) ; δC (CDCl3) 165.1 (C=O), 83.2 (CHNO2), 63.0 (CH2), 15.7 
(CH3CHNO2); m/z (EI) 147 (M+, <1%), 102 (45%), 84 (56), 73 (69), 45 (100). 
 
2-Nitro-1-phenyl-ethanone (2-16).278 N-Benzoyl imidazole (2.00 
g, 11.6 mmol) was added dropwise to a solution of nitromethane 
(0.63 mL, 12.7 mmol) and KOtBu (1.43 g, 12.7 mmol) in THF (30 
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mL). The mixture was then heated to reflux for 16 h, cooled to rt and filtered, washing 
the residue with CH2Cl2 (30 mL) and ensuring it never ran dry (CAUTION: dry nitro-
salts are potentially explosive). The residue was then dissolved in H2O, acidified to pH 
3 by the addition of 2 M HCl and extracted using CH2Cl2 (2 x 30 mL). The combined 
extracts were washed with H2O (30 mL), dried (MgSO4) and concentrated. The residue 
was recrystallised from methanol giving the ketone (536 mg, 29%) as white crystals; mp 
102-104 °C (lit.278 102-103 °C); νmax/cm-1 1699 (C=O), 1558 (NO2), 1333, 1226, 995; 
δH (CDCl3) 7.90 (2H, d, J 8.0, C-2), 7.71, (1H, t, J 7.6, C-4), 7.56 (2H, m, C-3), 5.93 
(2H, s, CH2); δC (CDCl3) 185.8 (C=O), 135.1 (C-4), 133.3 (C-1), 129.3 (Ar), 128.2 (Ar), 
81.4 (CH2); m/z (EI) 165 (M+, 23%), 105 (100), 77 (55), 51 (25). 
 
2-((1-Phenyl-meth-(E)-ylidene)-amino)-propionic acid 
ethyl ester (2-17).  According to the literature procedure,157 
alanine ethyl ester hydrochloride (1.5 g, 9.76 mmol) and 
sodium carbonate (1.03 g, 9.76 mmol) were dissolved in H2O (25 mL) and 
benzaldehyde (991 μL, 9.76 mmol) was added. The mixture was warmed to 40 °C for 2 
h then extracted using CH2Cl2, washed with H2O, dried (MgSO4) and concentrated in 
vacuo to give the imine (1.34 g, 59%) as a yellow oil. νmax/cm-1 1732 (C=O), 1455, 
1172; δH (CDCl3) 8.32 (1H, s, ArCH), 7.80-7.78 (2H, m, C-2), 7.44-7.41 (3H, m, C-3, 
C-4), 4.27-4.18 (2H, m, CH2), 4.15 (1H, q, J 6.8, CHC=O), 1.54 (3H, d, J 6.8, CHCH3), 
1.27 (3H, t, J 7.2, CH2CH3); δC (CDCl3) 172.5 (C=O), 162.8 (HC=N), 135.8 (Ar), 131.0 
(Ar), 128.5 (Ar), 128.5 (Ar), 68.0 (CHCH3), 61.0 (CH2), 19.4 (CHCH3), 14.2 
(CH2CH3); m/z (EI) 205 (M+, <1%), 176 (17), 132 (100), 105 (37). 
 
3-(2-Chloro-acetyl)-oxazolidin-2-one (2-22). According to the 
literature procedure,158 a solution of 2-oxazolidinone (3.48 g, 40 
mmol) in dry THF (600 mL) was cooled to -78 °C and nBuLi (1.6 M 
in hexanes, 25 mL, 40 mmol) was added dropwise. The mixture was 
allowed to warm to room temperature, stirred for 1 h, then cooled again to -78 °C. 
Chloroacetyl chloride (3.50 mL, 44 mmol) was then added dropwise, maintaining the 
temperature below -70 °C. When the addition was complete the mixture was warmed to 
room temperature and quenched by slow addition of saturated NH4Cl solution (20 mL). 
The solvents were removed in vacuo and the residue diluted with H2O (20 mL) and 
extracted using CH2Cl2 (3 x 40 mL). The combined extracts were dried (MgSO4) and 
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concentrated to give the imide (6.64 g, 100%) as a white crystalline solid; mp 63-64 °C 
(lit.158 61 °C); νmax/cm-1 1780 (C=O), 1719 (C=O), 1396, 1342, 1232, 1124; δH (CDCl3) 
4.73 (2H, s, CH2Cl), 4.51 (2H, t, J 8.0, CH2O), 4.08 (2H, t, J 8.0, CH2N); δC (CDCl3) 
166.1 (CH2C=O), 153.3 (OC=O), 62.9 (CH2O), 43.4 (CH2Cl), 42.6 (CH2N); m/z (EI) 
163 (M+, 45%), 165 (M+, 18), 88 (56), 77 (45), 70 (53), 44 (100). 
 
[2-Oxo-2-(2-oxo-oxazolidin-3-yl)-ethyl]-phosphonic acid 
diethyl ester (2-23). According to the literature procedure,279 a 
flask was charged with 2-22 (2.00 g, 12.2 mmol) and triethyl 
phosphite (4 mL, 23.4 mmol) and heated to 80 °C for 18 h. 
Upon cooling the residue was washed repeatedly with hexane (5 x 2 mL), then purified 
by column chromatography (EtOAc/hexane, 1/1 to 1/0) to give the phosphonate ester 
(3.02 g, 93%) as a colourless oil. νmax/cm-1 1781 (C=O), 1698 (C=O), 1390, 1260, 1165, 
1024; δH (CDCl3) 4.43 (2H, t, J 8.0, CH2OCO), 4.23-4.16 (4H, m, CH2CH3), 4.08 (2H, 
t, J 8.0, NCH2), 3.78 (2H, d, J 22.0, PCH2), 1.35 (6H, t, J 7.2, CH3); δC (CDCl3) 165.0 
(d, J 23.6, CH2C=O), 153.4 (OC=O), 62.7 (d, J 24.0, CH3CH2), 61.9 (CH2CH2O), 42.6 
(NCH2), 33.8 (d, J 527, PCH2), 16.2 (d, J 24.4, CH3); m/z (EI) 265 (M+, 12%), 238 (27), 
221 (37), 179 (100), 151 (59), 123 (63), 88 (49). 
 
3-((E)-But-2-enoyl)-oxazolidin-2-one (2-21).280 To a solution of 
[2-oxo-2-(2-oxo-oxazolidin-3-yl)-ethyl]-phosphonic acid diethyl 
ester (3.20 g, 12.07 mmol) in THF (11 mL) was added DBU (1.81 
mL, 12.07 mmol), followed by acetaldehyde (0.745 mL, 13.27 mmol). The mixture was 
stirred for 1 h, then H2O (20 mL) was added. The solution was extracted using ethyl 
acetate (3 x 30 mL) and the combined organic extracts were washed with brine (20 mL), 
dried (MgSO4) and concentrated, yielding a dark yellow oil which was purified by 
column chromatography (hexane/ethyl acetate, 2/1) to give the alkene (1.19 g, 63%) as 
colourless needles; mp 39-41 °C (lit.281 42-43 °C); δH (CDCl3) 7.21 (1H, dq, J 15.2, 1.2, 
H-2), 7.13 (1H, dq, J 15.2, 6.4, H-3), 4.40 (2H, t, J 7.6, CH2O), 4.05 (2H, t, J 7.6, 
CH2N), 1.93 (3H, dd, J 6.4, 1.2, CH3); δC (CDCl3) 165.1 (C-1), 153.5 (OC=O), 146.7 
(C-3), 121.4 (C-2), 62.0 (CH2O), 42.5 (CH2N), 18.4 (CH3); m/z (EI) 155 (M+, 15%), 
127 (8), 88 (8), 69 (100), 68 (40). 
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2-Nitro-5-oxo-hexanoic acid ethyl ester (2-31a).282 A 
Radley’s reaction tube was charged with 1-36c (45 mg, 0.025 
mmol) and THF (1 mL). Methyl vinyl ketone (162 μL, 2.0 
mmol) was then added, followed by ethyl nitroacetate (111 μL, 1.0 mmol). After 18 h 
the solution was concentrated in vacuo and purified by column chromatography 
(hexane/ethyl acetate, 10/1) to give the Michael adduct (83 mg, 43%) as a colourless oil. 
νmax/cm-1 1747 (C=O), 1715 (OC=O), 1568 (NO2), 1557, 1372; δH (CDCl3) 5.24 (1H, 
dd, J 8.0, 6.4, CHNO2), 4.28 (2H, q, J 7.2, CH2O), 2.67-2.53 (2H, m, CH2CO), 2.47-
2.41 (2H, m, CH2CHNO2), 2.16 (3H, s, CH3C=O), 1.30 (3H, t, J 7.2, CH3CH2); δC 
(CDCl3) 205.9 (CH3C=O), 164.2 (OC=O), 86.7 (CH), 63.1 (CH2O), 38.3 (CH2CHNO2), 
29.9 (CH3C=O), 24.0 (CH2C=O), 13.9 (CH3CH2); m/z (EI) 203 (M+, <1%), 188 (2), 173 
(2), 158 (3), 111(10), 101 (12), 85 (25), 43 (100). 
 
2-Methyl-2-nitro-5-oxo-hexanoic acid ethyl ester (2-
31b).283 A Radley’s reaction tube was charged with [{Pd(R-
BINAP)(μ-OH)}2]2+[TfO]-2 (23 mg, 0.0125 mmol) and 
CH2Cl2 (0.5 mL). Methyl vinyl ketone (81 μL, 1.0 mmol) was then added, followed by 
ethyl nitroacetate (65 μL, 0.5 mmol). After 72 h, the solution was concentrated in vacuo 
and the residue purified by column chromatography (hexane/ethyl acetate, 15/1 to 10/1) 
to give the Michael adduct (24 mg, 21%) as a colourless oil. νmax/cm-1 2988, 1748 
(C=O), 1723 (C=O), 1553, 1257; δH (CDCl3) 4.27 (2H, q, J 7.0, CH2O), 2.59-2.38 (4H, 
m, CH2), 2.18 (3H, s, CH3C=O), 1.78 (3H, s, CH3CNO2), 1.30 (3H, t, J 7.0, CH3CH2); 
δC (CDCl3) 205.7 (CH3C=O), 167.0 (OC=O), 91.8 (CNO2), 62.9 (CH2O), 37.8 
(CH2C=O), 30.2 (CH3CNO2), 29.9 (CH3C=O), 22.0 (CH2CNO2), 13.8 (CH3CH2); m/z 
(EI) 217 (<1%), 125 (10), 99 (9), 70 (10), 43 (100). 
 
Ethyl 2-methyl-4-(2-methyl-1,3-dioxolan-2-yl)-2-
nitrobutanoate (2-32).283 A solution of 2-31b (5 mg, 0.023 
mmol), ethylene glycol (0.26 mL, 0.46 mmol) and TsOH (1 mg, 
5.8 µmol) in toluene (0.5 mL) was heated to 80 °C for 4 h, then cooled and quenched 
with saturated NaHCO3 solution (1 mL). The organic layer was separated, dried 
(MgSO4) and analysed by HPLC. HPLC conditions: Chiracel OJ-H column, 
hexane/IPA, 90/10, 1 mL/min, 240 nm, tR (major) = 11.7 min, tR (minor) = 12.8 min. 
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Dimethyl adipate (2-40).172 The literature procedure was 
modified: A flask containing adipic acid (14.6 g, 100 
mmol), conc. sulfuric acid (0.30 mL, 5.00 mmol) and methanol (400 mL) was heated to 
reflux for 3 h, cooled, quenched with saturated NaHCO3 solution (40 mL) and reduced 
to 100 mL in vacuo. The remaining mixture was diluted with H2O (100 mL) and 
extracted using Et2O (3 x 60 mL). The combined organic extracts were then washed 
with saturated NaHCO3 solution (60 mL), dried (MgSO4) and concentrated in vacuo, to 
give the diester (14.07 g, 81%) as a colourless oil. νmax/cm-1 1732, 1436, 1197, 1168, 
1081; δH (CDCl3) 3.67 (6H, s, CH3), 2.36-2.31 (4H, m, CH2C=O), 1.67-1.63 (4H, m, 
CH2); δC (CDCl3) 173.7 (C=O), 51.5 (CH3), 33.6 (CH2C=O), 24.3 (CH2); m/z 174 (M+, 
2%), 114 (98%), 111 (87%). m/z (EI) 174 (M+, >1%), 143 (90), 114 (100), 111 (80), 
101 (90). 
 
Methyl cyclohexanone-2-carboxylate (2-33). According to the 
literature procedure,173 a round bottom flask was charged with NaH 
(60% suspension in mineral oil, 2.76 g, 68.9 mmol) and purged with 
nitrogen. The solid was then washed with pentane (3 x 10 mL), and toluene (80 mL) 
was added. The suspension was heated to 40 °C and dimethyl adipate (6 g, 34.4 mmol) 
was added dropwise over 5 min. When the addition was complete the mixture was 
heated to 110 °C for 19 h, then cooled to room temperature. The pH of the solution was 
adjusted to 4 by careful addition of 1 M HCl. The mixture was then extracted using 
Et2O (3 x 100 mL) and the combined extracts washed with H2O (2 x 100 mL), dried 
(MgSO4) and concentrated in vacuo to give the ketoester (4.29 g, 88%) a colourless oil. 
νmax/cm-1 1728 (C=O), 1662 (C=O), 1436, 1345, 1299, 1259, 1204, 1114; δH (CDCl3) 
3.69 (3H, s, CH3), 3.12 (1H, t, J 9.2, CH), 2.29-1.77 (6H, m, CH2); δC (CDCl3) 212.3 
(C-1), 169.7 (CO2Me), 54.6 (C-2), 52.3 (CH3), 38.0 (C-5), 27.3 (C-4), 20.9 (C-3); m/z 
(EI) 142 (M+, 24%), 114 (44%), 110 (40%), 87 (44%), 55 (100%). 
 
(E)-β-Nitrostyrene (2-41a). According to the literature procedure,174 
benzaldehyde (10.0 mL, 98.5 mmol) and nitromethane (6.00 g, 98.5 mmol) were 
dissolved in methanol (30 mL) and the mixture cooled to 5 °C. A solution of NaOH 
(5.13 g, 128 mmol) in ice/H2O (15 mL) was added dropwise, keeping the temperature of 
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the reaction mixture below 15 °C. Methanol (5 mL) was added to maintain stirring. 
After the addition was complete the slurry was diluted with ice/H2O (100 mL) and 
stirred until a clear solution formed. This was then added dropwise to a solution of conc. 
HCl (80 mL) and H2O (50 mL), and the yellow precipitate was collected by filtration, 
washed with H2O and recrystallised from methanol to give the alkene (11.32 g, 77%) as 
yellow needles; mp 59-61 °C (lit.174 57-58 °C); νmax/cm-1 1630, 1512, 1448, 1343, 1261; 
δH (CDCl3) 8.03 (1H, d, J 13.6, CHPh), 7.63-7.46 (6H, m); δC (CDCl3) 139.1 (CHPh), 
137.1 (CHNO2), 132.1, 130.0, 129.4, 129.1; m/z (EI) 149 (M+, 75%), 132 (18), 102 
(72), 91 (55), 77 (100), 51 (45). 
 
(E)-1-Nitro-propene (2-41b).284 A solution of acetaldehyde (1.4 mL, 25 
mmol) and nitromethane (1.53 g, 25 mmol) in methanol (6 mL) was 
cooled to 10 °C and a cold solution of NaOH (1.3 g, 32.5 mmol) in ice/H2O (4 mL) was 
added dropwise maintaining the temperature below 15 °C. After the addition the 
mixture was stirred for a further 30 min, then added dropwise to a solution of conc. HCl 
(16 mL) and H2O (24 mL). The resulting solution was extracted using CH2Cl2, dried 
(MgSO4) and concentrated. The crude product was purified by distillation (85 °C, 220 
Torr, lit.285 70 °C, 20 Torr) to give the nitroalkene (1.07 g, 49%) as a pale yellow oil. 
νmax/cm-1 1549, 1521, 1348, 1379, 920, 740; δH (CDCl3) 7.19-7.10 (1H, m, CHMe), 
6.90 (1H, d, J 13.6, CHNO2), 1.80 (3H, d, J 7.6, CH3); δC (CDCl3) 140.2 (CH), 138.5 
(CH), 13.4 (CH3). m/z (EI) 88 (MH+, 22), 69 (39), 59 (47).  
 
General method for additions to β-nitrostyrene 
Method A: A Radley’s reaction tube was charged with 2-41a (75 mg, 0.5 mmol), urea 
or thiourea (0.5 mmol), 1-36c (23 mg, 12.5 μmol) and THF (0.5 mL), followed by the 
alkyl cyclopentanone-2-carboxylate (0.6 mmol). After 2 h the mixture was concentrated 
in vacuo and purified by column chromatography. 
 
Method B: A Radley’s reaction tube was charged with 2-41a (89 mg, 0.6 mmol), 1-36c 
(23 mg, 12.5 μmol) and THF (0.5 mL), followed by the addition of alkyl acetoacetate 
(0.5 mmol). After 8 h the mixture was concentrated in vacuo and purified by column 
chromatography. 
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1-(2-Nitro-1-phenyl-ethyl)-2-oxo-cyclopentanecarboxylic acid 
methyl ester (2-44).88 Prepared by general method A to give the 
ketoester (239 mg, 84%, 3:1 mixture of diastereomers) as a white 
crystalline solid; mp 86-90 °C (lit.286 80-83 °C); νmax/cm-1 1747 
(C=O), 1718 (C=O), 1553, 1438, 1380, 1233, 1153; δH (CDCl3) 7.35-7.19 (5H, m, Ar), 
5.28 (0.3H, dd, J 13.4, 11.2, CHNO2), 5.18 (0.7H, dd, J 13.6, 4.0, CHNO2), 5.03 (0.7H, 
dd,  J 13.6, 10.8, CHNO2), 4.85 (0.3H, dd, J 13.4, 3.6, CHNO2), 4.22 (0.3H, dd, J 11.0, 
3.6, CHPh), 4.10 (0.70H, J 11.0, 4.0, CHPh), 3.77 (3H, s, CH3), 2.48-2.32 (2H, m, 
CH2), 2.08-1.78 (3.7H, m, CH2), 1.47-1.38 (0.3H, m, CH2); δC (CDCl3) 215.4 
(CH2C=O), 212.3 (CH2C=O), 171.5 (OC=O), 169.8 (OC=O), 135.4 (Ar), 135.2 (Ar), 
129.3 (Ar), 129.1 (Ar), 129.0 (Ar), 128.8 (Ar), 128.5 (Ar), 128.3 (Ar), 76.8 (CNO2), 
76.4 (CNO2), 62.4 (CC=O), 62.2 (CC=O), 53.1 (CH3), 53.1 (CH3), 47.3, 46.1, 39.6, 
37.9, 33.5, 31.1, 19.6, 19.3; m/z (EI) 291 (M+, <1%), 277 (44), 260 (9), 229 (17), 213 
(11), 202 (20), 184 (33), 57 (100); HPLC conditions: Chiracel OD-H column 
hexane/IPA, 90/10, 1 mL/min, 240 nm, major diastereomer: tR = 20.7, 30.9 min, minor 
diastereomer: tR = 18.1, 25.3 min. 
 
2-Acetyl-4-nitro-3-phenyl-butyric acid ethyl ester (2-52a).46 
Prepared by general method B to give the ketoester (1.28 g, 92%, 1:1 
mixture of diastereomers) as a white crystalline solid; mp 72-74 °C 
(lit.46 71-74 °C); νmax/cm-1 2989, 1737 (C=O), 1564, 1370, 1280, 
1146; δH (CDCl3) 7.35-7.26 (3H, m, Ar), 7.23-7.21 (2H, m, Ar), 4.86-
4.83 (1H, m, CH2NO2), 4.78-4.76 (1H, m, CH2NO2), 4.28-4.19 (2H, m, PhCH, OCH2), 
4.13 (0.5H, d, J 10.0, AcCH), 4.04 (0.5H, d, J 9.6, AcCH), 3.98 (1H, q, J 7.2, OCH2), 
2.32 (1.5H, s, CH3CO), 2.07 (1.5H, s, CH3CO), 1.29 (1.5H, t, J 7.2, CH2CH3), 1.02 
(1.5H, t, J 7.2, CH2CH3); δC (CDCl3) 201.1 (CH3CO), 200.3 (CH3CO), 167.5 (OCO), 
166.8 (OCO), 136.4 (Ar), 136.3 (Ar), 129.1 (Ar), 128.9 (Ar), 128.3 (Ar), 128.3 (Ar), 
128.0 (Ar), 127.9 (Ar), 77.9 (CNO2), 77.8 (CNO2), 62.2, 61.9 (2C), 61.6, 42.5, 42.3, 
30.3, 30.1, 14.0, 13.6; m/z (EI) 279 (M+, 3%), 233 (56), 191 (67), 159 (50), 145 (61), 43 
(100); HPLC conditions: Chirapak AD-H column, hexane/IPA, 95/5, 1 mL/min, 240 
nm, tR = 12.8, 19.5, 21.1, 38.7 min. 
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2-Acetyl-4-nitro-3-phenyl-butyric acid tert-butyl ester (2-52b).46 
Prepared by general method B to give the ketoester (38 mg, 25%, 2:3 
mixture of diastereomers) as white crystalline solid; mp 125-133 °C 
(lit.46 128-136 °C); νmax/cm-1 1738 (C=O), 1551, 1370, 1142; δH 
(CDCl3) 7.35-7.22 (5H, m, ArH), 4.88 (0.4H, dd, J 12.8, 5.0, CH2NO2), 4.83 (0.4H, dd, 
J 12.8, 8.8, CH2NO2), 4.75 (0.6H, dd, J 12.4, 4.6, CH2NO2), 4.70 (0.6H, dd, J 12.4, 8.0, 
CH2NO2), 4.24-4.19 (1H, m, ArCH), 4.04 (0.6H, d, J 10.4, CHC=O), 3.94 (0.4H, d, J 
9.6, CHC=O), 2.24 (1.8H, s, CH3C=O), 2.08 (1.2H, s, CH3C=O), 1.49 (3.6H, s, tBu), 
1.19 (5.4H, s, tBu); δC (CDCl3) 201.4 (MeC=O), 200.6 (MeC=O), 166.6 (OC=O), 165.8 
(OC=O), 136.6 (Ar), 129.1 (Ar), 128.8 (Ar), 128.2 (Ar), 128.2 (Ar), 127.9 (Ar), 83.5 
(CCH3), 82.9 (CCH3), 78.3 (CNO2), 77.9 (CNO2), 63.0 (CHC=O), 62.7 (CHC=O), 42.5, 
42.3, 30.1, 29.7, 27.8, 27.3; m/z (EI) 307 (M+, 2%), 234 (70), 161 (55), 159 (57), 145 
(85), 57 (100); HPLC conditions: Chirapak AD-H column, hexane/IPA, 95/5, 1 
mL/min, 240 nm, tR = 9.3, 13.6, 16.9, 22.4 min. 
 
Methyl 1-indanone-2-carboxylate (1-102).178 A round bottom 
flask was charged with NaH (60% suspension in mineral oil, 2.86 
g, 71.5 mmol) and purged with nitrogen. The solid was then 
washed with pentane (3 x 20 mL) and suspended in toluene (40 mL). Dimethyl 
carbonate (14.4 mL, 171.6 mmol) was added, and the mixture was warmed to 60 °C, 
whereupon a solution of 1-indanone (3.78 g, 28.6 mmol) in toluene (40 mL) was added 
dropwise over 1 h. After stirring for a further 1 h at 60 °C, the reaction mixture was 
cooled to rt, and quenched by the addition of acetic acid (5 mL) and 2 M HCl (60 mL). 
The mixture was extracted using toluene (2 x 50 mL) and the combined organic extracts 
washed with H2O (2 x 30 mL), dried (MgSO4) and concentrated in vacuo. The crude 
product was purified by distillation (140 °C, 0.1 Torr) to afford the ketoester (3.59 g, 
66%, keto/enol, 4/1) as a colourless oil that solidified on standing; mp 50-55 °C (lit.178 
51-60 °C); νmax/cm-1 2956, 1737 (C=O), 1708 (C=O), 1606, 1436, 1319, 1210, 1161; δH 
(CDCl3) 7.80 (1H, d, J 7.6, Ar), 7.68-7.63 (1H, m, Ar), 7.54-7.40 (2H, m, Ar), 3.82 (3H, 
s, CH3), 3.76 (1H, dd, J 8.4, 4.2, CHC=O), 3.59 (1H, dd, J 17.4, 4.2, CH2), 3.40 (1H, 
dd, J 17.4, 8.4, CH2). Minor peaks due to enol tautomer observed at 10.42 (1H, br s, 
OH), 3.88 (3H, s, CH3), 3.54 (2H, s, CH2); δC (CDCl3) 199.4 (C=O), 169.5 (OC=O), 
153.6 (Ar), 135.4 (Ar), 135.2 (Ar), 127.8 (Ar), 126.5 (Ar), 124.7 (2C, Ar), 53.1 
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(CHC=O), 52.8 (CH3), 30.2 (CH3). Minor peaks due to enol tautomer observed at 129.4 
(Ar), 126.8 (Ar), 120.7 (Ar), 32.5 (CH2); m/z (EI) 190 (M+, 71%), 159 (23), 130 (100). 
 
cis-Stilbene oxide (2-54).180 According to the literature procedure, 
cis-stilbene (2.00 g, 11.1 mmol) was dissolved in CH2Cl2 (20 mL) 
and mCPBA (3.00 g, 13.3 mmol) added in several portions. The 
mixture was then stirred for 24 h, filtered, washed with saturated NaHCO3 solution (2 x 
10 mL), dried (MgSO4) and concentrated in vacuo. The crude product was purified be 
column chromatography (hexane/ethyl acetate, 50/1) to give the epoxide (2.05 g, 99%) 
as a white crystalline solid; mp 37-39 °C (lit.287 38-40 °C); νmax/cm-1 1494, 1451, 1405, 
1371, 1174, 886; δH (CDCl3); 7.23-7.19 (10H, m, Ar), 4.41 (2H, s, OCH); δC (CDCl3) 
134.4 (Ar), 127.8 (Ar), 127.5 (Ar), 126.9 (Ar), 59.7 (OCH); m/z (EI) 196 (M+, 72%), 
178 (23), 167 (100), 90 (75). 
 
Methyl 2-(tetrahydrofuran-2-yl)-indanone-2-carboxylate (2-
56). 2,3-dihydrofuran (39.8 µL, 0.526 mmol) was added to a 
solution of methyl indanone-2-carboxylate (100 mg, 0.526 mmol) 
and [Pd(rac-BINAP)(H2O)2]2+[TfO]-2 (56.0 mg, 0.0526 mmol) in THF (1 mL). After 18 
h, the solution was concentrated in vacuo and the residue purified by column 
chromatography (hexane/ethyl acetate 4/1) to give the product (46.6 mg, 33%, 1:1 
mixture of diasteromers) as a colourless oil. νmax/cm-1 1727 (C=O), 1543, 1431, 1381, 
1153; δH (CDCl3); 7.79-7.75 (1H, m, Ar), 7.65-7.59 (1H, m, Ar), 7.53-7.49 (1H, m, Ar), 
4.77-4.71 (1H, m, H-2), 3.83-3.67 (5.5H, m, H-1, H-5, CH3), 3.59 (0.5H, d, J 16.8, H-
1), 3.29-3.22 (1H, m, H-1), 2.29-2.21 (0.5H, m, CH2), 2.02-1.93 (2.5H, m, CH2), 1.71-
1.61 (0.5H, m, CH2), 1.47-1.41 (0.5H, m, CH2); δC (CDCl3) 200.6 (C=O), 200.4 (C=O), 
170.3 (OC=O), 169.7 (OC=O), 154.1 (Ar), 154.0 (Ar), 135.6 (Ar), 135.5 (Ar), 135.4 
(Ar), 135.2 (Ar), 127.7 (Ar), 127.5 (Ar), 126.3 (Ar), 126.2 (Ar), 124.9 (Ar), 124.7 (Ar), 
81.1 (C-2), 80.3 (C-2), 68.8 (C-5), 64.6, 63.9, 52.9, 52.7, 33.4, 31.9, 28.5, 26.6, 25.9, 
25.6; m/z (EI) 260 (22%) 229 (19), 201 (100); Found: C, 66.81, H, 6.93%, Anal. Calcd 
for C15H16O4: C, 66.77, H, 6.85%. 
 
2-Phenylamino-cyclohexanol (2-61).180 A Radley’s reaction tube 
was charged with a solution of [Pd(R-BINAP)(sol)2]2+[TfO]-2 (53 
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mg, 0.05 mmol) in THF (0.5 mL), then cyclohexene oxide (121 μL, 1.2 mmol) and 
aniline (91 μL, 1.0 mmol) were added in quick succession. After 4 h the mixture was 
concentrated in vacuo and purified by column chromatography (hexane/ethyl acetate, 
15/1) to give the amine (106 mg, 55%) as brown crystals; mp 55-58 °C (lit.288 57-58 
°C); δH (CDCl3) 7.21 (2H, dd, J 8.4, 7.2, C-3), 6.76 (3H, m, C-2, C-4), 3.38 (1H, m, 
CHOH), 3.17 (1H, ddd, J 11.6, 9.6, 4.4, CHNH), 2.17-2.13 (2H, m, CH2), 1.82-1.73 
(2H, m, CH2), 1.48-1.28 (3H, m, CH2), 1.13-1.03 (1H, m, CH2); δC (CDCl3) 147.8 (C-
1), 129.3 (Ar), 118.4 (Ar), 114.4 (Ar), 74.5 (CHOH), 60.2 (CHNH), 33.1 (CH2), 31.6 
(CH2), 25.0 (CH2), 24.2 (CH2); m/z (EI) 191 (M+, 78%), 148 (20), 132 (100), 106 (50), 
77 (23).(23); HPLC conditions: Chirapak AD column, hexane/IPA, 90/10, 1 mL/min, 
240 nm, tR = 11.2 min, tR = 13.7 min. 
 
(1S,2S)-2-(4-Chloro-phenylamino)-1,2-diphenyl-ethanol (2-
65b).183 A Radley’s reaction tube was charged with cis-stilbene 
oxide (235 mg, 1.20 mmol), 4-chloroaniline (128 mg, 1.00 
mmol) and [Pd(R-BINAP)(sol)2]2+[TfO]-2 (106 mg, 0.1 mmol) 
followed by CH2Cl2 (0.5 mL). After stirring for 72 h the reaction miture was 
concentrated in vacuo and purified by column chromatography (hexane/ethyl acetate, 
10/1) to give the amine (244 mg, 75%) as a yellow oil. νmax/cm-1 3404, 3062, 3031, 
2885, 1298, 1498; δH (CDCl3) 7.35-7.22 (10H, m, Ar), 7.04 (2H, d, J 8.8, H-3), 6.47 
(2H, d, J 8.8, H-2), 4.87 (1H, d, J 5.6, CHO), 4.80 (1H, s, NH), 4.52 (1H, d, J 5.6, 
CHN), 2.64 (1H, s, OH); δC (CDCl3) 145.9 (Ar), 140.5 (Ar), 139.8 (Ar), 128.9 
(Ar),128.6 (Ar), 128.3 (Ar),128.0 (Ar), 127.7 (Ar), 127.3 (Ar),126.5 (Ar), 122.4 (Ar), 
115.2 (Ar), 78.0 (CH), 64.7 (CH); m/z (ESI) 324 (MH+, 100%), 306 (20), 197 (19).(19); 
HPLC conditions: Chirapak AD column, hexane/IPA, 80/20, 0.5 mL/min, 240 nm, tR 
(major) = 18.4 min, tR (minor) = 22.1 min; lit.186 Chirapak AD-H column, hexane/IPA, 
90/10, 1 mL/min, tR (S,S) = 14.6 min, tR (R,R) = 17.0 min. 
 
(E)-1-(2,4-Dinitrophenyl)-2-(2,2-diphenylethylidene)hydrazine (2-69).289 cis-
Stilbene oxide (196 mg, 1.0 mmol) was added to a solution 
of [Pd(rac-BINAP)(sol)2]2+[TfO]-2 (27 mg, 0.025 mmol) in 
CH2Cl2 (8 mL) and the mixture stirred for 2 h, then 
concentrated in vacuo and filtered through a plug of silica. 
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The crude aldehyde was added to a solution of 2,4-dinitrophenylhydrazine in ethanol 
(35 mL) and the mixture heated to reflux. Conc. HCl (1 mL) was then added, and after 5 
min the mixture was cooled to 0 °C and the precipitated product collected by filtration 
and recrystallised from ethanol to give the imine (177 mg, 47%) as orange crystals; mp 
147-150 °C (lit.289 150-151 °C); νmax/cm-1 3266, 1637, 1611, 1338, 1511, 1118; δH 
(CDCl3) 11.17 (1H, s, br, NH), 9.14 (1H, d, J 2.6, H-3), 8.32 (1H, dd, J 9.6, 2.6, H-5), 
7.98-7.88 (2H, m, CH=N, H-6), 7.45-7.25 (10H, m, Ph), 5.15 (1H, d, J 7.2, CHPh); δC 
(CDCl3) 152.0 (CH=N), 145.1 (Ar), 139.7 (Ar), 138.1 (Ar), 130.0 (Ar), 128.9 (Ar), 
128.5 (Ar), 128.3 (Ar), 127.4 (Ar), 123.4 (Ar), 116.7 (Ar), 53.9 (CHPh); m/z (EI) 376 
(M+, 26%), 341 (22), 193 (27), 178 (49), 165 (100). 
6.3. Compounds Used in Chapters 3 and 4 
General method for the transesterification of methyl 1-indanone-2-carboxylate. 
Method A. A round bottom flask was charged with methyl 1-indanone-2-carboxylate 
(1.00 g, 5.26 mmol), the corresponding alcohol (50 mL) and dibutyl tin oxide (131 mg, 
0.526 mmol). The mixture was refluxed until complete conversion of the methyl ester 
was observed by TLC, then concentrated in vacuo and purified by column 
chromatography. 
 
Method B. A round bottom flask equipped with a short air condenser was charged with 
methyl 1-indanone-2-carboxylate (1.00 g, 5.26 mmol), the corresponding alcohol (6.31 
mmol) and dibutyl tin oxide (131 mg, 0.526 mmol) and toluene (50 mL). The mixture 
was refluxed vigorously until complete conversion of the methyl ester was observed by 
TLC, then concentrated in vacuo and purified by column chromatography. 
 
Ethyl 1-indanone-2-carboxylate (3-2).192 Prepared by general 
method A in 4 h and purified by column chromatography 
(hexane/ethyl acetate, 50/1 to 6/1) to give the ethyl ester (851 mg, 
79%, keto/enol, 4/1) as a pink oil. νmax/cm-1 1738 (C=O), 1708 (C=O), 1367, 1206, 
1151, 1008, 760; δH (CDCl3) 7.77 (1H, d, J 7.8, Ar), 7.62 (1H, m, Ar), 7.50 (1H, d, J 
7.8, Ar), 7.41-7.38 (1H, m, Ar), 4.25 (2H, q, J 7.0, CH2O), 3.71 (1H, dd, J 8.2, 4.4, 
CH), 3.56 (1H, dd, J 17.2, 4.4, ArCH2), 3.37 (1H, dd, J 17.2, 8.2, ArCH2), 1.31 (3H, t, J 
7.0, CH3). Minor peaks due to enol tautomer observed at 10.45 (1H, br s, OH enol), 
4.32 (2H, q, J 7.0, CH2O enol), 3.52 (2H, s, ArCH2 enol), 1.37 (0.6H, t, J 7.0, CH3); δC 
O
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(CDCl3) 199.7 (C=O), 169.3 (OC=O), 153.8 (Ar), 135.6 (Ar), 135.5 (Ar), 127.9 (Ar), 
126.7 (Ar), 124.8 (Ar), 61.9 (CH2O), 53.5 (CHC=O), 30.5 (CH2), 14.4 (CH3 keto); 
Minor peaks due to enol tautomer observed at 129.5 (Ar), 127.0 (Ar), 124.9 (Ar), 120.9 
(Ar), 60.3 (CH2O), 32.7 (CH2), 14.6 (CH3); HRMS: m/z (EI) 204.0779 (M+, C12H12O3 
requires 204.0786), 159 (23%), 131 (72), 130 (100), 103 (32). 
 
iso-Propyl 1-indanone-2-carboxylate (3-3).36 Prepared by 
general method A in 18 h and purified by column chromatography 
(hexane/ethyl acetate, 25/1 to 8/1) to give the iso-propyl ester (791 
mg, 69%, keto/enol, 8/1) as a pink oil. νmax/cm-1 1736 (C=O), 1708 (C=O), 1256, 1207, 
1103, 988, 920, 760; δH (CDCl3) 7.76 (1H, d, J 7.8, Ar), 7.64-7.59 (1H, m, Ar), 7.50-
7.36 (2H, m, Ar), 5.08 (1H, septet, J 6.2, OCH), 3.67 (1H, dd, J 8.2, 4.4, CHC=O), 3.53 
(1H, dd, J 17.2, 4.4, CH2), 3.35 (1H, dd, J 17.2, 8.2, ArCH2), 1.28 (3H, d, J 6.2, CH3), 
1.27 (3H, d, J 6.2, CH3), Minor peaks due to enol tautomer observed at 10.48 (1H, br s, 
OH), 5.20 (1H, septet, J 6.2, OCH), 3.49 (2H, s, ArCH2), 1.33 (6H, d, J 6.4, CH3); δC 
(CDCl3) 199.8 (C=O), 168.9 (OC=O), 153.8 (Ar), 135.5 (Ar), 127.9 (Ar), 126.7 (Ar), 
124.8  (Ar), 69.5 (OCH), 53.7 (CHC=O), 30.5 (CH2), 21.9 (CH3), 21.9 (CH3). Minor 
peaks due to enol tautomer observed at 129.4 (Ar), 126.9 (Ar), 124.8 (Ar), 120.8 (Ar), 
67.7 (OCH), 32.8 (CH2), 22.3 (CH3); HRMS: m/z (EI), 218.0943 (M+, C13H14O3 
requires 218.0943), 192 (18%), 176 (38), 159 (33), 130 (100). 
 
Benzyl 1-indanone-2-carboxylate (3-4).210 Prepared by general 
method B in 4 h and purified by column chromatography 
(hexane/EtOAc, 50/1 to 6/1) to give the benzyl ester as a pink oil 
(1.24 g, 88%, keto/enol, 4/1). νmax/cm-1 1737, 1708, 1606, 1255, 
1205, 1150, 749; δH (CDCl3) 7.78 (1H, d, J 8.0, Ar), 7.66-7.59 (1H, m, Ar), 7.50-7.30 
(2H, m, Ar), 5.26-5.20 (2H, m, CH2Ph), 3.78 (1H, dd, J 8.2, 4.4, CHC=O), 3.57 (1H, 
dd, J 17.2, 4.4, CHCH2), 3.37 (1H, dd, J 17.2, 8.2, CHCH2). Minor peaks due to enol 
tautomer observed at 5.32 (2H, s, CH2Ph), 3.54 (2H, s, CH2); δC (CDCl3) 199.4 (C=O), 
169.2 (OC=O), 153.7 (Ar), 135.8 (Ar), 135.6 (Ar), 135.4 (Ar), 128.8 (Ar), 128.8 (Ar), 
128.5 (Ar), 128.0 (Ar), 126.8 (Ar), 124.9 (Ar), 67.5 (CH2Ph), 53.5 (CH), 30.5 (CH2). 
Minor peaks due to enol tautomer observed at 129.7 (Ar), 128.5 (Ar), 128.3 (Ar), 127.0 
(Ar), 124.9 (Ar), 121.0 (Ar), 65.9 (CH2Ph), 32.8 (CH2); m/z (EI) 266 (M+, 16%), 248 
(2), 238 (2), 221 (3), 191 (10), 132 (50), 91 (100). 
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tert-Butyl 1-indanone-2-carboxylate (3-5).36 Prepared by 
general method B in 3 h and purified by column 
chromatography (hexane/ethyl acetate, 20/1) to give the tert-
butyl ester (621 mg, 81%,  keto/enol, 9/1) as pink crystals; mp 43-44 °C (lit.36 44-46 
°C); νmax/cm-1 2975, 2932, 1713 (C=O), 1650 (C=O), 1373, 1265, 1151; δH (CDCl3) 
7.78 (1H, d, J 8.0, Ar), 7.63 (1H, m, Ar), 7.52 (1H, d, J 8.0, Ar), 7.42-7.39 (1H, m, Ar), 
3.65 (1H, dd, J 8.4, 4.0, CHC=O), 3.52 (1H, dd, J 17.2, 4.0, CH2), 3.36 (1H, dd, J 17.2, 
8.4, CH2), 1.51 (9H, s, CH3). Minor peaks due to enol tautomer observed at 3.49 (2H, s, 
CH2), 1.60 (9H, s, CH3); δC (CDCl3) 200.0 (C=O), 168.3 (OC=O), 153.7 (Ar), 135.4 
(Ar), 135.2 (Ar), 127.6 (Ar), 126.5 (Ar), 124.5 (Ar), 82.0 (CCH3), 54.2 (CHC=O), 30.3 
(CH2), 28.0 (CH3). Minor peaks due to enol tautomer observed at 129.0 (Ar), 126.7 
(Ar), 120.5 (Ar), 32.8 (CH2), 28.5 (CH3); m/z (EI) 232 (M+, 12%), 176 (16), 130 (17), 
43 (100). 
 
1-Adamantyl indanone-2-carboxylate (3-6).72 Prepared 
by general method B in 96 h and purified by column 
chromatography (hexane/EtOAc, 16/1) to give the 
adamantyl ester as a pink powder (826 mg, 51%, keto/enol 5/1); mp 103-104 °C; 
νmax/cm-1 2906, 2846, 1739, 1636, 1402, 1385, 1215, 1205, 1090, 717; δH (CDCl3) 7.74 
(1H, d, J 7.8, Ar), 7.59 (1H, t, J 7.2, Ar), 7.49-7.35 (2H, m, Ar), 3.61 (1H, dd, J 8.2, 4.0, 
CHC=O), 3.49 (1H, dd, J 17.4, 4.0, ArCH2), 3.31 (1H, dd, J 17.4, 8.2, ArCH2), 2.14 
(9H, m, Ad CH2, Ad CH), 1.65 (6H, m, Ad CH2). Minor peaks due to enol tautomer 
observed at 3.45 (2H, s, CH2), 2.23 (9H, m, Ad CH2, Ad CH), 1.70 (6H, m, Ad CH2); δC 
(CDCl3) 200.0 (C=O), 167.9 (OC=O), 153.7 (Ar), 135.4 (Ar), 135.1 (Ar), 127.6 (Ar), 
126.5 (Ar), 124.5 (Ar), 82.0 (Ad CO), 54.5 (CHC=O), 41.2 (Ad CH2), 36.1 (Ad CH2), 
30.8 (Ad CH). Minor peaks due to enol tautomer observed at 129.0 (Ar), 126.6 (Ar), 
124.5 (Ar), 120.4 (Ar), 81.0 (Ad CO), 41.7 (Ad CH2), 36.2 (Ad CH2), 32.9 (Ad CH), 
30.3 (ArCH2); m/z (EI), 310 (M+, 12%), 282 (1), 264 (1), 176 (3), 159 (7), 152 (6), 135 
(100).  
 
Benzyl cyclopentanone-2-carboxylate (3-7).191 A round bottomed 
flask equipped with a short air condenser was charged with methyl 
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cyclopentanone-2-carboxylate (500 μL, 3.71 mmol), benzyl alcohol (442 μL, 4.08 
mmol), DMAP (23 mg, 0.186 mmol) and toluene (10 mL). The mixture was refluxed 
strongly for 8 h, then cooled, concentrated in vacuo and purified by column 
chromatography (CH2Cl2/hexane, 1/1) to give the benzyl ester (438 mg, 55%) as a 
yellow oil. νmax/cm-1 2966, 1753 (C=O), 1726 (C=O), 1455, 1337, 1253, 1182; δH 
(CDCl3) 7.39-7.35 (5H, m, Ar), 5.20 (2H, s, CH2O), 3.23 (1H, t, J 9.2, CH), 2.34-2.32 
(4H, m, CH2), 2.16-2.13 (1H, m, CH2), 1.91-1.86 (1H, m, CH2); δC (CDCl3) 212.1 
(C=O), 169.2 (OC=O), 135.6 (Ar), 128.6 (Ar), 128.3 (Ar), 128.1 (Ar), 67.0 (OCH2), 
54.8 (CHC=O), 38.1 (CH2), 27.4 (CH2), 21.0 (CH2); m/z (EI) 218 (M+, 11%), 190 (19), 
91 (100), 84 (50). 
 
Methyl 1-tetralone-2-carboxylate (3-8).192 A 3-necked round-
bottomed flask equipped with an overhead stirrer and a dropping 
funnel was charged with NaH (60% mineral oil dispersion, 8.40 g, 
210 mmol), which was washed with hexane (3 x 60 mL). To this was added toluene 
(150 mL) and dimethyl carbonate (12.6 mL, 150 mmol). The mixture was warmed to 60 
°C with vigorous stirring, whereupon 1-tetralone (10 mL, 75.2 mmol) was added 
dropwise over 1 h. After a further 1.5 h stirring at 60 °C the mixture was cooled, 
quenched by dropwise addition of glacial acetic acid (18 mL) and poured into H2O (150 
mL).  with EtOAc (3 x 150 mL) and the combined extracts washed with H2O (150 mL), 
dried (MgSO4) and concentrated in vacuo. The crude product was purified by column 
chromatography (hexane/EtOAc 20/1 to 8/1) to give the ketoester (11.4 g, 74%, 
keto/enol 1/2) as a yellow oil. νmax/cm-1 2952, 1740, 1684, 1645, 1439, 1362, 1263, 
1212, 1084, 768; δH (CDCl3) 12.42 (1H, s, OH), 7.82 (1H, d, J 7.2, Ar), 7.37-7.25 (2H, 
m, Ar), 7.20 (1H, d, J 7.2, Ar), 3.85 (3H, s, CH3), 2.84 (2H, dd, J 9.0, 6.4, CH2), 2.59 
(2H, dd, J 9.0, 6.4, CH2). Minor peaks due to keto tautomer observed at 8.08 (1H, d, J 
8.0, Ar), 7.54-7.51 (1H, m, Ar), 3.81 (3H, s, CH3), 3.67-3.63 (1H, dd, J 10.0, 4.4, CH) 
3.12-2.99 (2H, m, CH2), 2.56-2.49 (1H, m, CH2), 2.41-2.36 (1H, m, CH2); δC (CDCl3) 
173.1 (OC=O), 165.1 (COH), 139.4 (Ar), 130.5 (Ar), 129.9 (Ar), 127.4 (Ar), 126.9 
(Ar), 124.3 (Ar), 96.8 (C=COH), 52.3 (CH3), 27.7 (CH2), 20.5 (CH2). Minor peaks due 
to keto tautomer observed at 193.1 (C=O), 170.6 (OC=O), 143.6 (Ar), 133.9 (Ar), 131.6 
(Ar), 128.8 (Ar), 127.7 (Ar), 126.6 (Ar), 54.4 (CH), 51.6 (CH3), 27.6 (CH2), 26.3 (CH2); 
m/z (EI) 204 (M+, 100%), 172 (85), 144 (82), 118 (77), 115 (57), 90 (40).  
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Ethyl 1-tetralone-2-carboxylate (3-9).290 Prepared by the 
procedure described for the synthesis of methyl 1-tetralone-2-
carboxylate (3-8) from diethyl carbonate (36.4 mL, 300.8 mmol) 
and 1-tetralone (20.0 mL, 150.4 mmol), and purified by column chromatography 
(hexane/EtOAc, 10/1) to give the ethyl ester (18.46 g, 56% keto/enol 2/1) as an orange 
oil. νmax/cm-1 2971, 1738, 1643, 1617, 1374, 1264, 1210, 1084, 768; δH (CDCl3) 12.56 
(1H, s, OH), 7.83 (1H, dd, J 7.6, 1.2, Ar), 7.32-7.25 (2H, m, Ar), 7.18 (1H, d, J 7.0, Ar), 
4.33-4.24 (2H, m, CH2CH3), 2.82 (2H, dd, J 9.0, 6.6, CH2), 2.59 (2H, dd, J 9.0, 6.6, 
CH2), 1.37 (3H, t, J 7.2, CH3). Minor peaks due to keto tautomer observed at 8.07 (1H, 
dd, 7.8, 0.8, Ar), 1H, td, J 7.6, 1.2, Ar), 3.61 (1H, dd, J 10.6, 4.8, CH), 3.09-2.96 (2H, 
m, CH2), 2.54-2.46 (1H, m, CH2), 2.40-2.33 (1H, m, CH2); 1.32 (3H, t, J 7.2, CH3); δC 
(CDCl3) 172.7 (OC=O), 165.0 (COH), 139.3 (Ar), 130.4 (Ar), 130.0 (Ar), 127.4 (Ar), 
126.8 (Ar), 124.2 (Ar), 97.0 (C=COH), 60.5 (OCH2), 27.7 (CH2), 20.5 (CH2), 14.3 
(CH3). Minor peaks due to keto tautomer observed at 193.3 (C=O), 170.2 (C=O), 143.7 
(Ar), 133.8 (Ar), 131.7 (Ar), 128.8 (Ar), 127.6 (Ar), 126.5 (Ar), 61.2 (OCH2), 54.6 
(CH), 27.6 (CH2), 26.3 (CH2), 14.1 (CH3); m/z (EI) 218 (M+, 100%), 172 (90), 144 (87), 
118 (70), 115 (62), 90 (32).  
 
Benzyl 1-tetralone-2-carboxylate (3-10).193 A mixture of 
ethyl 1-tetralone-2-carboxylate (3-9) (2.00 g, 9.16 mmol), 
benzyl alcohol (1.89 mL, 18.3 mmol) and dibutyl tin oxide 
(228 mg, 0.916 mmol)  were refluxed in toluene (20 mL) for 18 h, then concentrated in 
vacuo and purified by column chromatography (hexane/EtOAc, 20/1), giving the ester 
(1.89 g, 74%) as a yellow oil. νmax/cm-1 3029, 2971, 2946, 1738, 1645, 1615, 1390, 
1262, 1209, 1083, 695; δH (CDCl3) peaks due to enol tautomer observed at 12.56 (1H, s, 
OH), 7.90 (1H, d, J 7.6, Ar), 7.52-7.34 (2H, m, Ar), 7.22 (1H, d, J 6.8, Ar), 5.34 (2H, s, 
CH2Ph), 2.86 (2H, dd, J 9.0, 6.4,  CH2), 2.68 (2H, dd, J 9.0, 6.4, CH2), peaks due to 
keto tautomer observed at 8.14 (1H, dd, J 7.8, 0.8, Ar), 7.28 (1H, d, J 7.4, Ar), 7.52-
7.34 (2H, m, Ar), 5.35-5.27 (2H, m, CH2Ph), 3.72 (1H, dd, J 10.8, 4.6, CH), 3.10-2.97 
(2H, m, CH2), 2.61-2.51 (1H, m, CH2), 2.44-2.39 (1H, m, CH2); δC (CDCl3) peaks due 
to enol tautomer observed at 172.5 (OC=O), 165.5 (COH), 139.5 (Ar), 136.0-126.6 (6x 
Ar), 130.7 (Ar), 129.8 (Ar), 124.4 (Ar), 96.9 (C=COH), 66.2 (CH2Ar), 27.7-27.7 (CH2), 
20.6 (CH2). Peaks due to keto tautomer observed at 193.1 (C=O), 170.1 (C=O), 143.7 
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(Ar), 136.0-126.6 (6x Ar), 133.9 (Ar), 131.8 (Ar), 66.9 (CH2Ar), 54.7 (CH), 27.7-27.7 
(CH2), 26.4 (CH2);  m/z (EI), 280 (M+, 15%), 232 (3), 220 (4), 192 (3), 171 (6), 146 (6), 
129 (7), 91 (100). 
 
Dibenzyl pimelate.291 Pimelic acid (5.0 g, 31.2 mmol) 
was dissolved in MeOH (10 mL) and H2O (40 mL). A solution of Cs2CO3 (10.2 g, 31.2 
mmol) in H2O (10 mL) was then added, and the mixture evaporated to dryness. DMF 
(120 mL) was added to the residue, followed by benzyl bromide (8.15 mL, 68.6 mmol) 
and the mixture warmed to 50 °C for 18 h. After cooling to rt the solution was extracted 
using CH2Cl2 (80 mL), washed with H2O (80 mL), dried (MgSO4) and concentrated in 
vacuo. The residue was purified by column chromatography (hexane/EtOAc, 10/1 to 
5/1) to give the diester (10.65 g, 100%) as a colourless oil. νmax/cm-1 1733, 1498, 1456, 
1373, 1230, 1217, 726, 696; δH (CDCl3) 7.55-7.08 (10H, m, Ar), 5.14 (4H, s, CH2Ar), 
2.38 (4H, t, J 7.6, CH2), 1.85-1.60 (4H, m, CH2), 1.47-1.19 (2H, m, CH2); δC (CDCl3) 
173.3 (C=O), 136.1 (Ar), 128.5 (Ar), 128.2 (2xAr), 66.1 (CH2Ar), 34.0 (CH2), 28.5 
(CH2), 24.5 (CH2); m/z (EI) 340 (M+, <1%), 249 (6), 143 (71), 125 (20), 91 (100). 
 
Benzyl cyclohexanone-2-carboxylate (3-11).292 NaH (60% mineral 
oil dispersion, 647 mg, 16.2 mmol) was washed with hexane (3 x 10 
mL) and suspended in toluene (30 mL). The mixture was warmed to 
60 °C and a solution of dibenzyl pimelate S1 (5.00 g, 14.70 mmol) in toluene (15 mL) 
was added dropwise. The temperature of the reaction mixture was then increased and 
maintained at 100 °C for 18 h, before it was cooled and quenched by the addition of 
glacial acetic acid (1 mL) followed by H2O (100 mL) and extracted using EtOAc (3 x 
60 mL). The combined extracts were washed with H2O (40 mL), dried (MgSO4) and 
concentrated in vacuo. The residue was purified by column chromatography 
(hexane/EtOAc, 20/1) to give the ketoester (2.44 g, 71%, keto:enol 1:2) as a yellow oil. 
νmax/cm-1 2971, 2944, 1739, 1650, 1611, 1455, 1366, 1295, 1217, 1057, 696; δH (CDCl3) 
12.20 (1H, s, OH), 7.48-7.30 (5H, m, Ar), 5.32-5.11 (2H, m, CH2Ar), 2.31 (4H, m, 
CH2), 1.77-1.58 (4H, m, CH2). Peaks due to keto tautomer observed at 3.46 (1H, dd, J 
9.6, 6.2, CH), 2.57-2.48 (1H, m, CH2), 2.44-2.34 (1H, m, CH2), 2.27-2.10 (2H, m, CH2), 
2.06-1.76 (3H, m, CH2); δC (CDCl3) 206.0 (C=O keto), 172.6, 172.4, 169.8, 136.2 (Ar), 
135.7 (Ar), 128.9 (Ar), 128.5 (Ar), 128.2 (Ar), 128.2 (Ar), 128.1 (Ar), 127.8 (Ar), 97.6 
(C=COH enol), 66.8 (CH2Ar keto), 65.7 (CH2Ar enol), 57.2 (CH keto), 41.6 (CH2), 
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30.0 (CH2), 29.1 (CH2), 27.1 (CH2), 23.3 (CH2), 22.4 (CH2), 22.3 (CH2), 21.9 (CH2); 
m/z (EI) 232 (M+, 18%), 204 (5), 108 (12), 98 (21), 91 (100). 
 
Methyl 3-phenyl-2-acetylpropionate (3-12). A solution of ethyl 3-
phenyl-2-acetylpropionate (2.00 g, 9.08 mmol) and dibutyltin oxide (226 
mg, 0.908 mmol) in methanol (400 mL) was heated to reflux for 24 h. The 
mixture was then concentrated in vacuo, diluted with methanol (400 mL), and refluxed 
for a further 24 h. This process was repeated twice, giving complete conversion 
(monitored by 1H NMR). The mixture was then concentrated and purified by column 
chromatography (hexane/ethyl acetate, 16/1 to 10/1) to give the methyl ester (1.20 g, 
64%) as a colourless oil. νmax/cm-1 1740 (C=O), 1715 (C=O), 1435, 1359, 1217, 1145, 
749, 399; δH (CDCl3) 7.29-7.25 (2H, m, Ar), 7.22-7.16 (3H, m, Ar), 3.80 (1H, t, J 7.4, 
CH), 3.69 (3H, s, CH3O), 3.16 (2H, d, J 7.2, CH2), 2.17 (3H, s, CH3C=O); δC (CDCl3) 
202.5 (C=O), 169.7 (OC=O), 138.2 (Ar), 128.9 (Ar), 128.8 (Ar), 126.9 (Ar), 61.3 
(CH3O), 52.6 (CH), 34.2 (CH2), 29.9 (CH3C=O); HRMS: m/z (EI) 206.0936 (M+, 
C12H14O3 requires 206.0943), 163 (100), 147 (32), 131 (100), 104 (43), 91 (53). 
 
General method for alkylation of β-ketoesters. 
A mixture of β-ketoester (11.6 mmol), alkyl halide (23.1 mmol), K2CO3 (3.19 g, 23.1 
mmol) and MeCN (40 mL) was refluxed for 18 h. The mixture was cooled, quenched 
with H2O (100 mL), and extracted using Et2O (2 x 80 mL). The combined organic 
extracts were dried (MgSO4) and concentrated.  
 
Benzyl 3-phenyl-2-acetylpropionate (3-14).293 Prepared from 
benzyl acetoacetate (2.00 mL, 11.6 mmol) and benzyl bromide 
(1.14 mL, 23.1 mmol), and purified by column chromatography 
(hexane/EtOAc, 50/1 to 6/1) to give the ketoester (2.82 g, 86%, keto:enol 4:1) as a 
colourless oil. νmax/cm-1 3029, 2971, 1738, 1497, 1455, 1365, 1228, 1217, 1142, 696; δH 
(CDCl3) 7.35-7.32 (2H, m, Ar), 7.29-7.21 (6H,  m, Ar), 7.16-7.14 (2H, d, J 6.8, Ar), 
5.12 (2H, s, OCH2), 3.83 (1H, t, J 7.6, CH), 3.18 (2H, d, J 8.2, CHCH2), 2.15 (3H, s, 
CH3). Minor peaks due to enol tautomer observed at 12.87 (1H, s, OH), 5.16 (2H, s, 
OCH2), 3.61 (2H, s, CH2Ph), 2.07 (3H, s, CH3); δC (CDCl3) 202.4 (C=O), 169.2 
(OC=O), 138.1 (Ar), 135.3 (Ar), 129.0 (Ar), 128.8 (Ar), 128.6 (Ar), 128.5 (Ar), 127.9 
(Ar), 126.9 (Ar), 67.4 (CH2O), 61.5 (CH), 34.2 (CH2Ar), 29.8 (CH3); m/z (EI) 282 (M+, 
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1%), 256 (2), 226 (4), 191 (2), 180 (22), 148 (23), 131 (21), 122 (54), 105 (77), 91 
(100). 
 
tert-Butyl 3-phenyl-2-acetylpropionate (3-15). Prepared from tert-
butyl acetoacetate (2.00 mL, 12.1 mmol) and benzyl bromide (2.88 
mL, 24.2 mmol), and purified by column chromatography 
(hexane/ethyl acetate, 50/1 to 6/1) to give the ketoester (2.12 g, 72%) as a colourless oil. 
νmax/cm-1 1732 (C=O), 1713 (C=O), 1368, 1252, 1136, 843, 699; δH (CDCl3) 7.29-7.25 
(2H, m, Ar), 7.19-7.17 (3H, m, Ar), 3.68 (1H, dd, J 7.2, 7.8, CH), 3.14 (1H, dd, J 14.4, 
7.2, CH2Ph), 3.09 (1H dd, J 14.4, 7.8, CH2Ph), 2.18 (3H, s, CH3C=O), 1.38 (9H, s, 
C(CH3)3); δC (CDCl3) 203.0 (C=O), 168.5 (OC=O), 138.5 (Ar), 129.0 (Ar), 128.6 (Ar), 
126.7 (Ar), 82.2 (C(CH3)3), 62.5 (CH), 34.1 (CH2Ph), 29.6 (CH3C=O), 28.0 (C(CH3)3); 
HRMS: m/z (EI) 248.1408 (M+, C15H20O3 requires 248.1412), 192 (72), 175 (37), 149 
(100), 131 (55). 
 
Ethyl 2-benzoylpropionate (3-16).294 Prepared from ethyl 
benzoylacetate (2.00 mL, 11.6 mmol) and iodomethane (1.44 mL, 
23.1 mmol), and purified by column chromatography 
(hexane/EtOAc, 10/1 to 3/1) to give a colourless oil (2.02 g, 85%). νmax/cm-1 2971, 
1737, 1683, 1449, 1367, 1229, 1217, 957, 689; δH (CDCl3) 7.98 (2H, d, J 8.0, Ar), 7.58 
(1H, t, J 7.2, Ar), 7.47-7.37 (2H, m, Ar), 4.37 (1H, q, J 7.0, CH), 4.14 (2H, q, J 7.4, 
OCH2), 1.49 (3H, d, J 7.0, CH3CH), 1.16 (3H, t, J 7.2, CH3CH2); δC (CDCl3) 163.1 
(C=O), 171.1 (OC=O), 136.1 (Ar), 133.6 (Ar), 128.9 (Ar), 128.8 (Ar), 61.5 (CH2), 48.6 
(CH), 14.1 (CH3), 13.9 (CH3); m/z (EI) 206 (M+, 5%), 161 (6), 151 (3), 105 (100), 91 
(14), 77 (29). 
 
tert-Butyl benzoylpropionate (3-17).195 aq. NaOH (33%, 3.30 mL) 
was added to a solution of tert-butyl acetoacetate (10 mL, 74.6 
mmol) in hexane (12 mL) and H2O (25 mL) at 0 °C. Two dropping funnels were used 
for the addtition of aq. NaOH (33%, 13.5 mL) and benzoyl chloride (10 mL, 86.1 
mmol) simultaneously over 2 h, at <10 °C. The pH was maintained at ~11 by varying 
the rate of addition of NaOH. The mixture was then warmed to 35 °C for 30 min, before 
transferring to a separating funnel. The aqueous layer was separated and returned to the 
flask, to which NH4Cl (4 g, 74.8 mmol) was added. After stirring at rt for a further 18 h 
O
O
O
Ph
O
O
O
Ph
O
O
O
Ph
189 
the solution was diluted with brine (20 mL) and extracted using Et2O (3 x 40 mL). The 
combined organic extracts were dried (MgSO4) and concentrated in vacuo. The crude 
tert-butyl benzoylacetate was used in the next step without further purification.  
tert-Butyl benzoylpropionate was prepared from tert-butyl benzoylacetate (400 mg, 
1.82 mmol) and iodomethane (226 μL, 3.62 mmol), and purified by column 
chromatography (hexane/EtOAc, 50/1 to 10/1) to give the ketoester (321 mg, 75%) as a 
colourless oil. νmax/cm-1 2971, 2941, 1737, 1685, 1449, 1368, 1260, 1145, 959, 690; δH 
(CDCl3) 7.96 (2H, d, J 7.2, Ar), 7.57-7.73 (1H, m, Ar), 7.43-7.47 (2H, m, Ar), 4.24 (1H, 
q, J 7.0, CH), 1.44 (3H, d, J 7.0, CH3CH), 1.33 (9H, s, C(CH3); δC (CDCl3) 196.3 
(C=O), 170.3 (OC=O), 136.4 (Ar), 133.4 (Ar), 128.7 (2x Ar), 81.9 (C-O), 49.7 (CH), 
27.9 (C(CH3)3), 13.6 (CH3CH); m/z (EI) 234 (M+, 1%), 178 (38), 161 (21), 133 (10), 
105 (100), 77 (45). 
 
Benzyl 2-methylacetoacetate (3-18).295 Prepared from benzyl 
acetoacetate (2.00 mL, 11.6 mmol) and iodomethane (1.44 mL, 23.1 
mmol), and purified by column chromatography (hexane/EtOAc, 
10/1) as a colourless oil (1.96 g, 76%). νmax/cm-1 2971, 1739, 1714, 1455, 1365, 1229, 
1150, 743, 397; δH (CDCl3) 7.39-7.33 (5H, m), 5.17 (2H, s), 3.55 (1H, q, J 7.2), 2.19 
(3H, s), 1.36 (3H, d, J 7.2); δC (CDCl3) 203.6, 170.5, 135.6, 128.8, 128.6, 128.4, 67.2, 
53.7, 28.6, 12.9; m/z (EI) 206 (M+, 4%), 178 (22), 107 (13), 91 (100), 72 (41). 
 
Ethyl 2-benzyl-3-oxo-3-phenylpropanoate (3-20). Prepared from 
ethyl benzoyl acetate (2 mL, 11.6 mmol) and benzyl bromide (2.75 
mL, 23.1 mmol) and purified by column chromatography 
(hexane/ethyl acetate, 10/1) to give the ketoester (2.73 g, 83%) as a colourless oil. 
νmax/cm-11732, 1683, 1597, 1448, 1228, 1148, 689; δH (CDCl3) 7.97 (2H, dd, J 8.2, 1.1, 
Ar), 7.58-7.54 (1H, m, Ar), 7.47-7.43 (2H, m, Ar), 7.28-7.19 (5H, m, Ar), 4.63 (1H, t, J 
7.4, CH), 4.14-4.06 (2H, m, OCH2), 3.39-3.29 (2H, m, CH2Ph), 1.12 (3H, t, J 7.0, CH3); 
δC (CDCl3) 194.7 (C=O), 169.5 (OC=O), 138.7 (Ar), 136.4 (Ar), 133.7 (Ar), 129.2 (Ar), 
128.9 (Ar), 128.85 (Ar), 128.8 (Ar), 126.9 (Ar), 61.7 (OCH2), 56.4 (CH), 35.0 (CH2Ph), 
14.2 (CH3); HRMS: m/z (EI) 282.1254 (M+, C18H18O3 requires 282.1256), 264 (10%), 
237 (5), 209 (55), 177 (100), 131 (40). 
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Dimethyldioxirane (0.05-0.09 M in acetone).199 A flask was charged with H2O (80 
mL), acetone (50 mL) and NaHCO3 (96 g) and equipped with an air condenser, a solid 
addition flask containing OxoneTM (180 g, 0.29 mol) and a dropping funnel containing 
H2O (60 mL) and acetone (60 mL). The condenser outlet was connected to a dry-ice 
cold trap and bubbler. Whilst stirring vigorously the acetone-H2O mixture was added 
dropwise and the oxone was simultaneously added in 10 g portions over 45 min, 
maintaining continuous evolution of gas. After a further 30 min when the evolution has 
subsided the bubbler was removed and vacuum (50 mmHg) applied for 15 min. The 
distillate was collected in the cold trap, dried (Na2SO4) and stored at -25 °C. The 
solution was assayed by adding 1 mL to phenyl methyl sulfide (~25 mg). The resulting 
solution was concentrated in vacuo and analysed by 1H NMR, determining the 
conversion of phenyl methyl sulfide to phenyl methyl sulfoxide by integration. 
 
3-phenyl-2-para-tolyl-oxaziridine (1-94b).13  According to 
the literature procedure,12 a flask equipped with Dean-Stark 
apparatus was charged with benzaldehyde (7.05 g, 65.7 
mmol), para-toluenesulfonamide (11.26 g, 65.7 mmol), amberlyst-15 (0.20 g) and 
toluene (150 mL). The mixture was heated to reflux for 18 h. Upon cooling the mixture 
was filtered, concentrated in vacuo and triturated with pentane (50 mL). The crude 
sulfonimine was used in the next step without further purification. 
According to the literature procedure,13 a flask was charged with N-benzylidene para-
toluenesulfonamide (10.4 g, 39.9 mmol), saturated NaHCO3 solution (40 mL), benzyl 
triethyl ammonium chloride (1.00 g, 4.39 mmol) and CH2Cl2 (40 mL) and the mixture 
cooled to 0 °C. A solution of mCPBA (70%, 10.8 g, 43.9 mmol) in CH2Cl2 (80 mL) was 
then added dropwise, maintaining the temperature below 5 °C. When the addition was 
complete the solution was stirred for a further 100 min at 0 °C, then allowed to warm to 
room temperature. The organic layer was then separated, washed with H2O (2 x 80 mL), 
dried (MgSO4) and concentrated in vacuo. The oil was triturated with pentane (60 mL), 
and the residue recrystallised from hot ethyl acetate/pentane (2/1) giving the oxaziridine 
(8.96 g, 62%, over 2 steps) as a white crystalline solid; mp 93-94 °C (lit.296 94-95 °C); 
νmax/cm-1 2971, 1739, 1456, 1388, 1342, 1165, 1088, 773; δH (CDCl3) 7.95 (2H, d, J 
8.0, H-2), 7.47-7.42 (7H, m, Ar), 5.47 (1H, s, CHN), 2.51 (3H, s, CH3); δC (CDCl3) 
146.4 (Ar), 131.5 (Ar), 131.4 (Ar), 130.5 (Ar), 130.0 (Ar), 129.4 (Ar), 128.7 (Ar), 128.2 
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(Ar), 76.3 (OCH), 21.8 (CH3); m/z (EI) 275 (M+, <1%), 155 (45%), 105 (38%), 91 
(100%). 
 
3-(para-nitrophenyl-2-para-tolyl-oxaziridine (1-94c).296    Prepared by the procedure 
described for synthesis of 3-phenyl-2-para-tolyl-
oxaziridine (1-94b) from para-nitrobenzaldehyde 
(2.95 g, 19.5 mmol) and para-toluenesulfonamide 
(3.34 g, 19.5 mmol) giving the oxaziridine (3.25 g, 51%, over 2 steps) as a white 
crystalline solid; mp 140-144 °C (lit.296 146-147 °C); νmax/cm-1 2985, 1741, 1573, 1521, 
1314, 1253, 1141, 1083; δH (CDCl3) 8.28 (2H, d, J 8.8, H-2), 7.95 (2H, d, J 8.4, H-5), 
7.66 (2H, d, J 8.8, H-1), 7.47 (2H, d, J 8.4, H-4), 5.58 (1H, s, H-3), 2.53 (3H, s, H-6); δC 
(CDCl3) 149.7 (Ar), 146.9 (Ar), 137.3 (Ar), 131.0 (Ar), 130.2 (Ar), 129.5 (Ar), 129.4 
(Ar), 123.9 (Ar), 74.6 (C-3), 21.9 (C-6); m/z (EI) 320 (M+, <1%), 274 (2), 262 (31), 190 
(12), 155 (26), 91 (100). 
 
3-Methyl-1,2-benzisothiazole 1,1-dioxide oxide (1-96).198 According to 
the literature procedure, a solution of saccharin (1.47 g, 8.02 mmol) in 
Et2O (160 mL) was cooled to -78 °C, whereupon methyl lithium (1.6 M 
in Et2O, 10.0 mL, 16.0 mmol) was added dropwise. After 4 h the mixture was quenched 
with ice/H2O (100 mL) and the pH adjusted to 9 by addition of 2 M HCl. The product 
was then extracted using Et2O (3 x 100 mL), dried (MgSO4) and concentrated in vacuo. 
The crude benzisothiazole was used in the next step without further purification. 
A flask was charged with 3-methyl-1,2-benzisothiazole 1,1-dioxide (120 mg, 0.663 
mmol), saturated aq. K2CO3 (10 mL) and  CH2Cl2 (10 mL). A solution of mCPBA 
(70%, 245 mg, 0.994 mmol) in CH2Cl2 (10 mL) was added dropwise with vigorous 
stirring over 10 min. After 2 h, the mixture was diluted with  CH2Cl2 (10 mL) and 
washed with saturated Na2SO3 (10 mL) and H2O (10 mL) then dried (MgSO4) and 
concentrated in vacuo, giving the oxaziridine (120 mg, 12%, over 2 steps) as a white 
crystalline solid; mp 90-91 °C (lit.198 90-91 °C); νmax/cm-1 1558, 1316, 1168, 1125, 770; 
δH (CDCl3) 7.82-7.74 (4H, m, Ar), 2.16 (3H, s, CH3); δC (CDCl3) 135.2 (Ar), 134.0 
(Ar), 133.5 (Ar), 132.5 (Ar), 125.5 (Ar), 123.9 (Ar), 83.8 (CN), 15.6 (CH3); m/z (EI) 
197 (M+, 1%), 181 (88), 133 (52), 117 (50), 76 (100). 
 
General methods for α-hydroxylation of β-ketoesters. 
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Method A (catalyst 1-34c and DMD): A Radley’s reaction tube was charged with β-
ketoester (0.123 mmol), catalyst 1-34c (6.58 mg, 6.15 μmol) and CH2Cl2 (0.5 mL) and 
cooled to –20 °C. A solution of DMD in acetone (0.07 M, 2.10 mL, 0.147 mmol) at –20 
°C was then added dropwise. After 30 min the mixture was concentrated and filtered 
through a plug of silica. The crude product was either judged to be pure enough by 1H 
NMR, or purified by column chromatography. 
Method B (catalyst 1-36c and oxaziridine): A Radley’s reaction tube was charged with 
β-ketoester (0.123 mmol), catalyst 1-36c (5.51 mg, 3.08 μmol) and CH2Cl2 (0.5 mL). 
After 5 min, 1-94b (40.7 mg, 0.148 mmol) was added and the solution stirred until 
judged to be complete by TLC or 1H NMR. The reaction mixture was then concentrated 
in vacuo and purified by column chromatography. 
Method C (using catalyst 3-26 and oxaziridine): A Radley’s reaction tube was charged 
with a solution of catalyst 3-26 (25.0 mg, 24.6 μmol) in CH2Cl2 (0.5 mL) and powdered 
molecular sieves (4 Å, 125 mg). After stirring for 30 min, a solution of β-ketoester 
(0.246 mmol) in CH2Cl2 (0.5 mL) was added, followed by 1-94b (81.2 mg, 0.295 mg) 
and the solution stirred until judged to be complete by TLC or 1H NMR. The reaction 
mixture was then filtered through a plug of celite, concentrated in vacuo and purified by 
column chromatography. 
Method D (ligand screening): Under a nitrogen atmosphere, a Radley’s reaction tube 
was purged with nitrogen and charged with Pd(OTf)2.2H2O40 (5.4 mg, 12.3 μmol), the 
appropriate ligand (13.5 μmol) and CH2Cl2 (0.4 mL). After stirring for 30 min, a 
solution of 1-102 (23.4 mg, 0.123 mmol) in CH2Cl2 (0.1 mL) was added, followed after 
a further 5 min by a solution of 1-94b (40.7 mg, 0.148 mmol) in CH2Cl2 (0.1 mL) and 
the solution stirred for 18 h. The reaction mixture was then concentrated in vacuo, 
filtered through a plug of silica and analyzed by NMR and chiral HPLC. 
 
(S)-(+)-Methyl 2-hydroxy-1-indanone-2-carboxylate (3-30).72 
White crystalline solid; mp 132-134 °C (lit.297 131-132 °C); 
νmax/cm-1 1749 (C=O), 1708 (C=O), 1603, 1260, 1207, 1114; δH 
(CDCl3) 7.83 (1H, d, J 7.6, Ar), 7.70 (1H, t, J 7.6, Ar), 7.53 (1H, d, J 7.6, Ar), 7.46 (1H, 
t, J 7.6, Ar), 3.98 (1H, br s, OH), 3.76 (3H, s, CH3), 3.75 (1H, d, J 17.2, CH2), 3.28 (1H, 
d, J 17.2, CH2); δC (CDCl3) 200.8 (C-1), 171.9 (OC=O), 152.2 (Ar), 136.2 (Ar), 133.5 
(Ar), 128.2 (Ar), 126.5 (Ar), 125.3 (Ar), 80.3 (C), 53.5 (CH2), 39.2 (CH3); m/z (EI) 206 
O
O
OMeOH
193 
(M+, 47%), 147 (57), 118 (100), 91 (41); HPLC conditions: Chiracel OD-H column, 
hexane/IPA = 90/10, 1 mL/min, 254 nm, tR (major) = 11.9 min, tR (minor) = 13.7 min; 
lit.72 Chiracel OD-H column, hexane/IPA = 90/10, 1 mL/min, 254 nm, tR (S) = 12.9 
min, tR (R) = 15.4 min; [α]D25 +19.9 (c=1.21, CHCl3, 26% ee); lit.121 [α]D25 +52.1 (c=1.0, 
CHCl3, >98% ee) 
 
(S)-(+)-tert-Butyl 2-hydroxy-1-indanone-2-carboxylate (3-
31).72 White crystalline solid; mp 128-129 °C; νmax/cm-1 1736 
(C=O), 1711 (C=O), 1605, 1459, 1307, 1160; δH (CDCl3) 7.80 
(1H, d, J 7.6, H-7), 7.66 (1H, t, J 7.6, H-5), 7.49 (1H, d, J 7.6, H-4), 7.42 (1H, t, J 7.6, 
H-6), 4.04 (1H, br s, OH), 3.66 (1H, d, J 17.0, H-3), 3.23 (1H, d, J 17.0, H-3’), 1.37 
(9H, s, CH3); δC (CDCl3) 201.3 (C-1), 170.5 (OC=O), 152.3 (Ar), 135.8 (Ar), 133.9 
(Ar), 127.9 (Ar), 126.2 (Ar), 125.0 (Ar), 83.9 (C-2), 80.5 (C(CH3)), 39.4 (C-3), 27.6 
(CH3); m/z (EI) 248 (M+, <1%), 192 (75), 147 (71), 57 (100); HPLC conditions: 
Chiracel OD-H column, hexane/IPA, 98/2, 1 mL/min, 254 nm, tR (major) = 12.0 min, tR 
(minor) = 14.6 min; [α]D25 +32.4 (c=1.85, CHCl3, 85% ee); lit.121 [α]D25 +27.6 (c=1.1, 
CHCl3, >98% ee); 
 
(S)-(-)-tert-Butyl 2-hydroxycyclopentanone-2-carboxylate (3-
32).298 Colourless oil. νmax/cm-1 1753 (C=O), 1725 (C=O), 1370, 
1258, 1142, 844; δH (CDCl3) 2.45-2.41 (3H, m, CH2), 2.12-2.07 (3H, 
m, CH2), 1.48 (9H, s, CH3); δC (CDCl3) 213.9 (C=O), 170.8 (OC=O), 83.9, 79.7, 35.9 
(CH2), 34.8 (CH2), 27.8 (CH3), 18.4 (CH2); m/z (EI) 200 (M+, <1%), 191 (10), 132 (80), 
91 (100); GC conditions: Chiraldex G-TA (20 m x 0.25 mm), 90 °C (isothermal), tR 
(major) 19.8 min, tR (minor) 21.0 min; [α]D25 -4.6 (c=0.87, CHCl3, 94% ee); lit.72 [α]D25 
-4.8 (c=0.23, CHCl3, 93% ee). 
 
(S)-(-)-Benzyl 2-hydroxycyclopentanone-2-carboxylate 
(3-33).210 Colourless oil. νmax/cm-1 1755 (C=O), 1736, 1263, 1164; 
δH (CDCl3) 7.38-7.31 (5H, m, Ar), 5.25 (1H, d, J 12.4, CH2O), 5.16 
(1H, d, J 12.4, CH2O), 3.73 (1H, br s, OH), 2.53-2.42 (3H, m, CH2), 2.17-2.04 (3H, m, 
CH2); δC (CDCl3) 213.4 (C=O), 171.5 (OC=O), 134.8 (Ar), 128.7 (Ar), 128.6 (Ar), 
128.1 (Ar), 79.9 (COH), 67.9 (CH2O), 35.9 (CH2), 34.8 (CH2), 18.4 (CH2); m/z (EI) 234 
(M+, 4%), 216 (5), 206 (5), 143 (20), 115 (17), 91 (100); HPLC conditions: Chirapak 
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AD-H column, hexane/IPA, 90/10, 1 mL/min, 254 nm, tR (major) = 17.4 min, tR (minor) 
= 21.0 min; [α]D25 -17.4 (c=1.84, CHCl3, 66% ee); lit.121 [α]D25 -14.2 (c=0.7, CHCl3, 
>98% ee). 
 
(S)-(+)-Ethyl 3-phenyl-2-acetyl-2-hydroxypropionate (3-36)5 
Purified by column chromatography (pentane/Et2O, 20/1 to 3/2). 
Colourless oil. νmax/cm-1 1716 (C=O), 1356, 1268, 1203, 1119, 1013, 
7000; δH (CDCl3) 7.26-7.21 (5H, m, Ar), 4.21 (2H, q, J 7.0, CH2O), 4.06 (1H, s, OH), 
3.41 (1H, d, J 14.4, CH2Ph), 3.17 (1H, d, J 14.4, CH2Ph), 2.27 (3H, s, CH3C=O), 1.27 
(3H, t, J 7.0, CH3CH2); δC (CDCl3) 204.2 (C=O), 170.7 (OC=O), 134.8 (Ar), 130.4 
(Ar), 128.4 (Ar), 127.3 (Ar), 84.4 (COH), 63.1 (CH2O), 40.9 (CH2Ph), 25.3 (CH3C=O), 
14.2 (CH2CH3). m/z (EI) 236 (M+, 3%), 194 (56), 119 (22), 91 (100); HPLC conditions: 
Chiracel OJ-H column, hexane/IPA, 98/02, 1 mL/min, 220 nm, tR (minor) = 23.8  min, 
tR (major) = 25.9 min; [α]D25 +17.9 (c=0.67, CHCl3, 61% ee); lit.5 [α]D20 +18.9 (c=0.78, 
CHCl3, 56% ee). 
 
(S)-(-)-Ethyl 2-hydroxy-2-benzoylpropionate (3-37).299 
Colourless oil. νmax/cm-1 2971, 1738, 1692, 1449, 1366, 1268, 1229, 
1148, 1105; δH (CDCl3) 7.98-7.95 (2H, m, Ar), 7.57 (1H, t, J 7.4, 
Ar), 7.44 (2H, t, J 7.4, Ar), 4.46 (1H, s, OH), 4.21 (2H, q, J 7.2, CH2O), 1.73 (3H, s, 
CH3C), 1.15 (3H, t, J 7.0, CH3CH2); δC (CDCl3) 196.1 (C=O), 172.4 (OC=O), 133.9 
(Ar), 133.3 (Ar), 129.6 (Ar), 128.8 (Ar), 79.6 (COH), 62.7 (CH2O), 23.7 (CCH3), 14.0 
(CH2CH3); m/z (EI) 222 (M+, 1%), 180 (8), 149 (55), 105 (100), 77 (37); HPLC 
conditions: Chirapak AS-H column, hexane/IPA=98/2, 1 mL/min, 254 nm, tR (major) = 
14.6 min, tR (minor) = 19.8 min; [α]D25 -8.3 (c=0.72, CHCl3, 29% ee), lit.71 [α]D -3.8 (c 
= 1.1 CHCl3, 43% ee).  
 
(-)-Benzyl 2-hydroxy-2-methylacetoacetate (3-38).300 Colourless 
oil. νmax/cm-1 1718, 1454, 1361, 1260, 1149, 1109, 959; δH (CDCl3) 
7.37-7.32 (5H, m, Ar), 5.25-5.18 (2H, m, CH2Ph), 4.19 (1H, s, OH), 
2.19 (3H, s, CH3C=O), 1.60 (3H, s, CH3C); δC (CDCl3) 204.8 (C=O), 171.2 (OC=O), 
135.0 (Ar), 128.9 (Ar), 128.8 (Ar), 128.4 (Ar), 81.3 (COH), 68.2 (OCH2), 24.3 (CH3), 
21.9 (CH3); m/z (EI), 223 (MH+, 4%), 194 (13), 180 (90), 162 (17), 151 (20), 134 (10), 
91 (100); HPLC conditions: Chirapak AS-H column, hexane/IPA = 98/2, 1 mL/min, 
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254 nm, tR (minor) = 27.2 min, tR (major) = 29.0 min; [α]D25 –17.2 (c = 1.28, CHCl3, 
37% ee). 
 
(-)-Ethyl 2-hydroxy-2-phenylacetoacetate (3-39). Colourless oil. 
νmax/cm-1 1719, 1359, 124, 1173, 1072, 698; δH (CDCl3) 7.55 (2H, m, 
Ar), 7.41-7.35 (3H, m, Ar), 4.74 (1H, s, OH), 4.37-4.24 (2H, m, CH2), 
2.22 (3H, s, CH3C=O), 1.31 (3H, t, J 7.2, CH3CH2); δC (CDCl3) 203.8 (C=O), 170.5 
(OC=O), 133.3 (Ar), 128.9 (Ar), 128.6 (Ar), 126.5 (Ar), 84.7 (COH), 63.2 (CH2O), 24.3 
(CH3C=O), 21.9 (CH3C); HRMS: m/z (EI) 222.0893 (M+, C12H14O4 requires 222.0892), 
180 (48), 151 (16), 105 (100), 77 (42); Chiracel OJ-H column, hexane/IPA = 90/10, 1 
mL/min, 254 nm, tR (minor) = 21.2 min, tR (major) = 29.9  min; [α]D25 –19.0 (c = 0.21, 
CHCl3, 27% ee). 
 
(+)-Methyl 3-phenyl-2-acetyl-2-hydroxypropionate (3-40). Purified 
by column chromatography (pentane/CH2Cl2/Et2O, 50/50/1 to 6/6/1). 
Colourless oil. νmax/cm-1  1717 (C=O), 1356, 1271, 1208, 1119, 7000; 
δH (CDCl3) 7.29-7.19 (5H, m, Ar), 4.04 (1H, s, OH), 3.78 (3H, s, CH3O), 3.42 (1H, d, J 
14.2, CH2Ph), 3.18 (1H, d, J 14.2, CH2Ph), 2.29 (3H, s, CH3C=O). δC (CDCl3) 204.2 
(C=O), 171.1 (OC=O), 134.7 (Ar), 130.3 (Ar), 128.5 (Ar), 127.4 (Ar), 84.6 (COH), 53.6 
(CH3O), 41.2 (CH2Ph), 25.4 (CH3C=O); HRMS: m/z (EI) 222.0890 (M+, C12H14O4 
requires 222.0892), 180 (72%), 119 (18), 102 (20), 91 (100); HPLC conditions: 
Chirapak AD-H column, hexane/IPA, 90/10, 1 mL/min, 220 nm, tR (major) = 16.7  min, 
tR (minor) = 18.3 min; [α]D25 +8.1 (c=0.74, CHCl3, 48% ee). 
 
(+)-Benzyl 3-phenyl-2-acetylpropionate (3-41). Colourless oil. 
νmax/cm-1 3034, 1717, 1496, 1455, 1268, 1199, 1119, 696; δH (CDCl3) 
7.44-7.31 (5H, m, Ar), 7.27-7.19 (3H, m, Ar), 7.19-7.12 (2H, m, Ar), 
5.28-5.15 (2H, m, CH2O), 4.06 (1H, s, OH), 3.44 (1H, d, J 14.2, 
CH2COH), 3.20 (1H, d, J 14.2, CH2COH), 2.24 (3H, s, CH3); δC (CDCl3) δ 203.7 
(C=O), 170.3 (OC=O), 134.5 (Ar), 134.4 (Ar), 130.1 (Ar), 128.7 (Ar), 128.7 (Ar), 128.6 
(Ar), 128.2 (Ar), 127.1 (Ar), 84.3 (COH), 68.3 (OCH2), 40.7 (CH2COH), 25.1 (CH3); 
HRMS: m/z (ammonia, CI) 316.1554 (MNH4+, C18H22NO4 requires 316.1549), 300 
(4%), 272 (1), 182 (1); Chiracel OJ-H column, hexane/IPA = 90/10, 1 mL/min, 254 nm, 
tR (minor) = 25.7 min, tR (major) = 30.5 min; [α]D25 +2.8 (c = 0.70, CHCl3, 32% ee).  
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(S)-(+)-tert-Butyl 3-phenyl-2-acetyl-2-hydroxypropionate (3-42). 
Purified by column chromatography (pentane/CH2Cl2/Et2O, 50/50/1 
to 6/6/1). Colourless oil. νmax/cm-1 3471, 1715 (C=O), 1370, 1281, 
1149, 1119, 837, 700; δH (CDCl3) 7.25-7.24 (5H, m, Ar), 4.02 (1H, s, OH), 3.36 (1H, d, 
J 14.0, CH2Ph), 3.13 (1H, d, J 14.0, CH2Ph), 2.24 (3H, s, CH3C=O), 1.42 (9H, s, 
CH3C); δC (CDCl3) 204.0 (C=O), 169.7 (OC=O), 135.0 (Ar), 130.3 (Ar), 128.0 (Ar), 
127.0 (Ar), 84.2, 84.1, 40.0 (CH2), 27.7 ( C(CH3)3), 24.9 (CH3); m/z (EI) 264 (M+, 1%), 
221 (14), 208 (24), 166 (21), 148 (21), 120 (23), 91 (42); HPLC conditions: Chirapak 
AD-H column, hexane/IPA, 98/02, 1 mL/min, 220 nm, tR (major) = 11.8  min, tR 
(minor) = 16.9 min; [α]D25 +58.3 (c=0.72, CHCl3, 88% ee); lit.301 reported for R-isomer: 
[α]D31 = –62.6 (c = 1.0, CHCl3, 90% ee). 
 
(S)-(-)-tert-Butyl 2-hydroxy-2-benzoylpropionate (3-43).72 
Colourless oil. νmax/cm-1 2928, 1730, 1696, 1450, 1371, 1283, 1239, 
1146; δH (CDCl3) 8.04-7.93 (2H, m, Ar), 7.59 (1H, t, J 7.4, Ar), 
7.46 (2H, m, Ar), 4.29 (1H, s, OH), 1.70 (3H, s, CH3), 1.37 (9H, s, C(CH3)3); δC 
(CDCl3) 195.8 (C=O), 171.7 (OC=O), 133.7 (Ar), 133.3 (Ar), 129.3 (Ar), 128.4 (Ar), 
83.5 (C(CH3)3), 79.7 (COH), 27.5 (CH3), 23.3 (C(CH3)3);  m/z (EI) 250 (M+, <1%), 194 
(12), 166 (12), 150 (15), 149 (18), 123 (19), 105 (100); HPLC conditions: Chiracel OJ-
H column, hexane/IPA = 95/5, 1 mL/min, 254 nm, tR (major) = 6.3 min, tR (minor) = 9.8 
min, lit.72 OJ-H column, hexane/IPA = 95/5, 1 mL/min, 254 nm, tR (major) = 7.0 min, tR 
(minor) = 9.7 min; [α]D25 -7.4 (c = 0.82, CHCl3, 16% ee), lit.72 [α]D25 +2.2 (c = 0.1, 
CHCl3, 93% ee). HPLC data suggests formation of the (S)-enantiomer (by comparison 
to literature data) but optical rotation value correlates to (R)-enantiomer. We attributed 
this to a typographical error in the reported optical rotation.72 
 
(+)-Ethyl 2-hydroxy-1-indanone-2-carboxylate (3-46). 
Colourless oil. νmax/cm-1 1738 (C=O), 1709 (C=O), 1607, 1299, 
1249, 1184, 928, 751; δH (CDCl3) 7.79 (1H, d, J 7.8, Ar), 7.68-
7.64 (1H, m, Ar), 7.48 (1H, t, J 7.8, Ar), 7.44-7.42 (1H, t, J 7.4, Ar), 4.26-4.17 (2H, m, 
CH2O), 4.01 (1H, s, OH), 3.72 (1H, d, J 17.4, CH2), 3.24 (1H, d, J 17.4, CH2), 1.17 (3H, 
t, J 7.6, CH3). δC (CDCl3) 201.2 (C=O), 171.6 (OC=O), 152.5 (Ar), 136.3 (Ar), 133.8 
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(Ar), 128.3 (Ar), 126.6 (Ar), 125.5 (Ar), 80.5 (C-2), 63.0 (CH2O), 39.5 (C-3), 14.1 
(CH3); HRMS: m/z (EI) 220.0732 (M+, C12H12O4 requires 220.0736), 147 (95%), 135 
(50), 118 (100), 91 (68); HPLC conditions: Chiracel OD-H column, hexane/IPA=98/2, 
1 mL/min, 254 nm, tR (major) = 24.4 min, tR (minor) = 29.1 min; [α]D25 +24.4 (c=1.11, 
CHCl3, 48% ee).  
 
(+)-iso-Propyl 2-hydroxy-1-indanone-2-carboxylate (3-47). 
White crystalline solid; mp 68-74 °C; νmax/cm-1 3458, 1729 
(C=O), 1711 (C=O), 1606, 1374, 1273, 1207, 1101, 922; δH 
(CDCl3) 7.79 (1H, d, J 7.6, Ar), 7.68-7.64 (1H, m, Ar), 7.48 (1H, t, J 7.8, Ar), 7.46-7.42 
(1H, m, Ar), 5.11-5.01 (1H, m, CHMe2), 4.01 (1H, s, OH), 3.69 (1H, d, J 17.2, CH2), 
3.23 (1H, d, J 17.2, CH2), 1.17 (3H, d, J 6.2, CH3), 1.12 (3H, d, J 6.2, CH3); δC (CDCl3) 
201.2 (C=O), 171.2 (OC=O), 152.5 (Ar), 136.2 (Ar), 133.8 (Ar), 128.2 (Ar), 126.6 (Ar), 
125.4 (Ar), 80.5 (C), 71.1 (CHMe2), 39.5 (CH2), 21.76 (CH3), 21.5 (CH3); HRMS: m/z 
(EI) 234.0890 (M+, C13H14O4 requires 234.0892), 192 (100), 147 (100), 136 (55), 118 
(88), 91 (56); HPLC conditions: Chiracel OJ-H column, hexane/IPA, 90/10, 1 mL/min, 
254 nm, tR (major) = 13.0 min, tR (minor) = 23.7 min; [α]D25 +20.6 (c=1.02, CHCl3, 
48% ee). 
 
(S)-(+)-Benzyl 2-hydroxy-1-indanone-2-carboxylate (3-49).72 
White crystalline solid; mp 94-97 °C; νmax/cm-1 2971, 1740, 
1717, 1606, 1366, 1230, 1211, 1176, 928, 748, 1695; δH 
(CDCl3) 7.80 (1H, d, J 7.2, Ar), 7.68-7.64 (1H, m, Ar), 7.47 (1H, t, J 7.8, Ar), 7.42 (1H, 
t, J 7.0, Ar), 7.29-7.27 (3H, m, Ar), 7.16-7.13 (2H, m, Ar), 5.23 (1H, d, J 12.4, CH2O), 
5.12 (1H, d, J 12.4, CH2O), 4.04 (1H, s, OH), 3.72 (1H, d, J 17.4, CH2CO), 3.25 (1H, d, 
J 17.4, CH2CO); δC (CDCl3) 200.9 (C=O), 171.4 (OC=O), 152.4 (Ar), 136.4 (Ar), 134.9 
(Ar), 133.8 (Ar), 128.8 (Ar), 128.6 (Ar), 128.3 (Ar), 127.9 (Ar), 126.7 (Ar), 125.5 (Ar), 
80.8 (COH), 68.2 (CH2O), 39.4 (CH2COH); m/z (EI) 282 (M+, <1%), 264 (3), 249 (3), 
232 (2), 220 (5), 191 (21), 143 (24), 112 (19), 91 (100); HPLC conditions: Chiracel 
OD-H column, hexane/IPA = 90/10, 1 mL/min, 254 nm, tR (major) = 14.5 min, tR 
(minor) = 17.0 min, lit.72 Chiracel OD-H column, hexane/IPA = 90/10, 1 mL/min, 254 
nm, tR (S) = 14.0 min, tR (R) = 16.4 min; [α]D25 +9.1 (c=1.45, CHCl3, 15% ee), lit.210 
reported for the R-isomer: [α]Drt –34 (c = 1.05, CHCl3, 73%). 
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(S)-(+)-1-Adamantyl 2-hydroxy-1-indanone-2-
carboxylate (3-55).72 White crystalline solid; mp 73-75 °C; 
νmax/cm-1 2910, 1739, 1747, 1366, 1353, 1175, 1044; δH 
(CDCl3) 7.81 (1H, d, J 7.8, Ar), 7.66 (1H, t, J 7.6, Ar), 7.56-7.36 (2H, m, Ar), 4.01 (1H, 
s, br, OH), 3.68 (1H, d, J 17.2, CH2COH), 3.24 (1H, d, J 17.2, CH2COH), 2.14 (3H, m, 
Ad CH), 1.98 (6H, m, Ad CH2), 1.61 (6H, m, Ad CH2); δC (CDCl3) 201.4 (C=O), 170.2 
(OC=O), 152.3 (Ar), 135.8 (Ar), 134.0 (Ar), 127.9 (Ar), 126.2 (Ar), 125.0 (Ar), 83.9 
(Ad C-O), 80.5 (COH), 40.9 (CH2COH), 39.5 (Ad), 35.8 (Ad), 30.8 (Ad); m/z (EI), 326 
(M+, 2%), 256 (4), 192 (3), 143 (12), 135 (100); HPLC conditions: Chirapak AD-H 
column, hexane/IPA = 90/10, 1 mL/min, 254 nm, tR (major) = 17.8 min, tR (minor) = 
29.2 min; [α]D25 +4.4 (c=0.91, CHCl3, 33% ee), lit.72 [α]D26 +19.7 (c=0.60, CHCl3, 91% 
ee). 
 
(S)-(-)-Ethyl 2-hydroxycyclopentanone-2-carboxylate (3-56).298 
Colourless oil. νmax/cm-1 2923, 2853, 1728 (C=O), 1457, 1155; δH 
(CDCl3) 4.28 (2H, dq, J 7.2, 1.3, OCH2), 3.67 (1H, s, OH), 2.54-2.46 
(3H, m), 2.20-2.07 (3H, m), 1.31 (3H, t, J 7.2, CH3); δC (CDCl3) 213.4 (C=O), 171.6 
(OC=O), 79.7 (COH), 62.6 (CH2O), 35.8 (CH2), 34.7 (CH2), 18.4 (CH2), 14.0 (CH3); 
m/z (EI) 172 (M+, <1%), 167 (45), 97 (36), 83 (37); HPLC conditions: Chiracel OJ-H 
column, hexane/IPA, 90/10, 1 mL/min, 220 nm, tR (major) = 9.82 min, tR (minor) = 
11.47 min; [α]D25 -12.0 (c=1.00, CHCl3, 87% ee); lit.121 [α]D25 -9.3 (c=0.7, CHCl3, 93% 
ee). 
 
(S)-(-)-Methyl 1-tetralone-2-hydroxy-2-carboxylate (3-57).200 
White crystalline solid; mp 67-68  °C (lit.200 68 °C); νmax/cm-1 
3461, 2960, 1731, 1678, 1429, 1303, 1265, 1193, 1112, 961, 738; 
δH (CDCl3) 8.05-8.03 (1H, m, Ar), 7.54-7.50 (1H, m, Ar), 7.33 (1H, t, J 7.6, Ar), 7.26 
(1H, t, J 7.6, Ar), 4.45 (1H, s, OH), 3.73 (3H, s, CH3), 3.19-3.05 (2H, m, CH2), 2.78-
2.63 (1H, m, CH2), 2.32-2.17 (1H, m, CH2); δC (CDCl3) 194.5 (C=O), 171.0 (OC=O), 
144.0 (Ar), 134.4 (Ar), 130.1 (Ar), 128.9 (Ar), 128.2 (Ar), 126.9 (Ar), 77.7 (COH), 53.0 
(CH3), 32.7 (CH2), 25.5 (CH2); m/z (EI) 220 (M+, 40%), 202 (15), 170 (19), 161 (58), 
143 (15), 133 (30), 118 (100); HPLC conditions: Chiracel OD-H column, hexane/IPA = 
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95/5, 1 mL/min, 254 nm, tR (major) = 12.2 min, tR (minor) = 13.8 min; [α]D25 –7.8 
(c=1.02, CHCl3, 10% ee), lit.5 [α]D25 –11.3 (c = 0.55, CHCl3, 82% ee).  
 
(S)-(-)-Ethyl 1-tetralone-2-hydroxy-2-carboxylate (3-58).200 
Colourless oil. νmax/cm-1 3457, 2938, 1735, 1686, 1601, 1456, 
1291, 1257, 1190, 913, 727; δH (CDCl3) 8.08 (1H, dd, J 7.8, 1.2, 
Ar), 7.56 (1H, td, J 7.6, 1.4, Ar), 7.40-7.36 (1H,m, Ar), 7.32-7.25 (1H, m, Ar), 4.33 
(1H, s, OH), 4.30-4.18 (2H, m, OCH2), 3.19-3.13 (2H, m, CH2), 2.74 (1H, dt, J 13.6, 
5.2, CH2), 2.28 (1H, ddd, J 13.6, 8.2, 6.9, CH2), 1.24 (3H, t, J 7.2, CH3); δC (CDCl3) δ 
194.6 (C=O), 170.6 (OC=O), 143.9 (Ar), 134.3 (Ar), 130.2 (Ar), 128.9 (Ar), 128.1 (Ar), 
126.9 (Ar), 77.6 (COH), 62.2 (OCH2), 32.6 (CH2), 25.5 (CH2), 13.9 (CH3); m/z (EI) 234 
(M+, 51%), 216 (25), 170 (25), 161 (100), 143 (23), 118 (98); HPLC conditions: 
Chiracel OJ-H column, hexane/IPA = 90/10, 1 mL/min, 254 nm, tR (major) = 16.2 min, 
tR (minor) = 21.2 min; [α]D25 –5.3 (c = 1.14, CHCl3, 20% ee).  
 
Benzyl 1-tetralone-2-hydroxy-2-carboxylate (3-59). White 
crystalline solid; mp 87-89 °C; νmax/cm-1 2936, 1739, 1686, 
1602, 1455, 1227, 1189, 907, 725; δH (CDCl3) 8.07 (1H, dd, J 
7.8, 1.2, Ar), 7.59-7.52 (1H, td, J 7.6, 1.4, Ar), 7.37 (1H, t, J 7.6, Ar), 7.33-7.23 (4H, m, 
Ar), 7.18 (2H, m, Ar), 5.20 (2H, q, J 12.4, CH2Ar), 4.35 (1H, s, OH), 3.15-3.01 (2H, m, 
CH2), 2.75 (1H, dt, J 13.6, 5.0, CH2), 2.27 (1H, ddd, J 13.6, 8.8, 6.6, CH2); δC (CDCl3) δ 
194.5 (C=O), 170.4 (OC=O), 143.9 (Ar), 134.9 (Ar), 134.3 (Ar), 130.3 (Ar), 128.9 (Ar), 
128.5 (Ar), 128.3 (Ar), 128.1 (Ar), 127.7 (Ar), 127.0 (Ar), 77.8 (COH), 67.5 (OCH2), 
32.7 (CH2), 25.5 (CH2); HRMS: m/z (EI) 296.1045 (M+, C18H16O4 requires 296.1049), 
205 (22%), 180 (10), 161 (30), 107 (23), 91 (100); HPLC conditions: Chirapak AD-H 
column, hexane/IPA = 90/10, 1 mL/min, 254 nm, tR (major) = 26.7 min, tR (minor) = 
40.2 min. Optical purity was too low (1%) for accurate determination of [α]D. 
 
(S)-(-)-Benzyl 2-hydroxycyclohexanone-2-carboxylate (3-60). 
Colourless oil. νmax/cm-1 2947, 1744, 1717, 1455, 1216, 1056, 737, 
696; δH (CDCl3) 7.43-7.31 (5H, m, Ar), 5.28-5.17 (2H, m, CH2Ar), 
4.39 (1H, s, OH), 2.72- 2.62 (2H, m, CH2), 2.56-2.43 (1H, m, CH2), 2.05-1.95 (1H, m, 
CH2), 1.90-1.64 (4H, m, CH2); δC (CDCl3) 207.1 (C=O), 169.8 (OC=O), 135.0 (Ar), 
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128.6 (Ar), 128.5 (Ar), 128.1 (Ar), 80.7 (COH), 67.5 (CH2Ar), 38.8 (CH2), 37.6 (CH2), 
27.0 (CH2), 21.9 (CH2). HRMS: m/z (EI) 248.1044 (M+, C14H16O4 requires 248.1049), 
232 (6%), 220 (6), 157 (15), 129 (18), 111 (15), 91 (100); HPLC conditions: Chiracel 
OJ-H column, hexane/IPA=90/10, 1 mL/min, 220 nm, tR (minor) = 27.7 min, tR (major) 
= 30.7 min; [α]D25 -20.6 (c=1.55, CHCl3, 66% ee).  
 
Experimental procedure for monitoring conversion in α-hydroxylation of (3-13). A 
Radley’s reaction tube was charged with 3-13 (27.1 mg, 0.123 mmol), catalyst 1-34c 
(13.1 mg, 12.3 μmol) or 1-36c (11.0 mg, 6.15 μmol) and CH2Cl2 (0.5 mL). After 
stirring for 5 min, a solution of DMD in acetone (2.59 mL, 0.148 mmol, 0.057 M) or 1-
94c (40.1 mg, 0.148 mmol) in CH2Cl2 (2.59 mL) was added and the mixture stirred at 
room temperature. Reactions with DMD were quenched by removing an aliquot and 
concentrating in vacuo at room temperature to remove oxidant; whereas reactions with 
1-94c were quenched by filtering an aliquot through a plug of silica to remove catalyst 
(no observable uncatalysed reaction takes place in CDCl3). Conversion was calculated 
by comparing integrals of 1H NMR signals at 3.80 ppm (starting material) and 3.44 ppm 
(product). 
6.4. Compounds Used in Chapter 5 
N-(methoxycarbonyl)glycine ethyl ester (5-42a). According to 
the literarure procedure,259 a mixture of glycine ethyl ester 
hydrochloride (10 g, 71.6 mmol), methyl chloroformate (22.2 mL, 
287 mmol) and K2CO3 (59.4 g, 430 mmol) (150 mL) was refluxed in acetone for 18 h. 
Upon cooling the mixture was diluted with H2O (400 mL) and extracted using Et2O (2 x 
150 mL). The combined extracts were dried (MgSO4) and concentrated in vacuo, then 
purified by short path distillation (75 °C, 0.1 mmHg) to give the carbamate (9.83 g, 
85%) as a colourless oil. νmax/cm-1 1748 (C=O), 1703 (C=O), 1528, 1281, 1191, 1051, 
782; δH (CDCl3) 5.22 (1H, s, NH), 4.23 (2H, q, J 7.2, CH2O), 3.97 (2H, d, J 5.8), 3.71 
(3H, s, OCH3), 1.30 (3H, t, J 7.2, CH2CH3); δC (CDCl3) 170.2 (C=O), 157.0 (NC=O), 
61.4 (CH2CH3), 52.4 (OCH3), 42.7 (NCH2), 14.1 (CH2CH3); m/z (EI) 161 (M+, 11%), 
146 (18), 115 (14), 102 (15), 88 (100). 
 
N-(benzyloxycarbonyl)glycine ethyl ester (5-42b).260 
According to the literarure procedure,260 benzyl chloroformate 
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(11.1 mL, 78.8 mmol) was added dropwise to a solution of glycine ethyl ester 
hydrochloride (11.0 g, 78.8 g) and triethylamine (21.9 mL, 157.6 mmol) in THF (200 
mL) at 0 °C. The mixture was allowed to warm to room temperature, stirred for 18 h, 
then warmed to 50 °C for 3 h. Upon cooling, the solution was concentrated in vacuo, 
dissolved in CH2Cl2 (200 mL) and washed with aq. K2CO3 (100 mL) then 1 M HCl 
(100 mL). The organic layer was dried (MgSO4), concentrated, and purified by column 
chromatography (hexane/ethyl acetate, 5/1) to give the carbamate S2 (2.68 g, 14%) as a 
colourless oil. νmax/cm-1 1737 (C=O), 1725 (C=O), 1524, 1374, 1354, 1202, 1052, 696; 
δH (CDCl3) 7.45-7.29 (5H, m, Ar), 5.32 (1H, s, NH), 5.15 (2H, s, CH2Ph), 4.24 (2H, q, J 
7.2, CH2CH3), 4.00 (2H, d, J 5.6, CH2N), 1.31 (3H, t, J 7.2, CH3). δC (CDCl3) 170.0 
(C=O), 156.2 (NC=O), 136.2 (Ar), 128.5 (Ar), 128.2 (Ar), 128.1 (Ar), 67.1 (CH2Ph), 
61.5 (CH2CH3), 42.8 (CH2N), 14.1 (CH3); m/z (EI) 237 (M+, 17%), 108 (62), 91 (100). 
 
N-(tert-butoxycarbonyl)glycine ethyl ester (5-42c).261 
Similarly prepared from di-tert-butyldicarbonate (17.2 g, 78.8 
mmol), glycine ethyl ester hydrochloride (11 g, 78.8 mmol) and 
triethylamine ( 21.9 mL, 157.6 mmol) as a colourless oil (16.0 g, 100%). νmax/cm-1 1739 
(C=O), 1724 (C=O), 1514, 1366, 1205, 1158, 1026; δH (CDCl3) 5.02 (1H, s, NH), 4.23 
(2H, q, J 7.2, CH2O), 3.92 (2H, d, J 5.6, CH2C=O), 1.47 (9H, s, C(CH3)3), 1.30 (3H, t, J 
7.2, CH3); δC (CDCl3) 170.4 (C=O), 155.7 (NC=O), 79.9 (C(CH3)3), 61.3 (CH2O), 42.4 
(CH2N), 28.2 (C(CH3)3), 14.1 (CH3); m/z (EI) 203 (M+, <1%), 148 (20), 130 (18), 104 
(11), 102 (12), 57 (100).  
 
General method for the synthesis of 3-pyrrolidinones (5-43a-c). KOtBu (3.04 g, 27.1 
mmol) was added portionwise to a solution of an N-(alkoxyoxycarbonyl)glycine ethyl 
ester (24.6 mmol) and tert-butyl acrylate (3.60 mL, 24.6 mmol) in THF (50 mL) at 0 °C. 
After stirring at room temperature for 24 h the slurry was diluted with hexane (50 mL) 
and filtered. The residue was dissolved in 2 M HCl (100 mL), extracted with CH2Cl2 (3 
x 80 mL) and the combined extracts were dried (MgSO4) and concentrated.  
 
N-(methoxycarbonyl)-4-(tert-butoxycarbonyl)-3-pyrrolidinone 
(5-43a). Prepared by the general method for the synthesis of 3-
pyrrolidinones and purified by column chromatography 
(hexane/ethyl acetate, 1/1) to give the 3-pyrrolidinone (51%, 1.15 
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g) as a yellow oil which was stored in the freezer. NMR shows a keto-enol mixture as a 
mixture of rotamers. νmax/cm-1 1710 (C=O), 1444, 1369, 1247, 1145, 771; δH (CDCl3) 
10.22 (0.5H, br, s, enol OH), 4.29-4.21 (1.5H, m), 4.07 (1.5H, br, s), 3.91 (1.5H, br, s), 
3.79 (3H, br, s, keto CH3), 3.77-3.76 (1.5H, m, enol CH3), 1.53 (4.5H, s, enol C(CH3)3), 
1.50 (9H, s, keto C(CH3)3); δC (CDCl3) 203.8, 203.1, 166.5, 166.4, 166.2, 165.2, 154.6, 
154.4, 154.4, 97.7, 97.7, 82.1, 81.2, 54.3, 53.7, 52.1, 51.96, 51.81, 51.6, 50.8, 50.4, 
48.6, 48.2, 45.6, 27.5, 27.2; HRMS: m/z (ammonia CI) 261.1455 (MNH4+ C11H21N2O5 
requires 261.1450), 205 (100%), 193 (20), 179 (12), 151 (13). 
 
N-(benzyloxycarbonyl)-4-(tert-butoxycarbonyl)-3-
pyrrolidinone (5-43b).  Prepared by the general method 
for the synthesis of 3-pyrrolidinones and purified by 
column chromatography (hexane/ethyl acetate, 5/1) to 
give the 3-pyrrolidinone (33%, 660 mg) as a yellow oil which was stored in the freezer. 
NMR shows keto enol mixture as a mixture of rotamers. νmax/cm-1 1768 (C=O), 1705 
(C=O), 1418, 1367, 1146, 697; δH (CDCl3) 7.41-7.33 (5H, m, Ar), 5.22-5.19 (2H, m, 
CH2Ph), 4.30-4.09 (3.25H, br, m), 4.10-4.09 (1.25H, br, m), 3.94-3.93 (1.25H, br, s), 
3.52-3.48 (0.5H, br, m), 1.52 (4H, s, CH3), 1.48 (5H, s, CH3); δC (CDCl3) 203.7, 203.1, 
169.7, 166.7, 166.6, 166.3, 165.3, 156.1, 154.0, 153.9, 136.2, 136.1, 136.0, 135.8, 
128.1, 128.0, 128.0, 127.8, 127.6, 127.5, 97.9, 97.8, 82.4, 81.5, 66.9, 66.64, 66.43, 60.8, 
54.4, 53.8, 51.9, 51.7, 50.9, 50.6, 48.8, 48.4, 45.7, 42.3, 27.8, 27.8, 27.4, 20.5, 13.7; 
HRMS: m/z (ammonia CI) 337.1763 (MNH4+ C17H25N2O5 requires 337.1763), 297 
(100%), 281 (75), 255 (32), 197 (46), 108 (40), 91 (9). 
 
1,4-(di-tert-butoxycarbonyl)-3-pyrrolidinone (5-43c). 
Prepared by the general method for the synthesis of 3-
pyrrolidinones and purified by recrystallisation from hexane 
to give the pyrrolidinone (5.96 g, 85%) as a white 
crystalline solid. NMR shows keto enol mixture as a mixture of rotamers; mp 86 °C; 
νmax/cm-1 1766 (C=O), 1727 (C=O), 1699 (C=O), 1667 (C=O), 1643 (C=O), 1411, 
1360, 1319, 1143; δH (CDCl3) 10.19-10.14 (0.33H, br, m, enol OH), 4.22-4.12 (1.3H, 
m), 4.03-3.95 (1.3H, m), 3.85 (1.3H, br, s), 3.49 (0.66H, t, J 7.6, keto CH), 1.52-1.48 
(18H, m, CH3); δC (Tol, 373 K) 203.2, 168.6, 167.9, 166.2, 154.1, 82.2, 81.8, 80.0, 79.5, 
55.2, 52.6, 51.6, 49.3, 46.6 42.7, 36.6, 31.5, 28.7, 28.6, 28.6, 28.4, 28.1, 27.9; HRMS: 
NO
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m/z (ammonia CI) 303.1923 (MNH4+ C14H27N2O5 requires 303.1920), 286 (MH+, 16%), 
247 (100), 230 (10), 191 (22). 
 
N-benzyl-2-pyrrolidinone (5-44).302 In an oven dried flask, sodium hydride 
(60% dispersion in mineral oil, 5.16 g, 129 mmol) was washed with hexane 
(5 x 20 mL). THF (200 mL) was added and the suspension cooled to 0 °C. 2-
Pyrrolidinone (10 g, 118 mmol) was added dropwise, followed by benzyl bromide (15.3 
mL, 129 mmol). After stirring for 1 h the mixture was warmed to 60 °C and stirred for 
24 h. The solvent was removed in vacuo and the residue partitioned between CH2Cl2 
(200 mL) and H2O (200 mL). The organic layer was separated, washed with H2O (100 
mL), dried (MgSO4) and concentrated in vacuo, heating to 60 °C at 0.2 mmHg to 
remove the remaining benzyl bromide inpurity, giving the lactam (16.4 g, 79%) as an 
orange oil. νmax/cm-1 1673 (C=O), 1495, 1422, 1286, 1264, 699; δH (CDCl3) 7.44-7.21 
(5H, m, Ar), 4.45 (2H, s, CH2O), 3.26 (2H, t, J 7.2, CH2N), 2.44 (2H, t, J 8.2, 
CH2C=O), 2.02-1.89 (2H, m, CH2CH2N); δC (CDCl3) 174.9 (C=O), 136.5 (Ar), 128.6 
(Ar), 128.1 (Ar), 127.5 (Ar), 46.5 (CH2Ph, CH2N), 30.9 (CH2C=O), 17.7 (CH2CH2N); 
m/z (EI) 175 (M+, 100%), 146 (44), 104 (30), 91 (100).  
 
tert-Butyl N-benzyl-2-pyrrolidinone-3-carboxylate (5-45).245 
Sodium hexamethyldisilylamide (1 M in THF, 34.2 mL) was added 
dropwise to a solution of 5-44 (6.00 g, 34.2 mmol) in THF (40 mL) 
at -78 °C. After stirring for 1 h a solution of di-tert-butyldicarbonate (3.73 g, 17.1 
mmol) in THF (20 mL) was added dropwise over 30 min. The solution was stirred at 
-78 °C for a further 30 min then quenched with saturated NH4Cl solution (30 mL), and 
extracted using Et2O (3 x 30 mL). The combined organic extracts were dried (MgSO4), 
concentrated and the crude material was purified by column chromatography 
(hexane/ethyl acetate, 2/1 to 1/1) to give the pyrrolidinone (3.78 g, 80%) as a yellow oil. 
νmax/cm-1 1740 (C=O), 1670 (C=O), 1490, 1454, 1439, 1260, 1139, 843, 696; δH 
(CDCl3) 7.31-7.21 (5H, m, Ar), 4.52 (1H, d, J 14.8, CH2Ph), 4.40 (1H, d, J 14.8, 
CH2Ph), 3.36-3.33 (2H, m, CH2N), 3.23-3.18 (1H, m, CH), 2.28-2.16 (2H, m, CH2CH), 
1.48 (9H, s, CH3); δC (CDCl3) 170.3 (C=O), 169.5 (C=O), 136.1 (Ar), 128.6 (Ar), 128.0 
(Ar), 127.6 (Ar), 81.8 (C(CH3)3), 49.5, 46.8, 45.2, 27.9 (CH3), 22.3 (CH2); m/z (EI) 275 
(M+, 4%), 265 (18), 219 (81), 202 (33), 174 (49), 91 (100). 
 
BnN
O
BnN
O O
OtBu
204 
N-trimethylsilyl-2-pyrrolidinone (5-46).303 A mixture of 2-pyrrolidinone 
(7.59 mL, 100 mmol), triethylamine (17.4 mL, 125 mmol) and 
chlorotrimethylsilane (14.0 mL, 110 mmol) was stirred in toluene (100 mL) 
at room temperature for 4 h. The solution was cooled to 0 °C, diluted with hexane (50 
mL) and Et2O (50 mL) and filtered through a pad of celite, rinsing with hexane/Et2O 
(1/1). The filtrate was concentrated in vacuo and purified by distillation (72-82 °C, 7 
mmHg) to give S5 (11.2 g, 71%) as an orange oil. νmax/cm-1 1673 (C=O), 1381, 1246, 
1122, 832; δH (CDCl3) 3.37 (2H, t, J 7.0, CH2N), 2.34 (2H, t, J 8.2, CH2C=O), 2.08-
2.00 (2H, m, CH2CH2N), 0.28 (9H, s, CH3); δC (CDCl3) 183.4 (C=O), 46.5 (CH2N), 
32.7 (CH2C=O), 21.6 (CH2CH2N), -1.1 (CH3); m/z (EI) 157 (M+, 20%), 142 (100). 
 
tert-Butyl N-(tert-butoxycarbonyl)-2-pyrrolidinone-3-
carboxylate (5-47) was prepared in two steps by following a 
reported procedure for the synthesis of tert-butyl 2-pyrrolidinone-
3-carboxylate,244 however only tert-butyl N-(tert-butoxycarbonyl)-2-pyrrolidinone-3-
carboxylate was isolated. 
Sodium hexamethyldisilylamide (1 M in THF, 15.9 mL) was added dropwise to a 
solution of 5-46 (2.5 g, 15.9 mmol) in THF (15 mL) at -78 °C. After stirring for 1 h, a 
solution of di-tert-butyldicarbonate (1.74 g, 7.95 mmol) in THF (10 mL) was added 
dropwise over 30 min. The solution was stirred at -78 °C for a further 30 min then 
quenched with saturated NH4Cl solution (30 mL), and extracted using Et2O (3 x 30 
mL). The combined organic extracts were dried (MgSO4), concentrated and the residue 
was purified by column chromatography (hexane/ethyl acetate, 5/1 to 3/1) to give the 
pyrrolidinone (386 mg, 34%) as a white crystalline solid; mp 62-64 °C; νmax/cm-1 1768 
(C=O), 1724 (C=O), 1366, 1281, 1153, 1013, 940, 776; δH (CDCl3) 3.94-3.79 (1H, m, 
CH2N), 3.74-3.61 (1H, m, CH2N), 3.48-3.36 (1H, m, CH), 2.42-2.26 (1H, m, CH2CH), 
2.26-2.12 (1H, m, CH2CH), 1.62-1.44 (18H, m, CH3); δC (CDCl3) 169.1 (NC=O), 167.9 
(NC=O), 150.0 (OC=O), 83.2 (C-O), 82.4 (C-O), 51.1 (CH), 44.8 (CH2N), 27.9 (CH3), 
27.9 (CH3), 21.5 (CH2); HRMS: m/z (EI) 308.1473 (MNa+, C14H23NO5Na requires 
308.1471), 229 (9%), 212 (8), 173 (31), 156 (17), 130 (22), 112 (22). 
 
Mono-tert-butyl  malonate (5-51).263 Meldrum’s acid (20 g, 138 
mmol) and tert-butanol (40 mL) were heated to reflux for 5 h then 
cooled to rt and concentrated in vacuo. The residue was dissolved in ethanol (80 mL) 
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and cooled to 5 °C, whereupon ammonia (15 M, 9.25 mL) was added dropwise. After 5 
min further stirring the slurry was concentrated in vacuo, triturated with Et2O (80 mL), 
dissolved in H2O (80 mL), filtered, and washed with Et2O. The aqueous layer was then 
acidified with 2 M HCl (80 mL) and extracted using Et2O (3 x 80 mL). The combined 
organic extracts were dried (MgSO4) and concentrated in vacuo to give the malonate 
(13.7 g, 62%) as a colourless oil. νmax/cm-1 2981, 1713, 1369, 1141, 836; δH (CDCl3) 
8.73 (1H, s, br, OH), 3.35 (2H, s, CH2), 1.49 (9H, s, CH3); δC (CDCl3) 171.6 (C=O), 
166.4 (C=O), 83.0 (C(CH3)3), 41.8 (CH2), 27.8 (CH3); 245 (M+ <1%), 145 (18), 136 (3), 
121 (8), 105 (22), 59 (100).  
 
General method for synthesis of alkyl 3-((2-ethoxy-2-oxoethyl)amino)-3-
oxopropanoates.  
Ethyl bromoacetate (20.3 mL, 183 mmol) was added dropwise over 2 h to a solution of 
an amine (183 mmol) and triethylamine (51.0 mL, 366 mmol) in CH2Cl2 (600 mL). The 
mixture was then concentrated in vacuo, dissolved in Et2O (500 mL) and washed with 
H2O (3 x300 mL). The organic layer was dried (MgSO4) and concentrated to give the 
crude amine as a yellow oil. This material was used in the next step without further 
purification. 
The N-substituted glycine ethyl ester (4.54 mmol), mono-alkyl malonate (4.54 mmol) 
and triethylamine (633 mL, 4.54 mmol) were dissolved in CH2Cl2 (8 mL). The mixture 
was cooled to 0 °C and a solution of DCC (937 mg, 4.54 mmol) in CH2Cl2 (2 mL) was 
added in one portion. The solution was then allowed to warm to rt, stirred for 18 h, then 
concentrated in vacuo. The residue was dissolved in Et2O (10 mL), filtered, and washed 
with 2 M NaOH (10 mL), 2 M HCl (10 mL) and brine (2 x 10 mL). The organic layer 
was dried (MgSO4) and concentrated, then purified by column chromatography. 
 
tert-Butyl 3-((4-methoxybenzyl)(2-ethoxy-2-
oxoethyl)amino)-3-oxopropanoate (5-53). Prepared 
from (4-methoxybenzyl)amine and mono-tert-butyl 
malonate and purified by column chromatography (hexane/ethyl acetate, 2/1) to give the 
amide (2.90 g,  28%, over 2 steps) as a yellow oil. νmax/cm-1 1732, 1655, 1612, 1513, 
1247, 1173, 1143, 1027; δH (CDCl3, rotameric) 7.22-7.17 (1H, m, Ar), 6.95-6.84 (1H, 
m, Ar), 4.64 (0.8H, s, CH2Ar), 4.59 (1.2H, s, CH2Ar), 4.18 (2H, q, J 7.4, CH2O), 4.05 
(1.2H, s, NCH2C=O), 3.96 (0.8H, s, NCH2C=O), 3.83 (1.8H, s, CH3O), 3.82 (1.2H, s, 
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CH3O), 3.51 (1.2H, s, CH2(C=O)N), 3.41 (0.8H, s, CH2(C=O)N), 1.50 (5.4H, s, 
C(CH3)3), 1.49 (3.6H, s, C(CH3)3), 1.28-1.24 (3H, m, CH2CH3); δC (CDCl3) 168.9 
(C=O), 167.2 (C=O), 166.8 (C=O), 166.4 (C=O), 166.4 (C=O), 159.4 (Ar), 159.2 (Ar), 
129.8 (Ar), 128.4 (Ar), 128.2 (Ar), 127.2 (Ar), 114.3 (Ar), 114.0 (Ar), 82.2 (C(CH3)3), 
82.1 (C(CH3)3), 61.6 (CH2O), 61.1 (CH2O), 55.3 (CH3O), 55.2 (CH3O), 52.0 (CH2Ar), 
49.0 (CH2Ar), 48.6 (NCH2C=O), 46.5 (NCH2C=O), 42.7 (CH2(C=O)N), 42.4 
(CH2(C=O)N), 27.9 (C(CH3)3), 14.1 (CH2CH3); HRMS: m/z (EI) 365.1839 (M+, 
C19H27NO6 requires 365.1838), 309 (25%), 292 (8), 222 (100), 121 (78). 
 
Sodium 4-(tert-butoxycarbonyl)-1-(4-methoxybenzyl)-5-
oxo-2,5-dihydro-1H-pyrrol-3-olate (5-54). Sodium (69.2 mg, 
3.01 mmol) was dissolved in absolute ethanol (5.0 mL) and 
the solution concentrated in vacuo. To the residue was added 
toluene (10 mL) and 5-53 (1.00 g, 2.74 mmol), and the mixture heated to reflux for 4 h. 
Upon cooling, the suspension was filtered and the residue washed with Et2O and dried, 
giving the tetramic acid salt (835 mg, 89%) as a white crystalline solid. νmax/cm-1 1739, 
1691, 1621, 1595, 1448, 1231, 1129, 1029; δH (D2O) 7.12 (2H, d, J 8.6, Ar), 6.89 (2H, 
d, J 8.6, Ar), 4.37 (2H, s, CH2), 3.73 (3H, s, CH3O), 3.42 (1H, s, CH2), 1.40 (9H, s, 
C(CH3)3); δC (CDCl3) 192.3 (C-2), 175.1 (C-4), 166.0 (OC=O), 158.0 (Ar), 130.3 (Ar), 
129.0 (Ar), 114.1 (Ar), 92.7 (C-3), 80.0 (C(CH3)3), 55.3 (CH3O), 52.9 (CH2), 44.1 
(CH2), 27.9 C(CH3)3); HRMS: m/z (ESI) 318.1343 (M-, C17H20NO5 requires 318.1341), 
290 (5%), 262 (7), 218 (3).  
 
Ethyl 3-(benzyl(2-ethoxy-2-oxoethyl)amino)-3-
oxopropanoate (5-58). Prepared by the general method for 
synthesis of alkyl 3-((2-ethoxy-2-oxoethyl)amino)-3-
oxopropanoates from benzylamine and mono-ethyl malonate. Purified by column 
chromatography (hexane/ethyl acetate, 2/1) to give the amide (421 mg, 25%, over 2 
steps) as a yellow oil. νmax/cm-1 1737, 1655, 1441, 1259, 1192, 1155, 1024; δH (CDCl3, 
rotomeric) δ 7.40-7.16 (5H, m, Ar), 4.66 (0.75H, s, CH2), 4.63 (1.25H, s, CH2), 4.24-
4.08 (4H, m, CH2O), 4.03 (1.25H, s, CH2), 3.95 (0.75H, s, CH2), 3.53 (1.25H, s, CH2), 
3.46 (0.75H, s, CH2), 1.28-1.20 (6H, m, CH3). δC (CDCl3) 168.7 (C=O), 167.3 (C=O), 
167.1 (C=O), 167.0 (C=O), 166.6 (C=O), 136.1 (Ar), 135.3 (Ar), 129.0 (Ar), 128.6 
(Ar), 128.3 (Ar), 128.0 (Ar), 127.6 (Ar), 126.9 (Ar), 61.7 (CH2O), 61.5 (CH2O), 61.5 
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(CH2O), 61.1 (CH2O), 52.6 (CH2), 49.7 (CH2), 48.9 (CH2), 47.0 (CH2), 41.3 (CH2), 41.1 
(CH2C=O), 14.0 (CH2C=O); HRMS: m/z (EI) 307.1418 (M+, C16H21NO5 requires 
307.1420), 262 (9), 234 (4), 192 (100), 120 (33), 91 (90). 
 
 Ethyl 1-benzyl-4-hydroxy-2-oxo-2,5-dihydro-1H-pyrrole-3-
carboxylate (5-50).264 The sodium salt was prepared by the 
procedure for the synthesis of 5-54 from 5-58 (150 mg, 0.488 
mmol). The salt was dissolved in H2O (20 mL) and 1 M HCl was added dropwise to 
adjust the solution to pH 5. The precipitate was collected by filtration, washed with H2O 
and dried to give the tetramic acid (108 mg, 85%) which was stored in the freezer; mp 
101-103 °C; νmax/cm-1 1738, 1702, 1594, 1420, 1400, 1379, 1354, 1252, 1190, 1046; δH 
(CDCl3) 7.51-7.12 (5H, m, Ar), 4.62 (2H, s, CH2Ar), 4.42 (2H, q, J 7.0 CH2O), 3.86 
(2H, s, CH2N), 1.42 (3H, t, J 7.0, CH3); δC (CDCl3) 184.0 (COH), 167.5 (C=O), 166.1 
(C=O), 136.7 (Ar), 128.9 (Ar), 128.1 (Ar), 127.8 (Ar), 61.5 (CH2O), 48.5 (NCH2), 45.4 
(NCH2), 14.2 (CH3); m/z (EI) 261 (M+, 53%), 215 (72), 188 (15), 161 (21), 91 (100).  
 
Methyl tert-butyl malonate (5-63).304 According to the procedure 
of Gutman and co-workers,267 mono-tert-butyl malonate (1 g, 6.25 
mmol) and NEt3 (871 μL, 6.25 mmol) were dissolved in THF (30 mL) and the solution 
cooled to 0 °C. After dropwise addition of methyl choroformate the mixture was stirred 
for 30 min then filtered. The filtrate concentrated in vacuo to give the ester (1.02 g, 
93%) as a yellow oil. νmax/cm-1 1727, 1369, 1334, 1138, 838; δH (CDCl3) 3.71 (3H, s, 
CH3), 3.27 (2H, s, CH2), 1.44 (9H, s, CCH3); δC (CDCl3) 167.3 (C=O), 165.6 (C=O), 
82.0 (CCH3), 52.2 (CH3O), 42.5 (CH2), 27.8 (CCH3); m/z (EI) 174 (M+, <1%), 159 (6), 
145 (8), 119 (13), 101 (44), 59 (77), 57 (100). 
 
General method for synthesis of 2-bromoacetamides (5-61a-c): Bromoacetyl 
bromide (7.85 mL, 90.1 mmol) was added dropwise to a solution of the requisite amine 
(180.2 mmol) in CH2Cl2 (120 mL) at –20 °C. After stirring for 20 min, the mixture was 
filtered and concentrated. The product was of sufficient purity to be employed in further 
reactions. 
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N-Benzyl bromoacetamide (5-61a).305 Isolated as an orange oil 
(12.2 g, 60%). νmax/cm-1 3275, 1645, 1551, 1453, 1210, 1006; δH 
(CDCl3) 7.44-7.23 (5H, m, Ar), 6.83 (1H, s, br, NH), 4.48 (2H, d, J 5.8, CH2N), 3.91 
(2H, s, CH2Br); δC (CDCl3) 165.4 (C=O), 137.3 (Ar), 128.8 (Ar), 127.8 (Ar), 127.7 
(Ar), 44.2 (CH2N), 29.1 (CH2Br); m/z (EI) 227 (M+, <1%), 148 (100), 107 (45), 91 (44). 
 
N-(para-methoxybenzyl) bromoacetamide (5-61b). 
Isolated as an orange oil (29.4 g, 95%). νmax/cm-1 3280, 
1645, 1613, 1514, 1244, 1181, 1032; δH (CDCl3) 7.24 (2H, 
d, J 8.6, Ar), 6.90 (2H, d, J 8.6, Ar), 6.71 (1H, s, br, NH), 4.43 (2H, d, J 5.8, CH2N), 
3.93 (2H, s, CH2Br), 3.82 (3H, s, CH3); δC (CDCl3) 165.1 (C=O), 159.2 (Ar), 129.3 
(Ar), 129.2 (Ar), 114.2 (Ar), 55.3 (CH3), 43.7 (CH2N), 29.1 (CH2Br); HRMS: m/z (EI) 
257.0042 (M+, C10H12BrNO2 requires 257.0051), 235 (11%), 192 (13), 178 (7). 
 
N-tert-Butyl 2-bromoacetamide (5-61c).306 Isolated as a white solid, 
recrystallised from EtOAc/hexane (2.25 g, 24%); mp 97-99 °C (lit.306 
98-99 °C); νmax/cm-1 3306, 2973, 1678, 1649, 1548, 1451, 1358, 1207; δH (CDCl3) 6.36 
(1H, s, br, NH), 3.83 (2H, s, CH2), 1.4 (9H, s, CH3); δC (CDCl3) δ 164.9 (C=O), 52.1 
(C-N), 29.6 (CH2), 28.3 (CH3); HRMS: m/z (EI) 193.0103 (M+, C6H12NOBr requires 
193.0102). 
 
General method A for synthesis of 3-(alkoxycarbonyl)succinimides.265 
Sodium hydride (60% dispersion in mineral oil, 704 mg, 17.6 mmol) was washed with 
hexane (3 x 15 mL) and dissolved in DMF (20 mL). To this suspension was added a 
dialkyl malonate (8.81 mmol) dropwise. When effervescence had ceased (5 min) the 
solution was transferred via cannular into a solution of a 2-bromoacetamide (8.81 
mmol) in DMF (25 mL) and stirred for 1.5 h. The solution was then quenched with H2O 
(40 mL) and extracted using CH2Cl2 (2 x 50 mL). The combined organic extracts were 
washed with H2O (2 x 15 mL), dried (MgSO4) and concentrated at 50 °C under high 
vacuum to remove remaining DMF.  
 
General method B for synthesis of 3-(alkoxycarbonyl)succinimides. 
Dialkyl malonate (46.7 mmol) was added dropwise to a solution of KOtBu (5.24 g, 46.6 
mmol) in THF (100 mL). The slurry was then cooled to 0 °C and a solution of N-(para-
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methoxybenzyl) bromoacetamide (10 g, 38.9 mmol) in THF (60 mL) was added 
dropwise. The mixture was allowed to warm to rt, and additional KOtBu (4.18 g, 37.3 
mmol) was added in a single portion. After stirring for 16 h the mixture was poured into 
ice/H2O (100 mL) and extracted using Et2O (3 x 150 mL). The combined organic 
extracts were washed with brine (2 x 60 mL), dried (MgSO4) and concentrated in vacuo. 
The crude product was purified by column chromatography.  
 
N-Benzyl 3-(ethoxycarbonyl)succinimide (5-60a).265 Prepared 
by general method A for synthesis of 3-
(alkoxycarbonyl)succinimides from N-benzyl bromoacetamide 
and diethyl malonate, and purified by column chromatography 
(hexane/ethyl acetate, 2/1) to give the succinimide (441 mg, 19%) as a white crystalline 
solid; mp 71-73 °C; νmax/cm-1 1730, 1694, 1433, 1406, 1327, 1076, 930; δH (CDCl3) 
7.44-7.20 (5H, m, Ar), 4.66 (2H, close AB, CH2Ar), 4.24 (2H, q, J 7.2, CH2O), 3.74 
(1H, dd, J 9.4, 4.8, CH), 3.06 (1H, dd, J 18.2, 4.8 Hz, CH2C=O), 2.87 (1H, dd, J 18.2, 
9.4, CH2C=O), 1.28 (3H, t, J 7.2, CH3); δC (CDCl3) 176.8 (CH2C=O), 174.0 (CHC=O), 
169.4 (OC=O), 137.2 (Ar), 130.6 (Ar), 130.6 (Ar), 130.0 (Ar), 64.5 (CH2CH3), 48.5 
(CH), 44.8 (CH2Ar), 34.2 (CH2C=O), 16.0 (CH3); HRMS: m/z (EI) 261.0997 (M+, 
C14H15NO4 requires 261.1001), 216 (12%), 187 (16), 159 (23), 132 (28), 106 (61), 91 
(47). 
 
N-Benzyl 3-(tert-butoxycarbonyl)succinimide (5-60b). 
Prepared by general method A for synthesis of 3-
(alkoxycarbonyl)succinimides from N-benzyl bromoacetamide 
and methyl tert-butyl malonate, and purified by column chromatography (hexane/ethyl 
acetate, 5/1 to 3/1) to give the succinimide (279 mg, 34%) as a white crystalline solid; 
mp 88-90 °C; νmax/cm-1 2981, 1724, 1692, 1399, 1325, 1147; δH (CDCl3) 7.45-7.20 (5H, 
m, Ar), 4.66 (2H, close AB, CH2Ar), 3.68 (dd, J 9.3, 4.5 Hz, 1H), 3.06 (dd, J 18.3, 4.5 
Hz, 1H), 2.89 (dd, J 18.2, 9.3 Hz, 1H), 1.48 (s, 2H); δC (CDCl3) 175.0 (C=O), 
172.3(C=O), 166.4(C=O), 135.3 (Ar), 128.6 (Ar), 128.65 (Ar), 128.0 (Ar), 83.4 
(C(CH3)3), 47.6 (CH), 42.8 (CH2Ph), 32.3 (CH2), 27.8 (CH3); HRMS: m/z (EI) 
289.1318 (M+, C16H19NO4 requires 289.1314), 265 (2%), 233 (71), 216 (30), 187 (27), 
120 (52), 106 (50), 91 (100). 
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N-(para-Methoxybenzyl) 3-(tert-butoxycarbonyl)succinimide 
(5-60c). Prepared by general method A for synthesis of 3-
(alkoxycarbonyl)succinimides from N-(para-methoxybenzyl) 
bromoacetamide and methyl tert-butyl malonate (537 mg, 29%) and purified by column 
chromatography (hexane/ethyl acetate, 5/1 to 3/1) or by general method B from N-
(para-methoxybenzyl) bromoacetamide and di-tert-butyl malonate (8.40 g, 68%) and 
purified by column chromatography (hexane/ethyl acetate, 3/1 to1/1) to give the 
succinimide as a white crystalline solid; mp 84-85 °C; νmax/cm-1 3003, 2982, 1737, 
1695, 1514, 1404, 1245, 1154, 996; δH (CDCl3) 7.37-7.31 (2H, m, Ar), 6.88-6.83 (2H, 
m, Ar), 4.64 (2H, close AB, CH2Ar), 3.81 (3H, s, CH3O), 3.66 (1H, dd, J 9.4, 4.6, CH), 
3.04 (1H, dd, J 18.2, 4.6, CH2C=O), 2.87 (1H, dd, J 18.2, 9.4, CH2C=O), 1.48 (9H, s, 
C(CH3)3); δC (CDCl3) 175.0 (C=O), 172.4 (C=O), 166.4 (C=O), 159.3 (Ar), 130.2 (Ar), 
127.6 (Ar), 113.9 (Ar), 83.4 (C(CH3)3), 55.2 (CH3O), 47.6 (CH), 42.3 (CH2Ar), 32.3 
(CH2C=O), 27.8 (C(CH3)3); HRMS: m/z (EI) 319.1418 (M+, C17H21NO5 requires 
319.1420), 263 (100), 246 (33), 190 (40), 162 (34), 136 (25), 121 (100). 
 
1-tert-Butyl 3-methyl 2-(2-(tert-butylamino)-2-
oxoethyl)malonate (5-64). Prepared by general method A 
for synthesis of 3-(alkoxycarbonyl)succinimides from N-
tert-butyl 2-bromoacetamide (1.00 g, 5.15 mmol) and methyl tert-butyl malonate (1.79 
g, 10.3 mmol) in 90 min and purified by column chromatography (hexane/ethyl acetate, 
2/1) to give the malonate (1.09 g, 74%) as a yellow oil. νmax/cm-1 2973, 1729, 1651, 
1538, 1367, 1225, 1142, 844; δH (CDCl3, rotameric) 5.47 (1H, s, br, NH), 3.86 (1H, m, 
CH), 3.76 (3H, m, CH3O), 2.66 (2H, m, CH2), 1.47 (9H, m, C(CH3)3), 1.35 (9H, m, 
C(CH3)3); δC (CDCl3) 169.9 (C=O), 168.9 (C=O), 168.0 (C=O), 82.2 (OC(CH3)3), 52.5 
(CH3O), 51.3 (CN), 49.0 (CH), 36.0 (CH2), 28.7 (C(CH3)3), 27.8 (C(CH3)3); HRMS: 
m/z (EI) 287.1729 (M+, C14H25NO5 requires 287.1733) 272 (10%), 231 (32), 216 (31), 
176 (17), 158 (29), 86 (62), 84 (82), 49 (100). 
 
tert-Butyl 1-tert-butyl-2,5-dioxopyrrolidine-3-carboxylate (5-
60d). Sodium hydride (60% mineral oil dispersion, 69.6 mg, 1.74 
mmol) was washed with hexane (3 x 5 mL) and suspended in 
toluene (10 mL). 1-tert-butyl 3-methyl 2-(2-(tert-butylamino)-2-oxoethyl)malonate (500 
mg, 1.74 mmol)  was added and the mixture stirred for 5 min until effervescence ceased, 
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then heated to reflux for 7 h. Upon cooling the mixture was quenched with saturated 
NH4Cl solution (10 mL) and extracted with Et2O (2 x 15 mL). The combined organic 
extracts were washed with H2O (2 x 15 mL), dried (MgSO4) and concentrated. The 
residue was purified by column chromatography (hexane/ethyl acetate, 4/1) to give the 
succinimide (222 mg, 50%) as a colourless oil. νmax/cm-1 2979, 1731, 1700, 1369, 1338, 
1262, 1144; δH (CDCl3) 3.53 (1H, dd, J 9.6, 5.0, CH), 2.89 (1H, dd, J 18.0, 5.0, CH2), 
2.76 (1H, dd, J 18.0, 9.6, CH2), 1.59 (9H, s, CH3), 1.49 (9H, s, CH3); δC (CDCl3) 176.4 
(C=O), 173.7 (C=O), 167.2 (C=O), 83.04 (OC(CH3)3), 58.9 (NC(CH3)3), 47.8 (CH), 
32.8 (CH2), 28.2 (CH3), 27.9 (CH3); HRMS: m/z (EI) 255.1469 (M+, C13H21NO4 
requires 255.1471), 240 (2%), 199 (42), 184 (40), 182 (32), 144 (100), 126 (42). 
 
N-tert-Butoxycarbonyl succinimide (5-70).268 Di-tert-butyl dicarbonate 
(16.8 g, 77.3 mmol) was added in one portion to a mixture of succinimide 
(6.38 g, 64.4 mmol) and DMAP (787 mg, 6.44 mmol) in MeCN (130 mL). 
The solution was stirred for 18 h, then concentrated, filtered through a plug of silica 
(hexane/ethyl acetate, 2/1) and evaporated to give the succinimide (10.87 g, 71%) as a 
white crystalline solid; mp 80-83 °C (lit.268 86 °C); νmax/cm-1 1760, 1705, 1330, 1279, 
1252, 1137, 1002; δH (CDCl3) 2.76 (4H, s, CH2), 1.56 (9H, s, CH3); δC (CDCl3) 172.9 
(C=O), 146.5 (OC=O), 86.1 (C(CH3)3), 28.5 (CH2), 27.6 (CH3); m/z (EI) 199 (M+ <1%), 
184 (4), 144 (5), 126 (56), 100 (52), 57 (100). 
 
N-(Trimethylsilyl) succinimide (5-72).307 Chlorotrimethylsilane (25.6 
mL, 202 mmol) was added to a suspension of succinimide (20 g, 202 
mmol) in triethylamine (200 mL) and stirred for 10 min. the slurry was 
heated to 100 °C for 4 h, cooled, diluted with hexane (100 mL) and 
filtered. The filtrate was concentrated in vacuo, dissolved in hexane (150 mL) and 
refiltered to remove starting material. The filtrate was concentrated to give the 
succinimide (28.11 g, 81%) as an orange oil. νmax/cm-1 1686, 1324, 1247, 1165, 841; δH 
(CDCl3) 2.70 (4H, s, CH2), 0.44 (9H, s, CH3); δC (CDCl3) 182.9 (C=O), 30.5 (CH2), -
0.8 (CH3); m/z (EI) 171 (M+ 4%), 156 (100), 100 (13). 
 
1,3-di(tert-Butoxycarbonyl)succinimide (5-60e).308 A solution 
of NaHMDS (1 M in THF, 23.4 mL, 23.4 mmol) was added 
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dropwise to a solution of N-(trimethylsilyl) succinimide (4 g, 23.4 mmol) in THF (40 
mL) at -78 °C. After 30 min a solution of di-tert-butyl dicarbonate (10.2 g, 46.8 mmol) 
in THF (20 mL) was added dropwise and the pink slurry was allowed to warm to rt, 
forming a black solution. After stirring for 24 h, the mixture was quenched with H2O 
(30 mL) and extracted using Et2O. The combined organic extracts were washed with 
brine (30 mL), dried (MgSO4) and concentrated in vacuo. The crude product was 
purified by column chromatography (hexane/ethyl acetate, 4/1) to give the succinimide 
(965 mg, 14%) as a white crystalline solid; mp 76-79 °C; νmax/cm-1 1765, 1724, 1368, 
1235, 1137; δH (CDCl3) 3.73 (1H, dd, J 9.8, 5.4, CH), 3.15 (1H, dd, J 18.4, 5.4, CH2), 
2.92 (1H, dd, J 18.4, 9.8, CH2), 1.59 (9H, s, C(CH3)3), 1.52 (9H, s, C(CH3)3); δC 
(CDCl3) 171.0 (C=O), 168.3 (C=O), 165.6 (C=O), 145.9 (C=O), 86.5 (C(CH3)3), 83.8 
(C(CH3)3), 47.7 (CH), 32.3 (CH2), 27.8 (CH3), 27.6 (CH3); m/z (EI) 299 (M+, <1%), 228 
(2), 200 (5), 184 (6), 170 (3), 144 (28), 126 (19), 99 (11), 57 (100). 
 
(+)-N-(Methoxycarbonyl)-4-(tert-butoxycarbonyl)-4-hydroxy-3-
pyrrolidinone (5-73a). Colourless oil. νmax/cm-1 1716, 1154; 1H 
NMR showed a mixture of rotamers: δH (CDCl3) 4.46-4.14 (2H, 
m), 3.95-3.79 (2H, m), 3.63-3.57 (1H, m), 1.48 (9H, s, CH3); 
HRMS: m/z (ammonia CI) 277.1404 (MNH4+, C11H21N2O6 requires 277.1400), HPLC 
conditions: Chirapak AD-H column, hexane/IPA, 90/10, 1 mL/min, 240 nm, tR (major) 
= 14.7  min, tR (minor) = 17.7 min; [α]D25 +16.6 (c=0.56, CHCl3, 84% ee). 
 
(+)-N-(Benzyloxycarbonyl)-4-(tert-butoxycarbonyl)-4-
hydroxy-3-pyrrolidinone (5-73b). Purified by column 
chromatography (hexane/ethyl acetate, 2/1). Colourless oil. 
νmax/cm-1 1737 (C=O), 1703 (C=O), 1370, 1216, 1148, 734; 1H 
NMR showed a mixture of rotamers: δH (CDCl3) 7.36-7.32 (5H, m, Ar), 5.20-5.14 (2H, 
m, CH2Ph), 4.39-4.13 (2H, m), 3.91-3.84 (2H, m), 3.62-3.54 (1H, m), 1.39-1.36 (9H, m, 
CH3); HRMS: m/z (ammonia CI) 353.1711 (MNH4+, C17H25N2O6 requires 353.1713), 
339 (46), 297 (37), 255 (100), 227 (55), 197 (31), 164 (23);  HPLC conditions: 
Chirapak AD-H column, hexane/IPA, 90/10, 1 mL/min, 240 nm, tR (major) = 22.5 min, 
tR (minor) = 25.8 min; [α]D25 +7.5 (c=1.02, CHCl3, 90% ee). 
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(+)-1,4-(Di-tert-butoxycarbonyl)-4-hydroxy-3-pyrrolidinone 
(5-73c). Colourless oil. νmax/cm-1 1724 (C=O), 1700 (C=O), 
1369, 1145, 841; 1H NMR showed a mixture of rotamers:  δH 
(CDCl3) 4.39-4.07 (2H, m), 3.88-3.82 (2H, m), 3.63-3.45 (1H, 
m), 1.56-1.45 (18H, m); HRMS: m/z (ammonia CI) 319.1871 (MNH4+, C14H27N2O6 
requires 319.1869), 305 (100%), 288 (13), 263 (17), 249 (48), 221 (41), 164 (44), 137 
(22); HPLC conditions: Chiracel OD-H column, hexane/IPA, 98/02, 1 mL/min, 220 nm, 
tR (minor) = 25.0 min, tR (major) = 32.0 min; [α]D25 +18.7 (c=1.99, CHCl3, 93% ee). 
 
(+)-1-Benzyl-3-(tert-butoxycarbonyl)-3-hydroxy-2-
pyrrolidinone (5-74a). White crystalline solid; mp 89-91 °C; 
νmax/cm-1 3446, 1740 (C=O), 1670 (C=O), 1454, 1260, 1139, 843, 697; δH (CDCl3) 
7.43-7.24 (5H, m, Ar), 4.78 (1H, d, J 14.6, CH2Ph), 4.28 (1H, d, J 14.6, CH2Ph), 3.91 
(1H, s, OH), 3.40-3.25 (2H, m, NCH2), 2.48 (ddd, J 13.3, 7.0, 2.7, 1H, NCH2CH2), 
2.28-2.12 (1H, m, NCH2CH2), 1.44 (9H, s, CH3); δC (CDCl3) 170.9 (C=O), 170.8 
(C=O), 135.6 (Ar), 128.7 (Ar), 128.3 (Ar), 127.8 (Ar), 83.9 (C(CH3)3), 77.9, 47.4, 43.5, 
30.8, 27.8 (CH3); HRMS: m/z (ESI) 314.1376 (MNa+, C16H21NO4Na requires 
314.1368), 265 (38%), 235 (22), 191 (31), 174 (61), 91 (100); HPLC conditions: 
Chirapak AD-H column, hexane/IPA, 90/10, 1 mL/min, 220 nm, tR (major) = 27.0  min, 
tR (minor) = 29.9 min; [α]D25 +53.4 (c=1.63, CHCl3, 77% ee). 
 
(+)-3-(tert-Butoxycarbonyl)-3-hydroxy-2-pyrrolidinone (5-
74b). White crystalline solid; mp 70-72 °C; νmax/cm-1 3475, 
1781 (C=O), 1726 (C=O), 1367, 1295, 1157, 1137, 951; δH 
(CDCl3) 3.85 (1H, ddd, J 10.4, 9.2, 3.2, CH2N), 3.78-3.72 (1H, m, CH2N), 2.49 (1H, 
ddd, J 13.6, 7.6, 3.2, CH2COH), 2.23-2.13 (1H, m, CH2COH), 1.57 (9H, s, CH3), 1.52 
(9H, s, CH3); δC (CDCl3) 170.4 (NC=O), 169.5 (OC=O), 149.8 (N(C=O)O), 84.6, 83.6, 
78.6, 43.1 (NCH2), 29.6 (CH2COH), 27.9 (CH3), 27.8 (CH3). HRMS: m/z (ESI) 
324.1416 (MNa+, C14H23NO6Na requires 324.1423), 309 (8%), 265 (10), 238 (8), 224 
(7); HPLC conditions: Chirapak AD-H column, hexane/IPA=90/10, 1 mL/min, 220 nm, 
tR (minor) = 15.8  min, tR (major) = 22.0 min; [α]D25 +4.8 (c=1.26, CHCl3, 97% ee). 
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(+)-N-Benzyl 3-hydroxy-3-(ethoxycarbonyl)succinimide (5-
76a). White crystalline solid; mp 77-80 °C; νmax/cm-1 1743, 1702, 
1405, 1176, 1128, 967, 697; δH (CDCl3) 7.47-7.19 (5H, m, Ar), 
4.79-4.69 (2H, m, CH2Ar), 4.28-4.20 (2H, m, CH2O), 3.18 (1H, d, J 18.2, CH2C=O), 
2.90 (2H, d, J 18.2, CH2C=O), 1.15 (3H, t, J 7.2, CH3); δC (CDCl3) 173.8 (C=O), 172.9 
(C=O), 169.5 (C=O), 134.8 (Ar), 128.6 (Ar), 128.5 (Ar), 128.1 (Ar), 75.9 (COH), 63.81 
(CH2O), 42.9 (CH2), 40.5 (CH2), 13.7 (CH3); HRMS: m/z (EI) 277.0948 (M+, 
C14H15NO5 requires 277.0950), 261 (3%), 223 (4), 150 (9), 136 (32), 121 (100); HPLC 
conditions: Chirapak AD-H column, hexane/IPA=90/10, 1 mL/min, 254 nm, tR (major) 
= 21.0 min, tR (minor) = 24.6 min; [α]D25 +9.9 (c=1.22, CHCl3, 24% ee). 
 
 
(+)-N-Benzyl 3-hydroxy-3-(tert-butoxycarbonyl)succinimide 
(5-76b). White crystalline solid; mp 138-143 °C; νmax/cm-1 1742, 
1715, 1697, 1402, 1185, 1151, 133, 967; δH (CDCl3) 7.44-7.27 
(5H, m,  Ar), 4.74 (2H, q, J 14.0, CH2Ar), 4.09 (1H, s, OH), 3.12 (1H, d, J 18.0, 
CH2C=O), 2.87 (1H, d, J 18.0, CH2C=O), 1, CH3); δC (CDCl3) 174.0 (C=O), 173.0 
(C=O), 168.5 (C=O), 135.0 (Ar), 128.8 (Ar), 128.6 (Ar), 128.1 (Ar), 85.7 (C(CH3)3), 
75.9 (COH), 42.7 (CH2), 40.6 (CH2), 27.4 (CH3); HRMS: m/z (EI) 305.1256 (M+, 
C16H19NO5 requires 305.1263), 249 (28), 205 (34), 91 (52), 57 (100); Chirapak AD-H 
column, hexane/IPA=90/10, 1 mL/min, 254 nm, tR (major) = 16.0 min, tR (minor) = 17.7 
min; [α]D25 +18.5 (c = 1.29, CHCl3, 83% ee). 
 
(S)-(+)-tert-Butyl 3-hydroxy-1-(4-methoxybenzyl)-succinimide-
3-carboxylate (5-76c). Compound 5-76c (820 mg, 2.45 mmol) 
was recrystallised from hot hexane (16 mL) and EtOAc (19 mL) 
to give the optically pure sample (603 mg, 69% yield, >99% ee) as 
a white crystalline solid; mp 136-138 °C; νmax/cm-1 1739, 1703, 1614, 1588, 1514, 1402, 
1180, 1152, 1129; δH (CDCl3) 7.38-7.33 (2H, m, Ar), 6.88-6.83 (2H, m, Ar), 4.76-4.55 
(2H, m, CH2Ar), 3.80 (3H, m, CH3O), 3.10 (1H, d, J 18.0), 2.85 (1H, d, J 18.0), 1.32 
(9H, s, C(CH3)3); δC (CDCl3) 174.0 (C=O), 173.1 (C=O), 168.5 (C=O), 159.4 (Ar), 
130.3 (Ar), 127.4 (Ar), 114.0 (Ar), 85.6 (C(CH3)3), 75.9 (COH), 55.3 (CH3O), 42.2 
(CH2), 40.6 (CH2), 27.4 (C(CH3)3); HRMS: m/z (EI) 335.1369 (M+, C17H21NO6 requires 
335.1369), 278 (48%), 121 (100), 57 (47); Chiracel OD-H column, hexane/IPA=90/10, 
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1 mL/min, 254 nm, tR (minor) = 12.7 min, tR (major) = 13.8 min; [α]D25 +37.8 (c = 0.95, 
CHCl3, >99% ee). 
 
Crystal data for (S)-5-76c: C17H21NO6, M = 335.35, monoclinic, P21 (no. 4), a = 
6.34741(7), b = 10.76431(9), c = 12.86992(13) Å, β = 102.2709(10)°, V = 859.254(15) 
Å3, Z = 2, Dc = 1.296 g cm–3, μ(Cu-Kα) = 0.824 mm–1, T = 173 K, colourless tablets; 
3386 independent measured reflections (Rint = 0.0297), F2 refinement, R1(obs) = 0.0259, 
wR2(all) = 0.0688, 3221 independent observed absorption-corrected reflections [|Fo| > 
4σ(|Fo|), 2θmax = 145 °], 223 parameters. The absolute structure of (S)-5-76c was 
determined by a combination of R-factor tests [R1+ = 0.0259, R1– = 0.0262] and by use 
of the Flack parameter [x+ = 0.00(12), x– = 1.04(12)]. CCDC765842. 
 
(+)-tert-Butyl 3-hydroxy-1-(tert-butyl)-succinimide-3-
carboxylate (5-76d). White crystalline solid; mp 55-56 °C; νmax/cm-
1 2980, 1744, 1707, 1370, 1348, 1265, 1172, 1148; δH (CDCl3) 3.80 
(1H, s, br, OH), 3.00 (1H, d, J 17.6, CH2), 2.78 (1H, d, J 17.6, CH2), 1.61 (9H, s, 
C(CH3)3), 1.50 (9H, s, C(CH3)3); δC (CDCl3) 175.7 (C=O), 174.4 (C=O), 168.8 (C=O), 
85.3 (OC(CH3)3), 75.6 (COH), 59.2 (NC(CH3)3), 40.8 (CH2), 28.1 (C(CH3)3), 27.7 
(C(CH3)3); HRMS: m/z (ammonia CI) 289.1765 (MNH4+, C13H25N2O5 requires 
289.1763), 233 (23%), 217 (11); Chiracel OD-H column, hexane/IPA = 98/2, 1 
mL/min, 254 nm, tR (minor) = 11.9 min, tR (major) = 13.6 min; [α]D25 +18.1 (c = 1.10, 
CHCl3, 68% ee). 
 
1,3-Di-(tert-butoxycarbonyl)-3-hydroxysuccinimide (5-76e).  
Colourless oil. νmax/cm-1 2981, 1720, 1370, 1141, 909, 729; δH 
(CDCl3) 4.25 (1H, m, br, OH), 3.16 (1H, d, J 18.0, CH2), 2.93 (1H, 
d, J 18.0, CH2), 1.58 (9H, s, CH3), 1.50 (9H, s, CH3); δC (CDCl3) 
170.6 (C=O), 168.9 (C=O), 167.7 (C=O), 145.6 (C=O), 86.8 (C(CH3)3), 86.3 (C(CH3)3), 
76.3 (COH), 40.8 (CH2), 27.6 (C(CH3)3); HRMS: m/z (ammonia CI) 333.1663 (MNH4+, 
C14H25N2O7 requires 333.1662), 317 (28%), 233 (35); Chirapak AD-H column, 
hexane/IPA = 90/10, 1 mL/min, 254 nm, tR (major) = 9.4 min, tR (minor) = 12.1 min; 
[α]D25 +0.0 (c = 1.11, CHCl3, 49% ee).  
 
tBuN
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O O
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O O
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(+)-tert-Butyl 3-trimethylsilyloxy-1-(4-methoxybenzyl)-
succinimide-3-carboxylate (5-81). White crystalline solid; mp 
90-91 °C; νmax/cm-1 1755, 1702, 1515, 1248, 1217, 1179, 840; δH 
(CDCl3) 7.35 (2H, d, J 8.6, Ar), 6.83 (2H, d, J 8.6, Ar), 4.72-4.56 (2H, m, CH2Ar), 3.78 
(3H, s, OCH3), 3.06 (1H, d, J 17.8, CH2), 2.76 (1H, d, J 17.8, CH2), 1.29 (9H, s, 
C(CH3)3), 0.20 (9H, s, Si(CH3)3); δC (CDCl3) 174.0 (C=O), 173.3 (C=O), 168.0 (C=O), 
159.4 (Ar), 130.4 (Ar), 127.4 (Ar), 113.9 (Ar), 83.9 (C(CH3)3), 78.3 (COSi), 55.2 
(CH3O), 44.2 (CH2), 42.1 (CH2), 27.5 (C(CH3)3), 1.6 (Si(CH3)3); HRMS: m/z (EI) 
407.1757 (M+, C20H29NO6Si requires 407.1764), 350 (30), 336 (29), 307 (24), 199 (27), 
121 (100); [α]D25 +6.6 (c=1.21, CHCl3, >99% ee). 
PMBN
O
O
OTMS
O
OtBu
217 
APPENDIX 
Crystal data and structure refinement for 4-76c. 
 
 
 
Identification code CCDC765842 
Empirical formula C17 H21 N O6 
Formula weight 335.35 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å 
Crystal system, space group Monoclinic, P2(1) 
Unit cell dimensions a = 6.34741(7) Å α = 90° 
 b = 10.76431(9) Å β = 102.2709(10)° 
 c = 12.86992(13) Å γ = 90° 
Volume, Z 859.254(15) Å3, 2 
Density (calculated) 1.296 mg/m3 
Absorption coefficient 0.824 mm-1 
F(000) 356 
Crystal colour / morphology Colourless tablets 
Crystal size 0.23 x 0.20 x 0.09 mm3 
θ range for data collection 3.51 to 72.47° 
Index ranges -7<=h<=7, -13<=k<=13, -15<=l<=15 
218 
Reflns collected / unique 22418 / 3386 [R(int) = 0.0297] 
Reflns observed [F>4σ(F)] 3221 
Absorption correction Analytical 
Max. and min. transmission 0.937 and 0.852 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3386 / 2 / 223 
Goodness-of-fit on F2 1.040 
Final R indices [F>4σ(F)] R1 = 0.0259, wR2 = 0.0679 
 R1+ = 0.0259, wR2+ = 0.0679 
 R1- = 0.0262, wR2- = 0.0687 
R indices (all data) R1 = 0.0277, wR2 = 0.0688 
Absolute structure parameter x+ = 0.00(12), x- = 1.04(12) 
Extinction coefficient 0.0053(6) 
Largest diff. peak, hole 0.134, -0.112 eÅ-3 
Mean and maximum shift/error 0.000 and 0.000 
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Bond lengths [Å] and angles [°] for 4-76c. 
 
N(1)-C(2) 1.3728(16) 
N(1)-C(5) 1.3909(17) 
N(1)-C(6) 1.4689(16) 
C(2)-O(2) 1.2098(16) 
C(2)-C(3) 1.5380(17) 
C(3)-O(15) 1.4034(14) 
C(3)-C(4) 1.5220(17) 
C(3)-C(16) 1.5288(17) 
C(4)-C(5) 1.5038(18) 
C(5)-O(5) 1.2077(16) 
C(6)-C(7) 1.5080(19) 
C(7)-C(12) 1.376(2) 
C(7)-C(8) 1.393(2) 
C(8)-C(9) 1.3801(19) 
C(9)-C(10) 1.3898(19) 
C(10)-O(13) 1.3776(16) 
C(10)-C(11) 1.3817(18) 
C(11)-C(12) 1.394(2) 
O(13)-C(14) 1.4317(17) 
C(16)-O(16) 1.2024(16) 
C(16)-O(17) 1.3210(16) 
O(17)-C(18) 1.4932(16) 
C(18)-C(19) 1.510(2) 
C(18)-C(21) 1.515(2) 
C(18)-C(20) 1.520(2) 
 
C(2)-N(1)-C(5) 112.91(10) 
C(2)-N(1)-C(6) 123.33(11) 
C(5)-N(1)-C(6) 123.64(11) 
O(2)-C(2)-N(1) 125.82(12) 
O(2)-C(2)-C(3) 125.48(11) 
N(1)-C(2)-C(3) 108.70(10) 
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O(15)-C(3)-C(4) 110.04(10) 
O(15)-C(3)-C(16) 110.27(9) 
C(4)-C(3)-C(16) 114.84(10) 
O(15)-C(3)-C(2) 109.90(10) 
C(4)-C(3)-C(2) 103.85(10) 
C(16)-C(3)-C(2) 107.67(10) 
C(5)-C(4)-C(3) 105.81(10) 
O(5)-C(5)-N(1) 123.97(12) 
O(5)-C(5)-C(4) 127.54(13) 
N(1)-C(5)-C(4) 108.49(10) 
N(1)-C(6)-C(7) 113.95(10) 
C(12)-C(7)-C(8) 117.83(12) 
C(12)-C(7)-C(6) 120.91(12) 
C(8)-C(7)-C(6) 121.13(12) 
C(9)-C(8)-C(7) 121.39(13) 
C(8)-C(9)-C(10) 119.75(13) 
O(13)-C(10)-C(11) 124.06(12) 
O(13)-C(10)-C(9) 116.02(11) 
C(11)-C(10)-C(9) 119.92(12) 
C(10)-C(11)-C(12) 119.19(12) 
C(7)-C(12)-C(11) 121.91(13) 
C(10)-O(13)-C(14) 117.55(11) 
O(16)-C(16)-O(17) 127.70(12) 
O(16)-C(16)-C(3) 121.87(11) 
O(17)-C(16)-C(3) 110.42(10) 
C(16)-O(17)-C(18) 120.80(10) 
O(17)-C(18)-C(19) 109.70(12) 
O(17)-C(18)-C(21) 102.07(12) 
C(19)-C(18)-C(21) 111.15(14) 
O(17)-C(18)-C(20) 108.99(12) 
C(19)-C(18)-C(20) 112.83(15) 
C(21)-C(18)-C(20) 111.54(16) 
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